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Thesis Summary
Thesis Summary
Parenthood is a life goal desired by the majority of young people. However, 
not all couples who desire a pregnancy will achieve one spontaneously and a 
proportion of couples will need medical help to resolve underlying fertility problems. 
However previous research has highlighted a lack of fertility awareness in the general 
population. The aim of the studies to be presented in this thesis was to better 
understand help seeking behaviour in the context of fertility problems, establish risk 
factors associated with fertility potential, and identify targets for public health 
campaigns to improve fertility health related behaviour.
The results from the current set of studies demonstrated that infertility is a 
prevalent problem in society with around 9% of the adult population affected. Given 
that parenthood is a desired goal by the majority of adults, it was therefore surprising 
to find that on average just over 50% of people with fertility problems seek any 
medical advice or care; with an even smaller number receiving treatments. A key 
factor associated with fertility self-care and the initiation of treatment (when needed) 
was knowledge about fertility and the potential for successful treatment because such 
knowledge helps people take care of their fertility and reduces fear of diagnosis if a 
problem conceiving arises. Although young people (future parents) know that 
negative lifestyle factors can reduce fertility, they falsely believe in fertility myths and 
the power of being healthy.
Finally, the risk factors associated with reduced female fertility potential were 
established. The majority of these risk factors have the ability to be modified and even 
prevented and thus offer the opportunity to develop a tool for women to assess their 
own fertility potential, and take more responsibility and control over their fertility 
health. Overall, the work presented in this thesis demonstrates that raising public 
awareness about fertility health issues is key in helping women understand that their 
current actions can impact on their future life goals and to help those experiencing 
fertility problems to act in a timely manner to seek the medical advice and help they 
may require.
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Chapter 1 General Introduction
Chapter 1 
General Introduction and Thesis Overview
Taking Responsibility for Ones Own Fertility
In 2006 the British Government and Department of Health published a White 
paper detailing their future strategies and goals for building a world-class national 
health service (NHS) and social care system (Department of Health, 2006). Critically, 
the paper focused on how the individual, that is, the potential patient, can be involved 
in the choices surrounding his or her health. A wider ambition of this approach is to 
engage people into making healthier choices about all parts of their lives, from their 
day-to-day lifestyle habits to the decisions they make when faced with illnesses. To 
better enforce, encourage and maintain these changes the paper further proposed the 
introduction of a series of ‘LifeCheck’ tools for people to assess their lifestyle risks 
and to take the right steps to make healthier choices.
The NHS Choices is a website containing online assessment tools for people 
to complete providing them with their personalised risk of certain illnesses (e.g., 
diabetes) and more generally issues regarding their current health and lifestyles habits 
(e.g., diet, exercise). As well as providing people with a personalised assessment, the 
tools offer advice and support about how risks can be reduced (e.g., reduction in 
smoking) and how these changes can be maintained (e.g., local support groups, free 
prescriptions for nicotine replacement treatment).
Thus, the future of the health care system in the United Kingdom appears to 
centre on personalising and empowering people to take charge of their own health and 
well-being. Through this more personalised approach the ultimate aim of these 
strategies is to provide better prevention (e.g., reduction in smoking reduces risk of
1
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smoking related illness) and earlier intervention services (e.g., getting people to 
realise when, and how to, seek help; Department of Health, 2006). Such a strategy is 
supported by the World Health Organisation (WHO, 2002), who proposed that the 
most effective way of preventing diseases from occurring in the first place is the 
systematic assessment of the factors that cause the disease (i.e., what are the risk 
factors for disease A) and the implementation of effective strategies for the reduction 
of these causes.
All the NHS Choices tools aim to assess important and current health issues, 
such as, diabetes, obesity, cancer. The Choices website does cover a few issues with 
regard to fertility. Namely, issues surrounding trying to get pregnant (e.g., timing of 
sexual intercourse to maximise conception), when conception does not occur (e.g., 
what tests will the doctor do) and issues surrounding pregnancy (e.g., confirming a 
pregnancy, preparing for labour). As yet however, the information provided is very 
general and not personalised like the tools associated with risk of diabetes or cancer.
In accordance with current Government policies for the future of health care, 
that is, empowering people to take charge of their own health this thesis will explore 
these issues with regard to fertility health, namely the choices and motivations 
surrounding individuals when fertility difficulties occur. Further, it will establish the 
factors associated with a detrimental impact on fertility that could potentially be 
addressed in effective interventions (e.g., personalised risk assessment of fertility 
difficulties) targeting men and women who wish to become parents now (or in the 
future), with the aim of preventing (i.e., reduce risk) and intervening (i.e., guidance of 
when to seek help) to help couples achieve their parenting goals. Current research 
suggests that fertility issues are indeed an important health area worthy of further
2
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investigation and the following sections present an overview of the issues examined in 
the present thesis.
Need and Demand for Fertility Medical Services (Chapter 2)
Parenthood is a desired goal by the majority. A number of studies have 
revealed that around 95% of young women and men surveyed stated that they 
intended to have children in the future (Kemkes-Grottenthaler, 2003; Lampic, 
Svanberg, Karlstrom, & Tyden, 2006; Skoog Svanberg, Lampic, Karlstom, & Tyden, 
2006). Most societies around the world are pro-natalist, whereby the experience of 
parenthood is central to individual and group identity and the life plan of most people 
within the community (Whiteford & Gonzalez, 1995). This is further supported by the 
low prevalence of men and women who remain voluntarily childless when assessed at 
their end of their reproductive lives, less than 5% (Chancey, 2006). Indeed 
childlessness can be a discrediting attribute for both those childless by choice and by 
chance (Lampman & Downing-Guyer, 1995). Therefore any factor that may impact 
on achieving the goal of parenting applies to the vast majority of people.
Not everyone who tries to get pregnant will be successful in their natural 
attempts and in order to better help people achieve parenting goals one needs to know 
both prevalence of fertility problems and demand for fertility medical services. It is 
estimated that the average conception rate per month is about 30% (Zinaman, Clegg, 
Brown, O’Connor, & Selevan, 1996; Gnoth, Godehardt, Godehardt, Frank-Herrmann, 
& Freundl, 2003), with a cumulative conception rate of around 75% after six months 
and 90% after one year (A. Taylor, 2003). Consequently, around 10% of couples that 
have regular unprotected sexual intercourse for 12 months will not achieve a 
pregnancy and these couples are considered infertile (National Institute for Health and
3
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Clinical Excellence, NICE, 2004). The prevalence of infertility has been estimated in 
many national surveys (e.g., in Denmark: Schmidt, Munster, & Helm, 1995; United 
Kingdom: Buckett & Bentick, 1997; China: Che & Cleland, 2002) but worldwide 
comparisons have not yet been carried out and the full extent of this problem is not 
fully known. Therefore the first aim of Chapter 2 was to assess the number of couples 
affected by infertility in more and less developed nations by conducting a 
comprehensive literature review of population based surveys. Establishing such 
information will gauge the extent of the problem.
Treatment provides infertile couples with the chance of achieving their 
parenthood goal, yet demand for fertility treatment has not adequately been assessed. 
Assisted reproductive technology (ART) began to develop during the 1970’s 
(Hammond & Stillman, 1999) culminating in the birth of Louise Brown in 1978 
conceived with in vitro fertilization (IVF, Steptoe & Edwards, 1978). IVF involves 
the fertilisation of an egg outside of the woman’s body, i.e., ‘fertilisation in glass’ 
(HFEA, 2007/2008) by means of a series of pharmacologic (i.e., hormonal) and 
physical interventions. Treatments such as IVF have been shown to have good success 
rates, with the majority of couples (69.4%) who initiate treatment achieving their goal 
of parenthood with about 3.7 treatments within five years (Pinborg, Schmidt & Nyboe 
Andersen, 2007). Further, in the United Kingdom alone, the Human Fertilisation and 
Embryology Authority (HFEA) estimate that one baby in every 80 is bom as a result 
of IVF treatment (The HFEA guide to infertility, 2007/2008). This data clearly 
demonstrates that treatment can enable people to realise a major life goal when natural 
attempts to conceive have failed. There are a number of studies that have reported the 
demand for fertility medical services, but as yet there has been no comprehensive 
review of these studies, assessing whether people faced with a fertility difficulty seek
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and receive medical help, therefore a second aim of Chapter 2 was to assess the 
demand for fertility medical services using available worldwide data.
Factors Influencing the Decision to Seek Medical Advice for Fertility Problems 
(Chapter 3)
When faced with any illness or health related issue people are faced with a 
number of choices surrounding how to effectively (or ineffectively) deal with the 
situation. For example, the detection of a new lump in the breast or testicle may be 
dealt with in a number of ways. The person may ignore the lump, they may monitor 
the lump to see if it goes away or increases in size, or the person may immediately 
seek medical advice as to what the lump is. Any one of these decisions will have 
required people to think about the lump and make a decision about what to do (or 
what not to do). Depending on the diagnosis of the lump, these decisions can have 
major implications on the outcome. If the lump is cancerous, the person who ignored 
the lump or delayed seeking treatment will have risked due to inaction greater disease 
progression than those seeking more timely advice. Indeed, a delay of three months or 
more between the time when a lump in the breast is detected and the initial medical 
consultation has been found to decrease the potential for breast cancer survival 
(Facione, 1993; Richards, Westcombe, Love, Littlejohns, & Ramirez, 1999).
An extensive amount of literature has focused on the decision making 
processes when people are faced with the detection of a new lump and has identified 
factors that can facilitate or hinder seeking timely medical advice (Facione, 1993; 
Oliveria, Christos, Halpem, Fine, Barnhill & Berwick, 1999; Carney, Fitzsimons, & 
Dempster, 2002; Grunfeld, Ramirez, Hunter, & Richards, 2002; Bish, Ramirez,
Burgess & Hunter, 2005; Smith, Pope, & Botha, 2005; Facione & Facione, 2006). 
These factors may also be important to couples faced with an inability to conceive.
5
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The aim of Chapter 3 was to establish the critical factors associated with the 
initiation of fertility treatment when a fertility problem occurs. In Chapter 3 the 
empirical and theoretical literature on decision making about fertility difficulties was 
reviewed and a cross-sectional study was conducted to assess the decision making 
strategies of women who were currently trying to conceive, some of which had 
already sought medical advice or treatment about a potential fertility problem. A 
better understanding of these factors may help to facilitate effective advice and 
guidance to enable people to receive the medical help they may require and reduce 
unnecessary delay, to further aid them in their goals of becoming a parent.
Knowledge o f Fertility Risk Factors in Young People (Chapter 4)
Current research suggests people are not behaving optimally when it comes to 
factors that impact on fertility potential. For example, there has been a steady increase 
in the age at first pregnancy in Western societies. In the UK, the proportion of babies 
with mothers aged 35 years or more increased markedly from 6.5% in 1976 to 22.5% 
in 2000 (Bakeo, 2004) and in the US this rate has more than doubled since 1978 
(Hamilton, Martin, & Sutton, 2004). This is alarming considering female fertility 
rapidly declines after the age of 35 (Menken, Trussell, & Larsen, 1986; Dunson, 
Colombo, & Baird, 2004), with women aged 35-39 years having half the chance of 
conceiving compared to women aged 19 -26  years (A. Taylor, 2003). Further, a 
number of negative lifestyle factors are on the rise in more and less developed 
countries (e.g., obesity, sexually transmitted diseases/infections [STD/STI]), all of 
which have been negatively associated with female fertility potential. These figures 
are made all the more alarming when one considers that many of these factors are 
preventable and modifiable.
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It may well be that people are unaware of the factors detrimental to their 
fertility since fertility is not yet part of the mainstream public health issues. A number 
of studies have highlighted a lack of general understanding of fertility health issues. 
For example, participants have been found to have a poor understanding of the 
biology of reproduction (e.g., when ovulation occurs, Lampic et al., 2006; World 
Fertility Awareness Month, 2006), a general lack of understanding about infertility, 
such as a definition and its prevalence within the general population (Blake, Smith, 
Bargiacchi, France, & Gudex, 1997; Adashi et al., 2000), and a lack of awareness 
about risk factors associated with a detrimental impact on fertility potential (e.g., older 
age, Lansac, 1995; Lampic et al., 2006; Skoog Svanberg et al., 2006). The aim of 
Chapter 4 was to assess knowledge of factors associated with female fertility in young 
women and men. To assess knowledge about fertility health issues participants were 
asked to rate the impact that known risk factors (e.g., smoking, alcohol consumption), 
known myths (e.g., adopting a child) and healthy habits (e.g., being of normal weight) 
would have on the chances of 100 women getting pregnant.
Foundational Research for a Personalised Fertility Status Tool (Chapter 5)
Past research has shown that even if people are aware of risk factors, they may 
not apply them to their own situation and therefore may not feel at risk, even when 
they are. For example, research suggests that most people are aware of the detrimental 
effect of smoking (Hay, Shuk, Cruz, & Ostroff, 2005), yet nearly 30% of British 
women still smoke (Goddard, 2006). Indeed what underpins the NHS Choices is the 
fact that it provides people with a personalised score, enabling them to assess their 
own risk with regard to specific illnesses. Research suggests that personalising risk 
may be a more effective way of enabling behaviour change (Fischhoff, Bostrom, & 
Quadrel, 1993; Elton, Ryman, Hammer, & Page, 1994; NHS centre for reviews and
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dissemination, 1998; Strychar, Champagne, Ghadirian, Bonin, Jenicek, & Lasater, 
1998; McClure, 2002). Therefore what may be important in helping people 
understand and realise the factors associated with reduced fertility potential is to 
develop a tool that assesses an individual’s risk of fertility impairment. Consequently, 
the aim of Chapter 5 was to generate foundational research to develop a fertility 
assessment tool. The implications surrounding raising awareness about health issues 
and the development of a personalised risk assessment tool were explored. Study 5.1 
reviewed the current literature on factors associated with female infertility and Study 
5.2 examined whether these factors could differentiate between pregnant and non­
pregnant women.
General Discussion and Conclusions (Chapter 6)
The chapter will focus on the overall aims of the thesis, presenting the main 
findings for the studies conducted. Further, the clinical implications of such findings 
and future research goals will be discussed.
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Chapter 2 
Prevalence of infertility and demand for infertility medical care
Introduction
Most adults have life plans that include children. In a large survey (n = 2057) 
carried out in Sweden, 95 % of childless women and men aged 23-25 years stated that 
they wanted to have children in the future (Lampic et al., 2006), with most 
considering it to be a major life goal to fulfil (Tyden, Svanberg, Karlstrom, Lihoff, & 
Lampic, 2006; Virtala, Kunttu, Huttunen, & Viijo, 2006). However, not all couples 
that desire a pregnancy will achieve one spontaneously and for a proportion of 
couples medical help will be needed to resolve underlying fertility problems. Despite 
a strong desire for children in the population there is evidence to show that couples do 
not necessarily seek medical help when experiencing fertility difficulties for various 
reasons (e.g., psychological, socio-demographic: Schmidt et al., 1995; Wulff,
Hogberg, & Stenlund, 1997; Langdridge, Connolly, & Sheeran, 2000; Stephen & 
Chandra, 1998, 2000; Wyshak, 2001) but as the data on the prevalence of infertility 
and the use of fertility medical services is as yet not reviewed it is difficult to 
ascertain to what extent low treatment seeking behaviour is a problem that warrants 
further psychological investigation.
Infertility has been recognised as a public health issue worldwide by the 
World Health Organisation (WHO) and in his opening lecture of a WHO international 
meeting Dr Mahmoud Fathalla focused on accessibility as a key millennium challenge 
for those involved in the delivery of infertility treatment and assisted reproduction 
(see Vayena, Rowe, & Griffin, 2001). In order to set up adequate fertility services 
(both medical and psychological) to meet this challenge one must know both the 
potential need and demand for medical services. In this chapter the existing literature
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will be reviewed to assess the potential need for infertility medical care as indicated 
by the prevalence of infertility in world populations and ascertain the actual 
proportion of couples that seek and/or receive medical care for fertility difficulties.
Definition of Fertility and Infertility
There are two ways of looking at reproduction, one that focuses on the 
capacity to have children (e.g., fertility, fecundity) and one on the incapacity (e.g., 
infertility, subfertility, childlessness). The current chapter will focus on the latter. 
Infertility is broadly defined as a delay in conception for a given period of time and 
has been a major medical and social preoccupation (Morice, Josset, Chapron, & 
Dubuisson, 1995). Research often categorises infertility into primary and secondary. 
Primary infertility refers to the non-achievement of any conception whether it results 
in a live birth or not, whereas secondary infertility is the non-achievement of a 
subsequent pregnancy or live birth (Schmidt & Munster, 1995). Subfecundity 
describes any form of reduced fertility (Gnoth, Godehardt, Frank-Herrmann, Friol, 
Tigges & Freundl, 2005), for example, a reduced probability of conception, or 
difficulties carrying a pregnancy to term (Nguyen & Wilcox, 2005). Finally, 
childlessness refers to whether a woman has ever had a child in a given period of 
marriage (Larsen, 2005).
Definition of Prevalence
According to the World Health Organisation (WHO, Global InfoBase from 
http://www.who.int/infobase, retrieved February 28, 2008) the prevalence of a 
disease/risk factor is defined as the ratio of the number of cases of a disease/risk factor 
present and the number of individuals in the population at a designated time. With 
regards to infertility prevalence it is often distinguished by current or lifetime
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occurrence. Current prevalence is measured as the individual experiencing the 
disorder at the present time while lifetime prevalence is the probability that an 
individual will have had the disease/risk factor at some point in their life (up to the 
time of assessment) (Last, 1995).
Issues Surrounding the Use of Different Definitions
In order to determine the need for infertility treatment it is essential to know 
the prevalence of infertility within the population (Larsen, 2005). However there are a 
number of methodological issues that need to be taken into consideration when 
reviewing population studies that may impact on the prevalence ratings reported.
Defining infertility.
Within the reproductive health literature infertility is frequently defined in a 
number of varying ways. Infertility can cover disorders ranging from sterility to 
(nearly) normal fertility and is often used synonymously with other terms such as 
subfertility, which may lead to misinterpretation, errors in communication and 
confusion (Habbema, Collins, Leriodn, Evers, Lunenfeld, & te Velde, 2004). For 
example, Marchbanks, Peterson, Rubin, and Wingo (1989) found that the definition of 
infertility can influence research findings associated with the age at infertility 
classification, which women are classified as infertile, the number of women 
classified as infertile, and the probability of future conception. In an attempt to 
overcome these issues the generally agreed definition refers to infertility as an 
inability to conceive (American Society for Reproductive Medicine: ASRM, 2006; 
National Institute for Clinical Excellence: NICE, 2004). The WHO further clarifies 
infertility as the inability to achieve a spontaneous pregnancy (Rowe, Comhaire, 
Hargreave, & Mellows, 1993).
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Exposure time.
Exposure refers to the time period during which the woman has been exposed 
to unprotected regular sexual intercourse, that is, the time interval when conception 
was theoretically possible. Historically the exposure times most frequently used in 
research establishing the prevalence of infertility have been 12 and 24 months 
(Habbema et al., 2004). Overall there is an 84% conception rate following 12 months 
unprotected intercourse (te Velde, Eijkemans, & Habbema, 2000), and 95% after 24 
months of exposure (Joffe, Villard, Plowman, & Vessey, 1995). The discrepancy in 
intervals occurs because in clinical practice a 12 month interval is used due to the 
desirability of initiating fertility treatment as soon as infertility is suspected to avoid 
decrements in fertility due to disease progression or increasing age (Larsen, 2005). 
However, in theory many have argued to use a threshold of 12 months may be too 
soon to intervene medically if the success rates of achieving a pregnancy and the 
probability of future success is still considerably high, as shown by further increases 
in fertility for those exposed for 24 months (te Velde et al., 2000; Habbema et al., 
2004; Larsen, 2005).
Thus in epidemiological research it is important to reduce the number of false 
positives by allowing more time for fertile people to conceive (using the definition of 
a failure to conceive after 24 months of unprotected intercourse) (Habbema et al.,
2004; Larsen, 2005). Using different exposure times does impact on the prevalence 
reported; with the 24 months exposure showing lower prevalence rates (due to the 
larger denominator; Schmidt & Munster, 1995). While there is no clear distinction 
between which exposure time (12 or 24 months) is more appropriate for the definition 
of infertility, according to the current guidelines in the United Kingdom (NICE, 2004)
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and the United States (ASRM, 2006) infertility is defined as inability to conceive after 
1 year of regular unprotected intercourse.
In addition to the discrepancy in the use of different exposure intervals, studies 
also use different time frames when reporting prevalence. For example one may look 
at the prevalence of current infertility/subfecundity (“Are you now experiencing a 
delay in conception/difficulty carrying a child?”, Larsen, 2005), while others may 
report cumulative or lifetime infertility/subfecundity (“Have you ever experienced a 
delay in conception/carrying a child?”, Larsen, 2005). Finally, some may report a 
period of childlessness after marriage (“After being married for [specified number] 
years do you have a child?”, Larsen, 2005). The use of different points in time will 
impact on the prevalence rate reported, with lifetime childlessness reporting higher 
rates when compared to current (Schmidt & Munster, 1995), and must be taken into 
account when interpreting the rates drawn from the present review of the literature.
Demand for Fertility Services
Couples can follow several pathways once they suspect they have a fertility 
problem. They could do nothing; they could seek medical advice (e.g., general 
practitioner, gynaecologist) and, depending on the outcome of this consultation, they 
could go on to seek fertility treatment. They could also seek non-medical pathways 
for example adoption. It is also possible that couples will seek medical advice and 
decide against undergoing fertility treatment. For example, dropout in the early phase 
of diagnosis, before the start of fertility treatment can be as high as 40% (Gleicher, 
Vanderlaan, Karande, Morris, Nadhemey, & Prat, 1996; Malcolm & Cummings,
2004). In addition, couples may be unable to access the fertility services they require. 
For example, in sub-Saharan Africa formal public health care provides very limited
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treatment options and private health care is often too expensive for couples 
experiencing problems conceiving (Sundby, Mboge, & Sonko, 1998; Barden- 
O’Fallon, 2005; Dyer, 2008).
Fertility treatment encompasses a broad range of services that could range 
from medical advice about sexual relations to state-of-the-art assisted reproductive 
technologies and establishing the need for fertility medical services depends to some 
extent on the definition used for ‘infertility medical services’. There are practice 
guidelines for couples contacting medical General Practitioners (GPs) about suspected 
fertility treatment and these provide a more or less standard approach. For example, 
the NICE (2004) clinical guidance indicates that couples should first undergo a 
thorough medical history (including lifestyle habits and general health), followed by a 
series of diagnostic tests and then specific treatments to address the cause of the 
infertility. Thus surgery might be used to remove adhesions caused by endometriosis, 
injection of sperm directly into oocytes (i.e., intracytoplasmic sperm injection) to by­
pass infertility due to poor sperm motility or ovarian stimulation to restore ovulation 
for anovulatory disorders. Each treatment could be repeated more than once so that 
couples can, in theory, be in fertility treatment for many years (NICE, 2004). It is also 
the case that more conventional treatments will be used before more high 
technological (and costly) treatments so that there is a progression of treatments. For 
example, insemination will be used before in vitro fertilization and ovulation 
induction will be used before ovarian stimulation (e.g., NICE, 2004; ESHRE, 2008). 
How long couples spend in treatment is not known, and the success of being in 
treatment varies depending on diagnosis, age and other prognostic factors.
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Infertility Across More and Less Developed Nations
Infertility is an issue for men and women across all countries regardless of 
their developmental status (i.e., more or less developed countries). Previous research 
has however highlighted differences between more and less developed nations 
regarding the prevalence of infertility and the demand for fertility medical services. 
For example, as already mentioned, in less developed countries such as sub-Saharan 
Africa access to formal medical care for fertility difficulties is sparse and can often 
include irrelevant and even potentially damaging methods (Sundby et al., 1998). This 
is in stark contrast to more developed countries where a variety of the most up-to- 
date, high-tech treatments are available, with some countries such as Demark 
providing them for free. Such differences may impact on the reported up-take for 
medical treatments. One may also expect to find differences in the prevalence of 
infertility between more and less developed nations. Previous research has reported 
that the prevalence rate of infertility in more developed countries such as America 
ranges from 8-15% (Mosher & Bachrach, 1996), however in less developed countries 
such as sub-Saharan African the prevalence rates are estimated to be as high as 30% 
or more (Frank, 1983; Meheus, Reniers, & Colletet, 1986).
The Present Study
The aim of the present study was to determine the prevalence of infertility and 
demand for medical services by conducting a thorough literature review taking into 
account the methodological issues regarding the different uses and definitions of 
infertility. Given the diversity in definitions for infertility, exposure intervals, time 
frames, and specific details for each study were documented in order to determine the 
comparability of prevalence rates. Further, and where available, the percentage of 
couples that had sought medical advice and/or treatment for fertility problems was
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also recorded. Finally, all countries were categorised according to developmental 
status (e.g., more or less developed) in order to establish any differences in prevalence 
rates and the demand for fertility services due to economic differences.
Materials and Methods
Materials
Prevalence o f infertility.
In order to establish the prevalence of infertility, population surveys were 
examined. Citations eligible for the present study were those based on population 
surveys published since 1990. That is, estimates that defined infertility prevalence 
within a hospital or medical practice were excluded. According to Gunnell and 
Ewings (1994) many of those with infertility do not seek help, and of those who do, 
many are not referred for specialist advice. Therefore studies reporting prevalence 
ratings based on clinical and medical samples may be underestimating the true 
number of couples faced with fertility difficulties. PubMed was used for peer 
reviewed scientific reports. A specific PubMed search used the terms infertility 
[MeSH] (Medical Subject Headings) and epidemiological studies. The 85 citations 
since 1990 were scanned for relevance, full reports were obtained as necessary and 
other citations were identified in the reference lists of the relevant citations (see 
Appendix A for PubMed search history). The 28 studies selected for review involved 
populations from different countries and defined different reproductive states: 
infertility, subfecundity and childlessness. Distinctions were made between current 
and lifetime prevalence of infertility.
Demand for infertility medical care.
In order to assess demand for infertility, medical services literature searches 
were directed at identifying publications concerned with the take-up of any infertility
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medical services. Demand for infertility medical care was defined as the proportion of 
couples that decide to seek any medical advice or care to resolve their fertility 
problem. A specific PubMed search used the terms Infertility [MeSH] AND *Patient 
Acceptance of Health Care [MeSH] producing 141 records and 15 reviews since 1990 
(see Appendix A for PubMed search history). A further search used Infertility 
[Title/abstract] AND treatment-seeking (9 citations since 1990). All were scanned for 
relevance, full reports were obtained as necessary and other citations were identified 
in the reference lists of the relevant citations. In total 17 studies provided information 
on demand for medical care.
Procedure
Development status.
All empirical reports (prevalence, seeking medical care) were categorised 
according to development status using the United Nations listing of development 
status by country or region (http://unstats.un.org/unsd/methods/m49/m49regin.htm, 
last accessed April 10 2006). These guidelines take into consideration three criteria in 
order to assess the development status of each country: low-income status, economic 
vulnerability and human resources weakness (Sallam, 2008). Data extraction was 
conducted by two people (Author & John A. Collins).
Prevalence o f infertility.
A percent infertile was calculated for each study based on the proportion of 
women reported as infertile (or childless) compared to total number of women 
reported in the study population. For one report of 28 countries in sub-Saharan Africa 
(Larsen, 2000), a single averaged percent infertile score was calculated from available 
data in the report.
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Demand for infertility medical care.
An overall percentage that included seeking any type of medical care (e.g., 
general advice, diagnostic testing, treatment advice, actual treatment) was calculated 
for each study reporting treatment seeking behaviour ([total seeking medical care/total 
infertile] *100) and, where available, breakdowns according to the percentage seeking 
treatment advice versus percentage receiving treatment.
Deriving international estimates of infertility prevalence and treatment seeking.
In order to obtain the necessary population values for the international 
estimates, data from several sources were consulted:
i. The world population current (i.e., 6.508 billion) at the time of the review 
was obtained from the web site of the United States Census Bureau: 
http://www.census.gov/ipc/www/world.html (last accessed April 06 2006).
ii. The proportion of women age 15-49 who were in a married or consensual 
union was estimated from the World Contraceptive Use Report available on the web 
site of the Population Division, Department of Economic and Social Affairs, United 
Nations, New York, NY 10017, USA in the report:
http://www.un.org/esa/population/publications/contraceptive2003/wcu2003.htm (last 
accessed April 06 2006). The most recent estimates on this website were for 2000 and 
these were updated to 2006 by applying the 1.706% average population increase in 
less developed and 0.277% in more developed countries from 1993 to 2003 reported 
in the most recent World Health Report http://www.who.int/whr/2005/en/index.html 
(last accessed April 06 2006).
iii. Since estimates of infertility prevalence usually have as their denominator 
women aged 20-44, the population of women aged 20-44 years in married and
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consensual unions was derived from the population aged 15-49 using the age structure 
of global populations reported by the U.S. Census Bureau:
h t tp : / / c e n s u s .g O v / ip c /p r o d /w p 0 2 /w p - 0 2 0 0 4 .p d f  ( p a g e  3 3 ,  l a s t  a c c e s s e d  A p r i l  0 6  2 0 0 6 ) .
iv. The calculation of international estimates of prevalence began with the 
number of women aged 20-44 married or living in a consensual union in more 
developed and less developed countries. Each of the population estimates from more 
and less developed countries was multiplied by the corresponding proportion of 
women with infertility to get estimates of infertile women in more and less developed 
countries.
v. The estimated number of infertile women in more and less developed 
countries was then multiplied by the proportion of women seeking infertility medical 
care to get estimates of the number of infertile women seeking medical care in more 
and less developed countries.
Results
Prevalence o f Infertility
Table 2.1 shows data from population surveys reporting on prevalence of 
current and lifetime infertility.
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Table 2.1
Prevalence o f infertility according to developmental status (see page 28 for notes).
Authors (Year of 
survey)
Country or 
region
Women
sampled
Age of 
sample
Exposure
time
Sample
Size
Percent
infertile
Sample characteristics Sample 
used for 
prevalence 
estimate
Definition(s) used
More Developed countries 
Current Infertility ■ 
Philippov et al. 1998 Russia 
(1998)
Married 18-45 12 2,000 16.7 General population, selected 
at random from polling 
station lists of the electorate. 
Every 7th women was 
included in the selection, 
questionnaire
No
information
available
Infertility: not conceived 
after 12 months or more of 
unprotected intercourse
Royal Commission 
1993(1991)
Canada Married 
>1 yr
18-44 12 1,412 8.5 Randomly selected from 
general population, 
questionnaire
No
information
available
Infertility: cohabiting for 2 
years without contraception
Royal Commission 
1993(1991)
Canada married 
>1 yr
18-44 24 1,412 7.0 Randomly selected from 
general population, 
questionnaire
No
information
available
Infertility: cohabiting for 2 
years without contraception
Stephen & Chandra 
2006 (2002/
United
States
Married 15-44 12 15,303 7.4 Nationally represented 
survey, interview
No
information
available
Infertility: problems 
conceiving for more than 12 
months
Subfecundity : difficulties in 
carrying a pregnancy to 
term. The former was made 
up from a number of 
answers to questions about 
contraceptive use and coital 
frequency
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Prevalence o f infertility according to developmental status (continued, see page 28 for notes).
Authors (Year of 
survey)
Country or 
region
Women
sampled
Age of 
sample
Exposure
time
Sample
Size
Percent
infertile
Sample characteristics Sample 
used for 
prevalence 
estimate
Definition(s) used
More Developed countries (continued) 
Current Infertility (continued) 
van Balen et al. Netherlands 
1997b (1992)
All 25-49 12 3,295 10.7 National survey of 
households, randomly 
selected from all population, 
interview
Trying to 
conceive
Infertility: 12 months of 
unprotected regular 
intercourse without getting 
pregnant with a first child
Webb & Holman 
1992(1988)
Australia Married 16-44 12 1,495 3.5 Sample selected from 
women residing in the Perth 
metropolitan area, sample 
drawn using a cluster, 
multistage method, 
interview
Trying to 
conceive
Infertility: > 12 months of 
unprotected intercourse
Lifetime Infertility 
Buckett & Bentick 
1997 (1995)
United
Kingdom
All 45-54 12 728 17.3 Randomly selected from 
Shropshire FHSA primary 
care register, questionnaire
Trying to 
conceive
Infertility: >12 months 
trying to conceive
Dick et al. 2003 
(1991-3)
Australia All 15-50 12 1,638 18.4 Population based case 
control study, interview
Trying to 
conceive
Infertility: some stage 
during reproductive lives, 
were unable to conceive 
despite attempts for >12 
consecutive months
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Prevalence o f infertility according to developmental status (continued, see page 28 for notes).
Authors (Year of 
survey)
Country or 
region
Women
sampled
Age of 
sample
Exposure
time
Sample
Size
Percent
infertile
Sample characteristics Sample 
used for 
prevalence 
estimate
Definition(s) used
More Developed countries (continued) 
Lifetime Infertility (continued)
Ducot et al. 1991 France 
(1988)
All 18-49 12 3,181 12.2 Representative national 
sample
Trying to 
conceive
Infertility: had to wait at one 
time longer than would have 
wished to become pregnant 
(>12 months)
Greil & McQuillan 
2004(2002)
United
States
All 25-50 12 580 21.2 Randomly selected, 
interviews through 
computerised phone calls.
Trying to 
conceive
Infertility: ever tried 
unsuccessfully to get 
pregnant for >12 months 
Infertility: ever tried for 12 
months or more to conceive 
any of their pregnancies
Gunnell & Ewings 
1994(1993)
United
Kingdom
All 36-50 12 2,377 26.4 Randomly selected from the 
Somerset Family Health 
Services Authority 
population register, 
questionnaire
Includes 
voluntary & 
involuntary 
infertility
Infertility: Failure to 
become pregnant after 12 
months of regular 
unprotected intercourse
Olsen, Basso et al. 
1998(1991-3)“
Europe All 25-44 12 6,630 11.3 Population based survey 
from five European 
countries. Survey conducted 
through personal interviews 
and structured 
questionnaires translated 
into each national language
Trying to 
conceive
Infertility: >12 months 
trying to conceive
Table 2.1
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Prevalence o f infertility according to developmental status (continued, see page 28 for notes).
Authors (Year of 
survey)
Country or 
region
Women
sampled
Age of 
sample
Exposure
time
Sample
Size
Percent
infertile
Sample characteristics Sample 
used for 
prevalence 
estimate
Definition(s) used
More Developed countries (continued) 
Lifetime Infertility (continued)
Rostad et al. 2006 Norway 
(1985-95)
All 50-69 12 9,983 6.6 Cross sectional population- 
based health surveys, 
questionnaire
Trying to 
conceive
Infertility: inability to 
conceive within a year of 
unprotected intercourse, 
regardless of later 
pregnancy
Schmidt etal. 1995 
(1995)
Denmark All 15-44 12 2,865 15.7 Randomly selected, postal 
questionnaire
Trying to 
conceive
Infertility: A woman having 
attempted to become 
pregnant for > 12 months 
without achieving 
pregnancy
Templeton et al. 
1990(1988)
United
Kingdom
All 46-50 24 766 14.1 Randomly selected from an 
age cohort of women 
through the Grampian 
Health Board’s primary care 
register, postal 
questionnaire
Trying to 
conceive
Infertility: having difficulty 
in becoming pregnant for > 
24 months
Webb & Holman 
1992 (1988)
Australia Married 16-44 12 1,495
52,253d
19.1 Sample selected from 
women residing in the Perth 
metropolitan area, sample 
drawn using a cluster, 
multistage method, 
interview
Includes 
voluntary & 
involuntary 
infertility*
Infertility: >12 months of 
unprotected intercourse
23
Table 2.1
Prevalence o f infertility according to developmental status (continued, see page 28 for notes).
Authors (Year of 
survey)
Country or 
region
Women
sampled
Age of 
sample
Exposure
time
Sample
Size
Percent
infertile
Sample characteristics Sample 
used for 
prevalence 
estimate
Defmition(s) used
Less Developed countries 
Current Infertility
Che & Cleland 2002 
(1988-95)b
China Newly
Married
25-45 12 7,872 9.3 All couples marrying for the 
first time identified through 
the marriage licence offices 
of two districts. All couples 
who had the intention of 
delaying the first conception 
were enrolled, and those 
without such intention were 
randomly selected, 
interview
No
information
available
Infertility: inability to 
conceive a live birth after a 
specified duration (12 
months) of regular 
unprotected intercourse
Larsen 2005 (2003) Northern
Tanzania
All 20-44 24 2,019 6.9 Cross sectional study, 
random ally selected, first 
marital union, interview
Trying to 
conceive
Infertility: tried to conceive 
for at least 24 months: “how 
long have you tried to get 
pregnant”
Sundby et al. 1998 
(1994)
Gambia Married 15-49 12 2,918 9.2 Random selection of 24 out 
of 1847 Enumeration Areas 
(EA). All households in 
each of the 24 EA were 
interviewed
Trying to 
conceive
Primary infertility: no 
pregnancy or live children 
bom despite being married 
and not having used family 
planning for at least 12 
months
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Prevalence o f infertility according to developmental status (continued, see page 28 for notes).
Authors (Year of 
survey)
Country or 
region
Women
sampled
Age of 
sample
Exposure
time
Sample
Size
Percent
infertile
Sample characteristics Sample 
used for 
prevalence 
estimate
Definition(s) used
Less Developed countries (continued) 
Lifetime Infertility
Barden-O'Fallon 
2005 (2000-2)
Rural
Malawi
All 15-34 12 678 19.6 Population based survey, 
interviewed once a week for 
6 weeks, and at one and two 
years later
Trying to 
conceive
Infertility: whether an 
individual reports ever 
experiencing a difficult time 
in getting pregnant (>12 
months)
Infertility: whether they 
consider themselves or their 
partner to be infertile
Fuentes & Devoto 
1994(1993)
Santiago,
Chile
Married 15-45 12 474 25.7 Randomly selected from 
newly married wives using 
the National Electoral 
Registry, interview
No
information
available
Infertility: having 
unprotected sexual 
intercourse >12 months at 
some time in their lives 
disregarding whether they 
are currently infertile or not
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Prevalence o f infertility according to developmental status (continued, see page 28 for notes).
Authors (Year of 
survey)
Country or Women Age of Exposure Sample Percent
region sampled sample time Size infertile
Sample characteristics Sample 
used for 
prevalence 
estimate
Definition(s) used
Less Developed countriies (continued) 
Lifetime Infertility (continued)
Geelhoed et al. 2002 Rural Ghana All 
(1999)
15-44 12 1,073 11.8 Community based survey. A
probability sample was 
obtained though systematic 
random sampling of houses, 
one person of appropriate 
age and sex in each house 
selected, interview
No Infertility: no pregnancy has
information been achieved after >12
available months of unprotected
intercourse.
Women were regarded to 
have had infertility when 
they were >35 years and 
had fewer than three 
children. Men were assumed 
to have experienced 
infertility if they were > 45 
years and had fewer than 
two children.
Zargar et al. 1997 
(1997)b
Indian
Kashmir
Married 
>1 yr
15-44 12 10,063 15.1 Random selection of 30 
villages from each tehsil 
(administrative subunits) 
interview
Trying to Primary infertility: Failure
conceive to conceive after 12 months
of unprotected sexual 
intercourse in a couple 
trying to achieve a 
pregnancy who had not 
_____________previously conceived._____
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Prevalence o f infertility according to developmental status (continued, see page 28 for notes).
Authors (Year of 
survey)
Country or 
region
Women
sampled
Age of 
sample
Exposure
time
Sample
Size
Percent
infertile
Sample characteristics Sample 
used for 
prevalence 
estimate
Definition(s) used
Less Developed countries (continued) 
Lifetime Infertility (continued)
Che & Cleland 2002 
(1988-95)b
Shanghai,
China
Newly
Married
25-45 24 7,872 3.0 All couples marrying for the 
first time identified through 
the marriage licence offices 
of two districts. All couples 
who had the intention of 
delaying the first conception 
were enrolled, and those 
without such intention were 
randomly selected, 
interview
No
information
available
Infertility: inability to 
conceive a live birth after a 
specified duration (24 
months) of regular 
unprotected intercourse
Lifetime childlessness
Unisa 1999 (1998) India
(Pradesh)
Married 
>3 yrs
20-49 36 6,640 5.0 Random selection of 30 
villages in district, interview
No
information
available
Childlessness: inability to 
deliver a live bom child 
(trying for >12 months)
Ericksen & Brunette 
1996 (1977-92)°
sub-Saharan
Africa
Newly
Married
20-41 60 WFS & 
DHS
14.5 28 nations using the DHS 
and WFS surveys, interview
No
information
available
A women is considered 
infertile at last observation 
if she has had no live births 
during the last 5 years 
before censoring, otherwise 
she is considered fertile.
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Prevalence of infertility according to developmental status (continued).
Authors (Year of 
survey)
Country or 
region
Women
sampled
Age of 
sample
Exposure
time
Sample
Size
Percent
infertile
Sample characteristics Sample 
used for 
prevalence 
estimate
Deflnition(s) used
Less Developed countries (continued) 
Lifetime childlessness (continued)
Larsen 2000 (1977- 
97)
sub-Saharan
Africa
Newly
Married
20-44 60 66,453 16.4 28 nations using the DHS 
and WFS surveys, interview
No
information
available
A woman is considered 
infertile at last observation 
if she has had no live births 
during die last 5 years 
before censoring, otherwise 
she is considered fertile.
Liu et al. 2005 
(2005)
China
(national)
Newly
Married
15-57 84 21,970
120,160
1.3 Analysis was based on the 
National Two-Per-Thousand 
Sample Survey on Fertility 
and Contraception 
(NSSFC), interview
Trying to 
conceive
A non-contracepting and 
sexually active woman who 
had not reported a 
recognised pregnancy after 
at least seven years of 
marriage.
“Information from the European Study of Infertility and Subfecundity. Five countries included: Denmark, Germany, Italy, Poland, Spain. Data also used by Olsen et al.
(1996), and Karmaus and Juul (1999). bPrimary Infertility only. CDHS: Demographic and Health Surveys. WFS: World Fertility Survey; Lifetime: in pre-menopausal women 
this means lifetime to date of interview. dTotal does not include duplicate current and lifetime.e In the calculations for lifetime prevalence no distinctions were made between 
voluntary and involuntary childlessness. Prevalence based on subfecundity and infertility.
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More developed countries.
Fourteen studies provided estimates of infertility prevalence in 13 more 
developed countries, on the basis of surveys involving 52,253 women. In total, four 
estimates were for current infertility of 12 month duration (3.5% -16.7%), one was 
for current subfecundity and infertility of 12 month duration (7.4%) and one was for 
current infertility of 24 month duration (7.0%). The prevalence of current infertility 
ranged from 3.5% to 16.7%. The estimate of current infertility for this range was the 
median figure of 9% for 12 months delay.
Nine estimates were for lifetime infertility lasting 12 months (6.6% - 26.4%) 
and one was for lifetime infertility lasting 24 months (14.1%). The prevalence of 
lifetime infertility ranged from 6.6% to 26.4%. The estimate of lifetime infertility for 
this range was the median figure of 17% for 12 months delay.
Of the 14 studies reporting prevalence in more developed countries all studies 
used the definition infertility (see Table 2.1, pages 20-28). Five studies reported a 
definition of infertility that included an exposure time (e.g., 12 months), unprotected 
intercourse and outcome measured (i.e., lack of conception, pregnancy). A further two 
studies reported an exposure time and unprotected intercourse but provided no 
information on the outcome measured. The remaining six studies reported infertility 
with information on an exposure time (e.g., 12 months) but no information on 
contraceptive use. Finally, one study (Stephen & Chandra, 2006) used subfecundity 
and infertility in their calculations for prevalence of infertility, defining subfecundity 
as difficulties carrying a pregnancy to term and infertility as problems conceiving.
Ten studies reported that the prevalence rate documented was estimated using 
only women trying to conceive, two studies included women with voluntary and
29
Chapter 2 Prevalence and demand
involuntary infertility, and the remaining three studies provided no information on 
intentions to conceive within the women sampled (total equals 15 studies as Webb & 
Holman, 1992 calculated lifetime prevalence making no distinctions between 
voluntary and involuntary childlessness and current infertility using only women 
trying to conceive).
Less developed countries.
Eleven studies provided estimates of infertility prevalence in less developed 
countries in surveys involving 120,160 women. There were only three studies for 
prevalence of current infertility showing a range from 6.9% for a 24 month delay in 
northern Tanzania to 9.2% and 9.3% for 12 month delay in Gambia and Shanghai, 
respectively. The median estimate of current infertility for this range was 9% for 12 
months delay.
Five estimates were for lifetime occurrence of periods of infertility lasting 12- 
36 months (3.0% - 25.7%). A further four studies examined infertility prevalence for a 
period between 5 and 7 years after marriage (1.3% -16.4%). The lowest estimated 
rate of childlessness in the first 5 -8  years of marriage was 1.3% in China, whereas 
the highest estimated rate was 16.4% using the weighted average for sub-Saharan 
African countries (the range was 8 - 28% for the 28 countries as reported in the 
original report: Larsen, 2000). The prevalence of lifetime infertility ranged from 3.0% 
to 25.7%. The estimate of lifetime infertility for this range was the median figure of 
17% for 12 months delay.
Of the 11 studies reporting prevalence in less developed countries seven 
studies used the definition infertility, and four used the definition childlessness (see 
Table 2.1, pages 20-28). Of those that used infertility five studies included an
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exposure time (e.g., 12 months), unprotected intercourse and outcome measured (i.e., 
lack of conception, pregnancy). A further two studies reported infertility with 
information on exposure time (e.g., 12 months) and the outcome measured but no 
information on contraceptive use. Finally, four studies reported childlessness as the 
reproductive state defined. Of these four studies, one referred to childlessness as an 
inability to deliver a live bom child, two defined childlessness as the presence of no 
live births over a period of time (5 years of marriage) and one defined childlessness as 
no recognised pregnancy over a period of time (7 years of marriage).
Five studies reported that the prevalence rate recorded was based only on 
women trying to conceive and the remaining six studies provided no information on 
intentions to conceive within the women sampled.
Demand for Infertility Medical Care
Table 2.2 shows the proportion of women who sought and/or received medical 
care in more and less developed countries.
More developed countries.
Twelve studies provided estimates of seeking behaviour from six countries 
and one of these (Olsen, Basso, Spinelli, & Kuppers-Chinnow, 1998) provided an 
average estimate from a further five European countries. In total these surveys 
concerned 4,810 infertile women. The proportion of infertile couples seeking any 
infertility medical care ranged from 42% to 76.3%, with an average of 56.1%. It was 
also possible to examine the proportion of infertile women who underwent infertility 
medical care. An average of 42.0% of women sought medical advice (six studies) and 
22.4% underwent treatment (four studies).
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Table 2.2
Demand for infertility medical care according to developmental status.
Authors Country or 
Region
Number
infertile
Percent 
seeking 
any 
medical 
care (%)
Percent overall seeking 
different types of 
treatment (%)
Percent 
not 
seeking 
care (%)
More developed countries
Treatment
advice
Received
treatment
Buckett & Bemtick 1997 United Kingdom 126 61 (48.4) 43 (34.1) 26 (20.6) 65 (51.6)
Dick et al. 2003“ Australia 302 198 (65.6) - - 104 (34.4)
Ducotetal. 1991 France 387 240 (62.0) 118(30.0) 44(11.4) 147 (38.0)
Greil & McQuillan 2004 United States 123 64 (52.0) - 32 (26.0) 59 (48.0)
Gunnell & Ewings 1994 United Kingdom 618 310(50.2) 170 (27.5) - 308 (49.8)
Olsen, Basso et al. 1998“b* Europe 751 349 (49.0) - - 363 (51.0)
Philippov et al. 1998 Russia 333 254 (76.3) 186 (55.6) - 79 (23.7)
Schmidt et al. 1995° Denmark 448 198 (44.2) - - 250 (55.8)
Stephen & Chandra, 2000d United States 1,210 508 (42.0) - 380(31.4) 702 (58.0)
Templeton et al. 1990 United Kingdom 108 75 (69.4) 67 (62.0) - 33 (30.6)
van Balen et al. 1997bae Netherlands 351 85 (65.6) - - 46(35.1)
Webb & Holman 1992f 
Less developed countries
Australia 53 23 (48.9) 
56. l g
20 (42.6) 
42.0* 22.4*
24 (51.1) 
43.9*
Barden-O'Fallon 2005* Rural Malawi 133 77 (57.9) - - 56(42.1)
Che & Cleland 2002“ China 732 417(57.0) — - 315(43)
Fuentes & Decoto 1994“ Chile 122 33 (27.0) - - 89 (73.0)
Sundby et al. 1998 Gambia 281 112(40.0) 98 (34.9) - 169 (60.0)
Unisa 1999 India (Pradesh) 332 246(74.1)
51.2*
55.7h
.  __
34.9*
193 (58.0)
58.0*
86 (26.0) 
48.8* 
45.3h
“No information was provided on the type of medical care sought. bInformation from the European
Study of Infertility and Subfecundity. Five countries included: Denmark, Germany, Italy, Poland, 
Spain. Data also used by Olsen et al. 1996, and Karmaus & Juul (1999). °26 participants who sought 
treatment did not meet definition for infertility so were excluded from further analysis. dMost recent 
paper (Stephen & Chandra 2006) did not include information regarding type of treatment sought 
'Calculations based on number of people who responded to the final questionnaire (n = 131). fCurrent 
infertility. Calculations based on reproductive disability sample (n = 47). 8Averaged total percent per 
development status. hAveraged total percent across more and less developed countries. *Calculations 
based on the number of infertile people who participated in the treatment seeking section (n = 712).
- No data reported.
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Less developed countries.
From less developed countries, five studies provided estimates from five 
countries, involving 1,600 infertile women. The proportion of infertile couples 
seeking any infertility medical care ranged from 27.0% to 74.1% with an average of 
51.2%. Only one study in less developed nations provided the proportion of women 
who sought treatment advice (34.9%), and only one study gave the percentage who 
received infertility treatment (58.0%).
Care-seeking appears to follow a similar pattern in more and less developed 
countries, with slightly more couples seeking care in developed countries (mean 
56.1%) than in less developed countries (mean 51.2%). The average proportion of 
women not seeking treatment in all countries was 45.3%.
Estimated Number o f Couples Needing and Demanding Infertility Medical Services
Table 2.3 shows population values overall and according to age and marital 
status. An estimated 1.139 billion women aged 15 - 49 are currently in married or 
consensual unions in 2006 and they represent 17.5% of the 6.508 billion world 
population. The 804 million women aged 20-44 in married or consensual unions are 
12.4% of the 6.508 billion total, and this category includes 122 million women in 
more developed countries and 682 million women in less developed countries.
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Table 2.3
World estimate o f potential need and demand for infertility medical care.
World More Developed 
countries
Less Developed 
countries
(i) World population
09:44 GMT (EST+5) Apr 06,2006
6,508,032,884
(ii) Population data
Number of women of reproductive age 
(15-49 years) who are in a marital or 
consensual union: 2006
1,139,394,885 172,888,758 966,506,127
(iii) Number of women age 20-44 years 
who are in a marital or consensual 
union
804,278,743 122,039,123 682,239,619
(iv) Potential Need (Prevalence of 
infertility)
Number of women 20-44 years in 
marital or consensual union currently 
not conceiving in one year (while not 
using a contraceptive method) 
Estimate (9%) 72,385,087 10,983,521 61,401,566
(v) Demand for treatment 
Number of infertile couples seeking 
medical care 
Estimate (56%)
Number of infertile couples not seeking 
medical care 
Estimate (44%)
40,535,648
32,573,289
6,150,771
4,942,584
34,384,876
27,630,705
Note. See Methods section for notes on (i) to (v).
There are 72.4 million women aged 20-44 and living in married or consensual 
relationships who have infertility defined as currently experiencing >12 month delay 
in conception while not using contraception. Of these women, on average 40million 
are likely to seek medical health care and 32.6 million will not seek health care for the 
management of the infertility.
Discussion
Infertility is a prevalent problem in society with around 9% of the adult 
population affected. Given that parenthood is a desired goal by the majority of adults, 
it is therefore surprising to find that on average only 56% of infertile couples are
34
Chapter 2 Prevalence and demand
seeking any medical advice or care, with an even smaller number receiving treatment. 
There are a number of possibilities to account for the discrepancy between desire to 
have children and actually seeking treatment when a fertility problem occurs. The 
possible methodological, population and cultural issues will be explored here and the 
further psychological determinants that may facilitate or hinder engagement in the 
medical process will be discussed in Chapter 3.
Prevalence of Infertility
Perhaps unexpectedly the results indicate that there may not be as much 
difference in the prevalence of infertility according to development status as has 
previously been assumed. The prevalence estimates produced are valid insofar as 
these were based on all population surveys of current infertility published since 1990, 
totalling a sample of approximately 170,000 women, with almost all studies (88%) 
sampling at least 1000 women. Although current prevalence from less developed 
countries was based on only three reports, these sampled approximately 13,000 
women. Lifetime prevalence of infertility, which was based on many more studies (n 
= 19), was remarkably similar in more (10 studies = 6.6% - 26.4%) and less (nine 
studies = 5.0% - 25.7%) developed countries, suggesting that similarity in the current 
prevalence was not just an artefact of a smaller number of studies.
A number of possibilities could account for such similarities. One explanation 
is that the countries most affected by the factors that reduce fertility, which include for 
example curable sexually transmitted diseases (STDs), were not those sampled in the 
surveys reported. A WHO report showed that the number of adults per 1,000 
population infected with curable STDs was 19 in North America and 20 in Western 
Europe (WHO, 2001), which was comparable to the rates for less developed countries
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contributing to the review (see Table 2.1, pages 20-28), that is, 21 and 18 in North 
Africa and East Asia, respectively. By comparison the number infected in Sub- 
Saharan Africa was 119 and was 50 in Southeast Asia, which did not contribute to the 
estimate of current infertility. However, even with this consideration the results show 
that lifetime prevalence of infertility is similar in more and less developed countries 
even in those countries that have demonstrated higher exposure to infectious disease 
(e.g., Chile, sub-Saharan Africa).
Another possibility is that the course of infertility over time may show 
convergence of prevalence according to development status. For example, Stephen 
and Chandra (2006) recently reported from the National Survey of Family Growth 
(NSFG) that prevalence of 12-month infertility stayed more or less the same in the 
United States from 8.5% in 1982 to 7.4% in 2002. In contrast, in some African 
countries (e.g., Central African Republic, Cameroon, Nigeria) prevalence has dropped 
dramatically from an exceptionally high level reaching 30 - 40% in the 1950s and 
1960s compared to a national estimate of only 6% in 1994 (Larsen, 2005; WHO 
1991). This decline in the prevalence of infertility may be due to significant decreases 
of 30 - 40% in the prevalence of some STDs in African nations (WHO, 2001).
Similarities in prevalence rates between more and less developed countries 
could also be due to the category of women sampled in some of the studies, restricting 
the criteria to only ever-married or cohabiting women. This is problematic if a woman 
has to prove her fertility before she can get married (i.e., a pregnancy or birth is part 
of the process of getting married) as is customary in many West African societies 
(Larsen, 2005). Only three out of the 11 studies in the less developed countries 
sampled all women irrespective of marital status (prevalence range of 6.9% -19.6%),
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therefore the remaining 9 studies (prevalence range of 1.3% - 25.7%) sampling 
married or cohabiting women may not represent a true reflection of the number of 
women with fertility problems in less developed nations.
A further sampling issue is whether the study included all women, or a subset 
of women who stated trying to conceive currently or at some point in their 
reproductive life. The WHO (Rowe et al., 1993) recommends that in order to 
accurately represent involuntary childlessness researchers must include intentions to 
conceive in their questioning of couples. Within the current review, two studies 
reported including all women regardless of voluntary or involuntary infertility in more 
developed countries. However, in 10 studies (four from more developed and six from 
less developed countries) the intentions of the women sampled were unknown. By 
including all women one is removing the intention of those sampled, which may lead 
to distortion of the prevalence rating (Schmidt & Munster, 1995). Not knowing a 
couple’s intention to conceive may further impact on conclusions drawn about the 
need and demand for infertility medical care. One may find that prevalence may be 
reported as high (as it includes all women regardless of intention), yet the uptake of 
treatment low, as the treatment seeking behaviour only includes the women who 
actually intended to achieve a pregnancy. However, the rate of voluntary childlessness 
is generally low, about 5% (Chancey, 2006) and therefore would not necessarily 
produce significant bias. It would be imperative to consider these issues when 
developing future cross-country population studies on the prevalence of infertility.
Equally important to consider is the possibility that the similarity in prevalence 
of infertility between more and less developed countries is genuine but that the 
mechanism(s) contributing to that prevalence differs according to country. W. Cates,
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Farley, & Rowe (1985) reported that most cases of infertility in Africa were due to 
infection, which is very low in more developed countries. In the latter however, there 
is a steady increase in age-related infertility which is not found in less developed 
nations (Lunenfeld & Van Steirteghem, 2004). In the United Kingdom, the proportion 
of babies with mothers aged 35 years or more increased markedly from 6.5% in 1976 
to 22.5% in 2000 (Bakeo, 2004) and in the United States this rate has more than 
doubled since 1978 (Hamilton et al., 2004). This is in stark contrast to countries such 
as sub-Saharan Africa where women marry at young ages (average age = 19.03; 
Harwood-Lejeune, 2000) and the average age at first birth is 19.9 years (average 
based on data from the Demographic Health Survey conducted in Central African 
Republic, Mali and Eritrea, Population Council, 1997a, 1997b, 1997c).
In Western society the increase in age-related infertility is thought to be due to 
a number of demographic, social and lifestyle factors, leading people to spend more 
time than ever in education and in the so-called period of ‘emerging adulthood’ that 
focuses on education and individual growth and development (Arnett, 2000). For 
example people are taking longer to find a suitable romantic partner (age at first 
marriage in Europe has increased by more than 4 years since the 1980s, Chappell, 
Pearce, Carlos-Bovagnet, & Till, 2005), and are spending more time in the early years 
of partnership on non-parenting couple activities (e.g., ‘enjoying life’, travel, van 
Balen, 2005) made easier by highly effective contraception. Further, economic 
uncertainty and affordability of children is also of more concern now (ESHRE Capri 
workshop, 2001) than in previous decades as is female career aspiration and 
development (Bewley, Davies, & Braude, 2005) though interference with 
occupational goals is still more of an issue for men than women (Langdridge,
Connolly, & Sheeran, 2005).
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It would be important to establish the impact such factors (e.g., STDs, age) 
have on infertility rates in more and less developed countries, for it may be that these 
factors can be readily modifiable (e.g., via increased awareness about age related 
decline in fertility) and preventable (condom use to prevent transmission of STD: W. 
Jr. Cates & Stone 1992), which in turn may impact on future fertility rates in both 
societies.
Previous studies have found that the use of different definitions of infertility 
can lead to problems in the interpretation of results on prevalence rates (Marchbanks 
et al., 1989). In the current review the majority of the studies (96%) referred to 
infertility as an inability or difficulty in conceiving, which is generally the most 
agreed definition according to NICE, ASRM and the WHO. In addition the majority 
of studies (72%) reported using 12 months as the exposure time for infertility, again in 
accordance with the most agreed definition. Therefore one can be confident that the 
majority of the studies used in the current review to estimate the prevalence of 
infertility were using the most agreed definition, thus reducing the chances of any 
misinterpretation due to methodological issues impacting on the prevalence ratings.
Need and Demand for Treatment
As already mentioned parenting surveys have revealed that the vast majority 
of those surveyed wish to have children at some point in their lives (Virtala et al.,
2006, Lampic et al., 2006, Tyden et al., 2006) and one would therefore expect that 
most people would seek medical care when faced with fertility difficulties. However, 
demand for infertility treatment was unexpectedly low in more and less developed 
countries with just over half of the people who experienced fertility problems
39
Chapter 2 Prevalence and demand
deciding to seek any infertility medical care, and an even lesser number of couples 
(<25%) receiving treatment.
Why are there inconsistencies between desire to have children and treatment 
seeking behaviour when faced with problems conceiving? One possible factor is the 
period of exposure in a given study; with a current 12 month reported period of trying 
to conceive, perhaps the studies are underestimating the percentages of couples that, 
after a prolonged period of natural attempts, say two years, eventually do seek 
medical treatment. However, the average for engagement in medical services in the 
current studies was 58% (Webb & Holman, 1992; van Balen, Verdurmen & Ketting, 
1997b; Philippov, Radionchenko, Bolotova, Voronovskaya, & Potemkina, 1998; 
Stephen & Chandra, 2000) compared with 54% in the remaining lifetime surveys, 
suggesting that too short an exposure time was not the main cause of low treatment- 
seeking.
A lack of consensus for a definition of infertility may also obscure true 
estimate of the number of couples that seek treatment. Gunnell and Ewings (1994) 
found that many infertile couples who do seek help are not referred for specialist 
medical advice and therefore do not access the medical help they need. They 
concluded that this was primarily due to a lack of concrete referral guidelines for 
General Practitioners (GP) to use when couples present with difficulties conceiving.
If the majority of population surveys use 12 months as a definition of infertility but 
the medical practice within the country is delaying and sending couples for further 
investigations at a later stage, treatment up-take and use may be underestimated in the 
surveys.
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The mechanisms for why treatment seeking behaviour is low may be different 
according to development status even if the rate is the same; one possibility is due to 
cultural differences surrounding infertility. Firstly, in many developing countries 
there is a perception of infertility as being due to evil forces, and as a result many 
infertile couples often first seek traditional and religious treatments in an attempt to 
ward off the evil (Okonofua, Harris, Odebiyi, Kane, & Snow, 1997). In addition 
infertility may lead to divorce, or the husband taking on another partner who can 
produce children, thus reducing the need for medical care (Okonofua, 2003). In more 
developed countries van Balen et al. (1997b) found in a sample of 131 infertile 
couples that another way to cope with infertility was to pursue other life goals like a 
professional career, activities in voluntary associations or taking up 
educational/further study rather than seek medical help for the infertility problem, and 
this may reflect the changing importance of children as a developmental life goal. One 
third of the sample in that study believed that having children did not constitute the 
only pursuit that makes life meaningful (van Balen et al., 1997b).
Secondly, people may not be motivated to seek treatment if fertility services 
are known to be limited or unavailable. For example, in less developed countries 
medical treatment is not readily available, and when it is, it is often expensive and 
relatively ineffective. Often the couples that can afford treatment seek it overseas 
(Okonofua, 2003), paradoxically reinforcing limited availability in the less developed 
country because the demand decreases. Conversely, in more developed countries such 
as the USA treatment is a very expensive process and can only be obtained by those 
that have the appropriate insurance policies or the wealthy. However, it must be 
mentioned that although these are important implications for access to treatment 
seeking, even in the countries that provide generous access to treatment, for example
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Denmark, the rate of seeking medical care was about the same as that reported for 
Gambia where access is much more restricted (Sundby et al., 1998).
This discussion has highlighted a number of factors associated with the 
prevalence of infertility and the demand for medical treatment across the World. A 
number of the causes of prevalence and demand were common to both more and less 
developed nations (e.g., accessibility to medical care) while some were unique to 
developmental status (e.g., increasing change in age at first birth in Western 
societies). In addition, the results suggest that information on the prevalence and 
demand of fertility treatment is much more limited from the less developed countries. 
Cross-cultural epidemiological data is now needed to further explore and resolve the 
issues noted here. This is of great importance as all these factors will have an impact 
on decision making when couples are faced with fertility difficulties.
Notwithstanding the social and methodological implications cited in this 
chapter to explain the current findings, it is also important to establish the 
psychological factors associated with the reported low uptake of treatment. Together 
this may help to disentangle why people are not seeking treatment and what can be 
done to enable people (if they wish) to seek the medical help that may make their 
desired goal of parenthood more achievable.
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Chapter 3
Decision-making about seeking medical advice in an internet sample
of women trying to get pregnant
Introduction
Given the importance of parenthood as a central life goal, it is surprising to 
find from the results in Chapter 2 that on average just over 50% of couples who are 
faced with fertility problems actually seek medical care. Considering the current high 
success rates of treatment (Pinborg et al., 2007) it would be important to better 
understand this paradox in order to establish whether couples desiring to use medical 
intervention can be aided in their decision-making to help them better realise this 
goal. The aim of the present study was to identify demographic, fertility and 
psychological factors that differentiated those who had sought or not sought medical 
advice or treatment for fertility difficulties in order to identify factors that might 
facilitate or hinder treatment-seeking. Table 3.1 summarises the constructs in the 
theoretical framework reviewed in the next section.
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Description o f the constructs in each theoretical framework and those assessed in the present study.
Theory and Constructs Description of Construct
Theory of Planned Behaviour
External variables Demographic, socioeconomic, education
Personality traits Optimism, neuroticism etc.
Behavioural attitude Evaluations of the behaviour
Subjective norms, normative beliefs & motivation to comply Persons belief about whether significant others think he or she should engage in the behaviour
Perceived behavioural control Individual's perception of the extent to which the behaviour is easy or difficult to perform
Behavioural intention Intentions to perform the behaviour
Transtheoretical Model of Change
Precontemplation No intention of behaviour change, unaware of any problems
Contemplation Awareness that a problem exists no commitment to take action. Weighing of the pros and cons of resolving problem
Preparation Intention to perform the behaviour shortly, involve other people (e.g., spoke to family doctor, friends or family)
Action Modify behaviour to attempt to deal with problem
Maintenance* Continue behaviour change to achieve goal
Health Belief Model
Demographic, socioeconomic, personality variables Demographic, socioeconomic, personality variables (e.g., optimism)
Perceived susceptibility Awareness of a problem and seriousness of problem
Perceived threat Concerns about seriousness & consequences of problem
Cues to action Perception of symptoms, social influence
Barrier identification Perceived benefits versus barriers to behaviour
Help-Seeking Model for Infertility
Symptom salience Awareness of a problem
Life course factors Age, marital status, parity
Individual and social cues Importance of motherhood, partner's desires
Enabling and predisposing factors Socioeconomic, demographic, education, general perception of health, knowledge of a problem
Note. * Stage not assessed in present study.
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Help-seeking Theory and Empirical Literature
Medical help-seeking (hereafter help-seeking) refers to the efforts and/or 
actions used to assist individuals to seek and use health services when a behaviour or 
manifestation (i.e., symptom) is out of the ordinary or new (e.g., occurrence of a new 
lump in the breast) (Pescosolido, 2007). Patient delay in help-seeking refers to the 
time between an individual’s first awareness of a sign or symptom of illness and the 
initial medical consultation, and has been studied in numerous areas of health (Bish et 
al., 2005). Many people have mixed feelings about undergoing medical treatment (van 
Balen & Verdurmen, 1999). On the one hand, medical treatment may result in an 
improvement of health or even in saving one’s life; on the other hand treatments may 
be unpleasant and may even carry risks. Past research has highlighted the existence of 
two main reasons given by patients that delayed seeking help (Ristvedt & Trinkaus, 
2005). The first suggested a lack of awareness of the importance of potential dangers; 
the person believed that their symptoms were minor and would clear up without any 
medical intervention. The second suggested a delay in seeking treatment due to 
avoidance of the situation; the person was concerned that their symptoms were serious 
but became immobilised by fear, embarrassment or denial (Ristvedt & Trinkaus,
2005). In addition, several theoretical models have been proposed in order to describe 
and explain how people form intentions and take action, and these can be applied to 
help-seeking behaviour.
Theoretical Literature
The Theory of Planned Behaviour.
The theory of planned behaviour (TPB) (Ajzen, 1991) states that a person’s 
intention to perform a certain act (e.g. seek treatment) is determined largely by his/her 
attitude toward the act and the subjective norm about the act. Subjective norms consist
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of a person’s beliefs about whether significant others think he or she should engage in 
the behaviour. In the application of the TPB to help-seeking for suspected fertility 
problems attitudes (i.e., women’s evaluations of the treatment process), would be 
predictors of their behavioural intentions. The TPB also includes perceived 
behavioural control, which is the individual’s perception of the extent to which 
seeking treatment, for example, is easy or difficult. Control is seen as a continuum 
with easily executed behaviours at one end and behavioural goals demanding high 
resources, opportunities and specialised skills, at the other (Conner & Norman, 1996).
In support of the application of the theory to fertility, studies have highlighted 
that most women rely on the advice of friends and family to decide on the appropriate 
treatment before consulting a doctor (White, McQuillan, & Greil, 2006). Further, 
Callan, Kloske, Kashima, and Hennessey (1988) used the TPB toward better 
understanding of women’s decisions to drop out of fertility treatment. Those who did 
not continue with treatment (Discontinues) were less optimistic that another attempt 
would make them mothers, make their marriages happier, or improve the quality of 
their lives, and in terms of their perceptions of social pressures, discontinuers also 
believed that their husbands, family, friends and doctors did not think that they should 
have another IVF attempt. However, it was not a prospective study therefore one does 
not know whether negative attitudes and unsupportive environments were a cause or 
consequence of the decision not to pursue further treatment. Further, the study 
focused on decision making once already engaged in the treatment process (i.e., 
having more treatm ents discontinuing) and the factors shown to be important could 
differ in women deciding whether or not to initiate seeking medical help.
46
Chapter 3 Treatment seeking behaviour
The Transtheoretical Model o f Behaviour Change.
Another approach to understanding treatment-seeking suggests that decision­
making is a process involving specific stages (Prochaska, DiClemente, & Norcross, 
1992). At the Precontemplation stage individuals have no intention of changing their 
behaviour in the near future. Many individuals in this stage are unaware of their 
problems (e.g., fertility difficulties). Resistance to recognising or modifying the 
situation (e.g., seeking advice from the family doctor) is the main characteristic of 
precontemplation. Contemplation is the stage in which people are aware that a 
problem exists and are seriously thinking about overcoming it but have not yet made a 
commitment to take action. People can remain in the contemplation stage for long 
periods (DiClemente & Prochaska, 1985). An important aspect of the contemplation 
stage is the weighing of the pros and cons of the problem and the solution to the 
problem. Contemplators appear to struggle with positive evaluations of the situation 
(e.g., treatment may make me pregnant) and the amount of effort and energy it will 
cost to overcome the problem (e.g., treatment may be expensive or is unnatural) 
(DiClemente, Fairhurst, Velasquez, Prochaska, Velicer, & Rossi, 1991; Velicer, 
Prochaska, DiClemente, & Brandenburg, 1985). Serious consideration of problem 
resolution is the central element of contemplation.
The Preparation stage combines intention and behavioural criteria. Individuals 
in this stage are intending to take action shortly and may have taken some minor 
actions in the past (e.g., spoke to the family doctor). The Action stage is where 
individuals modify their behaviour, experiences, or environment in order to overcome 
effectively and deal with the situation (e.g., seeking treatment). Finally, in the 
Maintenance stage people work towards achieving their goal, (e.g., seek treatment 
until pregnancy is achieved). Traditionally, maintenance was viewed as a static stage.
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However, maintenance is a continuation of change (e.g., the continuation of treatment 
when it is uncomfortable or costly, or when it fails).
According to the transtheoretical model (TTM) successful behaviour change, 
that is, success in moving from one stage to another until behaviour has changed, is 
driven by a series of ten process (consciousness raising, self-re-evaluation, self- 
liberation, counter-conditioning, stimulus control, reinforcement management, 
helping relationships, dramatic relief, environmental re-evaluation & social 
liberation). There has been some debate as to whether all ten processes are important 
in behaviour change (Lamb & Joshi, 1996), for example, Bowen, Meischke, and 
Tomoyasu (1994) reported that people in the later stages of the model (e.g., Action 
and Maintenance) were more likely to endorse items for eight of these processes 
proposed than people in earlier stages (e.g., Precontemplation). Nevertheless, in an 
attempt to better understand these processes in determining a person’s transition from 
no behaviour change (e.g., still smoking) to behaviour change (e.g., quit smoking) 
many studies have developed sets of ‘staging’ questions to ascertain progress towards 
change . For example, “I have not given the matter of quitting smoking a thought at 
all” (Precontemplation) to “I have been consciously avoiding smoking for longer than 
the last six months” (Maintenance: Lamb & Joshi, 1996). These studies have been 
successful in establishing support for the model (e.g., Prochaska, DiClemente,
Velicer, Ginpil, & Norcross, 1985; Curry, Kristal, & Bowen, 1992; Lamb & Joshi, 
1996).
However, a number of authors have highlighted potential issues with the 
model, questioning the actual existence of the stages (Povey, Conner, Sparks, James,
& Shepherd, 1999; DeNooijer, Van Assema, De Vet, & Brug, 2005; Etter, 2005;
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West, 2005). Some studies have reported that there were no differences between 
people in early stages compared to later stages (Glanz et al.,1994) and that fewer 
processes than originally proposed by Prochaska and colleagues may be involved for 
behaviour change in certain contexts (e.g., dietary fat reduction: Lamb & Joshi, 1996). 
Taking into account these concerns proponents of the model argue that stages are a 
useful way of addressing the critical tasks involved in the transition to behaviour 
change, and that stages are considered states and not traits and thus quite unstable 
allowing individuals to move between them quickly (DiClemente, 2005). Previous 
research has also found support for a combination of the TPB and TTM, with the TPB 
providing good discrimination between the stages of change as proposed by the TTM. 
For example, people in the maintenance stage had more positive attitudes, perceived 
greater social pressure, more control, and had stronger intentions to maintain the 
behaviour change (e.g., continuing to eat a low-fat diet, continuing to stop smoking) 
compared to those in the precontemplation stage (Armitage & Arden, 2002). It is clear 
that while there are still some controversies over the existence of the stages and 
whether they can be applied effectively to decision making the TTM is still popular 
when discussing and attempting to understand behaviour change in health.
The Health Belief ModeL
The Health Belief Model postulates that individuals will take action (e.g. 
seeking treatment) if they regard themselves as susceptible to the disease in question 
(e.g., unable to conceive) and if they believe it to have potentially serious 
consequences (e.g., children central to their life plan). Action is also dependent on the 
belief that the anticipated barriers to (or costs of) taking the action are outweighed by 
its benefits (e.g., the success of having a child outweighing the financial or emotional 
costs of seeking treatment, Rosenstock 1990).
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The health belief model (HBM) is based on several beliefs and attitudes 
categorised into perceived susceptibility, perceived threat and perceived benefits and 
barriers. Perceived susceptibility refers to one’s own perception of the seriousness of 
the potential health condition, including personal estimates about one’s own 
susceptibility to illness in general (e.g., how likely one is to have a fertility problem). 
Perceived threat encompasses feelings of concern about the seriousness of an 
illness/disease and the consequences of not seeking help to attempt to overcome it 
(e.g., how childlessness would impact on one’s life). Perceived benefits and barriers 
of actively taking up health behaviours are also predictors of action (e.g., financial 
costs, invasiveness of treatment versus achieving parenthood, peace of mind that 
everything had been tried). In a review of 13 studies using the HBM, the best 
predictors of an outcome such as seeking medical treatment for an illness were the 
barriers associated with taking a course of action (Janz and Becker, 1984). The 
potential negative aspects of a particular health action, or perceived barriers, may act 
as impediments to undertaking the recommended behaviour. Other variables such as 
demographic, socio-psychological, personality and level of knowledge may also affect 
the individual’s perception and thus indirectly influence health-related behaviour. 
Research has found that such factors influence the perception of susceptibility, 
benefits and barriers (Rosenstock 1990).
The model also proposes that cues to action can trigger health behaviour when 
appropriate beliefs are held. These ‘cues’ include a diverse range of triggers such as 
individual perceptions o f symptoms, social influence and health education campaigns 
(Sheeran and Abraham, 1996). A main cue in the case of infertility would be lack of 
conception after a long period of exposure to unprotected sexual intercourse.
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There has been some criticism of the model regarding the lack of definitions of 
the formulated components (Armitage & Conner, 2000) and the weak correlations of 
the variables with behaviour (Sheeran & Abraham, 1996). However, a plethora of 
research exists supporting the HBM. Perceived barriers and benefits, perceived 
susceptibility, and cues to action have been found to be the most influential factors in 
predicting intention in a number of health settings, such as the uptake of cervical 
cancer screening (Agurto, Bishop, Sanchez, Betancourt, & Robles, 2004), use of birth 
control in adolescents (S. L. Wang, Charron-Prochownik, Sereika, Siminerio, & Kim,
2006), condom use in adolescents (Mahoney, Thombs, & Ford, 1995), uptake of 
testicular self-examination (McClenahan, Shevlin, Adamson, Bennett, & O’Neill,
2007), uptake of breast self-examination (Garcia & Mann, 2003), and increased 
calcium intake to prevent osteoporosis (Tussing & Chapman-Novaofski, 2005). Given 
these results it would be important to assess the model in the context of intentions to 
seek medical help for fertility difficulties, an area which to the author’s knowledge, 
has not previously been examined.
Model of helpseekingfor infertility.
Drawing on a number of theories of help-seeking White et al. (2006) proposed 
a help-seeking model specific to infertility, whereby action is dependent on inter­
relationships amongst personal and social cues, as well as on enabling (e.g. financial 
resources) and predisposing (e.g. a priori knowledge of symptoms) conditions. White 
et al. (2006) found that less than half of the infertile (defined as no conception after 12 
months of sexual intercourse without contraception) women (40%) sought medical 
help, results similar to those reported in Chapter 2. White et al. (2006) concluded that 
perceiving a fertility problem existed (e.g., via the realisation that persistent attempts 
at conceiving have failed) was central to a woman’s treatment seeking behaviour. The
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main barrier to perceiving that a fertility problem existed was having the perception of 
good overall health.
Empirical and Psychological Literature
In addition to the theoretical frameworks other factors accounting for variation 
in treatment-seeking have emerged from empirical work in comparing people who 
had sought/not sought fertility treatment. Firstly, treatment seekers were in better 
social and economic situations. They were older, more likely to be currently married, 
have a higher income (Stephen & Chandra, 1998, 2000), and be educated to a higher 
level (school education > 9 years) (Schmidt et al., 1995; Wulff et al., 1997; Wyshak, 
2001). Secondly, treatment seekers were more aware of their fertility and health. They 
had clearer intentions to get pregnant, were more likely to seek information on their 
own and were more likely to self-define as having fertility problems (Greil & 
McQuillan, 2004). Thirdly, they had a higher need for parenthood with stronger 
desires to have children (Langdridge et al., 2000), and were less likely to have 
previously delivered a child (Templeton, Fraser, & Thompson, 1990; Ducot, Spira, 
Thonneau, Toulemon, & Leirdon, 1991; Gunnell & Ewings, 1994; Schmidt et al., 
1995). Fourthly, they had more favourable attitudes toward treatment. Previous 
research has found that those who seek treatment for a fertility problem have a lower 
score on a medical anxiety questionnaire compared to non-treatment seekers (van 
Balen & Verdurmen, 1999).
Finally personality styles (e.g., optimism, neuroticism) have been shown to 
influence health and help-seeking behaviours through coping (Scheier & Carver,
1985). Dispositional optimism refers to a personality characteristic involving 
expectations that good as opposed to bad outcomes will generally occur (Scheier &
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Carver, 1987) and has been associated with less delay in seeking help in a variety of 
diseases (e.g., breast cancer symptoms: Lauver & Tak, 1995).
Research suggests that people high in optimism will deal with stressful events 
in ways that are more adaptive (Scheier & Carver, 1987). For example, optimistic 
individuals may use more problem-focused coping, namely manage or come up with 
effective solutions to the problem (e.g., making a plan of action to seek medical 
advice if not pregnant within 12 months and following it), whereas pessimists (high 
expectations that bad events will occur more than good events) may utilize more 
emotion-focused coping strategies brought about by the distress aroused by their 
negative expectations, that is, become disengaged from the situation (e.g., avoid 
talking about the persistent failed attempts at trying to conceive) (Lancastle & Boivin, 
2005). Indeed studies exploring women’s coping styles with failed IVF attempts have 
highlighted that escapism and/or avoidance coping styles are associated with poor 
adaptation to failure (Litt, Tennen, & Affleck, 1992; Terry & Hynes, 1998). Further, 
in the Callan et al. (1988) study exploring decision-making after a failed IVF attempt 
women who deterred from another treatment cycle were less optimistic about future 
treatment outcomes. However, Verhaak, Smeenk, van Minnen, Kremer, and 
Kraaimaat (2005) found that while personality factors such as neuroticism were 
important to emotional adjustment to infertility, coping styles such as problem 
management, emotion approach and cognitive avoidance were not. It could be that 
dealing with infertility requires a number of coping strategies that change in nature 
over time as failed attempts to conceive accumulate and reassessment of the 
parenthood goal occurs (Verhaak et al., 2005).
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Using Internet Methodology to Access people Trying to Conceive
Research thus suggests clear differences between treatment seekers and non­
treatment seekers on a variety of sociodemographic and trait variables. However, a 
criticism of previous studies is their reliance on using samples recruited from 
infertility clinics (Greil & McQuillan, 2004) thus potentially by-passing the views of 
the 45% of couples who are not seeking any medical care for fertility difficulties. In 
an attempt to overcome these sampling issues a number of studies have employed 
community designs targeting men and women who are currently trying to conceive or 
had tried to conceive in the past (van Balen & Verdurmen, 1999; Greil & McQuillan, 
2004). However, community studies are expensive and time consuming to setup and 
run. An alternative is recruitment through online internet studies, which offers 
inexpensive access to men and women from around the World. The UCLA World 
Internet Project (Lebo, 2004) has highlighted that while access and the use of the 
internet varies considerably from country to country, in more developed countries at 
least half of all people surveyed stated using the internet. In the United Kingdom over 
35 million people were active users of the World Wide Web in July 2008 
(Nielsen/NetRatings, accessed September 2008). With regard to health related habits, 
the internet is now frequently used by people to gain information (Bass, 2003; 
Bundorf, Wagner, Singer, & Baker, 2006) on a number of issues surrounding health 
habits (e.g., quitting smoking) and help-seeking behaviours (e.g., treatment options, 
access, availability and success).
The internet affords a number of advantages when conducting questionnaire 
research both for the researcher and the participant. For example, for the researcher 
there are low running costs (e.g., questionnaires can be placed on websites for free 
and there are often low to no participation costs), low maintenance (e.g., data can be
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downloaded immediately into analytical software packages reducing the time taken 
for data entry), and quick turn-around (e.g., response is immediate compared to 
manually sending out questionnaires to participants and waiting for mailed responses). 
For the participant, the internet offers its users anonymity (Strecher, 2007), and the 
convenience of completing research at home or work, at anytime, without having to 
travel to a specific place (e.g., university research lab) to complete and/or return 
responses.
However, using the internet as a research tool can be problematic. For 
example, use in less developed nations is more infrequent in comparison to more 
developed nations (Strecher, 2007), and within more developed nations access may 
not be readily available to everyone due to economic situations leading to a bias 
towards higher socioeconomic users (Weissman, Gotlieb, Ward, Greenblatt, &
Casper, 2000). Although studies specific to fertility have found that many couples 
from all socioeconomic levels are currently using the internet with regard to their 
fertility (Weissman et al., 2000). Internet use may also be prone to gender differences. 
With regard to internet use for fertility issues females have been found to be more 
active in its use than males (Haagen, Tuil, Hendriks, de Bruijn, Braat, & Kremer, 
2003). Finally, data may be prone to repeat responders (Gosling et al., 2004), which 
can be more controlled in paper and pencil questionnaires.
On the whole however, reviews of the use of the internet as a tool in 
psychological research have been positively appraised, suggesting the quality of the 
data obtained from such methods are as good as those provided by traditional paper 
and pencil methods (Gosling, Vazire, Srivastava, & John, 2004; Strecher, 2007).
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The Present Study
The main aim of the present study was to determine whether those who seek 
medical care for a fertility problem are different compared to those who do not seek 
treatment. In the present study, 426 women completed an online Treatment Decision- 
Making Questionnaire (TDMQ) posted on a website targeted at couples just starting 
out in the process of trying to conceive. The sample comprised two groups of women 
trying to conceive: those who had not yet sought medical advice (Non-consulters, NC) 
and those who had (Consulters, C).
The variables examined as potential discriminants of consultation status in the 
TDMQ were drawn from the four theories (i.e., theory of planned behaviour, health 
belief model, transtheoretical model and the help-seeking model for infertility) and 
empirical literature on fertility treatment-seeking. Taking a multifactorial approach to 
understanding decision making by combining elements from a number of help- 
seeking theories (as White et al., 2006 proposed) can be an effective way of drawing 
on the individual factors shown by past research to have the most salience influential 
effect on behaviour change to help better understand decision making. Fishbein and 
Yzer (2003) recently endorsed this approach by proposing an integrative model of 
behaviour change that brings together components from the HBM, theory of reasoned 
action and the social cognitive theory showing past evidence of good predictive 
abilities in determining behaviour. In line with theory predictions and previous 
research in other health areas, it was expected that perceptions of one’s fertility (e.g., 
how fertile are you), treatment beliefs, attitudes and knowledge (e.g., treatment is 
invasive), need for parenthood as well as coping strategies and personality traits 
would differentiate these two groups of women seeking/not seeking fertility treatment.
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Method and Materials
Design
A quasi-experimental cross-sectional between subjects design was employed. 
The independent variable was consultation status. Group status was determined by 
whether the participant had had sought (Consulters, C) or not yet sought medical 
treatment (Non-consulters, NC). The dependent variables were responses to 
Treatment Decision Making Questionnaire (TDMQ). The Ethics Committee of the 
School of Psychology, Cardiff University approved the study (for statement of 
approval see Appendix B).
Participants
Over an eight week period the Treatment Decision Making Questionnaire 
(TDMQ) was posted on a website targeted at couples just starting out in the process of 
trying for a child. The final sample consisted of 426 women, of which 48.1% were 
from the United Kingdom (UK), 38.0% from the United States (US) and 13.8% from 
the rest of the world. On average women were 28.61 (SD = 5.23) years of age and had 
been living with their partners for 4.44 {SD = 3.24) years. Of the 426 women 75.1%
{n = 320) were educated to college or university level, 8.0% to trade/technical level, 
13.1% to secondary, 2.8% to primary and 0.9% stated no educational attainments. Of 
the sample 15.4% (n = 64) had children with their current or a previous partner (9.2%, 
n — 39), and 13.4% (n = 57) of male spouses also had children from a previous 
relationship. Women had been trying to conceive for 12.42 (SD = 15.38) months, with 
a range of 0 to 132.
Materials
The TDMQ was designed for this study and addressed issues relevant to 
decision-making as identified in theoretical work and empirical literature. The
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questionnaire comprised of 80 questions in four sections (background information, 
your fertility, engaging in medical treatment and well being). Table Al (see Appendix 
C) shows how each question mapped onto theoretical constructs. The wording of the 
questionnaire was adapted according to whether the participant had (past tense) or had 
not (present tense) consulted a medical doctor.
The background information section consisted of 11 items. Participants 
indicated their gender, current country of residence, their age, their partner’s age, their 
and their partner’s highest educational qualification (0 = none, 1 = primary, 2 = 
secondary, 3 = trade/technical, 4 = college/university), how long they had been with 
their partner and whether they had any children together or separately. For the present 
research one question from the General Health scale (SF-36: Stewart, Hays, & Ware, 
1988) was used to ascertain how healthy the participant currently felt (1 = poor, 2 = 
fair, 3 = good, 4 = very good, 5 = excellent). This item was taken from the Short 
Form-36 health survey and has been widely used with past research showing validity 
with objective measures of health (Stewart et al., 1988). The Short Form 36 Health 
survey (SF-36: Stewart et al., 1988) is a multipurpose, short-form health survey 
consisting of eight scales (36 questions) and has been validated in a variety of medical 
settings (Ware, 2000).
The ‘your fertility’ section contained three items assessing participants 
appraisal of their fertility status (e.g., confidence in their success of conception, how 
fertile they perceived themselves to be, length of time trying). In the ‘engagement in 
medical treatment’ section 32 items were used to assess participants involvement in 
the medical process and the factors that contribute(d) to seeking medical care. 
Participants were presented with 16 reasons for or against seeking medical advice
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developed from the empirical and theoretical literature (1 = contributed not at all -  5 = 
contributed extremely). For example behavioural attitudes towards treatment derived 
from the TPB (e.g. medical treatment is successful, invasive etc.), barrier 
identification derived from the HBM (e.g., complicated to get help), and predisposing 
and enabling conditions drawn from the help-seeking model for infertility (e.g., 
financial cost of treatment). In the current study reliability of the 16 item scale was a 
=0.75. Participants were also presented with 4 positive consequences of seeking 
medical advice (e.g., become a mother, having a happier relationship) and 5 negative 
consequences (e.g. friction with spouse, financially worse off) adapted from the 
Callan et al. (1988) study. Women rated how these consequences would make them 
feel if they happened to them on a Likert scale from bad (-3) to good (+3).
Network beliefs (i.e., subjective norms) were measured using two items which 
assessed to what extent the participant felt that ‘my partner’ or ‘most people who are 
important to me’ would want them to seek medical advice. Motivation to comply was 
measured similarly by two items which assessed the extent to which participants felt 
they generally wanted to do what ‘my partner’ or ‘most people who are close to me’ 
thought they should do. Participants rated the statements on a Likert scale (+3 
“Strongly agree” to -3 “Strongly disagree”: adapted from the Callan et al., 1988 
study). Additionally, participants indicated how comfortable they were about 
confiding in family and friends regarding trying for a child (1 = not very comfortable 
to 5 = very comfortable).
The final section in the TDMQ (‘well being’) assessed strength of desire to 
become a parent, personality traits and coping styles. The need for parenthood scale 
used three items from the Infertility Reaction Scale (Collins, Freeman, Boxer, &
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Tureck, 1992) and three items from the Fertility Problem Inventory (Newton,
Sherrard, & Glavac, 1999) (six items, higher score is greater need for parenthood). In 
the present study reliability for the scale was a =0.73.
The Life Orientation Test (LOT) was used to measure dispositional optimism 
(Scheier & Carver, 1985). The LOT contained 8 items (4 filler items, total =12 items) 
assessing general outcome expectancies (e.g., “Good things usually happen to me”) 
with higher scores indicating greater optimism. Scheier and Carver (1985) report a = 
0.76 reliability of the scale, with a mean LOT score for a normative sample of female 
students was 21.41 (SD = 5.22; Scheier & Carver, 1985). In the current study 
reliability of the LOT was a = 0.85 for the 12-item scale and the mean for the whole 
sample was 18.65 (SD = 5.54).
The Ways of Coping questionnaire (Folkman & Lazarus, 1988) was used to 
assess coping but the original 66-item questionnaire was shortened to 16 items due to 
time limitations of the length of the TDMQ. In the current study items assessed 
problem-focused coping (problem management, problem appraisal), and emotion 
focused coping (emotion focused and escapist) according to Terry & Hynes (1998). 
Higher scores indicated greater use of the coping strategy. Problem management (four 
items) referred to effective attempts to manage a situation (e.g., ‘thought about what 
steps to take to deal with the problem’). Problem appraisal (four items) referred to 
attempts to manage one’s own appraisal of how stressful a situation was (e.g., ‘tried to 
see the positive side of the situation’). Emotion focused (four items) referred to one’s 
emotional reaction to a situation (e.g., ‘let my feelings out somehow’), and escapist 
coping (four items) referred to the avoidance or wishful thinking of a situation (e.g.,
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‘hoped a miracle would happen’). Cronbach’s alpha used to assess reliability was a = 
0.79, a = 0.56, a = 0.66, a = 0.62 for each subscale respectively.
Questionnaire construction.
The online survey was set up by iPsychExpts (Brand, 2005). Webmasters at 11 
websites aimed at couples just ‘starting out’ in the process of trying to get pregnant 
were contacted via email to ask whether they would post the TDMQ on their site. It 
was decided to intentionally avoid sites devoted to people who already had fertility 
problems. The TDMQ was placed on the only site that replied (i.e., 
gettingpregnant.co.uk).
Procedure
A sentence about the questionnaire (“Survey for people currently trying to 
conceive”) and an option button was placed at the top of every page on the website. 
Clicking on the option button took the participants to a consent form and description 
of the content of the questionnaire (see Appendix D). To continue to complete the 
questionnaire participants were asked to give their consent by following the 
instructions, otherwise they could close the page and leave the questionnaire. 
Questions were presented in specific sections outlined above and once a participant 
clicked to move to the next page they were unable to go back and change answers. 
Throughout the questionnaire participants had the option to click out and close the 
questionnaire with no data being submitted. Once they came to the final page they 
were given a more detailed explanation of the study and the option to submit their 
data if they wished. The questionnaire took around 10-15 minutes to complete.
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Data analysis
Preliminary data screening produced 57 participants that were excluded from 
analyses due to incomplete (>50% of data missing) or invalid data. In addition, the 
only 10 male participants were excluded because they were too few to analyse 
separately. Finally, 5 outliers (>3 standard deviations ± the mean) were identified and 
excluded, leaving a final sample of 426 female participants.
Multivariate analyses of variance (MANOVA) were carried out to examine 
differences between Consulters and Non-Consulters on all variables (except 
demographic characteristics which were compared using t-tests). If the multivariate F- 
test was significant, then single degree freedom t-tests were examined to determine 
those variables that maximally discriminated between Consulters and Non-consulters. 
This approach reduced the risk of alpha inflation associated with multiple testing. In 
addition, a factor analysis using varimax orthogonal rotation was used to group (and 
reduce) the 16 reasons that contribute(d) to seeking medical advice (in the 
‘engagement in medical treatment5 section). Factor loadings above .30 were 
considered significant and presented (Tabachnik & Fidell, 2001). All variables found 
to be significant at the univariate level were included in a logistic regression to 
determine factors that were associated with treatment seeking behaviour (coded as 1). 
Significant variables were entered as blocks in the following order: traits (i.e., coping 
variables), fertility appraisal (i.e., perception and confidence of fertility), decision 
making factors (i.e., factors contributing to and consequences of treatment seeking), 
and accessibility (i.e., treatment cost). The Wald statistic and odds ratio (± 95% 
confidence interval [Cl]) are presented.
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Reliability was conducted on all the scales using Cronbach alpha (a). Values 
between 0.70 -  0.80 indicate acceptable reliability (Field, 2005). A probability value 
of p<0.05 was regarded as statistically significant. All analyses were performed with 
the software Statistical Package for the Social Sciences (SPSS).
Results
Engagement in the Medical Process
In total 56.57% (n = 241) of women had not consulted a doctor about 
conceiving (Non-consulters, NC) and 43.43% (n = 185) had already done so 
(Consulters, C). On average the Consulters had been trying to conceive for 19.14 
months (SD = 18.76) and the Non-consulters for 7.24 months (SD = 9.32). The 
average time since first consultation was 8.79 (SD = 14.32) months for those who had 
sought advice. Women who had not sought advice said they would do so after a 
further 10.21 months (SD = 7.06) of trying.
Factors Associated with Decision Making Regarding Treatment Seeking Behaviour 
Background information.
As shown in Table 3.2 compared to Consulters, Non-consulters and their 
partners were younger and had been with their partner for less time. No significant 
difference was found between groups for country of residence, or level of education, 
with the majority of the sample (75%) educated to college/university level. There 
were no differences in the number of previous children (current partner, previous 
partner or step children) between Non-consulters and Consulters, with 15% of the 
sample having previously given birth. Finally, there was no difference between groups 
on the SF-36 General Health question assessing participants overall health (7(424) = 
0.21, P = 0.84) with both Consulters and Non-consulters rating their current health as 
good to very good (sample M — 3.47, SD = 0.88).
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Table 3.2
Demographic characteristics according to consultation group.
Background Information Whole Sample 
N = 426
Consulter 
(n = 185)
Non-consulter 
(n = 241)
t Degrees of 
freedom
P value
Mean (SD)
Female age 28.61 (5.23) 29.45 (5.22) 27.96 (5.15) 2.95 424 0.003
Partner age , 30.89 (5.93) 31.66 (5.98) 30.31 (5.83) 2.35 424 0.019
Years together 4.44 (3.24) 5.11 (3.32) 3.93 (3.09) 3.81 424 0.001
Range 0-21
General health (SF-36)8 3.47 (0.88) 3.46 (0.93) 3.48 (0.85) 0.21 424 0.837
Country of residence n(%) x2
United Kingdom 205(48.12) 93 (50.27) 112(46.47) 4.51 2 0.11
United States of America 162 (38.03) 61 (32.97) 101 (41.91)
Other 31 (16.76) 28(1.62)
Education
College/University 320(75.12) 140 (75.68) 180 (74.69) 2.32 4 0.68
Trade/technical 34 (7.98) 11 (5.95) 23 (9.54)
Secondary 56(13.15) 27 (14.59) 29 (12.03)
Primary 12 (2.82) 5 (2.70) 7 (2.90)
None 4 (0.94) 2(1.08) 2 (0.83)
Secondary 56(13.15) 27 (14.59) 29 (12.03)
Previous children
Current partner 64(15.02) 29(15.68) 35 (14.52) 0.11 1 0.74
Previous partner 39 (9.15) 20(10.81) 19 (7.88) 1.08 1 0.30
Step children
a x T *. i . ~ 57 (13.38) 28(15.14) 29 (12.03) 0.87
1 0.35
‘Higher scores means more of the attribute.
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Fertility characteristics,
A MANOVA comparing Consulters and Non-consulters on fertility 
perceptions was significant (Pillais = 0.16, Multivariate F(3,417) = 26.89, P = 
0.001). As shown in Table 3.3 univariate follow-up tests were significant for all 
variables. Non-consulters had significantly more confidence in their fertility, were 
more optimistic about their chances of conceiving, and had been trying for fewer 
months to conceive.
Table 3.3
Fertility characteristics according to consultation group.
Your Fertility Whole Sample 
N = 426
Consulter 
(n = 185)
Non-consulter 
(n = 241)
t Degrees of 
freedom
P value
Months trying to 
conceive 
Range
12.42 (15.38) 
0-132
Mean (SD) 
19.14(18.76) 7.24 (9.32) 8.54 421 0.00
Confidence in 
fertility 
Range (0 -100%)
59.30(29.51)
0 - 99
52.76 (29.20) 64.32 (28.82) 4.08 424 0.00
Perception of 
fertility*
2.78 (0.83) 2.53 (0.80) 2.97 (0.80) 5.58 422
“Higher scores means more of the attribute (1 = Not at all to 5 = Extremely).
Engagement in medical treatment
To group (and reduce) the 16 reasons that contribute(d) to seeking medical 
treatment a factor analysis was computed. Table 3.4 shows factor loadings for each 
variable for each component extracted. Four factors were extracted and were labelled 
as follows; (1) ‘fertility and treatment beliefs’ consisted of items concerned with 
fertility awareness and beliefs and attitudes toward treatment and its accessibility, (2) 
‘discovery threat’ consisted of items concerned with being labelled/diagnosed, and its 
effect (e.g., disrupt marital relationship), (3) ‘treatment safety & comfort’ consisted of 
items about the complexity of fertility treatment and being comfortable with
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disclosure, (4) ‘confidentiality and reassurance’ consisted of items concerned with 
privacy and desired outcomes of medical consultation, and finally; (5) treatment cost.
Table 3.4
Factor loadings for TDMQ items according to exploratory factor analysis.
Engagement in Medical 
Treatment
Fertility and 
Treatment 
Beliefs
Label
Discovery
Threat
given to factor 
Treatment 
Safety & 
Comfort
Confidentiality 
& Reassurance
Treatment
cost
Complicated to get help 0.83
Success of medical 0.80
treatment
How to get help 0.77
For/against medical 0.69 0.33
interventions
Had a problem -0.58 0.45
Being labelled 0.79
Scared of what doctor 0.77
might say
Told about fertility 0.48 0.56
Disrupt relationship 0.43
Medical treatment 0.74
invasive
Worry 0.69
High-tech procedure 0.33 0.57
Embarrassment 0.55
Talk confidentially 0.81
Reassurance 0.77
Finance 0.89
Eigenvalue 4.10 2.14 1.56 1.07 1.01
Percent variance 25.62 13.36 9.76 6.68 6.31
Note .Only factor loadings >0.30 presented. Items were assigned to factors with highest loadings.
A MANOVA comparing Consulters and Non-consulters on factor scores was 
significant (Pillais = 0.79, Multivariate F{16,409) = 97.45, P = 0.001). Univariate 
follow-up tests were significant for most factors. As shown in Table 3.5, ‘Fertility and 
treatment beliefs’, ‘Discover threat’ and ‘Treatment safety and comfort’ contributed 
more to decision making for the Consulters compared to the Non-consulters, whereas 
‘Treatment cost’ contributed more for the Non-consulters. No difference between 
Consulters and Non-consulters was found for the factor ‘Confidentiality and 
reassurance’.
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Table 3.5
Means (SD) for TDMQ factors according to consultation group.
Engagement in Medical 
Treatment
Consulter 
(n = 185)
Non-consulter 
(n = 241)
t Degrees of 
freedom
P value
Fertility and treatment 
beliefs
Mean (SD)
3.21 (0.73) 2.12(0.53) 17.98 424 0.001
Discovery threat 2.68 (0.67) 2.25(1.03) 4.97 424 0.001
Treatment safety & 
comfort 2.27 (0.83) 1.95 (0.81) 4.07 424 0.001
Confidentiality and 
reassurance 3.78(1.02) 3.73 (0.96) 0.53 424 0.598
Treatment cost 2.12(1.30) 3.18(1.46) 8.15 424 0.001
Note. For all items higher scores means more of the attribute.
The MANOVA on consequences of seeking treatment was significant (Pillais 
= 0.07, Multivariate F(9,416) = 3.61, P = 0.001). Univariate follow-up tests revealed 
that Non-consulters rated being financially worse off from seeking medical treatment 
as more negative compared to Consulters (7(424) = 1.98, P = 0.05) and believed 
seeking treatment would result in a happier relationship and marriage compared to the 
Consulters (t(424) = 3.30, P = 0.001). Finally, Consulters rated talking to someone 
about fertility concerns as a greater consequence of seeking medical treatment than 
did the Non-consulters (/(424) = 2.35, P = 0.02).
The MANOVA on subjective norms and social influence was significant 
(Pillais = 0.03, Multivariate F(5,420) = 2.51, P = 0.03). Follow-up tests showed that 
Non-consulters were less likely to perceive close family and friends to want them to 
seek advice than Consulters (see Table 3.6). No differences were found between Non- 
consulters and Consulters for the complying with friends and families wishes to seek 
medical treatment or any of the partner variables. Consulters scored marginally higher 
on comfortable confiding in others compared to Non-consulters (P =0.06).
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Table 3.6
Means (SD) for network beliefs and motivation to comply according to consultation group.
Normative beliefs and motivations 
to comply
Consulter 
(n = 185)
Non-consulter 
(n = 241)
t Degrees of 
freedom
P value
Mean (SD)
My partner wants me to seek medical 1.76(1.46) 1.54(1.50) 1.57 424 0.118
advice
I do what my partner thinks is best 0.96(1.46) 1.07(1.55) 0.80 424 0.425
People important want me to seek 2.22(1.15) 1.98(1.28) 2.02 424 0.044
medical advice
I do what people important to me think -0.02(1.71) 0.24(1.69) 1.56 424 0.120
I should do
Comfortable confiding with others 3.48(1.41) 3.22(1.49) 1.86 424 0.063
Note. For all items higher scores means more of the attribute.
Well being.
A MANOVA indicated significant multivariate group effects for all the well 
being questions (Pillais = 0.04, Multivariate F(6,419) = 2.66, P = 0.02). As shown in 
Table 3.7, the Non-consulters used problem focused coping (i.e., problem appraisal) 
more frequently, and were less likely to use emotion-focused (i.e., escapist) coping 
strategies compared to the Consulters. Both the Consulters and Non-consulters scored 
highly on the need for parenthood question (sample M — 21.24, SD = 4.24), and did 
not differ on this variable. No difference was found for level of optimism with the 
sample mean 18.56 (SD = 5.54).
Table 3.7
Means (SD) for personality and coping according to consultation group.
Well Being Consulter 
(n = 185)
Non-consulter 
(n = 241)
t Degrees of 
freedom
P value
Mean (SD)
Need for parenthood (6 items, 
total = 30)
21.44(4.28) 21.09(4.22) 0.86 424 0.391
How optimistic are you (Life 
Orientation Test, 12 items)
18.11 (5.49) 19.06 (5.55) 1.75 424 0.081
Coping style (THWC, 16 items)
Problem management 7.38 (2.47) 7.30 (2.72) 0.33 424 0.740
Problem appraisal 5.21 (2.12) 5.78(2.13) 2.76 424 0.006
Escapist 6.04 (2.63) 5.51 (2.61) 2.08 424 0.038
Emotion focused 6.70(1.90) 6.64(2.10) 0.323 424 0.747
Note. For all items higher scores means more of the attribute.
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Multivariate analysis.
All significant univariate analyses were included in a logistic regression. Table 
3.8 shows regression coefficients, Wald statistics, odds ratios and confidence intervals 
(Cl). Variables were entered in the following steps. Personality traits (e.g., coping 
styles) were entered first, then factors associated with fertility appraisal (e.g., 
perception of fertility status), then decision making factors (e.g., factors that 
contributed to decision making about treatment and the consequences of seeking 
medical help). Finally, accessibility to treatment (e.g., cost of treatment) was the last 
step.
As Table 3.8 shows all steps were significant, as was the overall model. Using 
problem appraisal coping was significantly associated with a lower likelihood of 
seeking medical treatment whereas the opposite was true for women using escapist 
coping. Women who had been trying for a longer number of months to conceive were 
4.46 (Cl = 2.74, 7.27) times more likely to have sought medical treatment. In addition 
being older was associated with a higher likelihood of seeking medical help.
However, having a positive perception of one’s fertility potential was associated with 
not seeking treatment.
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Table 3.8
Summary statistics for logistic regression (n = 424) examining the associations between significant univariate correlates and the outcome o f seeking medical treatmenf.
TDMQ Questions Coefficient Standard Wald Significance level Odds ratio 95% C.I
_____________________________________________ (J3)__________ Error________ Statistic_________________________ (OR)___________ Lower Upper
Traits
Problem appraisal (THWC) 
Escapist (THWC)
Block (x2=12.18, df=2, P=0.002)
-0.13
0.08
0.05
0.04
7.47
4.90
0.01
0.03
0.88
1.09
0.80, 0.96 
1.01, 1.17
Fertility Appraisal
Infertileb
Female age
Confidence in fertility
Perception of fertility
Block (x2=77.48, df=42, P=0.002)
1.50
0.06
0.00
-0.45
0.25
0.02
0.00
0.18
36.03
7.89
0.68
6.33
0.001
0.001
0.41
0.01
4.46
1.06
1.00
0.64
2.74, 7.27 
1.02, 1.11 
0.99, 1.01 
0.45, 0.91
Decision Making Factors
Factors contributing to decision making 
Fertility and Treatment Beliefs 
Discovery Threat 
Treatment safety & comfort 
Confidentiality and reassurance 
Consequences of treatment 
Financially worse off 
Happier relationship and marriage 
Talking to someone about fertility concerns 
People important want me to seek medical 
advice
Block (x2=204.39, df=8, P=0.001)
2.93
-0.05
-0.37
-0.52
0.14
-0.41
0.31
0.19
0.31
0.19
0.22
0.18
0.13
0.14
0.16
0.13
87.26
0.06
2.86
8.19
1.04
8.22
3.97
2.12
0.001
0.81
0.09
0.001
0.31
0.001
0.05
0.15
18.73
0.95
0.69
0.59
1.15
0.66
1.37
1.21
10.13,34.63 
0.65, 1.40 
0.45, 1.06 
0.41,0.85
0.88,1.49 
0.50, 0.88 
1.01, 1.85
0.94, 1.56
Accessibility
Treatment cost
Block (x2=90.08, df=l, P=0.001)
-1.34 0.19 52.10 0.001 0.26 0.18, 0.38
Overall model (*2=384.12, df=15, P=0.001)
Note. For all items higher scores means more of the attribute
“Dependent variable was 0 = Not consulted, 1 = Consulted. bInfertile refers to trying for more than 12 months to conceive (coded 1 = > 12months trying to conceive).
70
Chapter 3 Treatment seeking behaviour
With reference to the five factors produced from the factor analysis, ‘Fertility 
and treatment beliefs’ showed a strong association with treatment seeking behaviour, 
whereas having concerns with ‘Confidentiality and reassurance’ was associated with 
not seeking treatment. In addition concerns about ‘Treatment cost’ were associated 
with a lower likelihood of seeking medical treatment. Women who believed treatment 
allowed one to talk to someone about fertility concerns were 1.37 (Cl =1.01,1.85) 
times more likely to seek medical treatment. Conversely, believing treatment would 
result in a happier relationship and marriage was associated with a lower odds of 
seeking medical treatment. Being financially worse off as a consequence of seeking 
treatment was not significant nor was having important people close to you wanting 
you to seek medical advice in the multivariate model. The factor ‘Fertility and 
treatment beliefs’ had the largest odds ratio associated with treatment seeking (OR 
18.73, Cl = 10.13, 34.63) and ‘Treatment cost’ the largest odds ratio associated with 
not seeking treatment (OR 0.26, Cl = 0.18, 0.38).
Delayed Help-Seeking
One question raised by the results is whether the women who had not yet 
consulted a doctor should have been seeking medical advice. According to UK 
national guidelines, women should seek medical attention after 12 months of regular, 
unprotected intercourse (or 6 months if the woman is > 35 years) (National Institute of 
Clinical Excellence [NICE], 2004). The number of women who attained the criterion 
threshold when medical advice would typically be recommended in practice 
guidelines was therefore examined. In total 17.43% {n = 42) of NC women met the 
NICE criteria for referral to specialist fertility services.
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In a secondary analysis this sub-group of women were examined to establish 
whether their scores altered the pattern of results presented by comparing them 
(labelled Delayers, n = 42) to the remaining Non-Consulters (n = 199). All significant 
univariate analysis conducted on the Non-consulters and Consulters were re-analysed 
in the secondary analysis. As Table 3.9 shows most comparisons were not significant, 
but a few important differences emerged (after Bonferroni correction, P < 0.003). 
First, Delayers had been trying to conceive for longer, perceived themselves as less 
fertile and were less confident in their ability to conceive naturally compared to the 
remaining group of Non-consulters, further ‘Discovery threat’ was significantly 
higher for the Delayers compared to the remaining Non-consulters.
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Table 3.9
Mean (SD) for significant univariate correlates o f decision making for Delayers and Non-consulters.
TDMQ Questions Delayers
(n=42)
Non-consulter 
(n = 199)
t P value
Background Information 
Female age
Mean (SD)
27.81 (6.42) 27.99(4.86) 0.21 0.84
Your Fertility
Months trying to conceive8 22.98 (12.07) 3.88 (3.24) 19.30 0.001*
Confidence in fertility 36.93 (28.39) 70.10(25.44) 7.52 0.001*
Perception of fertility8 2.36 (0.79) 3.10(0.74) 5.81 0.001*
Engagement in Medical Treatment 
What contributes (a)/contributed (b) to 
seeking medical advice 
Fertility and treatment beliefs 
Discovery threat 
Treatment safety & comfort 
Confidentiality and reassurance 
Treatment cost
2.32 (0.74) 
2.67(1.08) 
2.21 (0.95) 
3.89(1.17) 
3.67(1.56)
2.08 (0.47) 
2.16(1.00) 
1.90(0.76) 
3.70 (0.91) 
3.08(1.42)
2.80
2.95
2.31
1.21
2.39
0.01
0.001*
0.02
0.23
0.02
How does each consequence make you feel 
Financially worse off 
Happier relationship and marriage 
Talking to someone about fertility 
concerns
-1.02(1.39) 
2.43 (1.25) 
1.86(1.59)
-1.23 (1.07) 
2.31 (1.06) 
1.72(1.12)
1.08
0.66
0.67
0.28
0.51
0.50
How strongly do you agree with the 
following:
People important want me to seek medical 
advice
2.14(1.24) 1.95(1.30) 0.91 0.36
Well Being 
Coping style (THWC) 
Problem appraisal 
Escapist
5.74 (2.43) 
6.05 (2.59)
5.79 (2.07) 
5.40(2.61)
0.14
1.47
0.89
0.14
Note .Degrees of freedom = 239. “Degrees of freedom = 237. Significant after Bonferroni adjustment
(P < 0.003).
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Discussion
The aim of the study was to examine psychological factors associated with 
decision-making about pursuing medical help for fertility issues. The findings 
revealed that women’s knowledge about their fertility (i.e., awareness that a problem 
existed) and their emotional reactions to that knowledge (i.e., discovery of a problem, 
being labelled infertile) were the core motivating forces behind engaging in the 
medical process.
Previous research has suggested that those who seek treatment for a fertility 
problem are characteristically different to those who do not, on a variety of socio­
demographic and trait variables. The present results lend support to such a statement, 
and in addition, validate the use of the internet as a valuable tool in accessing women 
currently trying to get pregnant. The results reveal that those who had sought 
treatment had positive treatment beliefs, a willingness to know if a problem existed 
and were more aware of their fertility potential. Consulters were more concerned with 
factors associated with how to get help, knowing where to get help and the ease of 
obtaining help. The Non-consulters were more confident about their fertility potential 
but reported greater worry of the diagnosis that could occur if they sought help. 
Moreover treatment costs were more of an issue for the Non-consulters than the 
Consulters.
Detailed analyses of the non-consulters revealed two potential groups of 
people who had yet to seek medical advice (those who had been trying for more than 
12 months [Delayers] and those who had not [rest of the Non-consulters]). For the 
majority of the Non-consulters their confidence in their fertility and inaction to seek 
advice may be justified; when the Delayers are removed from this group the Non-
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consulters had only been trying to conceive on average for 3.88 months. Given 
fecundity rates, there were good chances that most of these women would eventually 
conceive naturally (NICE, 2004). In contrast, the Delayers, who accounted for about 
20% of those that had not consulted, had been trying for nearly two years (22.98 
months). They were very pessimistic about their chances of getting pregnant naturally 
yet had never sought any medical advice/treatment, even though seeking advice was 
clearly warranted. Although many results were similar for the NC versus Delayers, 
there were some important differences as will be discussed.
Specifically the threat associated with the discovery of a fertility problem was 
critical to decision making for the Delayers. Specifically, worry about being labelled 
and diagnosed infertile coupled with not wanting to know that one had a fertility 
problem were major barriers to seeking help. Feelings of shame to expose a problem 
have been found in other fertility research (van Balen et al., 1997b). Moreover, fear 
has been shown to have an effect in decision making in many other health areas (e.g., 
breast and prostate cancer screening; Consedine, Magai, Krivoshekova, Ryzewicz, & 
Neugut, 2004; Consedine, Morgenstem, Kudadjie-Gyamfi, Magai, & Neugut, 2006). 
Research on cancer suggests that those who are most distressed about the possibility 
of a diagnosis are the slowest to seek help (Bish et al., 2005; Grunfeld, Hunter, 
Ramirez, & Richards, 2003). Applied to infertility, this suggests that those for whom a 
diagnosis of infertility would be most threatening, as would seem to the case with 
Delayers, might postpone (perhaps indefinitely) a visit that could confirm their worst 
fears (White et al., 2006).
Conversely, previous research has highlighted that those who are over anxious 
may seek medical advice sooner or more frequently, i.e. seeking medical advice after
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2-3 months of trying (White et al., 2006). The current study found a wide range in the 
number of months before consulting (1 - 47  months, M — 8.79, SD = 14.32). One 
cannot however determine why some women sought treatment earlier than others 
' because data was not collected on factors that might have predisposed one to seek 
treatment early (e.g., known reproductive problems). Personality traits (e.g., 
monitoring and blunting, S. M. Miller, 1987) might shed light on early treatment 
seeking as these determine a person’s behavioural reaction to everyday health 
dilemmas. However, in the current study the measured personality variables (e.g., 
optimism) were not associated with decision-making. This may be because the 
relevant personality dimensions were not assessed. In order to determine if, and to 
what extent such variables affect decision making future studies may need to assess a 
broader range of traits (e.g., monitoring and blunting: S. M. Miller, 1987).
There were unexpected findings for coping variables in that consulters were 
using less problem appraisal (e.g. saw less the positive side of the situation) and more 
escapism (e.g. more hoping that a miracle would happen). This is unexpected as prior 
research suggests problem focused coping (e.g., problem appraisal) is often linked to 
direct and effective management whereas emotion focused coping (e.g., escapism) is 
often viewed as inhibiting or delaying effective action. Verhaak et al., (2005) reported 
that dealing with infertility requires a number of coping strategies whose nature may 
change over time as failed attempts to conceive and reassessment of the goal (i.e., 
importance of becoming a parent) occurs (Verhaak et al., 2005). As emotional 
functioning was not assessed in the present sample one cannot say whether this 
seemingly ineffective pattern of coping would be associated with poorer mental health 
outcomes as has been shown in more advanced stages of treatment since variables
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were not measured but this is an issue that clearly warrants further investigation 
(Terry & Hynes, 1998).
Theoretical Implications
Four social cognition models were used to make predictions about help 
seeking behaviour (see Table 3.1, page 44). Being aware of one’s own fertility was 
found to be a main determinant of seeking medical help, as predicted by all the 
proposed models/theories. Another key prediction was also supported. Three of the 
models and theories (TPB, TTM and HBM) postulated that action/behaviour change 
would occur if one held positive attitudes towards the behaviour (TPB), and beliefs 
that the benefits of taking action would outweigh the negatives (TTM and HBM). In 
the present study the women who had consulted were more likely to possess positive 
treatment beliefs and attitudes surrounding the treatment process, for example, having 
confidence in medical interventions, believing treatment to be successful and knowing 
where to get medical help. Further, as predicted by three theories/models (TPB, HBM 
& Help-seeking model for infertility) sociodemographic and demographic variables 
differentiated the Consulters to the Non-consulters. For example, Non-consulters were 
more concerned with the financial burden of seeking treatment.
A few predictions were not supported in the present study. Firstly, limited 
support for the prediction that social pressures (e.g., subjective norms, and normative 
beliefs) impact on decision making regarding action/behaviour change was found. In 
support the Non-consulters were less likely to perceive close family and friends to 
want them to seek advice than Consulters. However, partner variables, motivation to 
comply, and comfort disclosing information to close family and friends were not 
associated with decision making, suggesting that social norms and pressures did not
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have as much influence in fertility decision-making as they appear to have in other 
areas of health. With regards to fertility issues it may be that people feel 
uncomfortable about discussing their concerns. Adashi et al. (2000) report that 
infertility is still surrounded by taboos and it is often difficult for couples to address 
this problem openly. Indeed Consulters reported that a positive consequence of 
seeking medical treatment would be having someone to talk to about fertility 
concerns, which may suggest a desire to disclose and talk about a topic that may not 
be discussed openly among family and friends. In a recent investigation Peronace, 
Boivin, and Schmidt (2007) found that couples’ willingness to speak to family and 
friends about fertility problems decreased over time as they experienced failed 
treatments. All the theories propose that social pressures are important in behaviour 
change so it would be important in future studies to establish in more detail how much 
of a role family and friends play towards decision making with regards to situations 
that are usually seen as private, discrete and often embarrassing.
Finally, all the stages of the TTM could not be adequately assessed in the 
current study due to the design employed (Cross sectional). In the current study the 
only stages that could be measured were the precontemplation, contemplation, action 
stage and preparation stage. In this cross-sectional investigation those who had not yet 
taken action (Non-consulters) were more confident and optimistic that they would 
eventually conceive, a feeling justified by the fact that they had been trying for few 
months, and these people could be seen to be in the Pre-contemplation stage. The 
Delayers might be placed more in the Contemplation stage since they had lost 
confidence in their ability to conceive after a long period of unsuccessful attempts but 
had not yet taken action due to fears about the implication of seeking help. In 
comparison, those who had taken action were clearly more positive about treatment
78
Chapter 3 Treatment seeking behaviour
and more willing to know about a fertility problem, as one would expect in the Action 
stage. Although the results are in keeping with what might be expected only 
longitudinal data would be able to test the transition from each stage proposed in the 
model, assess the time with which people take to move from one stage to another, and 
study what women do after initial action (consulting a doctor) has occurred.
Taken together the results lend support to all the theories and models proposed 
especially in relation to the fact that being aware of a problem existing and having 
adequate knowledge about how to get help are key determinants supported. However 
these results may lend more support to the HBM, TTM and Help-seeking model for 
infertility than the TPB as a main prediction of the TPB is that a person’s intention to 
perform a certain act is determined largely by his/her attitude and the attitudes of 
others in their environment toward the act (Callan et al., 1988). A prediction not fully 
supported in the current study. On a cautionary note, the aim of the study was to take 
a multifactorial approach, using a limited number of questions and it may therefore be 
that each theory/model was not sufficiently covered to test specific model predictions.
Methodological Implications and Limitations
The methodology proved successful. In 8 weeks the study recruited 426 
women currently trying to conceive consisting of both those who had and had not 
previously sought treatment, showing a good representation in terms of critical sample 
characteristics (e.g., age, month trying, and medical consultation). A criticism of 
internet studies is that they may consist mainly of women already in treatment that 
have spent years trying to conceive (Greil & McQuillan, 2004); however while this 
sample did include women who had been trying for a long time, it also included 
women at the very early stages of trying to conceive (31.9% of the sample had been
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trying for < 3 months, 17.6% for 3 -  6 months, 17.6% for 6 - 1 2  months and 32.2% 
more than 12 months) and compared to typical findings in women undergoing in vitro 
fertilisation, an advanced fertility intervention (e.g., female age, M=  34 years, Boivin 
& Schmidt, 2005) the women in the current study were younger, had been with their 
partners for less time and, more importantly, had not been trying to conceive for as 
long. The mean age of the sample (M= 28.61, SD = 5.23) was also in keeping with 
the mean age of first birth in the UK (M= 27.1, Social Trends 33, 2000: Office for 
National Statistics). A further benefit is the anonymity that the internet offers, which 
makes it a useful research tool to access couples who can discuss and relay their 
opinions on the very private matter of infertility without having the worry of their 
identity being revealed.
Three other methodological issues warrant comment. First, the current 
findings provide important information about the nature of variables that might be 
critical in motivating people to seek medical help. However, cross-sectional designs 
can only offer information about associations and not cause and effect. For example, 
positive treatment beliefs were higher in Consulters than the Non-consulters but it 
cannot be ascertained whether this means that positive treatment beliefs increase 
treatment seeking behaviour, treatment seeking behaviour increases positive treatment 
beliefs, or whether both occurs. The results of this study have made an important 
contribution in identifying that those variables warrant further study, not that they are 
causal. Only a prospective longitudinal investigation of the same women can provide 
definitive conclusions ubout the true causes of seeking medical help. In such a design, 
psychological assessments would take place when couples started trying to conceive, 
and would continue periodically until such efforts were discontinued. It would then be 
possible to examine the pre-consultation psychological processes of those who
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subsequently engaged in the medical process, how it changed as a result of their 
medical experiences and/or how it differed from the profile of those who never 
subsequently consulted. This methodology would also be an important way to 
evaluate the predictive value of the models proposed.
A second limitation was the bias potentially introduced by the high level of 
education of most women in the sample (75.1% educated to college or degree level). 
Although this could suggest a bias due to internet services being mainly available 
and/or used by those in higher socioeconomic status it may also be a result of the use 
of ‘college’ in the education response scale. In the UK (where 50% of the sample 
resided) ‘College’ can encompass a wide selection of qualifications from GCSE 
(General Certificate of Secondary Education) level to Degree and as only 16% of 
people of working age do not have qualifications in the UK (see United Kingdom 
Annual Population Survey, Office of National Statistics, 2004a) using this scale may 
have therefore lead to more women being classified in the highest educational group. 
This methodological issue may also explain why the present study did not support 
previous results showing that level of education is a significant predictor of treatment 
seeking behaviour (Schmidt et al., 1995; Wulff et al., 1997; Wyshak, 2001). In future 
it may be of use to ask participants their highest educational qualification.
A final limitation is that only 10 men responded to the survey, which was too 
few to analyse separately. There could be a number of reasons for this. Men often 
have a poor knowledge of matters related to health and they are less likely than 
women to seek help from health care professionals when they are ill (Banks, 2001). 
With reference to infertility interviews, married infertile couples show that throughout 
the treatment process, it is the female partner who takes the leadership role, regardless
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of who had the reproductive impairment, with the female partner typically the one to 
suggest new treatment options (Greil, Leitko, & Porter, 1988). Further, many of the 
websites available to couples who are facing difficulties in getting pregnant are 
female orientated, therefore when a man searches the internet for information on 
fertility problems and conception they may not be drawn to look at sites named 
gettingpregnant.co.uk, babyzone.com or thelaboroflove.com, which were the sites 
targeted. It may be the case that men would fill out such questionnaires if they were 
on male oriented health sites (e.g., Men’s Health, GQ and FHM), and such sites ought 
to be targeted in future studies. It would be imperative for future research to assess 
men’s perspectives on fertility decision making.
Clinical Implications and Future Directions
Couples faced with infertility have to cope with a complicated decision 
making process involving several options for a successful resolution of this crisis (van 
Balen et al., 1997b). Ultimately, if people do not have the correct information, 
judgements regarding resolution of a problem will be based on unfounded beliefs.
One way to improve decision-making would be to increase knowledge about 
infertility and the reliable solutions to this health problem, allowing people to be 
better able to evaluate information they come across and therefore make decisions that 
will improve their chances of reaching their parenthood goal. The results of the 
present study affirm the need for practical information about conceiving with medical 
help and further, support research by Dyer, Abrahams, Hoffman, and van der Spuy 
(2002) suggesting that interventions that include accurate and valid information and 
good health education will be the most effective in helping women in accessing 
medical care, complying with treatment and dealing with the possibility of 
childlessness.
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The results from the current study highlight that women’s knowledge about 
their fertility (i.e., awareness that a problem existed) was a key determinant for 
seeking medical treatment. In order for people to be able to assess their own fertility 
and become aware of existing problems they need to possess knowledge about 
fertility more generally (e.g., how long is too long to be trying to conceive? what are 
the factors that may impact on fertility potential?). Therefore the next chapter will 
assess knowledge regarding the factors associated with female infertility.
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Chapter 4
Knowledge about infertility risk factors, fertility myths and illusory 
benefits of healthy habits in young people
Introduction
The results of Chapter 3 highlighted that having an awareness that a problem 
exists is a key factor associated with the seeking of medical advice and initiation of 
treatment and that education about fertility issues is needed to prevent fear (i.e., fear 
of being labelled infertile or fear of what the treatment process entails) and potential 
unnecessary delay in seeking help when faced with problems conceiving. Knowledge 
about fertility health issues may also help prevent infertility in the first instance; for 
example, more information and advice regarding curable sexually transmitted diseases 
could reduce the number of cases of infertility, particularly in less developed 
countries, such as Africa where most cases of infertility are due to infection (W. Cates 
et al., 1985). However, there is a lack of fertility knowledge in the general population. 
The aim of the current chapter was to assess people’s knowledge about factors that 
may impact on fertility self-care (i.e., knowing and taking care of your own fertility 
potential).
Fertility Knowledge and Knowledge of Infertility Risk Factors
One would assume that most adults know about human reproduction (e.g., 
how to get pregnant). Research however would suggest otherwise; a global survey of 
almost 17,500 people (most of childbearing age) from 10 countries in Europe, Africa, 
the Middle East and South America, revealed that on the whole level of knowledge 
regarding fertility and the biology of reproduction was very poor (World Fertility 
Awareness Month; 2006). Other studies have found that participants overestimate the 
chances of pregnancy at time of ovulation (Lampic et al., 2006), have little awareness
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of when they are most fertile, and lack a general understanding of infertility, such as a 
definition and its prevalence within the general population (Blake et al., 1997; Adashi 
et al., 2000). With regards to infertility treatment, although most were aware of in 
vitro fertilisation (IVF) (Adashi et al., 2000) many overrated the chance of treatment 
being successful with 39% believing that couples had a success rate of achieving a 
live birth between 40-100% (Lampic et al., 2006) when in reality the per cycle 
success rate is closer to 20% (Adamson, de Mouzon, Lancaster, Nygren, Sullivan, & 
Zegers-Hochschild, 2006).
Knowledge studies to date have primarily focused on knowledge about the 
biological process of reproduction (e.g., when is a woman fertile, how long sperm 
survive) and the definition and prevalence of infertility. These are important issues to 
address as they help people understand when is the best chance of pregnancy (e.g., 
timing of unprotected intercourse), and the likelihood of having difficulties 
conceiving (e.g., number of couples affected by infertility). However, equally 
important is knowledge about the factors that may reduce the chances of conception 
as a lack of knowledge in these areas may mean that people unintentionally contribute 
to their own future fertility problems. Scarcely any studies have examined whether 
people are aware of the main lifestyle (e.g., smoking, alcohol consumption; Roth and 
Taylor, 2001) and reproductive (e.g., menstrual cycle irregularities; Koff, Rierdan, & 
Stubbs, 1990) risk factors for infertility. Research focusing on age (Lansac, 1995; 
Lampic et al., 2006; Skoog Svanberg et al., 2006) and sexually transmitted 
diseases/infection ([STD/STFs] e.g., increased risk of tubal damage, Mosher and 
Aral, 1991) also shows a lack of general knowledge. In light of such work it is 
imperative to assess understanding of the effects of other factors associated with 
reduced fertility.
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Numerous factors have been associated with reduced fertility problems in 
women that cover demographic information (e.g., age), reproductive history (e.g., 
menstrual cycle characteristics, history of pelvic surgery), and current lifestyle habits 
(e.g., alcohol consumption, smoking). The aim of the current study was to establish 
knowledge regarding risk factors associated with infertility in a young, university- 
educated sample, who should demonstrate the highest level of fertility knowledge one 
could expect from young people. Seven risk factors were selected based on their 
relevance for a young population; age, weight, smoking (tobacco and marijuana), 
alcohol consumption, stress and sexually transmitted infections (e.g., Chlamydia). 
There is a plethora of research associating all these factors to reduced fertility (see 
Chapter 5 for a review). It would therefore be important to ascertain whether young 
people know the potential influence of these factors. In the present study knowledge 
about these seven risk factors was examined and compared to knowledge and beliefs 
about other factors potentially associated with fertility self-care.
Fertility Myths and Illusory Benefits o f Healthy Habits
Another important source of misinformation that could impact on fertility self- 
care is erroneous belief about fertility or the benefits of healthy habits. As a taboo 
subject people accumulate many misconceptions about reproductive health and factors 
that affect fertility. For example, one avoids the use of contraception because they 
falsely believe that a girl cannot get pregnant at first intercourse, or because one 
believes that condoms reduce pleasure (Wang & Davidson, 2006). Furthermore, 
people may erroneously perceive themselves to be more fertile simply because they 
avoid engaging in unhealthy habits. To date knowledge studies have not examined 
beliefs in fertility myths or perceived associations between healthy habits and fertility 
potential.
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‘Old wives tales’ describe unusual events occurring due to a person carrying 
out a relatively normal behaviour (e.g., feed a cold, starve a fever; cracking your 
knuckles will cause arthritis; Castellanos & Axelrod, 1990; van den Brink, van den 
Boogaardt, van Deventer, & Peppelenbosch, 2002) and there are a number of tales or 
fertility myths often repeated in the popular press. For example, women who had 
given up all hope of conceiving naturally falling pregnant immediately after adopting 
a child (Lamb & Leurgans, 1979). Other myths concern post coital techniques (e.g., 
standing on your head, Daniluk, 2001) that would keep the egg and sperm in closer 
contact and facilitate fertilisation. Although all are relatively harmless in that they do 
not involve risky behaviour there is no empirical research that these factors have an 
effect on fertility. To match the number of risk factors examined in the present study 
seven myths were evaluated (3 regarding post coital behaviours; 2 regarding living 
area; 1 on healthy eating and 1 about adoption) in the present study.
Many people believe that not engaging in unhealthy habits actually increases 
health (Blenner, 1990). For example, that never smoking or drinking, or exercising 
and maintaining a healthy weight is conducive to better fertility. Although such 
abstinence is a positive way to act the healthy habits typically maintain baseline 
fertility and do not in and of themselves increase or decrease fertility. Seven healthy 
habits linked to the risk factors (e.g. never smoking, never drinking alcohol) were 
examined in this study.
Understanding Risk
In the present study people were asked to evaluate the risk associated with 
factors known to impact on a woman’s chances of becoming pregnant and those with 
no known associated link with female fertility (e.g., pseudo risk factors and protective
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factors). Risk and risk perception is defined in a number of diverse ways and is often 
interpreted differently by individuals (Sjoberg, 1997). A significant proportion of the 
public have difficulty understanding numerical risk information (Weinstein, 1999). 
People often grossly overestimate risks, frequently exaggerating the risk when the 
hazard is great and exceptional, but the probability of exposure is low, and 
depreciating the risk when the hazard is small and familiar, but the probability is high, 
a classic example of this is deterring from flying due to a fear of a plane crash, 
preferring to use alternative means of travel (i.e., car) even though air travel is 
markedly safer than travelling by car (Bellaby, 2001). The presentation of the risk also 
influences comprehension of the risk. For example, Fischhoff et al. (1993) reported 
that availability biases have been found to impact on risk perception as people often 
report higher estimates of risk for factors that are more frequently visible in every day 
lives (i.e., through reports in the mass media, or through individual experience). 
Framing effects can also impact on decision making and risk perception through the 
presentation of the same piece of information in varying ways (Tversky & Kahneman, 
1981; D. K. Wilson, Purdon, & Wallston, 1988). For example, information may be 
presented in a positive (e.g., 90% chance of survival) or negative (e.g., 10% chance of 
dying) way (Gigerenzer & Edwards, 2003), or as a gain (e.g., seeking treatment for 
infertility may give me a child) or loss (e.g., not seeking treatment for infertility may 
make me childless).
When developing a tool to assess risk it is imperative to explain to participants 
what is the risk being measured (for example, the risk of a fertility problem/not 
conceiving). Certain criteria to enhance understanding with regard to effective risk 
communication recommended by Berry (2004) were used in the present study. Firstly, 
it is important to avoid being ambiguous in the nature of the questions; text that has a
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clear and comprehensible structure allows the participant to clearly obtain the 
rationale behind the task (Fischhoff et al., 1993). Secondly, many researchers have 
noted that graphical representations can be particularly effective for conveying 
information about risks (Lipkus & Hollands, 1999; Edwards, Elwyn & Mulley, 2002). 
Graphical images can give visual clues about how to rate risks, for example, scales 
(i.e., -10 to +10) allow for representation of increase and decrease risk from a precise 
starting point (such as 0) (Lipkus & Hollands, 1999). Alternatively, using symbol 
displays that use different types of icons (such as stick figures, faces, asterisks or dots) 
to represent frequencies (indicated by the number of icons in a specified group) have 
been found to aid people when understanding the risks of cancer (e.g., number of 
people with lung cancer in two groups: smokers and non-smokers; Berry, 2004). In 
addition research has shown that combining visual displays with numerical 
information can have a positive affect on comprehension of risk (Julian-Reynier, 
Welkenhuysen, Hagoel, Decrugenaere & Hopwood, 2003). Finally providing anchors 
and “adjunct aids” such as highlighting and summarising relevant information is 
another way to encourage better understanding (Fischhoff, et al., 1993) and divert 
participants to the most essential information. The risk assessment task used in the 
present study was designed taking into consideration these factors.
The Present Study
The main aims of the study were to first ascertain knowledge/awareness of the 
effect certain risk factors have on a woman’s chance of achieving a pregnancy in a 
sample of 149 young men and women. To assess knowledge participants were asked 
to rate the impact that different factors (risks, misconceptions, healthy habits) would 
have on the chances of 100 women getting pregnant. A second aim was to determine 
whether participants could distinguish between factors that have an effect on
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pregnancy rates (risk factors) and those that do not (healthy habits and 
misconceptions). In line with the current research presented it was hypothesised that 
participant’s knowledge concerning the factors that affect fertility would be poor.
Materials and Methods
Design
A within-subjects design was employed to test participants knowledge of 
factors associated with female fertility. Dependent variables were percentage correct 
scores and gain/loss scores. Category (i.e., risk, healthy habit, myth) was treated as 
within subjects. This study was approved by the Ethics Committee of the School of 
Psychology, Cardiff University (for statement of approval see Appendix E).
Participants
The final sample consisted of 149 participants, 110 women and 39 men. On 
average the sample were 24.01 (SD = 7.81) years of age, with 61.7% educated to A- 
level standard (equivalent to the International Baccalaureate). The data was pooled 
from two waves of data collection. The first stage of collection (n = 83) were 
postgraduate (i.e., Master’s and doctoral) university students and junior staff, the 
second undergraduate (i.e., Bachelor’s) students (n = 66), all from Cardiff University. 
The first sample were older (M=  28.76 years, SD = 9.74) (r(147) = 7.86, P<.001) and 
educated to a higher standard ( j f  95.49 df = 3, P<.001) compared to the 
undergraduate sample (M= 20.23 years, SD = 1.53).
Materials
A background information form was developed for the study to obtain 
demographic information about the participants (3 items; gender, age, highest
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educational qualification [coded 1: GCSE or equivalent College qualification, 2: A 
Level, 3: Degree, 4: Postgraduate qualification]).
The Factors Affecting Fertility Scale (FAFS) was designed for this study. For 
each question participants marked a number on the response scale (see Figure 4.1) 
that represented their perception of the effect a given factor (e.g., smoking) had on the 
chance of pregnancy of 100 women trying to get pregnant. The online survey was set 
up by iPsychExpts (Brand, 2005).
Participants were asked to rate factors belonging to three categories: risk 
factors (7 items, e.g., smoking), myths (7 items, e.g., living in the countryside) and 
healthy habits (7 items, e.g., being normal weight). Each factor was evaluated by a 
number of questions depending on the level of risk associated with that factor in the 
literature review, resulting in 30 questions being presented to participants. For 
example the risk factor smoking produced four questions, namely the effect of never 
smoking (healthy habit), smoking 1-9 cigarettes per day (considered a low risk 
factor), 10-19 cigarettes (considered a high risk factor) or over 20 cigarettes 
(considered a high risk factor) per day (See Table 4.1 for all 30 questions, page 93).
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Figure 4.1. Example of the Factors Affecting Fertility Scale (FAFS).
- -  100 women
- -  95
- -  90
- -  85
— 80
- -  75
- -  70
- -  65
- -  60
- -  55
>[ 50 -  Factor has no effect
- -  45 
- -  40 
- -  35
- -  30 
- -  25
- -  20 
- -  15 
- -  10 
- -  5
0 women
Note. Scale presents the number of women from 0 - 1 0 0  who could get pregnant. 
Participants could slide the arrow up and down the scale to represent the number of 
women they perceived would get pregnant depending on the factor presented. Leaving 
the arrow on 50 meant the factor had no effect.
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Table 4.1
Questions according to category.
High Risk Factors Question
Age Being aged between 35 and 39 years old 
Being aged between 40 and 44 years old 
Being aged between over 45 years old
Weight Being overweight
Smoking Smoking 10-19 cigarettes per day 
Smoking more than 20 cigarettes per day
Alcohol Drinking more than 14 units of alcohol per week
Stress Stress that a person finds unable/impossible to cope with 
Ever having Chlamydia (a Sexually Transmitted Disease,
Chlamydia STD)
Marijuana Smoking marijuana more than 4 times per week
Low Risk Factors Question
Smoking Smoking 1-9 cigarettes per day
Alcohol Drinking less than 14 units of alcohol per week
Stress Experiencing an event that one finds difficult to cope with
Marijuana Smoking marijuana less than 4 times per week
Misconception Question
Fruit and vegetable Eating five portions of fruit and vegetables a day
Post coital behaviours Not urinating after sex
Lying down for 10 minutes after sex
Placing a pillow under the women's hips during and after sex
Living area Living in the countryside 
Living in the city
Adoption Adopting a baby
Healthy Habits Question
Age Being aged 24 or younger
Being aged between 25 and 34 years old
Weight Being of normal weight
Smoking Never smoking
Alcohol Never drinking alcohol
Stress Experiencing an event that one can cope with
Exercise Less than 7 minutes of exercise per day 
7-59 minutes of exercise per day
Marijuana Never smoking marijuana
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The response scale ranged from 0 to 100 women (intervals of 5: See Figure 4.1 
for scale, page 92). Participants were presented with 30 questions about 21 factors and 
asked to decide whether the given factor had an effect on the number of women in a 
group of 100 who would get pregnant in 3 months, and if so, the direction of the effect 
(i.e., an increase, decrease or no effect). The number 50 represented ‘no effect’ as 
population data predicts that 50 of 100 women would conceive after 3 months of 
unprotected intercourse1. The online response scale showed a vertical bar with 10 
radio buttons (0-100). The number 50 was always highlighted with a written reminder 
that choosing it meant that the factor was perceived to have no effect. If the mouse 
was held over a number a pop-up caption appeared providing the participant with 
additional information. For example if the participant was to hover the mouse over the 
number 85, a caption would appear on the computer screen, stating ’35 extra women 
will get pregnant, representing a 70% increase in the number of women getting 
pregnant’ (see Figure 4.2 for example) whereas the pop-up for the score of 15 stated 
“35 fewer women will get pregnant, representing a 70% decrease in the number of 
women getting pregnant”. The pop up box for each number contained the same 
amount of information.
It was calculated that if  100 women were trying to get pregnant, on average after 3 months o f unprotected sexual intercourse, it 
would be expected that half o f these 100 women would have achieved a pregnancy (calculation was made from time to 
pregnancy data; te Velde et al., 2000).
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Figure 4.2. Example of a caption produced by hovering over a number.
100 women
35 extra women will get pregnant, 
representing a 70% increase in the number 
of women getting pregnant
- -  95
50 -  Factor has no effect
40
0 women
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Two scores were derived from the FAFS. A percentage correct score was 
derived for each category (risk, myth and healthy habit) by summing the number of 
correct responses to the relevant items. For the correct response score, correct 
identification of the effect of the factor (i.e. correct identification that smoking 
decreases the number of women getting pregnant) was assigned a 1. An incorrect 
response (i.e., incorrectly responding that living in the countryside increases the 
number of pregnant women) was assigned a 0. The maximum correct score for each 
category was 7. The percentage correct score was obtained by dividing the total 
correct score (per category) by the maximum score (per category) (multiplied by 100).
The second score calculated was the pregnancy gain/loss score. A pregnancy 
gain/loss score was calculated to express the degree to which people believed a factor 
increased (positive score, maximum 50) or decreased (negative score, maximum 50) 
the number of women who would get pregnant. It was derived for each item by 
calculating an average deviation score from 50 (no effect).
Procedure
For the first wave of data collection participants were recruited through the 
university-wide electronic notice board system. Potential participants received a 
written announcement on the electronic notice board when they signed into their 
university account inviting them to participate in an online survey about fertility. In 
addition an email providing the same information was sent to all postgraduate 
students enrolled at the School of Psychology, Cardiff University. Those interested 
followed a link to the FAFS online survey website and were instructed on how to 
complete the survey (see Appendix F for instructions). In the second wave of data 
collection undergraduate participants were recruited through the electronic participant
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panel that advertises research studies to psychology students. Data for the second 
wave was collected by the author and Laura Brighton. All participants in the second 
wave of data collection received course credit for their time.
For all participants questions were randomly presented and completion of all 
the questions took around 5 -10  minutes. Once they completed the final question they 
were given a more detailed explanation of the study and the option to submit their 
answers if they wished (see Appendix F for additional information provided).
Data analysis
Preliminary data screening produced one participant that was excluded from 
the analyses due to incomplete data (>50% of data missing). An analysis of variance 
(ANOVA) was conducted with Category (Risk, Healthy Habit, Myth) as the within- 
subject factor and percentage correct score as the dependent measure. A significant 
Category effect was followed up with pairwise comparisons between categories using 
paired t-tests (using the Bonferroni correction, P < .017 for alpha inflation). To assess 
whether average scores were significantly different from no effect (50) one sample t- 
tests were conducted for the mean pregnancy gain/loss score per category (i.e., risk, 
myths, healthy habits). Pearson r correlation, t-tests and ANOVA were used to 
examine relationships between knowledge and demographic variables. A probability 
value of P<0.05 was regarded as statistically significant. Analyses were performed 
with the software Statistical Package for the Social Sciences.
Results
Knowledge regarding factors associated with infertility
Figure 4.3 presents average percentage correct scores per category. An 
ANOVA showed an overall significant effect (F(2,296) = 482.93, p<.001) of
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Category. Follow up tests revealed that participants had significantly higher 
percentage correct scores for risks compared to percent correct scores for myths 
(/(l48) = 22.43, P<.001) and percentage correct scores for healthy habits (/(l48) = 
30.70, 001), with an average correct score of 90.70% compared to 41.53% and
26.46% (respectively). In addition participants had significantly higher percentage 
correct scores for myths compared to the percentage correct scores for healthy habits 
(/(l 48)= 6.85, P<.001). Knowledge level was not associated with age (r = -.006, P = 
.942) or gender (/(l47) = .925, P =.36). A trend was found for education and 
knowledge (F(3,145) = 2.59, P =.06), with follow-up tests showing a trend for Degree 
students having higher knowledge scores compared to A-Level students (P =.088).
Figure 4.3. Average percent correct score per category (n = 149).
Risk Myths Health Habits
Category
***P<.001
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Figure 4.4 shows the pregnancy gain/loss score for each question in each 
category. Participants correctly identified all the high risk factors as decreasing the 
chances of getting pregnant as shown by negative deviations (i.e., loss). Being over 45 
years of age had the highest loss score of all the risk factors on the number of women 
getting pregnant, whereas being aged 35-39 the smallest score.
Participants believed that myths and healthy habits were associated with the 
number of women who would get pregnant as evidenced by average positive gain/loss 
scores. With the exception of two factors (living in the city and postcoital urination) 
participants rated myths as increasing the chance of getting pregnant (see Figure 4.4). 
Eating five portions of fruit and vegetables had the largest gain score (15.50); 
meaning that just over 15 extra women would achieve pregnancy due to eating the 
recommended number of fruit and vegetables a day. Participants also believed that 
living in the city decreased the number of women getting pregnant by 5.40, while 
living in the countryside actually increased chances by 5.77 women.
Other than doing less than 7 minutes of exercise per day (average decrease in 
the number of women pregnant by 7.82), all the healthy habits were rated as having a 
positive influence on the pregnancy rate (see Figure 4.4). Being under the age of 24 
was associated with a gain score of 19.56, with being able to cope with stressful 
events having the smallest gain (1.24).
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Figure 4.4. Pregnancy gain/loss scores per item (black bars) and per category 
(white bar).
HIGH REKFACTORS 
Being aged between 35 and 39 years old 
Being aged between 40 and 44 years old 
Being aged between over45 years old 
Being overweight 
Smoking D-19 cigarettes per day 
Smoking mote than 20 cigarettes per day 
Drinking more than 14 units o f  alcohol per week 
Stress that a person finds unable/impossirle to cope with 
Everhaving Chlamydia (a SexuatyTransmitted Disease, STD) 
Smoking marijuana more than 4 times per week 
MEAN***
MYTHS
Eating five portions o f  fruit and vegetables a day 
Not urinating after sex 
Lying down for Dmhutes after sex 
Placing a pillow under the women's hips durkig and after s ex 
Living in the countryside 
living in the city 
Adopting a baby
C O
C  MEAN***O
<D3a HEALTHY HABITS 
Being aged 24 oryounger 
Being aged between 25 and 34 years old 
Being ofnormal weight 
Never smoking 
Never drinking alcohol 
Experienchg an event that one can cope with 
Less than 7 minutes o f  exercise per day 
7-59 minutes ofexercise per day 
Never s mo king marijuana 
MEAN***
LOWRBKFACTORS 
Smoking 1-9 cigarettes per day 
Drinking less than 14 unis ofalcohol per week 
Experienckig an event that one finds difficult to cope with 
Smoking marijuana less than 4 times perweek
-50 -40 -30 -20 - D O  ID 20
Perceived decrease (-) or increase (+) in fertility 
caused by presence of factor
30 40
***p<.001
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Figure 4.4 also includes the four low risk factors. These follow a similar 
pattern to the high risk factors, in that participants are rating the majority of these 
behaviours as having a negative effect on the number of women getting pregnant. 
With the exception of drinking under 14 units of alcohol per week that showed an 
increase (4.29) in pregnancy rates, all the factors suggest participants were rating 
healthy habits as increasing the number of women getting pregnant and the risk 
factors (high and low) as decreasing the number of women conceiving.
Finally, an average pregnancy gain/loss score was computed for each category 
(risk, myths and healthy habits) and compared to no effect (50). Averaged pregnancy 
gain/loss scores were significantly different from no effect (50) for the risk category 
(t(148) = 34.61, P = 0.001), myths category (/(l48) = 14.64, P = 0.001) and healthy 
habits category (/(l 48) = 21.64, P = 0.001). Participants perceived a 33% reduction 
in the number of pregnant women in the risk category, an 18% increase in the myths 
category and a 10% increase in the number of pregnant women in the healthy habits 
category.
Discussion
Previous research has suggested that knowledge regarding fertility is very 
limited (Dyer et al., 2002; Kuang, Mahutte, Heyman, & Ouhilal, 2006; Lampic et al., 
2006). This study aimed to establish level of knowledge concerning factors that affect 
female fertility. Contrary to previous research the results demonstrated that 
participants were knowledgeable about the risk factors for female infertility but were 
not as knowledgeable at recognising factors that had no effect on fertility (myths and
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healthy habits), and believed that these factors actually increased a woman’s fertility 
potential.
Taking into account only the correct identification of the risk factors one 
would conclude from these results that in this young, educated sample, knowledge 
regarding the potential risks associated with female infertility was high. All the risk 
factors were correctly identified as decreasing the number of women who would get 
pregnant. Although such results may reflect genuine knowledge given the lack of 
fertility information in the public domain (Fuentes & Devoto, 1994; Adashi et al., 
2000; Dyer, et al., 2002; Kuang et al., 2006; Lampic et al., 2006;) it is more likely that 
participants were using their prior knowledge about negative lifestyle factors and their 
effect in other health conditions to make an assumption about the effect on fertility.
All the risk factors used (e.g., smoking, obesity) have been associated with serious 
health conditions that have received extensive media coverage (e.g., lung cancer, heart 
disease; Newcomb & Carbone, 1992; Hecht, 1999; Edwards, 2004). Many studies 
have shown that people are aware of the impact of such risk factors on health (Sutton, 
1998; Siahpush, McNeill, Hammond, & Fong, 2006) and research also shows that 
people apply scientific knowledge acquired from different sources (e.g., friends, 
acquaintances, and media) to novel domains (Collins & Evans, 2007). Whilst 
generalisation seems to be a good way to manage a large quantity of incoming health 
information it could occasionally lead to over-generalisation. For example, in the 
current study participants rated drinking small quantities of alcohol as beneficial to 
fertility possibly because of the perceived benefits of red wine as part of a healthy 
lifestyle (Gronbaek et al., 1999; Poikolainen & Vartiainen, 1999; Wollin & Jones, 
2001;).
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The results also show that people may perceive certain factors to be riskier 
than they actually are, and a number of low risk factors were perceived as reducing 
fertility to the same degree as high risk factors. For example being overweight is a 
major risk factor for female infertility (Hassan & Killick, 2004; Gesink Law, 
Maclehose, & Longnecker, 2007) but was rated as having a lesser effect than alcohol 
consumption and smoking (both tobacco and marijuana). This finding could be an 
artefact of the FAFS paradigm because gains/losses could only be made in intervals of 
5, but even with this consideration gains and losses seemed exaggerated. Therefore 
the results would seem to suggest that whilst young people have broad knowledge of 
risk factors they lack specific knowledge of how much exposure is too much exposure 
in relation to fertility effects. There is much debate in the health literature about 
whether one ought to implement zero tolerance policies or educate people to know 
critical thresholds for negative effects. For example, whether pregnant women should 
be told not to drink at all or whether they should be told not to drink more than one 
small glass of wine per day (NICE, 2003). It could be important to relay threshold 
information to the public to reduce the possibility that without such specificity people 
would consider themselves outside the risky zone of behaviour. Although the current 
results suggest that people do not know critical threshold levels when it comes to 
fertility, more research is needed to find out whether knowing such thresholds would 
indeed change negative behaviours.
One limitation of the present study is that young people were not asked 
whether they engaged in the risk behaviours or how they felt their lifestyle was 
affecting their own fertility. Although people may be able to identify risk factors this 
does not mean they apply this risk to themselves. Smokers present an excellent 
example of this as they often have a misguided invulnerability concerning their
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personal tobacco related health risks (Hay et al., 2005). There is evidence of similar 
beliefs for fertility, especially in relation to age. In the present study age was 
associated with the largest perceived pregnancy loss score (29.43%) with correct 
identification that fertility declines from 35 years of age. These results are consistent 
with numerous other studies that show people are aware of the relationship between 
age and declining fertility. Despite this, there is a steady increase in the number of 
women over the age of 35 having children in Western countries (Botting & Dunnell,
2003). The current research could therefore be extended by investigating differences 
between general versus personal risk as such work may show that people do not 
always apply risk to themselves in decision-making about everyday health habits 
(e.g., whether to smoke or not, at what age to have a child).
The Health Belief Model also proposes that a prerequisite of taking action 
(i.e., starting to try for a baby at an age before fertility declines) is if a person regards 
themselves as susceptible to negative aspects and realises the potential seriousness of 
not carrying out the behaviour (e.g., possibility of never having children). In addition 
having accurate knowledge may only be the first step in the process of behaviour 
change. It would be important to establish how people go from personal risk to actual 
behaviour change (i.e., reducing negative lifestyle habits) and what factors are 
important to this transition (i.e., perceived benefits versus barriers to change).
Previous research has highlighted that the extent to which the person wants, desires, 
or wills to change (W. R. Miller & Rollnick, 2002) is imperative to successful 
behaviour change. Thejnotivation to change (e.g., adapting one’s lifestyle) could be 
particularly high in the context of fertility as having a child is a highly valued life goal 
for the majority of young people (Lampic et al., 2006).
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In contrast to good risk knowledge, false beliefs were abundant. Participants 
erroneously believed they could increase fertility by, for example, moving to the 
countryside, using specific coital techniques, eating fruit and vegetables or adopting a 
child. All the myths chosen were the most frequently cited misconceptions (regarding 
factors affecting fertility) found on reputable infertility associated websites (e.g., 
RESOLVE.com, the national infertility association). In addition to these myths, 
participants also erroneously believed that one could be more fertile by being healthy 
(e.g., never drinking alcohol), which is an incorrect assumption to make as healthy 
lifestyles are only good because they reduce the exposure to risk and its effects rather 
than because they are in and of themselves health promoting. Healthy people have 
baseline fertility and not superior fertility.
Together these results would suggest that people could, if faced with a fertility 
problem, engage in ineffective behaviours that could delay seeking effective 
interventions. Indeed, people who keep a healthy lifestyle often express astonishment 
that they should be infertile given that they were the healthiest of their family and 
friends (Blenner, 1990). Further, White et al. (2006) found that possessing a 
perception of good overall health was the main barrier for women perceiving that a 
fertility problem existed. Feeling healthy has also been cited as a reason for delay in a 
number of other illnesses (e.g., heart disease; White & Johnson, 2000; cancer; Smith 
et al., 2005).
Methodological Implications and Limitations
The Factors Affecting Fertility Scale (FAFS) proved a useful tool to obtain 
data on people’s beliefs about the factors presented. Only one participant had to be 
excluded due to incomplete data and no negative comments were given at the end of
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the study by participants regarding the use and information provided by the scale. One 
problem with most attempts to learn whether people know what causes an illness is 
that the correct answer is often implied within the questions (Weinstein, 1999). Thus 
asking a person whether smoking is a risk factor for infertility reminds them of the 
health effects that are of concern and perhaps suggests it must have some effect. 
People might therefore assume that any factor questioned in the FAFS must have 
some effect, including the myths and healthy behaviours. To counteract this 
methodological artefact the instructions and scale were very specific in reminding 
participants that the marker could be left at 50 meaning the factor had no effect and 
the label attached to the number 50 stated that 50 meant ‘no effect’ (which always 
remained on the scale). The variability in responses (min 0 and max 100) showed that 
individuals were using all response options (the number 50 was chosen on average 
22.41% of the time). Despite this the FAFS was able to detect subtle but important 
grades of knowledge, for example broad versus specific risk knowledge and could be 
used to better inform health campaigns.
The results of this study could be extended in a number of ways. In the current 
study the sample was well educated, with the majority achieving at least A-level 
education. Studies looking at a wide range of health areas (cancer, diabetes, HIV) 
have found that education levels have negative relationships between literacy skills 
and health outcomes (DeWalt, Berkman, Sheridan, Lohr, & Pignone, 2004) and the 
initiation and uptake of health care campaigns (e.g. quitting smoking; Sander, 1995). 
Although public health campaigns do not discriminate and target all people exposed 
to the advertising including people with less education, it would be important to 
replicate the findings in other samples with varied educational backgrounds, different 
cultures and so on. Similarly, more in-depth analysis of gender effects could be
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carried out. Previous research has highlighted that women are more likely to express 
higher concern about health risks (Boholm, 1998) and that men often have a poor 
knowledge of matters related to health (Banks, 2001). In this sample no differences 
were found and this could be due to people not discriminating against gender, i.e. 
smoking is bad for anyone not just women. However, as the FAFS only included 
factors affecting female fertility it is not known to what extent people would show 
similar knowledge and false beliefs in regards to male fertility. It would be important 
to establish people’s knowledge surrounding male fertility and whether gender 
differences occur in the way people rate the influence of a factor on fertility.
Clinical Implications and Future Directions
In conclusion, participants were aware of the risk factors that impacted 
negatively on a woman’s fertility, however false beliefs about beneficial effects of 
benign factors were also abundant. Awareness about the genuine factors associated 
with female fertility (and infertility) is needed in order to resolve any erroneous 
beliefs people may have regarding fertility potential. In addition, once people are 
aware of what the risk factors are and can assess their own risk it would be important 
to establish clear guidelines of how to use the knowledge acquired (e.g., when should 
one seek advice, what can one modify) in order to minimise the chances of ineffective 
action (and perhaps delay) if a fertility problem is suspected (e.g., amenorrhea, no 
conception after 12 months of unprotected intercourse). In order to achieve the goal of 
raising personal awareness it is important to first ascertain what are the most 
important risk factors associated with female infertility, how people can assess their 
own risk and what are the effective actions people should take in order to maximise 
their chances of successfully conceiving. Therefore the next Chapter will focus on 
establishing the main risk factors for female infertility.
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Chapter 5 
Risk in female fertility
Introduction
The research to date has highlighted that 9% of couples will experience 
difficulties when trying to have a child. Given the importance of parenthood to the 
vast majority it is important to help people optimise their chances of eventual 
pregnancy. However, people may not be behaving in an optimal way to safeguard 
fertility potential; Chapter 4 demonstrated that young people have a good knowledge 
regarding the risk factors for female infertility, but possessed a number of 
misconceptions. In addition Chapter’s 2 and 3 highlighted that, when faced with 
difficulties in conceiving, a significant number of couples are not seeking the help 
they require. Such delay in seeking help could further decrease chances of pregnancy 
and increase the cost of providing medical help if it was eventually sought due to 
greater disease progression and reduced fertility due to increasing age.
The research conducted in the previous chapters has led to the conclusion that 
people need accurate personal risk information in order to optimise their chances of 
future successes when trying to conceive. In order to achieve this goal an increase in 
awareness surrounding the factors that impact on personal fertility is needed, targeting 
two populations; those who are thinking of having children in the future and those 
currently trying to conceive. Women who wish to conceive in the future need to be 
educated about what personal factors impact on their fertility (e.g., their age), factors 
that should be minimised (e.g., their weight, smoking habits) to avoid reducing 
chances of eventually conceiving and the factors that will warrant medical attention 
when they eventually do decide to conceive (e.g., the irregularity of their cycle).
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Making women aware of these personal factors is key to helping women realise that 
their actions now can impact on their future parenting goals. For those women who 
are currently trying to conceive it would be imperative for them to have practical 
information about factors that they themselves can take control of to improve fertility 
(e.g., reducing alcohol consumption) as well as guidance about when to seek medical 
advice (e.g., if they do not have a period). This chapter will focus on the early stages 
of the development of a tool that eventually aims to provide this information and 
guidance through the assessment of personal fertility status.
What is Health Promotion?
The awareness of signs and symptoms of disease is the critical motivating 
force for action and change according to health models. For example, the health belief 
model postulates that the likelihood of action is affected by perceived susceptibility 
and seriousness of a disease. Therefore if people are not aware of symptoms or signs 
of disease (i.e., do not perceive they are at risk) they may not engage in the action 
needed. Further, according to Prochaska’s stages of change model, action (e.g., 
seeking medical advice) cannot occur without a person realising a problem exists 
(e.g., lack of fertility). It is only once this realisation occurs that one can weigh up the 
pros or cons of the problem and any potential solutions to resolve the issue 
(Prochaska, DiClemente, & Norcross, 1992). Making people aware of the significance 
of signs and symptoms of different illnesses (e.g., lump in breast for breast cancer) is 
therefore an integral part of most efforts to improve individual health, whether that is 
achieved via primary prevention, health promotion or health monitoring.
Primary prevention specifies practices for the avoidance of disease, and is 
often used as the umbrella term for a number of practices relating to effective health
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promotion and monitoring (Last, 1995). Health promotion refers to the process of 
enabling people to increase control over their health thereby improving it. It is 
directed toward establishing the cause(s) of ill health (i.e., smoking is a risk factor for 
cancer), then finding the most efficient means of preventing such causes, for example, 
through warning people about the risk of it via the media or other public health 
campaigns (e.g., publication of written warnings such as ‘smoking causes cancer’ on 
all cigarette packaging sold in the UK) (WHO, 1986). Through effective health 
promotion, people can learn to monitor their health (e.g., regularly check one’s breasts 
for any changes) which may, in turn, increase awareness about and significance of 
potential signs and symptoms of disease for which action may be needed. For 
example, the promotion of self examination of one’s breasts has been widely 
publicised as a simple, low-cost, non-invasive and non-hazardous means of detecting 
breast cancer (Clarke & Savage, 1999). Breast self examination (BSE) has been 
shown to be effective in detecting breast cancer at an earlier stage (Hill, White, Jolley, 
& Mapperson, 1988). Making people aware of signs and symptoms and their 
significance can be beneficial but it can also have disadvantages as will be seen in 
next section.
Benefits and Drawbacks o f Health Promotion and Monitoring 
Benefits
Educating people about true risks and dispelling myths.
Campaigns promoting signs and symptom awareness are beneficial because 
they provide the public with accurate information based on scientific research 
establishing an association between a known risk (e.g., unprotected sexual 
intercourse) and the subsequent increased risk of ill health (e.g., sexually transmitted 
disease; STD). For example, the 2006 UK campaign to encourage young adults to
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always carry and use condoms when having sexual intercourse was based on research 
demonstrating that condoms provide protection against sexually transmitted diseases 
(W. Jr. Cates & Stone 1992). As well as providing accurate information regarding 
known risk factors, campaigns can also dispel myths and correct inaccuracies. For 
example, in New Zealand a 6 -  week public campaign regarding herpes raised 
awareness about the increasing prevalence of the disease, the need for people to get 
themselves tested and treated (if necessary) and in addition the campaign also 
emphasised that herpes was common, manageable and treatable and not a result of 
being dirty or bad (New Zealand Herpes Foundation, 2007; “Herpes -  Myth vs. Fact”: 
http://www.herpes.org.nz/patient/myths.htm).
Dispelling myths and correcting inaccurate knowledge is vital because 
evidence suggests these are common and may potentially inhibit proactive health 
monitoring. For example Hawkins, Berkowitz, and Peipins (2007) found that while 
the public were familiar with commonly advocated cancer prevention strategies 
people also frequently ascribed the onset of cancer to factors that had no scientific 
support (e.g., religious practices, drinking adequate amounts of water). In Chapter 4, 
young people were shown to possess a number of erroneous beliefs about factors 
impacting on female fertility. It would be important to ascertain whether erroneous 
beliefs impact on decision making when faced with health issues. The beliefs held by 
many teenagers regarding birth control use and risk of pregnancy is a prime example 
of the negative impact of erroneous beliefs. For example, beliefs that girls cannot get 
pregnant at first intercourse (Senderowitz, 1999) or that teenagers are immune to 
pregnancy (Kaiser Family Foundation Survey, 1996). Ultimately, a lack of accurate 
knowledge regarding risk factors and ways of promoting good health habits is highly 
likely to reduce the chances that individuals will be able to take steps to improve their
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day-to-day health (Hawkins et al., 2007) and timely decision making when faced with 
ill health issues.
Reduce fear and unnecessary delay through early detection.
An important benefit of making people aware of signs and symptoms is that it 
can reduce delay in seeking medical advice. A systematic review of the literature on 
reactions to discovering a symptom of breast cancer demonstrated that while the 
majority of women promptly sought medical advice 20 -  30% delayed seeking any 
medical help for three months or more (Richards, Smith, Ramirez, Fentiman, & 
Rubens, 1999; Richards, Westcombe et al., 1999). Delay of this duration decreases 
potential for breast cancer survival (Facione, 1993; Richards et al., 1999). In Chapter 
2 it was established that just under half of couples faced with a fertility problem ever 
seek any medical advice/treatment and if they do, 20% or so delay for more than 2 
years as found in Chapter 3. Research on the reasons for delay indicates that a lack of 
knowledge/awareness of the signs and symptoms of disease (Oliveria et al., 1999; 
Grunfeld et al., 2002; Facione & Facione, 2006) and fear of what may happen 
(Facione, 1993; Carney et al., 2002; Bish et al., 2005; Smith et al., 2005) are 
important contributing factors; nobody likes to hear bad news and the possibility of a 
threatening diagnosis may inhibit some people from seeking advice or medical help in 
a timely way. These issues can be readily tackled in public awareness campaigns by 
increasing knowledge about the advantages of early detection (e.g., improved 
prognosis: Hillis, Joesoef, Marchbanks, Wasserheit, Cates, & Westrom, 1993) and by 
reducing the threat that seeking medical advice/treatment may pose for some 
individuals (e.g., better understanding of what happens during a biopsy or scan: Smith 
et al., 2005).
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Reducing delay through awareness of signs and symptoms may also impact on 
health care costs. For example, the Mary Woodward Lasker Charitable Trust found 
that the decline in deaths in the US between 1972 and 1992 from cardiovascular 
disease and stroke was worth more than 1.5 trillion dollars per year to the US 
economy (Ratzan, 2008). With regards to infertility treatment, if couples entered the 
health care system earlier for suspected fertility difficulties then their chance of 
success would be greater due to less disease progression and earlier age. In the UK, 
the average age for first births is now 27.1 years of age (Office of National Statistics, 
2000) so that a 2-3 year delay will mean entering treatment at an age when fertility 
and treatment success are beginning to decline. A delay in seeking medical help for 
fertility problems results in an increase in age and according to Collins (2002) each 
year of infertility reduces the likelihood of IVF conception by 2%, impacting on the 
costs to health care systems providing subsidised treatment.
Reducing delay also increases the chances of earlier detection of a disease. 
Early detection of a problem is often the goal in health promotion campaigns because 
early detection generally improves prognosis. For example in cancer campaigns the 
aim is to engage the public into looking out for early signs and symptoms of the 
disease (i.e., the detection of a new lump in the breast or testicle). Fries, Koop, 
Sokolov, Beadle, and Wright (1998) suggest that the best way to reduce costs and 
improve health at the same time, are not just to control the services provided but also 
reduce the need and demand for care. Early detection of a problem may reduce the 
need and demand for medical care. For example early detection (and treatment) of a 
sexually transmitted disease may reduce the likelihood of further infections, such as 
PID, as a result of the initial disease, that may lead to an increased risk of infertility 
that would require further, more expensive treatment than if the initial infection had
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been detected and treated (Scholes, Stergachis, Heidrich, Andrilla, Holmes, & Stamm, 
1996). Similarly, identifying and treating obesity-linked infertility may reduce the 
need for costly infertility treatment. A. M. Clark, Thomley, Tomlinson, Galletley, and 
Norman (1998) reported that prior to a weight loss programme 67 women had 
treatment costing just over lA million American dollars resulting in two live births. 
However, after the programme the same women had 18 babies spontaneously for the 
minimal costs of the weight-loss program. A. M. Clark et 2d., (1998) concluded that 
weight loss should always be considered first for women who are infertile and 
overweight.
Delay may not just be a factor to tackle with the individual who discovers a 
potential symptom, but one to also address with the medical provider (e.g., general 
practitioner). Studies have found that a barrier for couples seeking treatment for 
persistent failed attempts when trying to conceive is due to delay caused by incorrect 
diagnosis and/or delayed referral from general practitioners. Gunnell and Ewings 
(1994) found that many infertile couples were not referred for specialist medical 
advice and therefore did not access the expertise they needed. They concluded that 
this was primarily due to a lack of concrete referral guidelines for general 
practitioners to use when couples presented with difficulties conceiving. NICE (2004) 
recently developed guidelines but degree of adherence to these strategies is not fully 
known. One report by the Audit Commission highlighted that few respondents to their 
survey (recruited through all primary care trusts) were fully aware of the guidelines 
(especially those relating to cost implementations: Audit Commission, 2005). 
Therefore awareness campaigns may also contribute to better health via effects on 
providers in the medical setting (e.g., general practitioners).
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Generating motivation to change.
Increasing personal awareness of risk may be beneficial because it provides 
greater motivation to act then does more general risk information. Even when general 
awareness and knowledge about risk factors for certain diseases is good a lack of 
awareness about ones own risk has been cited as a barrier to uptake of medical care in 
health care settings, such as cancer (Sabates & Feinstein, 2004). It is well documented 
that people do not apply the same risk to themselves as they do to others and people 
inherently believe that negative events are less likely to happen to them than to others, 
(Weinstein, 1980). In addition people do not make the same estimate when they rate 
the risk to themselves and/or their family, compared to people in general (Sjoberg, 
2000). Smokers present an excellent example of this as even though all the available 
studies indicate that the majority of people realise that smoking is harmful and believe 
that the risk of diseases like emphysema and lung cancer is higher for smokers than 
non-smokers, a large percentage of people still smoke (Hay et al., 2005). Personal risk 
calculators can be useful in providing individualised information about one’s own 
risk. For example the introduction of the cardiovascular risk calculator allows a 
person to enter in their personal information (e.g., smoking status, cholesterol) and 
then calculate a score that is their risk of cardiovascular problems (P. W. F. Wilson, 
D’Agostino, Levy, Belanger, Silbershatz, & Kannel, 1998). Such tools may also allow 
an individual to see what effect a reduction in negative lifestyle habits (e.g., smoking) 
would have on their chances of a disease (e.g., reduction in risk of heart attack), 
highlighting the positive impact health monitoring can have on the chances of 
developing a disease. This is of great importance with regards to the factors associated 
with female fertility difficulties as the prevalence of some negative lifestyle factors 
are on the increase in Western society. Negative lifestyle factors such as obesity, illicit
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drug and alcohol use (especially in young people), and reproductive factors such as 
sexually transmitted diseases, have all increased markedly over the past decade; for 
example, there has been a 60% increase in the number of STDs since 1997 in the 
United Kingdom (Health Protection Agency, 2007) and the WHO estimate that 1.6 
billion adults were overweight in 2005, with approximately 2.3 billion adults’ 
projected to be overweight by 2015 (WHO, 2006). Further still, there has also been a 
steady increase in the age at first pregnancy in Western societies. This increase is 
believed to be a direct result of a change in the social status of women in western 
societies, whereby an increasing number of women are delaying childbearing to an 
age where their reproductive abilities have substantially declined in order to fulfil 
education and career desires (Weston & Vollenhoven, 2002, Ryan, Maassen, Dokras, 
Syrop, & VanVoorhis, 2005). In the UK, the proportion of babies with mothers aged 
35 years or more increased markedly from 6.5% in 1976 to 22.5% in 2000 (Bakeo, 
2004) and in the US this rate has more than doubled since 1978 (Hamilton et al.,
2004). Increasing awareness of the impact these factors may have on a woman’s 
chances of pregnancy may aid motivation to change or reduce behaviours that may 
impact on their future life goals.
Drawbacks
Provoking unnecessary worry andfear.
While educating individuals regarding the factors associated with certain 
diseases may reduce fear in a number of cases it may also have the adverse affect in 
actually provoking fear unnecessarily. For example, the media often covers stories on 
the link between mobile phone use and brain tumours leading to suggestions of how 
long people should spend using their phone or how phones should be held against the 
head when making phone calls (e.g., Telegraph, January 26, 2007) despite a lack of
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concrete research to suggest whether a relationship actually exists (Hepworth, 
Schoemaker, Muir, Swerdlow, van Tongeren, & McKinney, 2006).
Communicating risk information as a precautionary measure may not always 
be the best for the public as a whole; often providing precautionary advice is 
interpreted as causing concern rather than providing reassurance (Barnett, 
Timotijevic, Shepherd, & Senior, 2007). For example, campaigns that are ‘hard 
hitting’ such as a cancer poster showing three young girls sitting together with tags 
above their heads depicting their future; ‘teacher’, ‘lawyer’, ‘cancer’ (Kent, 2000), 
attempt to highlight the lifetime statistic of an individual’s chance of developing 
cancer (one in three: Quinn, Babb, Kirby, & Brock, 2000). However, according to 
Kent (2000) such campaigns induce fear rather than the intended goal of increasing 
personal knowledge regarding one’s individual risk. Further, Kent (2000) argues that 
campaigns and media involvement can often mislead the public, for example breast 
cancer campaigns have been criticised for focusing too much on young women when 
in reality the majority of cases are in older women (Office of National Statistics, 
2004b).
Modest benefits o f health monitoring.
Case study evidence, meta-analysis, and systematic literature reviews have 
each concluded that public health communication initiatives are, on the whole, 
effective in changing behaviour, but usually only modestly so (Maibach, Abroms, & 
Marosits, 2007). Noar (2006) believes that evidence is beginning to converge that 
targeted, well-executed mass media health campaigns that are capable of reaching a 
wide audience of people can have small-to-moderate effects on health knowledge, 
beliefs and attitudes, and behaviours. However, while campaigns may have initial
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impact in preventing risky behaviours the long-term impact on behaviour change and 
cost of this may be questionable. The UK government planned to invest 50 million 
pounds over 3 years to increase public awareness regarding the link between STDs 
and unprotected sexual intercourse (House of Commons Health Committee, 2005) but 
while the campaign is still running so concrete conclusions on its success cannot be 
determined, a recent report from the Health Protection Agency (2007) revealed that 
STDs are still on the rise.
Raising awareness without support to implement change.
Another problem inherent in the battle to promote health is changing existing 
behaviours. Health monitoring increases awareness but does not help to overcome 
hurdles of getting people to reduce or cut-out unhealthy habits that people enjoy 
and/or are prevalent in society (e.g., smoking, drinking alcohol). Research has shown 
that campaigns that promote the adoption of a behaviour that is new (e.g., encourage 
parents to place the baby to sleep on its back to reduce the risk of Sudden Infant Death 
Syndrome; Maibach et al., 2007) have a greater success rate than campaigns aiming to 
cease an unhealthy behaviour people are already doing, or prevent commencement of 
a risky behaviour (e.g., tobacco use; Snyder, 2007). A. M. Clark et al. (1998) showed 
that only 18 of 30 (60%) women took up the offer of a weight-reduction program that 
could reduce or eliminate the need for invasive fertility treatment with a further 28% 
of women dropping out before the end of the six-month bi-weekly program, despite 
the program being very good at improving pregnancy rates (i.e., 84% pregnancy 
rates).
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The Present Studies
The literature review on the benefits and costs to making people aware of 
signs and symptoms of disease generally supports that doing so helps people in 
decision-making about their health. To this authors knowledge there has only been 
one initiative (i.e., mass media campaign) to help people take better care of their 
fertility and it was a general campaign. In 2001 the American Society for 
Reproductive Medicine (ASRM) ran an advertising campaign to promote the message 
of protecting one’s fertility through a number of posters highlighting key factors 
associated with infertility, such as age, smoking, weight and practising safe sex (See 
Appendix G for posters). These posters were displayed in a variety of settings (e.g., 
tube stations, college health centres, community health centres, and YWCA gyms) 
across America. However, the ASRM never assessed the impact of the campaign but 
evidence reviewed would suggest that effects might have been modest (Rebar 2008, 
personal communication). The results from Chapter 4 indicated that people were 
generally already aware that these factors influenced fertility. Furthermore, past 
research shows that a focus on personal risk is likely to be more effective in 
promoting change than awareness of general risk (Fischhoff et al., 1993; Elton et al., 
1994; NHS centre for reviews and dissemination, 1998; Sjoberg, 2000; Strychar et al., 
1998; McClure, 2002; Greening, Chandler, Stoppelbein, & Robison, 2005). In light of 
the review and lack of initiatives concerned with fertility the ultimate goal of the 
present research programme is to produce a risk assessment tool that will raise public 
awareness about risk of reduced fertility by enabling women to assess their own 
fertility status. Such tools are now increasingly used by the National Health Service 
(NHS) to help people make healthier choices. The NHS ‘Choices’ 
(http://www.nhs.uk/tools/Pages/Toolslibrary.aspx) website currently has more than 30
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health check tools from body mass index calculators to mole self-assessment tools. 
The aim of the two studies presented in this chapter was to carry out foundational 
research for a fertility risk assessment tool by (1) identifying the risk factors for 
reduced fertility (Study 5.1) by conducting a comprehensive literature review and (2) 
assessing whether such factors could differentiate between pregnant and non-pregnant 
women (Study 5.2).
Study 5.1 
Literature review of potential risk factors for reduced female fertility
Introduction
In order to develop a tool that allows the assessment of personal fertility 
status, one needs to define risk, identify the factors associated with female infertility, 
and establish the outcomes for which the risk is relevant (e.g., effect on fertility; 
longer time to pregnancy).
Defining Risk and a Risk Factor
According to the WHO (2002) preventing diseases from occurring in the first 
place requires systematic assessment and reduction of their causes. There are a 
number of factors, known as health determinants, that are linked to the development 
of an illness and that impact on a person’s health status (i.e., genetic, environmental, 
social, economic & lifestyle; Caiman, 1998). Health determinants for specific diseases 
(e.g., lung cancer) have been rigorously studied in order to identify the risk factors 
associated with the onset, progression and underlying causes of a disease. Once such 
determinants have been recognised a number of preventative measures can be put in 
place in an attempt to reduce the development and/or prevention of such diseases (i.e., 
governmental regulations, public health campaigns). Risk is often defined as a
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probability of an adverse outcome occurring (i.e., heart attack), and a risk factor (i.e., 
smoking) is a factor that raises this probability (WHO, 2002). To prevent the onset of 
a disease, such as heart disease, one must establish the risk factors that are known to 
increase the risk of onset of the disease. Establishing the presence of known risk 
factors for a disease is a method often used in order to ascertain a person’s individual 
risk for such a disease. For example, the Gail Model uses a number of risk factors to 
estimate the chance that a woman will develop breast cancer over a particular interval 
of time (Gail et al., 1989; Decarli, Calza, Masala, Specchia, Palli, & Gail, 2006).
A main principle of identifying risk factors has been to highlight the need for 
prevention (e.g., promoting the use of sun cream to reduce the risk of skin cancer) and 
early detection (e.g., noticing changes or new lumps in the breast or testicle) of 
potentially fatal diseases. Research from the Framingham Heart Study has shown that 
personal blood pressure, total cholesterol, and low-density lipoprotein (LDL) 
cholesterol can effectively predict individual risk of coronary heart disease in middle- 
aged white men and women (P. W. F. Wilson et al., 1998). Self-detection of risk 
factors enables people to assess their own risk for a disease by ascertaining the 
presence or absence of various risks or indicators.
As well as establishing that certain factors appear to be risks for the onset of a 
disease, for example, more smokers develop chronic obstructive pulmonary disease 
[COPD] than non-smokers, it is also important to ascertain how much of a risk the 
factor poses, for example, male smokers are 11.7 times more likely to develop COPD 
than male non-smokers (National Cancer Institute, 1997). Such information is often 
provided as a relative risk ratio or as an odds ratio. To explain the difference between 
odds ratios and relative risks one needs to start with odds. An odds is the probability
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of an event (i.e., pregnancy) occurring in one group (e.g., number of 
pregnancies/sample size).
For example if you had two groups of 100 women and in one group 30 women 
fell pregnant the odds of pregnancy in this group would be 30%, if in the other group 
of 100 women 15 fell pregnant the odds of pregnancy in this group would be 15%. If 
you wanted to compare these groups you could compute a relative risk (RR). A 
relative risk compares the number of pregnant women in one group (i.e., 30) to the 
number of pregnant women in the other group (i.e., 15) by dividing the two (i.e., 
30/15), therefore the relative risk of pregnancy is two times higher in group one (30 
pregnant women) compared to group two (15 women). An odds ratios (OR) also 
provides an estimate for risk by comparing the event occurring in one group compared 
to the event occurring in another group but adjusts for the frequency of the event in 
each of the groups (i.e., (pregnant women in group one/sample size of group 
one)/(pregnant women in group two/sample size of group two)) therefore the odds 
ratio for the two groups would be 2.43 ((30/70)/(l 5/85)), representing a 2.43 higher 
odds of pregnancy in group one compared to group two. Whilst odds ratios and 
relative risks are slightly different in their meaning they are often used 
interchangeable as the two numbers are often similar, as can be seen in the example, 
RR was 2 and OR was 2.43. Odds ratios and relative risks will however diverge when 
the frequency of the event becomes more frequent (i.e., more than 10%) or the effect 
size is large (Davies, Crombie, & Tavakoli, 1998; Scott, 2008). Odds ratios and 
relative risks are interpreted using confidence intervals (Cl). A Cl is a statistically 
defined range of population values with which a sample statistic is likely to represent 
at a given level of confidence (most often, 95%: Heiman, 1999; Sin & Reid, 1999). 
When used to interpret odds ratios if the confidence interval includes unity, that is, it
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overlaps 1.0 the increased risk is not statistically significant, and could have been due 
to chance (Fathalla & Fathalla, 2004).
In regard to infertility there are a number of different categories of risks and 
indicators that could help establish a woman’s fertility status, for example those 
connected to lifestyle factors, reproductive disease or other diseases that impact on 
fertility (e.g., cancer and its treatment). The effect a risk factor may have on fertility 
can be measured in a number of ways. For example, a risk factor may be associated 
with a longer time or delay in achieving a pregnancy (measured in months and/or 
years) or an increased risk of a type of infertility (e.g., ovulatory infertility) that may 
reduce success of conception attempts. Alternatively a factor may have an impact on 
fertility once conception has occurred, for example by increasing the risk of 
miscarriage or perinatal morbidity or mortality. A factor may have a short-term effect 
on fertility, for example, ceasing once the risk factor has been eliminated (i.e. 
cessation of smoking) or a long-term irreversible effect on fertility, for example 
blocked tubes as a consequence of an untreated sexually transmitted disease.
Assessment of study quality.
In this study a review of risk factors associated with female infertility was 
carried out. When conducting a literature review it is important to consider the quality 
of the designs employed by each study reviewed, in particular strengths or limitations 
that may lead to systematic errors or bias (Ryan, Hill, Broclain, Horey, Oliver, & 
Prictor, 2007). The quality of the design can be assessed on a number of levels. 
Randomised Control Trials (RCTs) aim to reduce any biases that could lead to any 
invalid conclusions and are often thought of as the most robust and effective research 
designs (Barlow, 2003). However, RCTs are not always practical to implement (e.g.,
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not having a ‘no treatment’ group) and in some fields of research non-randomised 
controlled trials or quasi-experimental designs (e.g., prospective studies with a control 
group) provide the best evidence (Petticrew & Roberts, 2006). Within non­
randomised controlled designs there are some methods deemed of ‘better quality’ than 
others, for example prospective studies (i.e., cohort studies) are considered of superior 
quality to retrospective designs (i.e., cross-sectional studies) as participants are 
followed over a period of time to observe the development of the outcome in question 
(Petrie & Sabin, 2000) and can be designed to reduce the impact of certain biases that 
may influence the outcome, that are not as easily controlled in retrospective studies 
(e.g., recall bias). However, prospective studies are more costly and time consuming 
to develop and are not always as practical to set-up and implement compared to 
retrospective designs (Petrie & Sabin, 2000).
According to Khan, Riet, Popay, Nixon, and Kleijnen (2001) there are a 
number of types of bias that should be taken into account when reviewing studies, 
such as selection bias (i.e., were the groups comparable; representative), performance 
bias (i.e., were there any differences in the care provided apart from the intervention 
being evaluated?), attrition bias (i.e., were there any differences between groups due 
to drop out within groups?), and measurement bias (i.e., were there any differences 
between comparison groups in how outcomes were ascertained?). In addition the use 
of different outcome measures may impact on the ability to generalise effects across 
studies. For example, time to pregnancy (TTP) is a widely used means of measuring 
differences among populations of women trying to conceive. However, women 
reporting TTP based on an early pregnancy test (i.e., hormonal pregnancies detected 
by human chorionic gonadotropin, hCG) may lead to an overestimation of eventual 
live birth rates compared to women reporting TTP based on a clinical pregnancy test
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(detected by a fetal heart beat; Zegers-Hochschild, Nygren, Adamson, de Mouzon, 
Lancaster, Mansour, & Sullivan, 2006) as the former pregnancy has a much higher 
risk of miscarriage compared to the later definition of pregnancy (Wang, Chen, Wang, 
Chen, Guang, & French, 2003).
Expert consultation and consensus.
The principles of evidence-based medicine (EBM) offer a framework to guide 
the search for and appraisal of clinically relevant information and these would support 
the use of empirically determined risk factors to guide clinical judgement about 
whether a fertility problem exists and if it does what its causes might be (e.g., Straus 
& Sackett, 1998). EBM underpins practice guidelines such as the NICE series. 
However where evidence is lacking more emphasis may be placed on expert opinion. 
In the present study the set of empirically selected risk factors were presented to 
fertility experts to ascertain consensus about their relevance in predicting potential 
fertility status, using a similar method to that of the Delphi technique. The Delphi 
technique is used to aid decision-making and to obtain the most reliable consensus of 
opinion from a group of experts (Dalkey & Helmer, 1963, p. 458 in Rowe & Wright, 
1999). Using such a procedure allows access to the collective knowledge from a 
variety of experts, with potentially differing opinions (Rowe & Wright, 1999). For 
the present study not all the main principals of conducting a Delphi technique (e.g., 
expert anonymity, re-iteration, controlled feedback: Okoli & Pawlowski, 2004) could 
be adhered to due to time constraints of the experts, therefore only one meeting was 
held to discuss the results of the literature review of the empirical evidence.
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The Present Study
The aim of the present study was to determine which risk factors would be 
essential indicators of female fertility potential that could be used to develop a tool to 
assess personal fertility status. A comprehensive literature review was conducted to 
establish all factors that have been previously associated with female fertility 
difficulties. All risk factors identified in the literature were examined using odds ratios 
extracted and then presented to the panel of fertility and reproductive experts for a 
consensus on which factors were the most important. All experts were asked to 
discuss and justify reasons for and against each risk factor until all were happy with 
the final selection. The 14 risk factors identified in the literature review and selected 
through the expert consultation will be discussed in the results section.
Materials and Methods 
Procedure for Extraction o f Risk Factors 
Literature review.
A number of PubMed searches were conducted to establish factors associated 
with female infertility. Firstly, the term Female Infertility [MeSH] was searched 
resulting in 19,026 records and 2,335 reviews, which was narrowed by including the 
term Risk Factors [MeSH]. The 600 records and 157 reviews were then scanned for 
relevance, full reports were obtained as necessary and other citations were identified 
in the reference lists of the relevant citations. All records and reviews were excluded 
if the outcome reported was assessing a risk factors impact on treatment outcome 
(e.g., smoking during a cycle of IVF associated with a reduced chance of treatment 
success). Studies were classified according to the outcomes and whether a definition 
of the outcome had been provided. The outcomes were: (1) ‘risk of infertility’ 
referred to no conception after 12 months and/or a medical diagnosis (e.g., tubal
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factor infertility); (2) ‘time to pregnancy’ referred to the number of months needed to 
achieve pregnancy; (3) ‘reduced conception rate’ referred to a reduced chance of 
clinical pregnancy; (4) ‘menstrual irregularities’ referred to either short (<21 days) or 
long (>35 days) menstrual cycles and/or sporadic or unpredictable periods; (5) 
‘specific diagnosis’ referred to medical diagnosis of a reproductive disorders (e.g., 
pelvic inflammatory disease, endometriosis).
All risk factors identified were then individually searched for using PubMed 
with the term (e.g., Female Age) and Female Infertility (i.e., ‘Female age AND 
Female Infertility’); see Appendix H for a full search history. In addition a number of 
other reproductive health references/guidelines were searched to ascertain any 
additional factors not detected in the original review (i.e. National Institute for Health 
and Clinical Excellence [NICE], WHO).
Expert consultation and consensus building.
Twenty-five medical reproductive experts and patient advocacy group leaders 
were contacted through the Assisted Conception Taskforce (ACT) which provides 
information for people with fertility problems (see Appendix I for a full list of 
reviewers). At the annual meeting of the taskforce (December, 2006), experts were 
provided with the list of the factors identified in the review and asked to discuss the 
importance of each risk factor with the goal of producing a list of critical factors that 
would be associated with a woman’s fertility status. During the meeting panellists 
were asked to provide explanations for their chosen risk factors, and to respond to the 
reasons and justifications for risk factors identified by other experts. Each chosen risk 
factor was discussed within the group until all contributors were happy with a final
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list of risk factors (all information was documented by Dr Jacky Boivin who attended 
the meeting).
Assessment of Study Quality
The NICE Hierarchy of Evidence (NICE, 2004) and the Cochrane Study 
Quality Guide (Ryan et al., 2007) were used to assess the quality of the studies 
extracted. These guidelines emphasise the importance of assessing the quality of 
studies through the review of a number of elements that may lead to the 
misinterpretation of the research findings, such as the methodological design utilised 
(e.g., Randomised Control Trials [RCT]; observational studies), any study bias or 
potential confounding factors (e.g., attrition), and outcome measures used (e.g., live 
birth, clinical pregnancy). In the present review each study was categorised according 
to the following elements:
Design,
Studies that assessed the risk factor prior to the occurrence of the outcome 
were categorised as prospective whereas studies that assessed risk after the occurrence 
of the outcome were categorised as retrospective.
Pregnancy confirmation.
If the pregnancy had been confirmed with an ultrasound scan (clinical 
pregnancy, at least 12 weeks gestation) or delivery then the study was categorised as 
confirmed if the outcome was based solely on a positive pregnancy test then the study 
was categorised as unconfirmed pregnancy (only studies using pregnancy as an 
outcome were categorised on this measure).
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Analytic approach.
Studies were also categorised according to components of the analysis, 
namely whether power calculations had been computed and whether analyses 
controlled for confounding factors (e.g., smoking, body mass index, age).
Results
Assessment o f  Study Quality
In total 58 studies were reviewed (46 original articles and one review paper), 
of which 45 (76%) were retrospective in design and 13 (22%) prospective. Twenty- 
four studies reported risk of infertility, 23 studies reported time to pregnancy (TTP), 
seven studies reported reduced conception rate, two studies reported menstrual 
irregularities and two studies reported specific diagnosis.
Of the studies (n = 29) sampling women either currently pregnant or those 
who had had a pregnancy in the past, 21 studies (72.41%) reported the pregnancy was 
clinically recognised or had resulted in a live birth. Finally, 50 studies (86.21%) 
reported controlling for confounding variables (47 [94%] studies provided 
information on the factors controlled), 45 studies (77.59%) provided information on 
potential biases due to the study design and three studies (5.17%) reported performing 
power calculations prior to conducting the studies (Juhl, Olsen, Nybo Anderson, & 
Gronbaek, 2003; Urbach, Marrett, Kung, & cohen, 2001; Maheshwari, Hamilton, & 
Bhattacharya, 2008). (See Table 5.1.1, 5.1.2 & 5.1.3 for breakdown per risk factor and 
Appendix J, Table A2 for further information on quality assessment of each study)
In total 31 risk factors were identified from the literature review categorised 
into the following four areas; demographic (3 factors), reproductive (6 factors), 
lifestyle (11 factors) and medical factors (11 factors).
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Expert Consultation and Consensus
From the original list of 31 factors, 14 were chosen by the experts as the most 
vital factors for assessing fertility potential. Appendix K shows the 17 factors made 
redundant after the expert meeting. There were four main reasons why factors were 
not included in the final list. First, factors that were not deemed independent were 
excluded. For example, excessive exercise is only important if it is associated with a 
negative effect on menstruation (e.g., anovulation); otherwise it is not predictive of 
reduced fertility. It was therefore decided that having questions about a woman’s 
menstrual cycle would be more informative to determine a female’s fertility status 
then questions about causes that may or may not produce cycle effects in individual 
cases. Five factors were excluded for this reason: exercise, underweight (BMI <19), 
ethnicity, polycystic ovarian syndrome (PCOS), and epilepsy.
Second, some factors were eliminated because the evidence was weak or too 
inconsistent about the effects of the given factor on fertility. The review showed a 
substantial number of studies exploring the association between alcohol consumption 
and fertility, producing both positive and negative impacts, often measured by longer 
or shorter TTP. In the end the experts decided that the evidence supporting a link 
between moderate to large amounts of alcohol consumption and reduced female 
fertility was sufficient and this factor was included in the final list. However the 
effects of four other factors were deemed too inconclusive and were excluded: asthma 
medication; occupational and environmental factors; contraception use; prescribed 
drug use. Factors identified in the review as having an inconsistent evidence-base 
were rigorously discussed until all experts were content with inclusions and 
exclusions.
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Third, while miscarriage and perinatal problems encompass female fertility 
they are problems occurring after conception. When conducting the review and the 
expert consultation the emphasis was placed on factors associated with fertility 
problems impacting on conception (i.e., inability to conceive, longer time trying to 
conceive). Three factors (heart disease; coeliac; thrombophillia) were excluded 
because their primary effect on female fertility was associated with an increased risk 
of miscarriage, ectopic pregnancy, genetic abnormalities and/or perinatal risks 
(Molteni, Bardella, & Bianchi, 1990; Sher & Mayberry, 1994; Buchholz & Thaler,
2003).
Finally, all the non-reproductive medical diseases not already excluded were 
removed (n = 5) and there were two reasons for this decision. First, when conducting 
the review it was established that the incidence of a number of these medical 
conditions was very low in the general population and it was decided that it would be 
impractical to have an exhaustive list of questions about relatively rare diseases for a 
tool with the aims proposed. Second, it was thought that in such cases the individual 
concerned would already be aware of the detrimental impact of the disease and/or its 
treatment on her fertility status through information provided in specialist clinics 
and/or through consenting to procedures for treatment and as such would not benefit 
additionally from an awareness tool as proposed. On the basis of these two issues it 
was decided that the following non-reproductive medical diseases would be excluded: 
sickle cell anaemia; lupus erythematosus (SLE); cancer; diabetes; kidney disease and 
transplantation.
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Risk Factors
The following section details the 14 risk factors identified in the literature 
review and retained after the expert consultation. The factors have been divided into 
three categories; demographic factors (1), reproductive factors (5), and lifestyle 
factors (8). Each of the following sections will identify what the risk factor was and 
the outcome it had on fertility potential. A number of the studies computed odds ratios 
or relative risks to highlight the impact the factor had on female fertility. Table 5.1.1, 
5.1.2 and 5.1.3 present the odds ratio or relative risks for each risk factor identified in 
the literature review and the outcome measure (i.e., longer time trying to conceive) 
according to category.
Demographic Factors 
Age.
When females are bom they already have the entire stock of follicles needed 
for reproduction, as they get older the number of follicles decline to the point that by 
the time the menopause is reached (mean age of 51 years), not enough remain to 
sustain the process necessary for menstruation, and thus reproduction (Faddy, Gosden, 
Gougen et al., 1992). Research has shown that even from the age of 20 a woman’s 
fertility is unavoidably declining, with a steep drop after the age of 35 (Menken, 
Trussed & Larsen, 1986; Dunson, Colombo & Baird, 2004). Thus increasing age is 
associated with a number of fertility problems, relating to both the decline of the 
quantity and quality of the oocytes (Velde & Pearson, 2002) and the utems (Stein & 
Susser, 2000). In Table 5.1.1 a total of one prospective and six retrospective studies 
demonstrated that increasing age was significantly associated with female infertility. 
Two studies established an increased TTP with advancing age with Axmon et al.
(2006) reporting a 3% longer TTP when women were compared to women one year
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younger. However Hassan & Killick (2003) found a significant effect of age only in 
relation to the chance of a TTP greater than 24 months. Specifically women aged 30 
to 35 years had nearly a 5 fold increase TTP and women over the age of 35 years a 7 
fold longer TTP compared to women aged 25 years or less. Kaplan et al. (2005) found 
that older women were more likely to encounter a failure when trying to conceive 
compared to younger women: women > 36 years were 3.52 times less likely to have 
conceived within 3 months. Dunson, Baird, and Columbo (2004) also found that older 
women were less likely to have conceived within 12 months using a prospective study 
design whereby women were asked to collect and record daily fertility and menstrual 
characteristics (e.g., basal body temperature) over several menstrual cycles. In La 
Rochebrochard and Thonneau (2003) study they interviewed 6,188 women, finding 
that women aged 35 to 39 years were significantly more likely to experience a delay 
in conception compared to women 26 years and younger. Finally two studies (Urbach 
et al., 2001; Maheshwari et al., 2008) sampling over 7,000 women found that 
progressing age was a significant risk factor for tubal infertility in women over the 
age of 30 (OR range 1.70 -  33.00) and for unexplained infertility in women aged 30 
to 34 (OR 1.50) and 35 to 39 years (OR 1.80) compared to women under the age of 
30.
133
Table 5.1.1
Effect o f demographic factors on female fertility (see page 135 for notes).
Risk Factor, Study Design Outcome
Measure
Odds ratio Cl) N (Age), Sample, Country 
and Year
Sources of 
Bias
Control of Confounding 
Factors
Authors
AGE
Prospective studies
19-26 years old (R)a 
27 - 34 years old 
35 -39 years old
Risk of 
Infertility
1.00d 
1.80® 
2.53
782 women (18 - 40), 
randomly selected, daily 
fertility & menstrual 
characteristics recorded, 
Europe 1992 - 1996
No information 
available
No information available Dunson et al. 
(2004)
Retrospective studies
Compared to 1 year younger Increasedrp-ppC 0.95b (0.93, 0.96) 1,578 women (23 - 39), randomly selected from 
general population, 
questionnaire, Sweden, 
2000
Selection Yes (menstrual cycle, age 
at conception, use of oral 
conception, nulliparity)
Axmon et al. 
(2006)
25 years old or less (R) 
25 - 30 years old 
30 - 35 years old 
>35 years old
Increased TTP 
> 12 months
1.00
1.10 (0.60,2.00/ 
0.90 (0.40, 1.80/ 
2.20 (0.80, 5.80/
1,976 pregnant women (25 
- 44), antenatal units, 
questionnaire, United 
Kingdom 2000 - 2001
No information 
available
Yes (coital frequency, 
weight, smoking, partner's 
age, alcohol, caffeine, age 
at menarche)
Hassan & 
Killick (2003)
25 years old or less (R) 
25 - 30 years old 
30 - 35 years old 
>35 years old
Increased TTP 
> 24 months
1.00
1.60(0.60,4.60/ 
4.80(1.50, 16.00/ 
7.70(1.50,38.90/
£ 30 years old (R) 
£ 36 years old
Increased TTP 1.00d
3.52**
798 pregnant women (20 - 
40), antenatal unit, 
questionnaire, Israel 2003
No information 
available
No information available Kaplan et al. 
(2005)
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Effect o f demographic factors on female fertility (continued).
Risk Factor, Study Design Outcome
Measure
Odds ratio Cl) N (Age), Sample, Country 
and Year
Sources of Bias Control of Confounding 
Factors
Authors
AGE
Retrospective studies (continued) 
<30 years old (R)
30 - 34 years old 
35 -39 years old
Risk of 
Infertility
1.00
1.16(0.96, 1.41) 
1.79(1.30, 2.46)
3,287 women (25 - 44), 
randomly selected from 
census registers, interview, 
Europe 1991 - 1993
Selection & 
recall
Yes (country of origin, 
number of previous 
pregnancies, smoking, 
coital frequency, history 
of miscarriage, history of 
induced abortion)
La
Rochebrochard 
& Thonneau 
(2003)
<30 years old (R) 
30 - 34 years old 
35 - 39 years old 
£ 40 years old
Risk of tubal 
infertility
1.00
1.70(1.40, 1.90) 
2.20(1.70, 2.70) 
2.20(1.60, 3.00)
7,172 infertile women (20 - 
50), medical records based 
on first clinic visit, United 
Kingdom 1993-2006
Change in 
diagnostic 
methods over 
time
Yes (partner's age, 
diagnosis of male factor, 
duration of infertility)
Maheshwari et 
al. (2008)
< 30 years old (R) 
30 - 34 years old 
35 - 39 years old 
£ 40 years old
Risk of
unexplained
infertility
1.00
1.50(1.30, 1.80) 
1.80(1.40, 2.20) 
1.20(0.90,1.60)
20 - 24 years old (R) 
25 - 29 years old 
30 - 34 years old 
35 - 39 years old 
40 - 44 years old
Risk of 
primary tubal 
infertility
1.00
5.10(0.60,44.70) 
12.20(1.50,100.80) 
13.30(1.60,111.70) 
33.00 (3.60, 301.80)
121 primary infertile cases 
& 490 clinically pregnant 
controls (20 - 44), 
questionnaires, Canada 
1998
Selection, recall, 
cases not aged 
matched
Yes (socioeconomic 
status, smoking, PID, 
endometriosis, oral & 
intrauterine contraceptive 
use, appendectomy)
Urbach et al. 
(2001)
a R refers to reference group. Based on fecundibility ratio (FR), i.e., the monthly conception rate among exposed compared with that among the unexposed (1/0.94 = 1.03) 0.94 indicates 3% longer TTP compared
with women one year younger. °TTP refers to Time Trying to Pregnancy. dOdds ratios calculated from data available in publication see Appendix L for full calculations. Calculations for odds ratios were from Bland 
and Altman (2000). No confidence Intervals available. *No significance levels provided. fRelative risk ratio. *P<0.05, **P<0.01, ***P<0.001.
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Reproductive Factors 
Endometriosis.
Endometriosis is defined as the presence of endometrial glands and stroma 
outside the uterine/endometrial cavity and musculature commonly characterised by 
general pelvic pain, dysmenorrhea (pain presenting around the time of menstruation), 
dyspareunia (pain during sexual intercourse), abnormal uterine bleeding and infertility 
(Olive & Schwartz, 1993; Schenken, 1999). According to Khadem and Mazlouman 
(2004) the most established cause of the disorder is the retrograde flow of menstrual 
flow through the fallopian tubes and deposition of viable endometrial tissue, with 
subsequent implantation on the peritoneal surface. The disease is almost exclusively 
found in women of reproductive age (Olive & Schwartz, 1993), with a prevalence rate 
estimated at 3-15% (Jones, 1997; Keye, 2006), although this rate can vary depending 
on the technique used for diagnosis (Olive & Schwartz, 1993). As Table 5.1.2 (page 
142) shows four retrospective studies reported a negative impact on female fertility 
potential in women suffering from endometriosis. In the Akande et al. (2004) study 
they split endometriosis sufferers into two groups; women presenting with primary or 
secondary infertility and by age and found that younger women with endometriosis 
were significantly more likely to have a reduced chance of a natural pregnancy in the 
primary and secondary infertility groups compared to women with a diagnosis of 
secondary unexplained infertility. Three case-controlled studies established an 
association between endometriosis and infertility. Khadem and Mazlouman (2004) 
demonstrated that women with endometriosis were nearly 5 times more likely to have 
infertility compared to women without endometriosis. Lalos (1988) also reported 
increased risk of infertility in women diagnosed with moderate endometriosis 
compared to women without endometriosis (OR 3.91). In addition both Lalos (1988)
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and Urbach et al. (2001) found that women suffering from endometriosis were at an 
increased risk of tubal infertility (OR 3.50), including women who had ever had the 
condition (OR 6.00; Urbach et al., 2001).
Menstrual Cycle.
Menstruation centres on the development of the egg and ovulation (Gersh & 
Gersh, 1981). The menstrual cycle averages the length of a lunar month (29.5 days), 
however it is estimated that only 10-15% of cycles are exactly 29.5 days (Jones,
1997). It is estimated that between 91-97 % of women with a regular cycle will have 
evidence of ovulation (Taylor & Collins, 1992). Cycle length can vary greatly within 
and between women and there are a number of problems related to menstrual cyclicity 
that are associated with infertility. Two studies used prospective designs to assess the 
impact of menstrual cycle irregularities on conception. Specifically, Small et al.
(2006) found that shorter bleed length (< 4 days) and shorter cycle lengths (i.e., 26 to 
29 days) were associated with a reduced chance of clinical pregnancy compared to 5- 
day bleeds or cycles of 30 to 31 days, respectively. Conversely longer cycles (i.e., >32 
days) were also found to have reduced chance of clinical pregnancy (OR 0.63) 
although the confidence intervals (Cl) included unity. Kolstad et al. (1999) also found 
that longer cycles (i.e., >40 days) were associated with reduced conception rate (OR 
1.54).
Two retrospective studies (Axmon, Rylander, Albin, & Hagmar, 2006; 
Rowland et al., 2002) also reported longer menstrual cycle length significantly 
associated with an increased TTP and risk of infertility. Rowland et al. (2002) also 
found that irregular cycles (OR 2.80) and inter-menstrual bleeding (OR 1.70) were 
also significantly related to an increased risk of infertility.
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Chronic Menstrual Pain.
It is estimated that between 30 -  90% of women will experience a certain 
amount of discomfort during menstruation and that for roughly 7 -  15% this 
menstrual pain will be so severe it will impinge on normal day to day functioning 
(Svanberg & Ulmsten, 1981; Pullon, Reinken, & Sparrow, 1988; C. A. Wilson & 
Keye, 1989; Ng, Tan & Wansaicheong, 1992; Jamieson & Steege, 1996; Zondervan et 
al., 1998). Dysmenorrhea is the medical term to define chronic menstrual pain, caused 
by severe contractions of the uterine smooth muscle (Jones, 1997) and as Table 5.1.2 
(pages 143-145) shows it is associated with an increased risk of infertility (OR 3.71), 
as is chronic pelvic pain (OR 12.57), and dyspareunia (medical term to define pain in 
the lower pelvic region experienced during sexually intercourse; OR 4.41).
Pelvic Surgery.
Women who undergo surgery in their pelvic region are at risk of adhesions or 
infections as a result of such operations (van Goor, 2007). According to Lalos (1988) 
such tubal occlusion and/or adhesions in the pelvic region are a major cause of 
infertility and in Table 5.1.2 (page 143) two case-controlled studies reported 
significant associations. Thonneau et al. (1992) found that women with a history of 
pelvic surgery were 1.80 times more at risk of primary and secondary infertility. Lalos 
(1988) found that previous abdominal surgery was the most frequent risk factor for 
tubal infertility (OR 4.32).
Sexually Transmitted Infections (STI)ZDiseases (STD),
Research on the effect of STDs on fertility strongly indicates that such 
diseases are the primary aetiology of tubal infertility, acting through the intermediary 
of pelvic inflammatory disease (R. T. Cates, Rolfs, & Aral, 1990). Six retrospective
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studies were reviewed. Thonneau et al. (1992) found that women who have ever had a 
STD were 10 times more at risk of secondary infertility compared to women who had 
never had an incidence of an STI (see Table 5.1.2, pages 145-147).
Chlamydia infections occur twice as frequently as other STI’s such as 
gonorrhoea in most population studies (R. T. Cates et al., 1990). Chlamydia is 
suggested to cause more severe sub-clinical inflammation and subsequent tubal 
damage compared to other STD’s (Sciarra, 1997). Hills et al. (1997) reported that 
women who contracted the infection more than once had a significantly increased risk 
of pelvic inflammatory disease (PID) compared to women infected once. Wiesenfeld 
et al. (2002) also reported a significant association between positive chlamydia 
infection and sub-clinical PID. Chlamydia was also associated with an increased risk 
of infertility in two case-controlled studies. Women who had suffered from chlamydia 
were 11.45 times at risk of infertility (Malik, Jain, Hakim, Shukia, & Rizvi, 2006) and
3.20 times at risk of tubal infertility (Swasdio et al., 1996) compared to women who 
had never tested positive for chlamydia.
Gonorrhoea (often referred to as gonococcal infection, Jones, 1997) is less 
prevalent compared to chlamydia infection. Gonorrhoea is often asymptomatic; with 
at least 50% of women having no symptoms at all (Eschenbach, 1999). Two studies 
reported a significant increased risk of tubal infertility following this infection, with 
Swasdio et al. (1996) reporting that women had a 32.40 fold increase of tubal factor 
infertility and Lalos (1988) a 7 fold increase compared to women who had never had 
the disease (see Table 5.1.2, pages 145-147). Past gonorrhoea infection was also 
associated with a 2.40 times increased risk of sub-clinical PID.
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Pelvic Inflammatory Disease (PID),
Pelvic Inflammatory Disease (PID) also known as acute salpingitis (Rhoton- 
Vlasak, 2000) refers to infection of the uterus, fallopian tubes and adjacent pelvic 
structures unrelated to prior surgery or pregnancy (McCormack, 1994). The exact 
incidence of PID is unknown because the disease cannot be diagnosed reliably from 
clinical symptoms and signs (Ross, 2008); however of those diagnosed it is thought to 
affect around 1.5 million women in the United States (Crossman, 2006). Symptoms of 
PID include lower abdominal pain, abnormal vaginal discharge, abnormal uterine 
bleeding, dysuria (painful or problematic urination), dyspareunia, nausea, vomiting 
and fever (Rhoton-Vlasak, 2000). If the disease is left untreated, it can ascend to the 
upper genital tract (Land & Evers, 2002), causing tubal obstruction, pelvic adhesions 
and/or endometriosis (Sciarra, 1997). Research suggests that PID is predominately 
caused by chlamydia, gonorrhoea and anaerobes infections with 20-50% of cases in 
the U.S. occurring in association with chlamydia and 20-80% in association with 
gonorrhoea (Rhoton-Vlasak, 2000).
In Table 5.1.2 (pages 147-148) all four studies reviewed found a significant 
association between PID and infertility. One prospective study (Westrom, 1993) 
found that the incidence of PID significantly increased the risk of infertility compared 
to women with no history of the infection (OR 7.00) and that the risk of infertility 
significantly increased as the number of episodes of PID increased (OR two episodes 
= 16.20, three or more episodes = 28.30). In addition for those women who had the 
infection a significant association was found with the severity of the disease and 
subsequent risk of infertility (OR moderate = 1.80, severe = 5.60).
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Urbach et al, (2001) found that women suffering from PID were six times 
more at risk of tubal infertility and Lalos (1988) reported women with PID had a four 
fold increase risk of tubal infertility compared to women not suffering from PID. 
Finally Thonneau et al. (1992) reported a significant increased risk of primary and 
secondary infertility in women who had a past episode of salpingitis.
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Effect o f reproductive factors on female fertility (see page 148 for notes).
Risk Factor, Study 
Design
Outcome Measure Odds ratio (Cl) N, Sample, Country and Year Sources of 
Bias
Control of
Confounding
Factors
Authors
ENDOMETRIOSIS 
Retrospective studies 
Unexplained infertility (R)a 
Mild Endometriosis (at 
median age 31 years) 
Primary infertility 
Secondary infertility 
Mild Endometriosis (at 
maximum age 39 years) 
Primary infertility 
Secondary infertility
Reduced 
conception rate
1.00
0.26 (0.11, 0.62)bf 
0.21 (0.10, 0.43)bf
0.68 (0.16, 2 .88)bf 
0.53 (0.13, 2.20)bf
117 unexplained infertile women & 75 
women with laparoscopic diagnosed 
endometriosis (< 40), questionnaire & 3 year 
follow-up United Kingdom 1985 - 1995
Selection, 
drop out
Yes (age, duration 
of infertility, type of 
infertility, smoking)
Akande et 
al.(2004)
Yes (versus no) Risk of infertility 4.67**° 100 infertile women & 120 fertile age- 
matched controls (25 - 40), laparoscopy 
performed & medical records, Iran
Selection No information 
available
Khadem &
Mazlouman
(2004)
Yes moderate 
endometriosis (versus no)
Risk of Infertility 2 9 i* * c 120 infertile cases & 126 pregnant controls 
with no history of infertility (18 - 43), 
questionnaire & medical records, Sweden 
1978 - 1982
Small
sample size
No information 
available
Lalos
(1988)
Yes (versus no) 
Ever (versus never)
Risk of tubal 
infertility 
Risk of tubal 
infertility
3.59°
6.00 (2.80, 12,80) 121 primary infertile cases & 490 clinically 
pregnant controls (20 - 44), questionnaires, 
Canada 1998
Selection, 
recall, cases 
not aged 
matched
Yes (socioeconomic 
status, age, 
smoking, PID, oral 
& intrauterine 
contraceptive use, 
appendectomy)
Urbach et 
al. (2001)
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Effect o f reproductive factors on female fertility (continued, see page 148 for notes).
Risk Factor, Study 
Design
Outcome Measure Odds ratio (Cl) N, Sample, Country and Year Sources of 
Bias
Control of
Confounding
Factors
Authors
PELVIC SURGERY 
Retrospective studies
Yes (versus no) 
Yes (versus no)
Risk of primary 
infertility
Risk of secondary 
infertility
1.80(1.20, 1.90) 
1.80(1.10,3.00)
301 infertile cases & 380 controls who had 
just given birth, interview, France 1988 - 
1989
Recruitment Yes (age) Thonneau et 
al.(1992)
Yes (versus no) Risk of tubal
infertility
MENSTRUAL CYCLE IRREGULARITIES 
Prospective studies 
Cycle length
4 32***c 120 infertile cases & 126 pregnant controls 
with no history of infertility (18-43), 
questionnaire & medical records, Sweden 
1978 - 1982
Small
sample size
No information 
available
Lalos (1988)
£28 -29  days (R) Reduced 1.00 295 trade union women (20 - 35), daily urine Selection Yes (age, history of Kolstad et
£ 40 days conception rate 1.54° samples for 5 menstrual cycles or until 
conception, Denmark 1992 - 1995
STD & salpingitis, 
appendectomy, 
history of 
andrologic disease, 
contraceptive use, 
BMI, study centre, 
coital frequency)
al.(1999)
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Risk Factor, Study 
Design
Outcome Measure Odds ratio (Cl) N, Sample, Country and Year Sources of 
Bias
Control of
Confounding
Factors
Reduced 
conception rate
MENSTRUAL CYCLE IRREGULARITIES (continued) 
Prospective studies (continued)
Bleed length
< 4 days
4 days
5 days(R)
6 days 
£ 7 days
Cycle length
< 26 days 
26 - 27 days 
28 - 29 days 
30-31 days (R)
£ 32 days
Retrospective studies 
1 day increase in menstrual 
cycle length 
Yes (versus no)
Reduced 
conception rate
Increased TTP
Long cycle 
Yes (versus no)
Irregular cycle 
Yes (versus no) 
Inter-menstrual bleeding 
Yes (versus no)_______
Risk of infertility 
Risk of infertility 
Risk of infertility
0.50(0.29, 0.87)e 
0.57 (0.36, 0.90)e 
1.00
0.90(0.56, 1.44)e 
0.70 (0.40, 1.24)e
0.60 (0.34, 1.06)e 
0.56 (0.32, 0.99)e 
0.52 (0.31, 0.88)e 
1.00
0.63 (0.38, 1.03)e
0.96 (0.94, 0.98)e
2.40(1.60,3.50) 
2.80 (2.00, 3.90) 
1.70(1.30, 2.10)
470 women employed by government (< 40), 
interviews & urine collection 2 days per 
cycle for 1 year or until a clinical pregnancy, 
United States 1990 - 1994
Sample size
1,578 women (23 - 39), randomly selected 
from general population, questionnaire, recall 
menstrual cycle length every 3 months of 
trying to conceive, Sweden, 2000
3,941 women (21 - 40), questionnaire, 
United States 1994 - 1996
Selection
Yes (coital 
frequency, number 
of cycles women at 
risk of pregnancy, 
age, BMI, race, 
caffeine, alcohol, 
smoking)
Yes (menstrual 
cycle, age at 
conception, use of 
oral conception, 
nulliparity)
Selection Yes (age)
Authors
Small et 
al.(2006)
Axmon et 
al.(2006)
Rowland et 
al. (2002)
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Risk Factor, Study 
Design
Outcome Measure Odds ratio (Cl) N, Sample, Country and Year Sources of 
Bias
Control of
Confounding
Factors
MENSTRUAL CYCLE IRREGULARITIES (continued) 
Prospective studies (continued)
Menstrual Pain
Dysmenorrhea (pain during 
menstruation)
Yes (versus no)
Chronic pelvic pain 
Yes (versus no) 
Dyspareunia (pain during 
sexual intercourse)
Yes (versus no)
Yes (versus no)
Risk of infertility
Risk of infertility 
Risk of infertility
Risk of secondary 
infertility
3.71*c
12.57*°
4.41*°
10.00 (3.00, 
36.30)
SEXUALLY TRANSMITTED INFECTIONS (STIs)
Retrospective studies
Chlamydia Trachomatis
No. of chlamydial
infections
1 (R) Risk of PID
2
>3
100 infertile women & 120 fertile age- 
matched controls (19-39), laparoscopy 
performed & medical records, Iran
301 infertile cases & 380 controls who had 
just given birth, interview, France 1988 - 
1989
1.00
4.00(1.30, 9.90)f 
6.40 (2.20, 18.40/
11,000 women known to have had 
chlamydia trachomatis (10 - 44), medical 
records of registered hospitalisation for PID, 
United States 1985 - 1992
Selection No information 
available
Recruitment Yes (age)
Under­
representation 
of all
chlamydia
cases
Yes, but for a 
number of lifestyle 
factors no 
information 
ascertained
Yes (versus no) Risk of subclinical 
PID
3.40 (1.80, 6.30) 556 women (15- 30) with lower genital tract No
infections or determined at risk of such information
infections, sexual & reproductive health available
clinics, endometrial sampling for histologic 
analysis, United States 1998 - 2000
Yes (menstrual 
cycle, previous 
pregnancy, race, 
positive for 
chlamydia, 
gonorrhoea
Authors
Khadem &
Mazlouman
(2004)
Thonneau et 
al.(1992)
Hillis et al. 
(1997)
Wiesenfeld 
et al.(2002)
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Risk Factor, Study 
Design
Outcome Measure Odds ratio (Cl) N, Sample, Country and Year Sources of 
Bias
Control of
Confounding
Factors
Authors
SEXUALLY TRANSMITTED INFECTIONS (STIs) (continued) 
Chlamydia Trachomatis (continued)
Yes (versus no) Risk of infertility 11.45 * * 110 primary & secondary infertile cases & 
30 healthy term pregnant controls (18 - 40), 
hysterosalpingography performed on all 
patients, India 2003 - 2004
No
information
available
No information 
available
Malik et al. 
(2006)
Yes (versus no) Risk of tubal 
infertility
3.20(1.20, 8.50) 55 primary infertile confirmed tubal damage 
cases & 59 postpartum controls, past 
infections assessed measuring serum IgG 
antibodies, Thailand 1990 - 1992
No
information
available
Yes Swasdio et 
al.(1996)
Neisseria Gonorrhoea 
Yes (versus no) Risk of subclinical 
PID
2.40(1.10, 5.10) 556 women (15-30) with lower genital tract 
infections or determined at risk of such 
infections, sexual & reproductive health 
clinics, endometrial sampling for histologic 
analysis, United States 1998 - 2000
No
information
available
Yes (phase of 
menstrual cycle, 
previous 
pregnancy, race, 
positive for 
chlamydia, 
neisseria 
gonorrhoea, 
bacterial vaginosis 
or T vaginalis
Wiesenfeld 
et al.(2002)
Yes (versus no) Risk of tubal 
infertility
7 32***c 120 infertile cases & 126 pregnant controls 
with no history of infertility (18 - 43), 
questionnaire & medical records, Sweden 
1978 - 1982
Small sample 
size
No information 
available
Lalos (1988)
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Risk Factor, Study Outcome Measure 
Design
Odds ratio (Cl) N, Sample, Country and Year Sources of 
Bias
Control of
Confounding
Factors
Authors
SEXUALLY TRANSMITTED INFECTIONS (STIs) (continued) 
Neisseria Gonorrhoea (continued)
Yes (versus no) Risk of tubal
infertility
PELVIC INFLAMMATORY DISEASE (PID) 
Prospective studies
32.40 (4.30, 
242.20)
55 primary infertile confirmed tubal damage 
cases & 59 postpartum controls, past 
infections assessed measuring serum IgG 
antibodies, Thailand 1990 - 1992
No
information
available
Yes Swasdio et 
al.(1996)
None (R) Risk of infertility
1 episode of PID
2 episodes of PID
£ 3 episodes of PID 
Mild (R)
Moderate
Severe
1.00
7.00*8
16.20*8
28.30*8
1.00
1.80*8
5.60*8
1,966 women all diagnosed with acute 
salpingitis (15 - 34), laparoscopy & follow- 
up interviews, Sweden 1960 - 1989
No
information
available
Yes Westrom
(1993)
Retrospective studies
Yes (versus no) Risk of tubal
infertility
Past Salpingitis
4.27***c 120 infertile cases & 126 pregnant controls 
with no history of infertility (18 - 43), 
questionnaire & medical records, Sweden 
1978 - 1982
Small sample 
size
No information 
available
Lalos (1988)
Yes (versus no) Risk of primary
infertility
Yes (versus no) Risk of secondary
infertility
21.20(4.90,
129.00)
12.20 (5.10, 
30.30)
301 infertile cases & 380 controls who had 
just given birth, interview, France 1988 - 
1989
Recruitment Yes (age) Thonneau et 
al.(1992)
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Risk Factor, Study Outcome Measure Odds ratio (Cl) 
Design
N, Sample, Country and Year Sources of 
Bias
Control of
Confounding
Factors
Authors
PELVIC INFLAMMATORY DISEASE (PID) (continued) 
Retrospective studies (continued)
Ever (versus never) Risk of tubal 6.00 (2.80, 12.80) 121 primary infertile cases & 490 clinically Selection, Yes Urbach et al.
infertility pregnant controls (20 - 44), questionnaires, recall, cases (socioeconomic (2001)
a n  n  „ , „ c  „ _ „ _ b A J J  „ 1. 1___ 1 _ ^ „ j _ a! _
Canada 1998
• r- _ _ j  • ,  /  _ i t  .• t i . i
not aged 
matched
status, age, 
smoking,
endometriosis, oral 
& intrauterine 
contraceptive use, 
appendectomy)
aR refers to reference group. Odds ratios below 1 represent a reduction in fecundity/conception. cOdds ratios calculated from data available in publication see Appendix L
for full calculations. Calculations for odds ratios were from Bland and Altman (2000). No confidence Intervals available. dTTP refers to Time Trying to Pregnancy. fBased on 
fecundability ratio (FR), i.e., the monthly conception rate among exposed compared with that among the unexposed (1/0.94 = 1.03) 0.94 indicates 3% longer TTP compared 
with women one year younger. 8Relative risk ratio. * P< 0.05. ** P< 0.01. *** P< 0.001.
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Lifestyle Factors
Alcohol consumption.
Eleven studies (four prospective and seven retrospective) investigated the 
association between alcohol consumption and female infertility. In Table 5.1.3 (pages 
157 -  159) four retrospective studies found that consumption of alcohol had a 
significant negative effect on time trying to conceive (Hassan & Killick, 2004; Olsen, 
Bolumar, Boldsen, & Bisanti, 1997; Axmon et al., 2006; Juhl et al., 2003). However 
one large cohort study (Juhl et al., 2003) found that while consumption of more than 
seven spirits per week was associated with a longer TTP (OR 2.40), consumption of 
wine was actually associated with a shorter TTP (OR 0.71) and consumption of beer 
had no effect (OR 0.98). Two prospective studies (Hakim, Gray, & Zacur, 1998; 
Jensen et al., 1998) found that increased alcohol consumption reduced conception 
rates (OR range 0.34 -  0.61 [for these studies an OR below 1 indicated a reduction in 
conception rate]). In addition, higher consumption was associated with an increased 
risk of infertility in three studies (Grodstein, Goldman, & Cramer, 1994; Greenlee, 
Arbuckle, & Po-Huana, 2003; Tolstrup et al., 2003). In the Tolstrup et al. (2003) 
study however, the increased risk of infertility was only significant in women aged > 
30 years. Alcohol consumption was also associated with an increased risk of 
ovulatory infertility, endometriosis, tubal disease and cervical disease (Grodstein et 
al., 1994), however the confidence intervals for the latter two included unity.
Finally, in a prospective diary study of women providing a daily urine sample 
and a record of lifestyle habits Liu, Larson, and Wyshak (2004) found that women 
who drank one or more drinks per week were significantly more likely to have 
menstrual irregularities.
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Caffeine Consumption.
In Table 5.1.3 (pages 159-162) eight studies (two prospective and six 
retrospective) reported the effect of caffeine consumption on female fertility. Four 
studies reported caffeine consumption and TTP irrespective of whether the woman 
was a smoker or not. All these studies reported a significant impact on consumption of 
caffeine and a longer TTP, with Hassan and Killick (2004) finding that women who 
drank seven or more cups of caffeine per day (~ 700mg) were 1.70 times more likely 
to have an increased TTP compared to women who drank less than 7 cups per day. 
Hatch et al. (1993) found that caffeine consumption of more than 151 mg per day (~ 1 
-  2 cups of coffee) was also associated with a significantly longer TTP, especially in 
women who drank >301 mg per day (~ 3 cups of coffee). Bolumar, Olsen, Rebagliato, 
and Bisanti (1997) reported women who drank >301 mg per day (~3 cups of coffee) 
were 1.45 times more likely to have an increased TTP of 9 or more months compared 
to women who drank 0 -1 0 0  mg of caffeine per day (~ 1 cup of coffee). In addition 
women who consumed more than 7000 mg per month (~ 70 cups of coffee) were 
significantly less likely to have conceived within 13 months compared to women who 
drank less than 501 mg per month (Wilcox, Weinberg, & Baird, 1988). Three studies 
showed an association between smoking and caffeine consumption on waiting times 
to conception. One of these studies found an association only in women who smoked 
and drank > 8 coffee/teas per day (Stanton & Gray, 1995). A similar finding by Jensen 
et al. (1998) showed that women who smoked and consumed 0 -  299 mg caffeine per 
day (~ 2 cups of coffee) had a reduction in fertility. However another study found an 
association in women who did not smoke and drank >301 mg per day (~3 cups of 
coffee) and in women who smoked but drank no caffeine or 1 -  150 mg per day (~ 1 -  
2 cups of coffee). Caffeine consumption was also associated with an increased risk of
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infertility. Drinking more than 7 grams of caffeine per month (~ 70 cups of coffee) 
was associated with a significant increased risk of tubal infertility and endometriosis 
related infertility.
Anabolic Steroids,
Anabolic steroids or anabolic-androgenic steroids (AAS) are a group of 
synthetic derivatives related to the male hormone testosterone (Hartgens & Kuipers,
2004), and are frequently used illegally as performance enhancing drugs. Anabolic 
steroids work by increasing the protein synthesis within cells resulting in the build-up 
of cellular tissue in the muscles (Kuhn, 2002) thereby improving muscle strength. 
Research on the prevalence of its use in society is limited (Talih, Fattal, & Malone, 
2007), however, its use is increasing among women (Kutscher, Lund, & Perry, 2002). 
There has however been very limited research on investigating the impact of anabolic 
steroid use on female reproduction (De Cree, 1998; Hartgens & Kuipers, 2004). The 
literature search produced six studies reporting the effect of anabolic steroids on 
human female reproduction, with none reporting odds ratios. Orchard, Fricker, White, 
Burke, and Healey (2006) found that women who reported use of the drug were at a 
higher risk of infertility. In addition menstrual irregularities have been reported in 
women using the substance (Hartgens & Kuipers, 2004). Korkia and Stimson (1997) 
reported that out of the 13 women interviewed on the effects of anabolic steroid use 
eight (62%) reported menstrual irregularities. Misuse has also been found to have 
irreversible effects on menstruation (Strauss, Liggett & Lanese, 1985; Elliot & 
Goldber, 2000; Kutscher et al. 2002). However, Strauss and Yesalis (1991) reported 
that menstrual cessation or irregularity does return after termination of use of the 
drug, but that the menopause may be reached sooner in women with long history of 
drug misuse. Finally, Bolch and Warren (1973) found that menstrual irregularities
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(e.g., inhibited ovulation, shortened the luteal phase and induced premature 
menstruation and amenorrhoea) only occurred when women used certain types of 
anabolic steroid.
Class A drugs.
Illegal drugs are categorised by the British Home Office into three classes; A, 
B and C (The Misuse of Drugs Act 1971). Class A drugs are deemed the most harmful 
of all drugs due to the addictive nature of them and the consequences of developing a 
dependency on the life of the user and those around them (Home Office, 2007) and 
include ecstasy, heroin, cocaine, LSD, psilocybin mushrooms, and when prepared for 
by injection, amphetamines (The Misuse of Drugs Act 1971). As Table 5.1.3 (page 
162) shows Hassan & Killick (2004) found that women who had ever taken a Class A 
drug had an increased TTP (Cl included unity). However, the outcome of these drugs 
on infertility is not fully understood with only a few studies testing the effects, and 
this mainly for cocaine. Cocaine is a stimulant that is strictly regulated by law due to 
its toxicity and addictive potential (Rizk, Atterbury, & Groome, 1996). In Table 5.1.3 
(page 162) women who reported ever taking cocaine had a higher risk of primary 
tubal infertility (OR -11.10), however, another study found conversely that women 
had a shorter TTP (OR -  1.20) compared to women who had never taken the drug.
LSD is an illegal drug that induces hallucinogenic effects in its users. Mueller, 
Daling, Weiss, and Moore (1990) reported that women who had ever taken LSD were
2.20 times more at risk of primary tubal infertility (OR -  2.20) however this was not 
significant (Cl 0.60 — 7.90; see Table 5.1.3, page 162).
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Smoking marijuana.
Marijuana is one of the most commonly used illegal drugs (Roe & Man,
2006). The majority of research focusing on the effects of marijuana on fertility has 
been carried out on non-human animals; such research suggests that these substances 
(marijuana, tetrahydrocanabinnol and cannabinoids) can have powerful effects on the 
reproductive health of females (B. Park, McPartland, & Glass, 2004). In regard to 
human (female) studies, Table 5.1.3 (page 163) shows that women who reported 
smoking marijuana within 12 months prior to trying to conceive were 2.10 times more 
likely to present with ovulatory infertility compared to those who had never used the 
drug. However one study did report a shorter TTP in women who regularly and 
irregularly smoked marijuana, however these OR’s including unity.
Smoking tobacco.
As Table 5.1.3 (pages 165-167) shows several observations suggest that 
cigarette smoking (actively and passively) is associated with a detrimental effect on 
female fertility. One prospective study that was conducted (Liu et al., 2004) reported 
longer and shorter menstrual cycles in women who smoked (actively and passively) 
compared to women who did not smoke (actively and passively); all the Cl’s 
however, included unity.
Three retrospective studies (Hull, North, Taylor, Farrow, & Ford, 2000;
Hassan & Killick, 2004; Axmon et al., 2006) reported an association between time to 
pregnancy (TTP) and smoking habits, although in the Axmon et al. (2006) the OR 
was not significant. In Hassan & Killick’s (2004) study women who smoked lightly 
(<15 cigarettes per day) and heavily (>15 cigarettes per day) had a significantly 
increased TTP of more than 12 months compared to women who were non-smokers.
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Similarly, Hull et al. (2000) reported increased TTP of more than 6 and 12 months, 
but, when looking at the six month analysis of TTP the only significant findings were 
in women smoking 20 or more cigarettes a day (OR 1.59), those smoking passively 
only (OR 1.17) or those smoking actively and passively (OR 1.51) when compared to 
women who never smoked. In the 12 month analysis of TTP women who smoked 1 -  
4 cigarettes a day (OR 1.67), 1 5 -1 9  cigarettes a day (OR 1.99), > 20 cigarettes a day 
(OR 1.58), women who actively smoke (OR 1.54) and women who actively and 
passively smoke (OR 1.57) all had a significant TTP of more than 12 months when 
compared to women who never smoked. Smoking was also associated with an 
increased risk of infertility in women who were passively exposed for 1 -  5 hours a 
week (OR 1.80) and > 7 hours a week (OR 1.80) but not significant in the women 
who were exposed 6 - 1 2  hours a week (OR 1.50 Cl 0.80, 2.50). Finally a review by 
Augood, Duckitt, and Templeton (1998) found that of 12 primary studies (11 
retrospective and one prospective) all indicated a detrimental effect of smoking on 
reproduction (average OR 1.60).
Stress.
The literature to date on the effect of psychological stress on fertility is 
somewhat inconsistent, but there does appear to be converging opinion that increasing 
levels of stress are associated with reduced fertility (Homan, Davies, & Norman,
2007; Boivin & Schmidt, 2005). In Table 5.1.3 (pages 163-165) five studies were 
reviewed, of which three were prospective in design and two retrospective. Women 
who reported perceived work stress had an increased TTP of more than 12 months 
compared to women reporting no work stress (OR = 0.78). Women reporting higher 
distress scores in relation to three factors assessing the quality of experiences related 
to the project of having a child (i.e., maternal, child and marriage factors) were at
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more risk of infertility compared to women who scored lower on the individual 
factors (Stoleru, Teglas, Fermanian, & Spria, 1993). Psychological stress may reduce 
female reproductive performance in a number of ways. The biological interaction 
between stress and reproduction is the result of the stress hormones and the 
hypothalamic-pituitary adrenal axis interacting with the hormones that are responsible 
for normal ovulatory cycles (Schenker, Meirow, & Schenker, 1992), thus potentially 
affecting the menstrual cycle. A number of studies in the literature review found a 
significant relationship between stress and menstrual irregularities. In Hjollund et al. 
(1999) women trying to conceive completed the General Health Questionnaire (GHQ) 
each month (Day 21) and results showed that women who had a menstrual cycle 
length of > 35 days and poor GHQ scores were 8.40 times less likely to conceive in 
the next menstrual cycle. Fenster et al. (1999) also reported menstrual irregularities in 
women experiencing extreme stress in the work place, finding that women were 2.24 
times more likely to experience short cycles (<24 days) compared to women 
experiencing no stress. Finally, Gordley, Lemasters, Simpson, and Yiin (2000) found 
women reporting life events were significantly more likely to have a number of 
menstrual irregularities (dysmenorrhea OR 2.20; hypermenorrhea OR 2.99; and 
abnormal cycle lengths OR 3.42) than women who did not report life events.
Weight
Weight is most commonly assessed according to Body Mass Index (BMI). The 
BMI is calculated as the weight in kilograms divided by the square of the height in 
metres (kg/m2) (World Health Organisation; WHO, 2000). According to the WHO a 
BMI < 18.5 is considered underweight, 18.5 to 24.99 a normal range, >25.00 
overweight and obese (WHO, 2000).
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As Table 5.1.3 (pages 167-169) shows a high BMI was associated with a 
number of fertility problems. Four retrospective studies reported a longer time to 
conception in women with a high BMI. Specifically Bolumar, Rebagliato, Saez- 
Lloret, and Bisanti (2000) found women with a BMI of > 30 had nearly a 12 fold 
increase in their TTP compared to women with a BMI range within 20 -  24.99. 
Gesink-Law et al. (2007), Hassan and Killick (2004) and Ramlau-Hansen, Thulstrup, 
Nohr, Bonde, Sorensen, and Olsen (2007) all reported that women with a BMI of 25 
or more had a significantly longer TTP compared to women with BMI in the range of 
18.5 -  24.99. Kaplan et al. (2005) found that women with a BMI > 25 were 1.34 times 
more likely to not have conceived within 3 months, and 2.42 times more likely to not 
have conceived within 6 months compared to women with a BMI <25. Higher BMI in 
women was also associated with a significant increased risk of infertility (Greenlee et 
al., 2003; Rich-Edwards et al., 1994) and in particular ovulatory infertility (Green et 
al., 1988; Grodstein et al., 1994).
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Effect o f lifestyle factors on female fertility ( see page 169 for notes).
Risk Factor, Study Design Outcome
Measure
Odds ratio (Cl) N (Age), Sample, Country and 
Year
Sources of 
Bias
Control of Confounding 
Factors
Authors
ALCOHOL CONSUMPTION 
Prospective studies 
<30 years old 
< 1 alcoholic drink per week (R)b 
1 - 6 per week 
> 7 per week
Risk of 
infertility
LOO
0.87 (0.60, 1.27) 
0.79 (0.51, 1.22)
7,760 women (20 - 29), randomly 
selected from general population, 
interview, Denmark 1991 - 1993
Recruitment No control for variables 
developing over time (e.g., 
endometriosis)
Tolstrup et al. 
(2003)
>30 years old 
< 1 alcoholic drink per week (R) 
1 - 6 per week 
> 7 per week
Risk of 
infertility
1.00
1.95(1.04,3.66) 
2.26(1.19, 4.32)
1-12  g/wk (versus none) 
13-90 g/wk (versus none) 
> 91 g/wk (versus none)
Reduced
conception
rate
0.43 (0.25, 0.76)a 
0.40 (0.21,0.77)“ 
0.65 (0.20, 2.15)a
124 women (23 - 41), daily urine 
samples & reports of lifestyle 
habits, United States 1989 - 1991
Recall & 
sample size
Yes (age, race, education, 
pregnancy & fertility 
history, coital frequency, 
smoking)
Hakim et al. 
(1998)
I - 5  drinks per week (versus none) 
6 - 1 0  drinks per week (versus none)
I I - 1 5  drinks per week (versus 
none)
>15 drinks per week (versus none) 
6 - 1 0  drinks per week (versus none)
Reduced
conception
rate
0.61 (0.40, 0.93)a 
0.55 (0.36, 0.85)a 
0.34 (0.22, 0.52)a
0.34 (0.11, 1.07)a 
0.55 (0.36, 0.85)8
423 women (20 - 35), monthly 
questionnaires for 6 menstrual 
cycles or until clinical pregnancy, 
Denmark 1992 - 1995
Recruitment 
& Selection
Yes (age, smoking, diseases 
in the reproductive system, 
menstrual cycle, oral 
contraceptives, BMI)
Jensen et al. 
(1998)
> 1 drinks per week (versus none) Short
follicular
phase
1.19(0.70, 2.03) 338 women (20 - 44), daily urine 
samples & reports of lifestyle 
habits, United States 1989 - 1991
Selection Yes (age, ethnicity, BMI, 
smoking, physical activity)
Liu et al. 
(2004)
Retrospective studies 
Yes (versus no) Increased 
TTPC > 12 
months
0.83 (0.72, 0.95)d 1,578 women (23 - 39), randomly 
selected from general population, 
questionnaire, Sweden, 2000
Selection Yes (menstrual cycle, age at 
conception, use of oral 
conception, nulliparity)
Axmon etal. 
(2006)
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Risk Factor, Study Design Outcome
Measure
Odds ratio (Cl) N (Age), Sample, Country and 
Year
Sources of 
Bias
Control of Confounding 
Factors
Authors
ALCOHOL CONSUMPTION (continued) 
Retrospective studies (continued)
Yes (versus no) Increased
Tipc > X2
months
0.83 (0.72, 0.95)d 1,578 women (23 - 39), randomly 
selected from general population, 
questionnaire, Sweden, 2000
Selection Yes (menstrual cycle, age at 
conception, use of oral 
conception, nulliparity)
Axmon et al. 
(2006)
Mild < 20 units per week (verses 
none)
Increased
TTP
o.8o (0.60, l.ooy 1,976 pregnant women (25 - 44) 
antenatal units, questionnaire, 
United Kingdom 2000 - 2001
Sample size
within
groups
Yes (coital frequency, 
weight, smoking, partner's 
age, alcohol, caffeine, age at 
menarche)
Hassan & 
Killick (2004)
Spirits > 7 per week (verses none)
Wine > 7 per week (verses none) 
Beer > 7 per week (verses none)
Increased 
TTP > 12 
months
Shorter
TTP
2.40(1.00, 5.75)
0.71 (0.58, 0.88) 
0.98 (0.67, 1.43)
29,844 pregnant women at least 12 
weeks gestation (14 - 44), national 
birth cohort, interview, Denmark 
1997-2000
Sample size
within
groups
Yes (age, parity, smoking, 
BMI, PID, occupational 
status)
Juhl et al. 
(2003)
1 -7  drinks per week (verses none) 
8-14  drinks per week (verses none) 
>15 drinks per week (verses none)
Increased 
TTP > 9.5 
months
1.20(1.00, 1.50) 
1.70(1.10,2.70) 
1.70 (0.80,3.50)
2,587 pregnant women at least 20 
weeks gestation & those just given 
birth (25 - 44), interview, Europe, 
1992
Selection & 
Recall
Yes (education, occupation, 
age, parity, alcohol, 
caffeine, oral contraceptives 
within 12 months before 
starting to try, coital 
frequency)
Olsen et al. 
(1997)
Low consumption 
Moderate consumption (R) 
High consumption
Risk of 
infertility
0.65 (0.46, 0.92y 
1.00
1.58(1.07,2.34)*
7,393 (18 - 28) randomly selected 
women from general population, 
questionnaire, Sweden, 1969
No
information
available
No, did not ascertain 
information on lifestyle 
factors other than alcohol
Eggert et al. 
(2004)
158
Table 5.1.3
Effect o f lifestyle factors on female fertility (continued, see page 169 for notes).
Risk Factor, Study Design Outcome
Measure
Odds ratio (Cl) N (Age), Sample, Country and 
Year
Sources of 
Bias
Control of Confounding 
Factors
Authors
ALCOHOL CONSUMPTION (continued) 
Retrospective studies (continued)
1 -2  per week (verses none) Risk of 
3 - 6 per week (verses none) infertility 
> 7 per week (verses none)
1.80(1.20, 2.80) 
2.00(1.20,3.50) 
6.70(1.50, 30.30)
322 primary infertile cases & 322 
age-matched pregnant (during 1st 
trimester) controls (18-35), 
interview, Canada 1997 - 2001
No
information
available
Yes (education, income, 
smoking, alcohol, time 
spent reviewing exposure 
lists, BMI, partner's age, 
age at menarche, number of 
sexual partners)
Greenlee et 
al. (2003)
<100 g/week (verses none) 
> 100 g/week (verses none)
<100 g/week (verses none) 
>100 g/week (verses none) 
<100 g/week (verses none) 
>100 g/week (verses none) 
<100 g/week (verses none) 
>100 g/week (verses none)
Risk of
ovulatory
infertilityf
Risk of tubal 
disease 
Risk of 
cervical factor 
Risk of 
endometriosis8
1.30(1.00, 1.70) 
1.60(1.10, 2.40)
1.00 (0.70, 1.40) 
1.20 (0.70, 1.90) 
1.70 (0.80,2.10) 
1.80 (0.80,3.30) 
1.60(1.20, 2.50) 
1.50(1.00,3.20)
1,050 infertile women & 3,833 
women admitted for delivery of 
pregnancy, interview, United 
States & Canada 1981 - 1983
Interviewer
bias
Yes (fertility centre, age, 
number of sexual partners, 
smoking, caffeine, 
exercise, BMI, intrauterine 
device)
Grodstein et 
al. (1994)
CAFFEINE CONSUMPTION 
Prospective studies 
Non-smokers 
0 - 299 mg per day (R)
300 - 699 mg per day 
> 700 per day
Reduced
conception
rate
1.00
0.88(0.60, 1.3 l)a 
0.63 (0.25,1.60)a
423 women (20 - 35), monthly 
questionnaires for 6 menstrual 
cycles or until clinical pregnancy, 
Denmark 1992 - 1995
Recruitment 
& Selection
Yes (age, smoking, 
diseases in the reproductive 
system, menstrual cycle, 
oral contraceptives, BMI)
Jensen et al. 
(1998)
Smokers
0 - 299 mg per day 
300 - 699 mg per day 
> 700 per day
0.55 (0.32, 0.98)a 
0.68(0.42, 1.11)8 
0.77 (0.35, 1.72)a
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Risk Factor, Study Design Outcome
Measure
Odds ratio (Cl) N (Age), Sample, Country and 
Year
Sources of Bias Control of
Confounding Factors
Authors
CAFFEINE CONSUMPTION (Continued) 
Prospective studies (Continued)
< 501 mg per month (R) Risk of
> 7000 mg per month infertility
1.00
4.70**
221 women, daily menstrual
characteristics recorded & 
interviews at 0, 3, 6,12 & 24 
months or until clinical pregnancy, 
United States
No
information
available
Yes, but did not 
measure all 
lifestyle factors
Wilcox et al. 
(1988)
Retrospective studies 
0 -100 mg per day (R)
101 - 300 mg per day
301 - 500 mg per day 
> 501 mg per day
Increased TTP 
> 9.5 months
1.00
1.02 (0.77, 1.36)
1.01 (0.74, 1.37) 
1.45(1.03,2.04)
3,187 women (25 - 44) randomly 
selected from general population, 
interview, Europe 1991 - 1993
Selection Yes (oral 
contraceptives 
within 12 months prior 
to starting time, 
education, occupation, 
alcohol, smoking, coital 
frequency, PID, parity, 
age)
Bolumar et 
al. (1997)
Mild < 7 cups per day (R) 
Heavy > 7 cups per day
Increased
TTP
1.00
1.70(1.10,2.70)*
1,976 pregnant women (25 - 44) 
antenatal units, questionnaire, 
United Kingdom 2000 - 2001
Sample size 
within groups
Yes (coital frequency, 
weight, smoking, 
partner's age, alcohol, 
caffeine, age at 
menarche)
Hassan &
Killick
(2004)
1 -150 mg per day (verses none) 
151 - 300 per day (verses none) 
> 301 per day (verses none)
Increased
TTP
1.39(0.90,2.13) 
1.88(1.13,3.11) 
2.24(1.06,4.73)
1,909 pregnant women antenatal 
unit, interview, United States 
1980 - 1982
Misclassification Yes (last contraceptive 
used, parity, smoking)
Hatch & 
Bracken 
(1993)
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Risk Factor, Study Design Outcome
Measure
Odds ratio (Cl) N (Age), Sample, Country and 
Year
Sources of Bias Control of Confounding 
Factors
Authors
CAFFEINE CONSUMPTION (continued)
Retrospective studies (continued)
Non-smokers 10,886 pregnant women at 36th Recall Yes Olsen (1991)
0 - 3 cups coffee/tea per day (R) Increased 1.00 week of gestation,
4 -7  cups coffee/tea per day TTP > 12 1.05 (0.87, 1.27) questionnaire, Denmark 1984 -
> 8 coffee/tea per day months 0.98 (0.70, 1.37) 1987
Smokers
0 -3  cups coffee/tea per day (R) 1.00
4 -7  cups coffee/tea per day 1.03 (0.90, 1.41)
> 8 coffee/tea per day 1.35(1.02, 1.48)
1 -150 mg per day (verses none) Increased 0.91 (0.64, 1.29) 2,501 pregnant women Selection Yes (age at conception, Stanton &
151 - 300 per day (verses none) TTP > 12 0.92 (0.59, 1.42) employed at semioconductor parity, smoking, last Gray (1995)
>301 per day (verses none) months 1.44 (0.85,2.44) plants, interview, United States, method of contraception,
1989 - 1990 known history of
Non-smokers infertility, race)
1 -150 mg per day (verses none) 0.92 (0.61, 1.37)
151 - 300 per day (verses none) 1.20(0.70, 2.02)
> 301 per day (verses none) 2.65(1.38,5.07)
Smokers
None (R) 2.99(1.52,5.89)
1-150 mg per day 2.99(1.40,3.75)
151 - 300 per day 1.52 (0.84, 2.74)
> 301 per day 1.75 (0.89,3.62)
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Risk Factor, Study Design Outcome
Measure
Odds ratio (Cl) N (Age), Sample, Country and 
Year
Sources of Bias Control of Confounding 
Factors
Authors
CAFFEINE CONSUMPTION (continued) 
Retrospective studies (continued)
> 7 grams per month (verses none)
> 7 grams per month (verses 
none)
RECREATIONAL DRUG USE 
Class A drugs 
Retrospective studies
Risk of tubal 
infertility
Risk of 
endometriosis- 
related 
infertility
1.50(1.10, 2.00)1 
1.60(1.20,2.90)*
1,050 infertile women & 3,833 
women admitted for delivery of 
pregnancy, interview, United 
States & Canada 1981 - 1983
Interviewer bias Yes (fertility center, age, 
number of sexual partners, 
smoking, caffeine, 
exercise, BMI, intrauterine 
device)
Grodstein et 
al. (1994)
Previous/current (verses never) Incresaed TTP 1.60 (0.30, 7.80)1 1,976 pregnant women (25 - 44) 
antenatal units, questionnaire, 
United Kingdom 2000 - 2001
Sample size 
within groups
Yes (coital frequency, 
weight, smoking, partner's 
age, alcohol, caffeine, age 
at menache)
Hassan & 
Killick (2004)
Ever use cocaine (verses never) Shorter TTP 1.20(1.10, 1.40) 1,818 infertile cases & 2,817 
controls given birth same year, 
interview, United States & 
Canada 1981 - 1983
Limited
information
Yes (age, BMI, education, 
age at menarche, number 
of previous pregnancies, 
coital frequency, number 
of previous miscarriages, 
alcohol, smoking)
Joesoef et al. 
(1993)
Ever use cocaine (verses never) Risk of 11.10(1.70, 84 infertile cases & demographic Response & Yes (Smoking, number of Mueller et al.
Ever use LSD (verses never)
primary tubal 
infertility
70.80)1
2.20 (0.60, 7.90)*
& socioeconomic-matched 
controls given birth same year 
(20 - 39), interview, United 
States 1979- 1981
Recall sexual partners, 
intrauterine contraceptive 
device use)
(1990)
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Risk Factor, Study Design Outcome Odds ratio (Cl) N (Age), Sample, Country and Sources of
Measure Year Bias
Control of Confounding
Factors
RECREATIONAL DRUG USE (continued) 
Smoking marijuana 
Retrospective studies
Irregular (verses never) 
Regular (verses never)
Ever (verses never)
Used > 1 year before reference date 
(verses never)
Used within 1 year of reference date 
(verses never)
Ever (verses never)
STRESS
Prospective studies 
Menstrual cycle length <35 days 
Same score (R)
Lower score 
Higher score
Menstrual cycle length >35 days 
Same score (R)
Lower score
Higher score_______________
Shorter
TTP
Risk of 
ovulatory
1.10(0.90, 1.20) 
1.1 0 ( 1.00, 1.20)
1.70(1.00,3.00)* 
1.40(0.70, 2.60)*
infertility 2.10 (1.10, 4.00)1
Risk of 
primary 
tubal 
infertility
Reduced
conception
rate
1.30(0.50,3.30)*
1.00
1.10(0.60, 1.90) 
1.50 (0.90,2.40)
1.00
8.40(1.60,45.30) 
1.70 (0.30,8.90)
1,818 infertile cases & 2,817 Limited
controls given birth same year, information
interview, United States & Canada 
1981 - 1983
84 infertile cases & demographic 
& socioeconomic-matched controls 
given birth same year (20 - 39), 
interview, United States 1979 - 
1981
Response & 
Recall
393 women (20 - 35) monthly 
questionnaires for 6 menstrual 
cycles or until clinical pregnancy, 
Denmark 1992 - 1995
Planning
Yes (age, BMI, education, 
age at menarche, number of 
previous pregnancies, coital 
frequency, number of 
previous miscarriages)
Yes (Smoking, number of 
sexual partners, intrauterine 
contraceptive device use)
Yes (cycle number, trade 
union, education, age, BMI, 
contraceptive method 12 
months prior to time 
starting, self-reported male 
or female reproduction- 
related disease, partner's 
sperm count, smoking, 
caffeine, alcohol________
Authors
Joesoef et al. 
(1993)
Mueller et al. 
(1990)
Hjollund et al. 
(1999)
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Risk Factor, Study Design Outcome
Measure
Odds ratio (Cl) N (Age), Sample, Country and 
Year
Sources of 
Bias
Control of Confounding 
Factors
Authors
STRESS (continued)
Prospective studies (continued) 
Factor I: Need for parenthood & 
marital relationship 
Low Scores (R)
High Scores
Factor II: Negative thoughts & 
concerns for child 
Low Scores (R)
High Scores
Factor III: Quality of expectations 
related to mother, child & marriage 
Low Scores (R)
High Scores
Risk of 
infertility
1.00
16.50*
1.00
3.84
1.00
45.60*
63 women (20 - 35) trying to 
conceive, questionnaire at 1 & 12.8 
months, France
Selection Yes (age, medical history, 
time of marriage, time 
interval between 
contraception cessation & 
first psychological 
assessment)
Stoleru et al. 
(1993)
Stressful work 
Yes (verses no) Short 
menstrual 
cycle < 24 
days
2.24(1.09,4.59)
403 women (18-39) daily 
menstrual characteristics, urine 
samples & interviews, United 
States 1990 - 1991
Selection Yes (age, race, smoking, 
alcohol, caffeine, life 
events, noise level at work, 
frequency of overexertion at 
work)
Fenster et al. 
(1999)
Yes (verses no) Risk of 
anovulatio 
n>  36 
days
1.34 (0.35,4.28)
Perceived work stress 
Yes (verses no)
Increased 
TTP >
12 months 0.78(0.67, 0.9l)d
1,578 women (23 - 39), randomly
selected from general population, 
questionnaire, Sweden, 2000
Selection Yes (menstrual cycle, age
at conception, use of oral 
conception, nulliparity)
Axmon et al. 
(2006)
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Risk Factor, Study Design
STRESS (continued) 
Retrospective studies (continued) 
Life event
Yes (verses no)
Yes (verses no)
Yes (verses no)
SMOKING TOBACCO 
Prospective studies 
Smokers (verses non-smoker)
Passively exposed (verses never)
Retrospective studies 
Median number per day =10 
(verses none)
Outcome Odds ratio (Cl) N (Age), Sample, Country and Sources of
Measure Year Bias
Control of Confounding Authors
Factors
Menstrual
irregularities
Dysmenorrhea 2.20(1.08,4.50) 
Hypermenorrhea 2.99 (1.20, 7.42)
Abnormal cycle 
length
3.42(1.12,
10.50)
170 women employed by the US Selection,
Air Force (18 - 41), measurement
questionnaire about menstrual error
patterns in preceding 3 months ,
United States
No information available Gordley et al. 
(2000)
Short menstrual 
cycle < 25 days
Long menstrual 
cycle >35 days 
Short menstrual 
cycle < 25 days 
Long menstrual 
cycle >35 days
1.05 (0.54, 2.07)
1.52 (0.64, 3.66)
1.13 (0.59, 2.18)
1.79 (0.90, 3.54)
338 women (20 - 44), daily urine Selection 
samples & reports of lifestyle 
habits, United States 1989 - 1991
Yes (age, ethnicity, BMI, Liu et al.
smoking, physical activity) (2004)
Increased TTP > 0.93 (0.79, 1.08)d 1,578 women (23 - 39), Selection Yes (menstrual cycle, age Axmonetal.
12 months randomly selected from general at conception, use of oral (2006)
population, questionnaire, conception, nulliparity)
________________________________ Sweden, 2000 ______________________________________ _______________________
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Risk Factor, Study Design Outcome
Measure
Odds ratio (Cl) N (Age), Sample, Country and 
Year
Sources of 
Bias
Control of Confounding 
Factors
Authors
SMOKING TOBACCO (continued) 
Prospective studies (continued) 
Light < 15 per day (verses none)
Heavy > 15 per day (verses none)
Increased 
TTP > 12 
months
1.50(1.10,2.20)* 
3.60(1.90, 7.10)*
1,976 pregnant women (25 - 44) 
antenatal units, questionnaire, 
United Kingdom 2000 - 2001
Sample size
within
groups
Yes (coital frequency, 
weight, smoking, partner's 
age, alcohol, caffeine, age at 
menarche)
Hassan & 
Killick (2004)
1 - 4 per day (verses none)
5 - 9 per day (verses none)
10 -14 per day (verses none)
15 -19 per day (verses none)
> 20 per day (verses none) 
Passive only (verses never) 
Active only (verses never) 
Active & passive (verses never)
Increased 
TTP >6 
months
1.22 (0.92,1.62) 
1.24 (0.93, 11.64) 
0.93 (0.71, 1.22) 
1.47 (0.71, 1.22) 
1.59(1.28, 1.99) 
1.17(1.02, 1.37)
1.23 (0.98, 1.49) 
1.51 (1.27, 1.78)
8,515 pregnant women at least 18 
weeks gestation, questionnaire, 
United Kingdom 1991 - 1992
Recall,
selection
Yes (age, alcohol, caffeine, 
recreational drugs, 
industrial pollutants, heat, 
education, occupation)
Hull et al. 
(2000)
1 - 4 per day (verses none)
5 - 9 per day (verses none)
10 -14 per day (verses none) 
15-19 per day (verses none)
> 20 per day (verses none) 
Passive only (verses never) 
Active only (verses never) 
Active & passive (verses never)
Increased 
TTP > 12 
months
1.67(1.18, 2.38) 
1.29 (0.88, 1.90) 
0.95 (0.63, 1.36) 
1.99(1.48,2.69) 
1.58(1.18, 2.12) 
1.14(0.92,1.42) 
1.54(1.19,2.01) 
1.57(1.26, 1.96)
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Table 5.1.3
Effect o f lifestyle factors on female fertility (continued, see page 169 for notes).
Risk Factor, Study Design Outcome Odds ratio (Cl) N (Age), Sample, Country and Sources of
Measure Year Bias
Control of Confounding
Factors
SMOKING TOBACCO (continued) 
Prospective studies (continued) 
Former (verses never)
Current (verses never)
Passive smoke exposure 
1 - 5 hours per week (versus none) 
6-12 hours per week (versus 
none)
> 7 hours per week (versus none) 
Ever (verses never)
Review - meta analysis 
Smoker (versus non-smoker)
WEIGHT
Retrospective studies 
20 - 24.9 kg/m2 (R) (smoker) 
25 -29.9 kg/m2 (smoker)
> 30 kg/m (smoker)
Risk of 
infertility
Risk of 
infertility
Risk of 
primary 
tubal 
infertility
Risk of 
infertility
Increased
TTP
1.40 (0.90,2.10) 
1.60 (0.90,2.90)
1.80(1.20,2.50) 
1.50 (0.80, 2.50)
1.80 (1.10, 2.90)
2.00(1.20,3.20)
1.60(1.34, 1.91)
1.00
0.80 (0.35, 1.81) 
11.54 (3.68, 
36.15)
322 primary infertile cases & 322 
age-matched pregnant (during 1st 
trimester) controls (18-35), 
interview, Canada 1997 - 2001
121 primary infertile cases & 490 
clinically pregnant controls (20 - 
44), questionnaires, Canada 1998
Meta analysis of 12 cohort and 
case-control studies in the general 
population 1985 - 1997.11 
retrospective & 1 prospective
2,587 pregnant women at least 20 
weeks gestation (25-44), prenatal 
care unit, questionnaire or 
interview, Europe 1992
No
information
available
Selection, 
recall, cases 
not aged 
matched
Publication,
self-report,
recall,
misclassificati 
on, selection
No
information
available
Yes (education, income, 
smoking, alcohol, time 
spent reviewing exposure 
lists, BMI, partner's age, 
age at menarche, number of 
sexual partners)
Yes (socioeconomic status, 
age, PID, endometriosis, 
oral & intrauterine 
contraceptive use, 
appendectomy)
Yes, in all studies reviewed
Yes (age, education, 
occupation, menstrual cycle, 
coital frequency, oral 
contraceptives, number of 
miscarriages, previous 
pregnancies, caffeine, 
alcohol, smoking) -
Authors
Greenlee et 
al. (2003)
Urbach et al. 
(2001)
Augood et al. 
(1998)
Bolumar et al. 
(2000)
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Effect o f lifestyle factors on female fertility (continued, see page 169 for notes).
Risk Factor, Study Design Outcome
Measure
Odds ratio (Cl) N (Age), Sample, Country and 
Year
Sources of 
Bias
Control of Confounding 
Factors
Authors
WEIGHT (continued) 
Retrospective studies (continued) 
20 - 24.9 kg/m2 (R) (smoker)
25 -29.9 kg/m2 (smoker)
> 3 0  kg/m2 (smoker)
Increased
TTP
1.00
0.80 (0.35, 1.81) 
11.54 (3.68,36.15)
2,587 pregnant women at least 20 
weeks gestation (25-44), prenatal 
care unit, questionnaire or 
interview, Europe 1992
No
information
available
Yes (age, education, 
occupation, menstrual cycle, 
coital frequency, oral 
contraceptives, number of 
miscarriages, previous 
pregnancies, caffeine, 
alcohol, smoking)
Bolumar et al. 
(2000)
18.5 - 24.9 kg/m2 (R) 
25.0 - 29.9 kg/m2 
> 30.0 kg/m2
Increased
TTP
1.00
0.84 (0.77, 0.92)a 
0.72 (0.63, 0.83)a
7,327 pregnant women median 
gestation 16 weeks, interview, 
United States 1959 - 1965
No
information
available
Yes (smoking, race, 
education, occupation, study 
centre)
Gesink Law 
et al. (2007)
19-24 kg/m2 (R) 
25 - 39 kg/m2 
> 39 kg/m2
Increased 
TTP > 12 
months
1.00
2.20(1.60,3.20)* 
6.90 (2.90, 16.80)*
1,976 pregnant women (25 - 44) 
antenatal units, questionnaire, 
United Kingdom 2000 - 2001
Sample size
within
groups
Yes (coital frequency, 
weight, smoking, partner's 
age, alcohol, caffeine, age at 
menarche)
Hassan & 
Killick (2004)
<25 kg/m2 (R) 
> 25 kg/m2
Increased
TTP < 3 
months
1.00
1.34e
798 pregnant women (20 - 40),
interview & questionnaire, Israel 
2003
No
information
available
No information available Kaplan et al. 
(2005)
<25 kg/m2 (R) 
> 25 kg/m2
Increased 
TTP > 6 
months
1.00
2.42°
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Risk Factor, Study Design Outcome
Measure
Odds ratio (Cl) N (Age), Sample, Country and 
Year
Sources of Bias Control of Confounding 
Factors
Authors
WEIGHT (continued) 
Retrospective studies (continued)
18.50-24.99 kg/m2 (R) Increased 1.00 47,835 pregnant women at least No information Yes (age, partner's age, Ramlau-
25.00 - 29.99 kg/m2 TTP > 12 1.27(1.18, 1.36) 16 weeks gestation (15-44), two available number of previous Hansen et al.
> 30 kg/m2 months 1.78(1.63, 1.95) telephone interviews during & 
after pregnancy, Denmark 1996 - 
2002
pregnancies, 
socioeconomic status)
(2007)
<120% ideal weight Risk of 1.00 380 infertile cases & 1,520 Misclassification, Yes (race, age, census Green et al.
>120% ideal weight ovulatory
infertility
2.10(1.00, 4.3oy demographic & socioeconomic- 
matched controls given birth 
same year (20 - 39), interview, 
United States 1979 - 1981
recall tract, reference year) (1988)
18.5 - 24.9 kg/m2 (R) Risk of 1.00 322 primary infertile cases & 322 No information Yes (education, income, Greenlee et
25.0 - 29.9 kg/m2 
> 30.0 kg/m2
infertility 1.10(0.70, 1.70) 
1.30 (0.90,2.00)
age-matched pregnant (during 1st 
trimester) controls (18-35), 
interview, Canada 1997 - 2001
available smoking, alcohol, time 
spent reviewing exposure 
lists, BMI, partner's age, 
age at menarche, number 
of sexual partners)
al. (2003)
20 -21.9 kg/m2 (R) Risk of 1.00 2,527 infertile women & 46,718 Selection, recall Yes (age at menarche, age Rich-
22 - 23.9 kg/m2 .
24 - 25.9 kg/m2 
26 - 27.9 kg/m2 
28 - 29.9 kg/m2 
30-31.9 kg/m2 
> 32 kgm2
aA jj„  1__i~... i _________________ •
infertility 1.10( 1.00, i.2oy
1.30(1.20, 1.60)* 
1.70(1.40, 2.10)* 
2.40(1.80. 3.10y 
2.70(1.90,3.80)* 
2.70 (2.0, 3.70)*
women whose first pregnancy 
lasted > 6 months with no history 
of infertility (25 - 42), 
questionnaires, United States 
1989 - 1995
. . .  dr.___A __ c _____
at reference event, year of 
birth, ethnicity, coital 
frequancy, smoking, 
alcohol, diabetes meilitus, 
oral contracpetives)
rcr>\ : A
Edwards et 
al. (1994)
itinn rotp omono
exposed compared with that among the unexposed (1/0.94 = 1.03) 0.94 indicates 3% longer TTP compared with women one year younger. eOdds ratios calculated from data available in publication see Appendix L for 
full calculations. Calculations for odds ratios were from Bland and Altman (2000). No confidence Intervals available/ Excluding women with additional diagnosis of endometriosis. * Excluding women with additional 
diagnosis of ovulatory infertility. h Planning bias refers to under-representation of highly fertile women in the sample. ‘Relative risk ratio. * P< 0.05. ** P< 0.01. *** P< 0.001. *P< 0.10.
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Evaluation and Synthesis o f the Risk Factors
In order to compare risks across the studies and types of risks, the odds or
relative ratio (hereafter referred to as ratio) in the highest category for each risk factor
per study (i.e., oldest age, largest unit of alcohol) was examined in a set of secondary 
2 * •  •analyses . No significant difference was found between the average relative risk 
(overall M — 4.90, SD = 6.78) and the average odds ratio (overall M= 4.92, SD = 
7.87) and these were treated as comparable in the following secondary analysis.
Table 5.1.4 shows the average ratios for each risk factor. As can be seen pelvic 
inflammatory disease had the largest average ratios (M=  14.94, SD = 11.71) and 
marijuana the smallest ratios (M= 1.70, SD = 0.57). Risk factors were grouped 
according to whether they were lifestyle (n = 29 studies, sampling 189,214 women), 
reproductive (n = 13 studies, sampling 20,378 women) or demographic ( n ~ l  studies, 
sampling 19,105 women) risk factors. An analysis of variance (ANOVA) comparing 
the average ratio per risk category (i.e., demographic, lifestyle, reproductive) was not 
significant (P = 0.16). The average ratio was 5.94 (SD = 10.96) for the demographic 
factor, 3.63 (SD = 6.67) for the lifestyle factors, and 7.05 (SD = 8.03) for the 
reproductive factors.
Average ratios were compared against the main quality indicator; study 
design. A t-test showed that the difference between the average ratio for retrospective 
studies (M= 4.43, SD = 6.07) was not significantly different from the average ratio 
for prospective studies (M= 7.05, SD = 12.21) (t(83)=1.26, P = 0.21). However,
2 All fecundability ratios were reversed according to Axmon et al. (2006) so they would be in the same 
direction as the odds ratios or relative risks. Any odds or relative risks that were in the opposite 
direction (i.e., below 1 indicated an increased risk of infertility) compared to the rest of the numbers 
(i.e., above 1 indicated an increased risk of infertility) and could not be reversed were not included in 
the calculation of the means (n = 5).
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when within risk category (i.e., demographic, lifestyle, reproductive) there was a 
significant difference for the lifestyle prospective (M= 7.04, SD = 12.87) and 
retrospective average (M= 2.61, SD = 2.45) (t(48)=2.05, P=0.04) ratios. The 
difference between the reproductive prospective (M= 8.22, SD = 13.39) and 
retrospective average ratio (M= 6.84, SD =7.18) (t(25)= 0.31 P = 0.76) was not 
significant. A statistical test could not be performed for the demographic category as 
there was only one prospective study (prospective OR 2.53, retrospective M= 6.42, 
SD= 11.75).
Table 5.1.4
Average odds ratios for each risk factor and according to category.
Factors Average odds ratio SD
Demographic 5.94 10.96
Age 5.94 10.96
Lifestyle 3.63 6.67
Alcohol 2.07 1.51
Caffeine 1.88 1.11
Class A drugs 6.35 6.72
Marijuana 1.70 0.57
Smoking 1.79 0.86
Stress 8.09 13.94
Weight 3.98 3.51
Reproductive 7.05 8.03
Endometriosis 4.86 1.06
Menstrual irregularities 3.32 3.43
Pelvic surgery 3.06 1.78
Sexually transmitted disease 9.57 9.78
Pelvic inflammatory disease 14.94 11.71
Note. Menstrual irregularities include pelvic pain. No odds ratios were found for anabolic steroid use.
Discussion
The results from the present study demonstrate that there are identifiable 
determinants of reduced fertility potential in women and many of these are risks that 
women could avoid. The literature review and expert consultation produced 14 risk 
factors associated with a detrimental effect on female fertility in three categories:
171
Chapter 5 Risk factors associated with female fertility potential
demographic (one factor); reproductive (five factors) and lifestyle habits (eight 
factors). Pelvic inflammatory disease, sexually transmitted diseases, misuse of illegal 
drugs, stress and age had the largest averaged odds ratios, suggesting that these factors 
could be the most important determinants to target in public health campaigns about 
fertility in women.
The ultimate goal of the present research programme is to produce a risk 
assessment tool that will raise public awareness about risks of reduced fertility by 
enabling women to assess their own fertility status. The results of this study clearly 
showed that such a tool was possible. The literature review and expert consultation 
produced 14 risk factors. These factors were identified from research that spanned 35 
years of investigation, much of which was of relatively good quality using NICE and 
Cochrane criterion. Specifically, nearly a quarter of the studies used prospective 
designs, with the majority of all studies controlling for confounding variables and 
identifying potential biases associated with the methodologies used, sampling over 
200,000 women. Further, the majority of studies focused on pregnancy reported that 
the pregnancy was clinically recognised (at least 12 weeks gestation) or had resulted 
in a live birth indicating that risks were associated with genuine markers of fertility. 
To confirm relevance of these empirical factors to clinical practice the 14 factors were 
the subject of in-depth discussion among 25 medical experts and patient leaders in 
reproductive health. These experts discussed and established which of the risk factors 
were critical, which were common and which, in their clinical judgement, were not 
important or associated with female infertility. The experts based their decision 
making on their prior clinical experience and the odds ratios extracted from the 
literature review. Odds ratios across factors showed that the presence of these factors
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were associated with an averaged 4.92 (SD = 7.64)3 times higher risk of reduced 
fertility, clearly demonstrating that these are genuine risks for reduced fertility. Other 
reviews of risk factors exist but these are mainly focused on a single or at most five 
risk factors (Augood et al., 1998; Greenlee et al., 2003; Hassan & Killick, 2004; 
Khadem & Mazlouman, 2004; Axmon et al., 2006). To this authors knowledge this is 
the first comprehensive review of all risk factors for reduced fertility.
The goal of raising public awareness about fertility issues is to motivate 
people to take care of their fertility whether they are trying to conceive now or expect 
to do so sometime in the future. All the lifestyle factors identified in the current 
review are modifiable by individuals (e.g., cessation of smoking habits). In addition 
awareness of the detrimental effects of reproductive factors such as STDs or PID may 
lead to greater use of condoms or early diagnosis and treatment which is the most 
cost-effective means of preventing their long term consequences on female fertility 
(R. T. Cates, Rolfs, & Aral, 1990; Ray, 2006). Indeed the UK National Health Service 
(NHS) is increasingly focusing on such awareness to help people make healthier 
choices in their day to day life (e.g., what to eat, whether to exercise) (Department of 
Health, 2006). Finally, even if a factor cannot be changed (e.g., age, menstrual 
irregularity) awareness of its association with fertility may impact on reproductive 
decision-making, for example a reduction in time taken before seeking expert medical 
advice. Interestingly, in the present study there was no difference in the odds 
according to risk category (lifestyle, reproductive, demographic) suggesting that 
targeting any variable would produce equal benefits to fertility.
3 Averaged odds ratios does not include the odds that were in the opposite direction (i.e., below 1 
associated with reduced female fertility as opposed to above 1 in the majority of the studies reviewed), 
these ranged from 0.21 -  0.93.
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Raising awareness about the impact the 14 risk factors may have on female 
fertility is all the more relevant when one looks at the increasing prevalence of a 
number of these factors in Western society. Negative lifestyle factors such as obesity, 
illicit drug and alcohol use (especially in young people), and reproductive factors such 
as sexually transmitted diseases, have all increased markedly over the past decade. 
While it cannot be guaranteed that individuals would act to modify risk factors there 
is evidence that using the presence/absence of risk factors (as identified here) to help 
people derive their own health status vis-a-vis a given condition can change 
behaviour. For example, Alm-Roiier, Fridlund, Stagmo, and Erhardt (2006) found that 
self-reported lifestyle change was significantly correlated with a participant’s 
knowledge about their personal risk for future coronary heart disease and the risk 
factors associated with the disease. Further research needs to establish whether the 14 
factors, taken together, adequately discriminate between pregnant and non-pregnant 
women and/or allow some prediction of time to pregnancy and thus whether they 
would be useful for women to aid decision making regarding having children in the 
present day or future.
Methodological Implications and Limitations
The strengths of this study were its comprehensive search and critical 
evaluation of all studies reporting an association between a risk factor and female 
fertility potential as well as in-depth discussion of the value of each indicator with 
fertility experts. Whilst most of the studies used were good quality and one can be 
confident that claims for the effects on fertility are valid, cross study comparisons 
were difficult to make because of variations in methodology, therefore some aspects 
of the present methodology warrants further discussion. First, the inclusion and 
exclusion of risk factors relied heavily on the opinions of the experts and these were
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not selected randomly, since they were experts attending the annual meeting of a 
fertility taskforce. There is no reason to suspect that the experts would have promoted 
one factor over another but their clinical intuition may not necessarily have been 
empirically based. For example the inclusion of Class A drugs and anabolic steroids 
was weighted more on the basis of their clinical impression since the literature review 
produced few studies on this topic. However, the experts were asked to discuss all risk 
factors (inclusions and exclusions) and to achieve a consensus therefore one can at 
least be confident that factors were not reflective of idiosyncratic judgements.
A second methodological issue is that the majority of studies (78%) reported 
potential biases. Two types of bias were frequently mentioned: selection bias and 
recall bias. Forty-six studies (76%) in the review were retrospective and relied on 
recall of past behaviours such as lifestyle habits. Recall of TTP and lifestyle habits 
may be less accurate compared to prospective designs. Of the retrospective studies in 
the current review 21 (47%) were based on accounts of a current pregnancy or women 
currently trying to conceive. According to Joffe et al. (2005) this type of sample 
maintains a good level of accuracy and is the most reliable approach, which is 
confirmed in studies that show that retrospective recall of TTP is reasonably accurate 
when compared to actual TTP (Zielhuis, Hulscher & Florack, 1992; Joffe, 1997; Hull 
et al., 2000; Joffe et al., 2005) even with recall up to 20 years (Joffe, Villard, 
Plowman, & Vessey, 1993). Further, some studies also show excellent recall of other 
events such as smoking during pregnancy (six to nine years after pregnancy) 
compared to medical records taken at the time of pregnancy (Rice et al., 2007). 
Nevertheless it would be important to cross-validate this work in prospective 
evaluation, especially to evaluate the relative importance of each category of risk 
(lifestyle, reproductive, demographic) to the outcomes of interest.
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Selection bias was an issue in a number of the studies. In the cross-sectional 
studies, all infertile women were recruited from clinics and hospitals prior to the start 
of any treatment (usually after diagnostic tests). Using these women compared to 
pregnant women is a useful way to assess the discriminatory power of a risk indicator. 
However, as the results from chapter 2 and 3 demonstrated, not everyone seeks 
treatment when fertility difficulties occur therefore these studies may not represent all 
women facing difficulties conceiving, and may under or overestimate the degree of 
association between risk and outcome to an unknown degree. Furthermore, having 
been diagnosed with fertility problems may influence recall in a way that 
underestimates the risk-outcome association perhaps to avoid self-blame (e.g., recall 
less smoking, alcohol consumption). A further selection bias issue was due to the 
exclusion of women with unplanned pregnancy because one cannot establish TTP. 
However, those women who have an unplanned pregnancy may differ in their health- 
related behaviours compared to women planning to achieve a pregnancy (Augood et 
al., 1998). For example unplanned pregnancy is more common in younger compared 
to older mothers, meaning that selecting only planned pregnancy may truncate the age 
distribution and therefore its association to the outcome (Delgado-Rodriguez, Gomez- 
Olmedo, Bueno-Cavanillas, & Galvez-Vargas, 1997).
Clinical Implications and Future Directions
Future research should be focused on the evaluation of existing risk factors for 
infertility and their ability to predict, uniquely or in combination, fertility potential if 
the ultimate goal is to use these in an applied way (i.e., as a fertility risk tool). It 
would be important to update the literature on each of the risk factors (e.g., 
prevalence) particularly those factors that have received comparatively little research 
attention but which experts felt were important based on clinical intuition. This update
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would also need to identify critical thresholds demarcating dose at which a factor has 
an impact. For example, how many cigarettes or extra pounds make a difference to 
fertility? As noted previously, none of the studies in the current review investigated 
the impact of all the risk factors and only 19% investigated more than one risk factor 
simultaneously despite evidence of a significant association between longer time 
trying to conceive and increasing number of negative lifestyle habits (Hassan & 
Killick, 2004). Some factors may only be important because of their shared 
association with other risk factors and/or may only exert their influence when in the 
presence of another risk. Indeed in the present study shared associations were found 
between smoking and caffeine intake (Stanton & Gray, 1995). Another important 
consideration is to what extent the potency of risk factors are due to other 
uncontrolled factors. Tjonneland, Gronbask, Stripp and Overvad (1999) found that 
women who drank in moderation were more likely to lead a healthier lifestyle in 
comparison to women who drank moderate to large amounts of alcohol. Finally, the 
studies used different outcomes to assess fertility. Some studies assessed the impact of 
risk factors on risk of infertility, others investigated TTP and still others risks 
associated with fertility problems (i.e., menstrual irregularities, PID). Measuring 
different outcomes can make the interpretation of the results across studies difficult 
and there should be a minimum amount of information on the effects of each risk on 
each outcome as the importance of the risk may vary according to outcome.
The results of the current study demonstrated that it was possible to identify a 
list of critical factors that could help people assess their fertility status. The next step 
in the research was to validate the risk factors by assessing whether such factors can 
discriminate between pregnant and non-pregnant women and length in time trying to 
conceive (i.e., more than or less than 12 months).
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Study 5.2
Univariate and multivariate risk correlates of pregnancy and time to
pregnancy
Introduction
Study 5.1 identified 14 risk factors associated with reduced female fertility and 
in the empirical reports each factor demonstrated significant association with at least 
one aspect of fertility potential (e.g., pregnancy, time to pregnancy). However, as risk 
factors are correlated (e.g., smoking and cannabis use; sexually transmitted infection 
(STI) and pelvic inflammatory disease (PID)) it is not known to what extent the 
significant association reported between risk and fertility indicator is due to the 
unique aspects of the risk factor (e.g., STI) or due to its shared variance with another 
risk factor (e.g., PID) that is itself more critical to fertility potential. Too few studies 
examining more than one risk factor exist to separate unique from shared 
contributions to fertility potential. Therefore the aims of the current study were to (1) 
replicate the association between the identified 14 risk factors and fertility potential 
by examining whether the identified risk factors could differentiate between pregnant 
and not yet pregnant women, and between fertile and infertile women (according to 
time to pregnancy) and (2) examine whether individual factors remained significant in 
their association to fertility potential when considered as a group by comparing the 
results of univariate and multivariate analyses.
Taking a multifactorial approach to assessing the impact of the risk factors is 
vital in the development of a risk tool to assess female fertility status for a number of 
reasons. First, it is important to ascertain whether all risk factors are important to all 
outcomes or just some outcomes, and if the latter, which risk influences which
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outcome. While it has been previously established that all the identified factors were 
related to female fertility potential they were all assessed using different designs and 
outcome measures (e.g., longer time trying to conceive, menstrual irregularities, 
increased risk of PID), therefore one needs to confirm their importance when using 
one design assessing the same outcome. Second, one needs to establish whether the 
risk factor explains unique variance in the outcome when assessed together with other 
correlated risks. In the literature review in study 5.1 Tolstrup et al. (2003) reported 
that alcohol consumption was significantly associated with an increased risk of 
infertility but in reality the association was not significant in women less than 30 
years of age, when age was taken into account in the statistical analyses. Establishing 
such relationships could give greater specificity on the critical factors to address to 
improve fertility but also would help from a methodological perspective about key 
questions to put in a self-administered fertility risk tool and the feedback women 
would get regarding their personal scores.
The best design to establish a relationship between an outcome of interest 
(e.g., chance of pregnancy) and an exposure variable (e.g., smoking tobacco) when 
participants cannot randomly be exposed to the risk is the prospective design. In these 
designs, participants can be followed over a period of time to determine whether an 
outcome occurs (e.g., pregnancy) and whether there are any factors (e.g., smoking 
tobacco) predictive of that outcome. To investigate the predictive validity of the 14 
risk factors identified in the literature review (see study 5.1), women would report on 
the presence of all the risk factors, and then be followed from the time they decided to 
start trying to conceive until pregnancy. One could then establish which risk factors 
measured prior to the start of trying to conceive predicted pregnancy.
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Examples of such designs include the prospective observational study (Petrie 
& Sabin, 2000). In prospective observational studies information is collected on a 
number of different variables (measured at time one, T l) to see who develops the 
outcome of interest (e.g., lung cancer, heart disease, mortality) at time two (T2). 
People who develop the outcome are then compared to those who did not on the Tl to 
identify variables that could have potentially caused the outcome (e.g., smoking, diet, 
alcohol consumption). The advantage of the observational design is that a large group 
of individuals, usually representative of the population, are assessed and monitored 
over a period of time, and that the measurement of risk factors precedes the 
occurrence of the outcome. The main limitation is that because the true causes of the 
diseases of interest are not known many different variables need to be measured at Tl 
in the hope of identifying the genuine causes. However, measuring multiple factors 
for different purposes (i.e., multiple outcomes) may reduce the likelihood that all the 
relevant information specific to one outcome has been collected and/or that there will 
be sufficient cases in risk groups to powerfully test the link between risk and outcome 
(Mann, 2003). In the current study a prospective observational design could not be 
conducted because none were in progress that collected data on all the risk factors of 
interest.
An alternative approach to this design would be the cohort prospective design 
with pre-selected samples based on a specific factor, for example smoking (smokers 
and non-smokers), who would then be followed over time to see the frequency of 
outcomes (e.g., lung cancer). The advantage here is that one has a sufficient number 
of cases in the risk groups to detect effects if these exist. However, employing such a 
design for the present thesis would have been too expensive and timely to set-up (e.g., 
finding and recruiting a cohort of women trying to conceive), and to follow-up over
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time (Petrie & Sabin, 2000) and these practical issues made the prospective study 
impractical in the context of the present doctoral work.
In the present study a cross-sectional design was employed to examine 
associations between risk (e.g., smoking) and fertility indicators (pregnancy status, 
infertility status). Cross-sectional studies are conducted at a single point in time taking 
a ‘snap shot’ of the situation at that time and can be the most economically and 
convenient first step in investigating and establishing associations between risk 
factors and disease which can then lead to further prospective assessment of the 
causes of disease (Mann 2003; Beaglehole, Bonita, & Kjellstrom, 2006). Such a 
design is relatively inexpensive and quick to run (Petrie & Sabin, 2000), with no risk 
of loss of follow-up often seen in prospective designs. In such designs people report 
on risk and outcome at the same time (concurrent assessment) or people recall risk 
after the outcome has occurred (retrospective assessment). A major limitation of the 
cross-sectional design is that it cannot be used to infer causal associations. For 
example, finding an association between stress and infertility (measured as time trying 
to conceive), for instance that women who report higher levels of stress also report 
longer time trying to conceive, does not demonstrate whether infertility causes stress, 
or stress causes infertility, but merely that a relationship exists between the two 
variables.
Another disadvantage of a cross-sectional design is due to the recall of 
information prior to the outcome in question. This is an issue as recollection can be 
biased by the experience of the outcome (e.g., pregnancy) and/or the passage of time, 
subsequent life events and so on. This is of particular relevance to the present study as 
cross-sectional designs can limit the use of certain outcome measures and thus often
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rely on recall. For example, when assessing associations between risk factors and 
pregnancy or fertility potential one cannot measure changes in hormonal levels to 
indicate an early pregnancy, or conduct tests to diagnose tubal factor infertility since 
these outcomes have already occurred. Previous cross-sectional studies assessing 
female fertility potential have often relied on the time to pregnancy (TTP) when 
biological markers of fertility potential were not available. Using TTP women are 
asked to recall how long had they been having unprotected sexual intercourse while 
trying to conceive. In TTP studies pregnant women provide time to pregnancy 
whereas women still trying to conceive provide time trying to conceive.
Consequently, a main issue with using TTP is how comparable is recall of pre­
pregnancy behaviour to actual behaviour at the time. However, a number of studies 
have found that retrospective recall of TTP is reasonably accurate when compared to 
actual TTP (Zielhuis et al., 1992; Joffe et al., 1993; Joffe, 1997; Hull et al., 2000;
Joffe et al., 2005). Moreover, recall of risk factors in infertile populations (e.g., 
smoking) has been shown to be fairly accurate. For example in a sample of women 
who had conceived with fertility treatment recall of smoking pre, during and post 
pregnancy, even up to nine years after pregnancy showed high concordance with 
actual medical records (Rice et al., 2007).
While cross-sectional designs cannot determine whether a factor is likely to 
have caused a disease, they can show associations between factors (Mann, 2003) and 
thus in the present study a cross-sectional study design was employed to test 
associations between a factor and fertility to replicate associations reported in study 
5.1. This design was mainly used due to resource limitations but designs that could be 
used for future research are described in the Discussion.
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The Present Study
The aim of the present study was to replicate the association between the 14 
risk factors and female fertility by testing whether these factors could discriminate 
pregnant and not yet pregnant women, and time to pregnancy (more than versus less 
than 12 months trying to conceive) using a cross-sectional study design. Women 
participated in either an online or a clinic survey. All women completed the Fertility 
Risk Factor Survey that included questions ascertaining information on the 14 risk 
factors identified in study 5.1. Women were then categorised according to their 
fertility status. In light of past empirical and clinical data it was expected that risk 
factors would differentiate pregnant and not yet pregnant women, and women trying 
for more than or less than 12 months.
Materials and Methods
Design
A cross-sectional design involving a between-subjects comparison of different 
groups (i.e., pregnant/not pregnant) was employed. Dependent variables were Time 
Trying to get Pregnant (or time trying to conceive for those not pregnant) (TTP) and 
currently Pregnant/Not Pregnant. Independent variables were the presence or absence 
of the 14 risk factors. This study was approved by the Ethics Committee of Cardiff 
University (UREC) and by the South Wales Ethics Research Committee (for 
statements of approval see Appendix M).
Participants
During an eight-month period 1073 women completed the Fertility Risk 
Factors Survey. To achieve the study goals (i.e., assess presence of risk factors in 
pregnant women and women actively trying to conceive) it was decided to recruit 
only women who were of reproductive age (18 — 44), and of an age to consent to
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participate in line with the School of Psychology, Cardiff University ethics guidelines 
(18 and above).
Table 5.2.1 shows the demographic characteristics of the sample. On average 
women were 29.57 (SD = 5.80) years of age, with the majority educated to university 
level and from the United Kingdom.
Table 5.2.1
Demographic characteristics o f  total sample (N = 1072).
Total %
Sample Size 1073 100
Country of Origin8
United Kingdom 730 77.00
America 128 13.50
Canada 43 4.54
Australia 18 1.90
Other 29 3.06
Highest Educational levelb
University 386 48.37
Post secondary/college 285 35.71
Secondary 119 14.91
Primary 8 1.00
Age (SD)C 29.57 (5.80)
Age range
18-25 250 24.20
26-30 349 33.79
31-34 219 21.20
35-39 155 15.00
40-44 60 5.81
Recruitment Source 
Online (n = 603)
Askbaby 172 16.03
Myspace 115 10.72
Facebook 158 14.73
Verity 26 2.42
University 132 12.30
Clinic (n = 470)
Antenatal 326 30.38
Fertility 103 9.60
Abortion
a r x ___ ,  -  t r ____ r \  a c t
41
b r -v ___ * _______ __________ x t -
3.82
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The sample was pooled from two waves of data collection. The first wave of 
data was collected on women (n = 603) recruited using an online version of the survey 
(via four websites and the Cardiff University electronic notice board). As the survey 
was online it was not possible to estimate participation rates for this wave of data 
collection. The second sample (n = 470) consisted of women recruited via three 
medical clinics (fertility, antenatal and abortion). A total of 1,450 questionnaires were 
distributed to these clinics by the researcher, making the participation rate 32.41% (n 
= 470).
Participant’s level of education (^(18, 798) = 51.00, P = 0.001) and age (F(7, 
1025) = 22.52, P = 0.001) differed significantly according to recruitment source with 
the fertility sample being the oldest (mean age = 34.07, SD = 4.97) and the abortion 
sample the youngest (mean age = 25.10, SD = 5.30). The abortion sample had fewer 
women educated to University level (n = 9, 25%) and the infertility website (Verity) 
sample the highest (n — 16, 61.53%). There was no significant difference between 
groups on country of origin, with the majority of the women in each sample coming 
from the United Kingdom.
Study groups.
To ensure the sample was representative in terms of risk the prevalence of risk 
factors in the sample was compared to population values. The analysis on the 
prevalence of risk factors was carried out on the total sample of women (N= 1073). 
The remaining analyses required women to be grouped according to pregnancy status 
or infertility status but within the total sample 339 women stated that they were not 
currently trying to conceive or currently pregnant and these women were excluded
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from further analysis since they could not be grouped (i.e., not pregnant because they 
were not trying).
The remaining participants were grouped according to two indicators of 
fertility: pregnancy status (n = 734) and infertility status (n = 399). For the pregnancy 
status variable, women who were currently pregnant were assigned to ‘pregnant’ (n = 
532), regardless of whether the pregnancy was planned or not, the number of weeks 
pregnant (weeks pregnant range = 3 - 4 0  with 78.82% 12 weeks or more) or how long 
it had taken them to achieve the pregnancy. All other women were assigned ‘not 
pregnant’ {n = 202). For the infertility status variable, women who had been trying to 
get pregnant for less than 12 months were assigned [presumed] ‘fertile’. Women were 
assigned ‘infertile’ if they had been trying (or tried) to get pregnant for more than 12 
months (or 6 months if the woman was >35 years: NICE, 2004) regardless of whether 
she was currently pregnant or not. In analyses on infertility status women who had 
become pregnant unexpectedly (n = 335) were excluded because the period of 
exposure to unprotected sexual intercourse could not be ascertained.
Materials
The Fertility Risk Factors Survey (FRFS, see Appendices N and O) was 
developed for this study and contained 21 questions. Participants were presented with 
the FRFS containing the 14 risk factors identified in study 5.1 resulting in 19 risk 
factors. The five additional risk factors were made up of two risk factors. Specifically, 
the risk factor menstrual irregularities was separated into four questions ascertaining 
information on whether the participants had a period and whether the cycle was short, 
long or irregular. An item on unprotected sexual intercourse was included to assess 
risk of sexually transmitted infection (W. Jr. Cates & Stone 1992). The 19 risk factors
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were grouped into three categories: demographic (age), reproductive (8 questions), 
and lifestyle (10 questions). Reproductive factors were defined as risk factors 
associated with the female reproductive system, for example menstrual cycles. 
Lifestyle factors were defined as risk factors associated with general unhealthy 
behaviours, for example smoking, drinking alcohol, having unprotected sexual 
intercourse.
All 19 questions were derived from the specific risks identified in the literature 
(e.g., “I am a smoker who regularly smokes 10 or more cigarettes a day”) and the 
response scale for all risk factors was either ‘yes’ for the presence of the factor (coded 
1) or ‘no’ for the absence of the factor (coded 0). Therefore higher scores mean more 
of the risk.
Six questions were added to establish the exact amount of exposure (i.e.,
“How many cigarettes do you smoke per day?”). These exact questions inquired about 
weight (and height), smoking (tobacco and marijuana), alcohol, caffeine (coffee, tea 
and caffeinated soft drinks) and Class A drug use (see FRFS, Appendices N and O). A 
total caffeine score (coffee = 1 unit of caffeine, tea/soft drink = 0.5 unit of caffeine: 
Ministry of Agriculture, Fisheries and Food [MAFF], 1998) and a total marijuana use 
score (one joint = 0.5 grams: McGlothlin, 1972, 1975) was calculated for these 
variables. Body mass index was calculated from self-reported weight and height 
scores using the formula kilograms/metres (WHO, 2000).
Three questions concerned educational status, intentions to conceive, parity 
and contraceptive use. Education status was coded ‘1’ primary, ‘2’ secondary, ‘3’ post 
secondary/college and ‘4’ university. Intentions to conceive were ascertained via two 
questions. Women were asked length of time trying to conceive (months and years)
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and contraceptive use (e.g., always using contraception, not using contraception and 
trying to get pregnant, not using contraception but not particularly intending or trying 
to get pregnant)4.
Finally, three questions referring to risk factors associated with male infertility 
were included in the survey (mumps after puberty, undescended testicles and use of 
anabolic steroids). These three items were not included in the data analysis as they 
concerned another project.
The online version of the survey (see Appendix N) was developed using 
SurveyTracker (Survey Tracker for Windows, Training Technologies Inc, Cincinnati, 
Ohio, 2007).
All FRFS questions were developed with the help of reproductive and medical 
specialists from the expert consultation group in order to ensure wording was 
appropriate to the risk (e.g., I have versus I have had endometriosis). The webmaster 
at askbaby.com and the medical staff at each clinic (fertility, antenatal, and abortion) 
were similarly consulted for wording and suitability among participants from their site 
or clinic. For example, care was taken that the wording for pregnancy items were 
suitable to women in both the abortion and the antennal clinic and, where necessary, 
wording was adapted to avoid any potential upset. The tense used in the FRFS was 
adapted according to the recruitment method and target sample. For the pregnant
4 For the online version of the FRFS women were asked an additional feeder question 
regarding their intentions to conceive (‘are you currently trying to get pregnant, coded 0 ‘no’, 1 ‘yes’) 
prior to receiving questions on contraceptive use.
188
Chapter 5 Risk factors associated with female fertility potential
women all questions were presented in the past tense asking them to recall their 
lifestyle habits and reproductive history prior to their current pregnancy. For the 
women who were not pregnant but trying to conceive all questions were presented in 
the present tense to ascertain their current lifestyle habits and reproductive history.
Population values were used to compare the sample frequency of demographic 
variables (i.e., education) and risk factors. Population values were extracted from a 
number of sources (e.g., United Kingdom office of national statistics, WHO) and 
where available from large population surveys (e.g., General Household Survey, 
British Crime Survey). Precise sources are given in data Table 5.2.2 (page 194).
Procedure
Websites and university notice board.
Websites and groups on social networking sites (Myspace.com) aimed at 
women just ‘starting out’ in the process of trying to get pregnant and those aimed at 
women already pregnant were contacted via email to ask whether they would post the 
FRFS on their site (for survey see Appendix N). Two websites (Askbaby.com and 
groups on Mypsace.com) posted the link on their sites. In addition Verity.org.co.uk 
also posted a link indirectly through a group on Myspace.com. For Facebook.com the 
study was promoted through their advertisement scheme, whereby adverts pop-up by 
the side of individual users homepage. Adverts can be tailored depending on the aim, 
and desired sample characteristics (i.e., age, gender) can be pre-set so the advert is 
presented only to people who meet a selected criterion (i.e., age restricted to target 
sample: 18 -  44). Participants recruited via the university-wide electronic notice board 
system received a written announcement on the electronic notice board when they
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signed into their university account inviting them to participate in an online survey 
about fertility health issues.
A sentence about the survey (“Survey about fertility health issues”) and an 
option button was placed on each site. Clicking on the option button took the 
participants to a consent form and description of the content of the survey. To 
continue to complete the survey they were asked to give their consent by following 
the instructions, otherwise they could close the page and leave the survey. Questions 
were presented in specific sections outlined above and once a participant clicked to 
move to the next page they were unable to go back and change answers. The survey 
took around 5 -1 0  minutes to complete. Throughout the survey participants had the 
option to click out and close the survey with no data being submitted. Once they came 
to the final page they were given a more detailed explanation of the study and the 
option to submit their data if they wished. For the online version of the survey a 
number of questions such as age, pregnant/not pregnant, trying/not trying were fixed, 
that is, participants could not continue to the next page until such questions were 
answered. If participants closed the survey window at any point or did not click 
submit on the debriefing page no information was submitted.
Clinic recruitment.
All participants in the clinics samples were provided with a pack including an 
invitation letter, an instruction form, the FRFS, a debriefing form (see Appendix O) 
and a pre-paid pre-addressed envelope. The survey took around 5 — 10 minutes to 
complete. For all clinics, consent to participate was provided by returning the 
completed anonymous survey in the marked collection box in the waiting room or via 
post using the pre-paid self addressed envelope provided. If women did not wish to
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take part in the survey they were informed that they could leave unfilled surveys in 
the collection box at the clinic. The distribution of survey packs differed according to 
the specific clinic.
Women (aged 18 and above) presenting at the antenatal clinic for their 12 
week pregnancy scan were presented with the information pack by the nurse and 
asked if they were willing to participate in a survey about fertility health issues. 
Women completed the survey while they waited for their scan or posted it using the 
pre-paid envelope at a later date.
Two recruitment methods were employed in the fertility unit. First, all new 
patients (aged 18 and above) were sent a survey pack at the same time as their 
booking letter, asking them to participate in the study. If they wished to take part they 
could fill out the survey and bring it with them to their first appointment. Second, as 
patients came into clinic and registered for their appointment survey packs were 
handed out by the secretary. Potential participants were informed that if they wished 
to fill out the survey they could do so in the waiting room or return it in the post using 
the pre-paid self addressed envelope.
All women being admitted to the abortion clinic were taken to a private room 
while waiting for the medication to take affect. As per routine procedures for research 
a nurse would inform the potential participant (aged 18 and above) that a survey was 
on the participant’s bedside locker if they wished to fill it out while they waited. 
Completed surveys could be placed in sealed collection boxes or posted in the pre­
paid envelope provided. If the patient did not wish to take part in the study they were 
asked to place the incomplete survey into the pre-paid envelope, sealed, on their 
bedside locker. At the end of each day/once the room was vacated a nurse would
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collect all envelopes and place them in the box by the nurses’ station. At the end of 
each week all packs were sent back to the university.
A summary of the main research findings was provided to the websites and 
clinics at the end of data collection.
Data Analysis
Preliminary data screening produced two participants for exclusion due to 
extreme outliers for the variable years/months trying to conceive (37.83 and 37.5 
years trying to conceive: more than 3 SD ± Mean) (final sample N  = 1073). Data 
screening produced a further 28 scores that were outliers (more than 3 SD ± Mean) on 
a number of the lifestyle factors (e.g., number of alcohol units). These scores were 
adjusted by assigning the outlying case a score that is one unit greater than the next 
most extreme score in the variable distribution according to Tabachnick & Fidell’s 
(2001) recommendations. A minimum of 1008 participants was required to detect low 
frequency events (e.g. drug use, calculated using G-Power computer program; Faul & 
Erdfelder, 1992).
Preliminary analysis examined differences according to recruitment source. 
Prevalence of the risk factors was compared to population values. Logistic regressions 
were conducted on individual risk factors (univariate) and combined risk 
(multivariate) to determine associations with outcome measures. The dependent 
measure in these analyses was pregnancy status (pregnant (coded 1) versus not 
pregnant (coded 0)) or infertility status (trying for >12 months (coded 1) or trying <
12 months (coded 0)). In multivariate logistic regressions all the risk factors were 
entered in the same step. The odds ratio (± 95% confidence interval [Cl]) is presented. 
Secondary analysis compared participants according to fertility category using
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ANOVA and Chi-square. Significant effects were followed up with Tukey 
(continuous variables) or Chi-square (categorical variables). A probability value of 
p<0.05 was regarded as statistically significant. All analyses were performed with the 
software Statistical Package for the Social Sciences (SPSS).
Results
Prevalence o f Risk Factors Compared to Population Values
As can be seen in Table 5.2.2 total sample frequencies (N= 1073) were similar 
to the population values (i.e., about 5% or smaller difference between the sample 
score and the population value) with a few exceptions. First, the number of women 
educated to university level in the sample was higher than in the general population. 
Second, the frequency of period pains, unprotected sexual intercourse and being 
overweight were higher in the population than the sample. Finally the sample reported 
more alcohol consumption per week (any amount) compared to the population but 
reported less excessive alcohol consumption (e.g., more than 14 units a week). For 
these factors the average difference score was 12.50%. If we exclude the women who 
were not actively trying to conceive or currently pregnant the results are similar 
except that the smaller sample report less unprotected sex with multiple partners, less 
stress and less Class A drug use (ever) and more of these women are overweight (see 
difference score 2 in Table 5.2.2).
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Table 5.2.2
Frequency o f risk factors compared to population values.
Factors Sample (%) Population (%) Difference score1 Difference score2
Demographic
Education (University level) 48.37 31.20a 17.17 16.76
Reproductive
Period pains 32.92 46.83b -13.91 -16.98
Endometriosis 5.48 6.00 - 10.00c 0.52-4.52 1.38-5.38
Pelvic Inflammatory Disease (PID) 2.19 2 .00d 0.19 0.08
Menstrual cycle less than 21 days 8.54 3.20e 5.34 5.46
Menstrual cycle more than 35 days 13.19 8.05f 5.14 7.09
Menstrual cycle irregular 34.03 30.00f 4.03 3.24
Period 5.84 3.10f 2.74 2.82
Pelvic surgery 11.89s 10.00s
Sexually Transmitted Disease (STD) 11.57 12.60h -1.03 -1.43
Lifestyle
Overweight 23.40 33.00* -9.60 -5.07
Unprotected sexual intercourse with 23.96 32.00ir -8.04 -14.39
multiple partners
Stress 16.12 11.00k 5.12 2.6
Class A drug ever used 13.43 10.001 3.43 -0.02
Last 12 months 3.96 2 .101 1.86 1.62
Anabolic Steroid 0.85 0.60"11 0.25 0.09
Alcohol 69.25* 56.50" 12.75 12.12
£ 14 units a week 10.00 23.50° -13.50 -14.80
Smoke 23.58* 26.67p -3.09 -4.48
Caffeine 91.59* 97.10* -5.51 -6.34
Marijuana 4.56* 9.70*“ -5.14 -5.82
Note. ^Number based on participants reporting o f  any consumption o f the variable. 'Difference score for total sample minus
population values. Excluding women not actively trying to conceive (n=734). “Office o f  National Statistics (2008). The level of 
highest qualification held by adults in England. bZondervan et al. (1998) review o f United Kingdom community and hospital 
based studies. Percentage based on an average o f all studies reported (Table 1, page 95). cGiudice & Kao (2004). Review paper. 
dPercentage obtained from NHS Choices website (one in 50 women per year develop the disease). “World Health Organisation 
study in family planning programs (1983). fHarlow & Ephross (1995). Percentage based on an average of studies reviewed. *No 
data could be obtained for comparison. hFenton et al. (2001). Survey o f 11,161 men and women in Britain. Percentage recorded 
refers to women only. 'Health Survey for England, Department o f Health, Social Trends 33 Figure 7.20. jFontes & Roach (2007). 
Web-based survey o f 10,138 men and women from the United Kingdom. Percentage based on those reporting having had up to 
five sexual partners. '“National Statistics Online. Survey o f Psychiatric Morbidity among Adults in Great Britain, 2006. 'Roe & 
Man (2006). Drug Misuse & Declared: Findings from the 2005/06 British Crime Survey (Table4.6, page 24). “Roe & Man 
(2006). Drug Misuse & Declared: Findings from the 2005/06 British Crime Survey (TableA2.1, page 45). “Goddard (2006). 
General Household Survey 2006: smoking and drinking among adults, 2006. Number based on an average o f women aged 16 - 
44 (Table 2.3, page 63). “Goddard (2006). General Household Survey 2006: smoking and drinking among adults, 2006. Number 
based on an average o f women aged 1 6 - 4 4  (Table 2.2, page 62). pGoddard (2006). General Household Survey 2006: smoking 
and drinking among adults, 2006. Number based on an average o f women aged 20 - 49 (Table 1.1, page 15). qHeatherley et al. 
(2006). The Dietary Caffeine and Health Study. 'Percentage includes men. “Percentage o f women who report pelvic surgery 
excluding the women not actively trying to conceive.
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Univariate and Multivariate Association Between Risk Factor and Fertility 
Outcomes
Table 5.2.3 and 5.2.4 presents the odds ratios between the risk factors and (a) 
pregnancy status (Table 5.2.3) and (b) infertility status (Table 5.2.4) for the univariate 
and multivariate logistic regressions.
a) Pregnancy status (n = 734).
For pregnancy status analyses, an odds ratio below 1 was associated with a 
decrease in the chances of pregnancy and an odds ratio above 1 is associated with an 
increased chance of pregnancy. The risk factors significantly associated with a 
decreased chance of pregnancy in the univariate analysis were age, endometriosis, 
pelvic inflammatory disease, reporting a long menstrual cycle (>35 days), reporting 
an irregular menstrual cycle, not having a period, previous pelvic surgery, being 
overweight, and having unprotected sexual intercourse. A trend was found for 
reporting period pains and reduced chance of pregnancy. In addition the odds were in 
the predicted direction for reporting a prior sexually transmitted disease, use of class a 
drug5, and stress. Risk factors significantly associated with an increased chance of 
pregnancy were short menstrual cycles (<21 days), consuming more than 14 units of 
alcohol per week, smoking more than 10 cigarettes a day and misusing marijuana.
For the multivariate analysis the model was significant (]?=\19.94, df=18, 
P=0.001). As found in the univariate analysis age, endometriosis, menstrual 
irregularities, no period, pelvic surgery, being overweight and reporting unprotected 
sexual intercourse with multiple partners remained significantly associated with a 
reduction in likelihood of pregnancy. The odds ratios for pelvic inflammatory disease
5 The variable ‘Class A drug use ever’ was used in the analysis (univariate and multivariate) as the 
frequency of Class A drug use in the past 12 months was too few.
195
Chapter 5 Risk factors associated with female fertility potential
and long menstrual cycles (>35 days) were in the same direction to that of the 
univariate analysis but were no longer significant. Previous sexually transmitted 
diseases remained non-significant but still in the same direction as would be 
predicted. Two variables (period pains and Class A drug use) changed predicted 
direction but neither was significant.
For the variables that were significantly associated with an increased 
likelihood of pregnancy in the univariate analysis only alcohol remained significant in 
the multivariate analysis. Short menstrual cycles (<21 days), smoking tobacco and 
marijuana all remained in the same direction (increased pregnancy) but smoking 
tobacco was no longer significant and marijuana was a trend. Finally, the odds ratio 
for caffeine consumption changed direction, suggesting drinking more than seven 
units of caffeine a day was associated with decreased likelihood of pregnancy; 
however, the confidence intervals included unity.
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Table 5.2.3
Factors Pregnant 
n = 532
Not pregnant 
n = 202
Univariate analysis 
Pregnancy Status*
CIb Multivariate analysis 
Pregnancy Status*
CIb
Time to pregnancy (SD)C 9.16(18.47)“ 48.14(40.61)
Demographic
Age (SD) 29.16(5.86) 30.81 (5.37) 0.95** 1.02, 1.10 0.94 0.90,0.98
Reproductive, n (%)
Period pains 147 (27.95) 70 (34.83) 0.73* 0.51,1.03 1.07## 0.62,1.86
Endometriosis 12(2.31) 21 (10.77) 0.20*** 0.09,0.41 0.27 0.09, 0.86
Pelvic Inflammatory Disease (P1D) 6(1.15) 9 (4.50) 0.25** 0.09, 0.70 0.91 0.17,5.01
Menstrual cycle less than 21 days 55 (10.68) 7 (3.48) 3.31** 1.48,7.41 2.61 0.74,9.18
Menstrual cycle more than 35 days 66 (13.07) 40(20.51) 0.58* 0.38, 0.90 0.81 0.41, 1.60
Menstrual cycle irregular 156(29.89) 84 (42.00) 0.59** 0.42, 0.82 0.42***# 0.23, 0.74
Period 23 (4.47) 19 (9.70) 0.43** 0.23, 0.81 0.26 0.10,0.65
Pelvic surgery 30 (5.75) 42(21.21) 0.23*** 0.14,0.37 0.24*** 0.11,0.54
Sexually Transmitted Disease (STD) 54 (10.27) 27(13.57) 0.73 0.44,1.19 0.86 0.38, 1.95
Lifestyle, n (%) ***
Overweight 89 (17.45) 67 (34.72) 0.40*** 0.27, 0.58 0.40 ~ — ^ *** 0.24, 0.68
Unprotected sexual intercourse with 66 (12.67) 61 (30.50) 0.33*** 0.22,0.49
0.20 0.10,0.38
multiple partners
Stress 63 (12.40) 33 (16.67) 0.71 0.45,1.12 0.84 0.40,1.76
Class A drug ever 63 (12.40) 33 (16.67) 0.74 0.43,1.27 1.00* 0.40,2.47
Alcohol 55 (10.48) 9 (4.52) 2.47* 1.20,5.10 3.68 1.22, 11.12
Smoke 92 (17.66) 18 (9.09) 2.15** 1.26,3.66 1.22 0.55,2.68
Caffeine 39 (7.44) 13 (6.47) 1.16 0.61,2.23 0.95 0.34,2.68
Marijuana 24 (4.68) 2 (1.01) 4.81* 1.13,20.55 5.52* 0.77,39.31
Anabolic steroid6 4 (0.76) 1 (0.50)
a r v w  — n n. .^—_1 /n____ ____.\ b^i _  __j cr?_M / v i_ = mAnthc tr\/1tlO> tn mnwivp dT
P = 0.001f
ime tn nreffnancv onlv available for 197 pregnant
excluded from univariate and multivariate analysis due to low frequency. fOverall multivariate model significance level. *P< 0.10. P< 0.05. P<0.01. P<0.001.
'Anabolic Steroid was
197
Chapter 5 Risk factors associated with female fertility potential
b) Infertility status (n = 399).
In the univariate and multivariate analysis for infertility status an odds ratio 
below 1 indicated fertile (i.e., trying for < 12 months) and an odds ratio above 1 
indicated infertile (i.e., trying for > 12 months or > 6 months if woman age > 35 
years). Being older, experiencing painful periods, endometriosis, irregular menstrual 
cycles, previous pelvic surgery, being overweight, having unprotected sexual 
intercourse and experiencing stress one cannot cope with were all significantly 
associated with increased odds of trying for more than 12 months. The odds ratios for 
pelvic inflammatory disease, sexually transmitted disease, Class A drug use, alcohol 
and caffeine consumption were all in the predicted direction but were not significant.
Reporting short menstrual cycles was significantly associated with shorter 
time trying to conceive. Further, reporting long menstrual cycles (>35 days), no 
period, smoking tobacco and marijuana misuse were all in the opposite direction to 
predicted (that is increased risk of longer time trying) but were not significant.
For the multivariate analysis the model was significant (^=68.93, df=18, 
P=0.001). In the multivariate analysis being older, suffering from period pain, having 
irregular menstrual cycles, having unprotected sexual intercourse and experiencing 
high levels of stress were all significantly associated with an increased time trying to 
conceive. Further a trend was found for endometriosis and increased time trying to 
conceive. Being overweight and reporting previous pelvic surgery were in the same 
direction as the univariate analysis but were no longer significant. Similarly, sexually 
transmitted disease and caffeine consumption remained in the same direction as 
predicted. The odds ratio for reporting no period changed to the direction from that 
reported in the univariate analysis and became significant in the multivariate analysis.
198
Chapter 5 Risk factors associated with female fertility potential
Contrary to the univariate analysis and prior predictions the odds ratios for 
pelvic inflammatory disease and alcohol consumption reversed direction, although all 
the confidence intervals included unity, indicating a lack of significance. The odds 
ratio for Class A drugs changed to 1.00, showing no effect.
Finally, while the odds ratio for short menstrual cycles (<21 days) remained in 
the opposite direction to predicted it was no longer significant in the multivariate 
analysis. Further, long menstrual cycles (>35 days), smoking and marijuana misuse all 
remained in the opposite direction to predicted, although none were significant.
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Table 5.2.4
Frequencies and odds ratios between risk factors andfertility status in univariate and multivariate analysis (n = 399)._____________________________
Factors < 12 months > 12 months* Univariate analysis CI Multivariate analysis Cl
___________________________________________ n=  172________ n -  227 Infertility Status1*__________ Infertility Statusbc__________
Time to pregnancy (SD)e 4.54(3.44) 49.13(38.73)
uemugi apnii;
Age (SD) 29.72 (4.90) 31.43 (5.65) 1.06** 1.02, 1.10 1.11*** 1.05,1.17
Reproductive, n (%)
Period pains 37(21.51) 81 (35.84) 2.04 1.29,3.21 1.97 1.05,3.70
Endometriosis 5 (2.92) 20 (9.09) 3.32* 1.22, 9.04 4.04* 0.90,18.11
Pelvic Inflammatory Disease (PID) 5 (2.98) 8 (3.54) 1.20 0.38,3.72 0.48 0.10,2.30
Menstrual cycle less than 21 days 15(8.82) 9(3.98) 0.43* 0.18, 1.00 0.65 0.20,2.10
Menstrual cycle more than 35 days 33 (19.76) 41 (18.47) 0.92 0.55, 1.53 0.60 0.27,1.32
Menstrual cycle irregular 42 (24.56) 96 (42.67) 2.29 1.48,3.54 _ _ . ♦** 3.74 1.88,7.46
Period 10 (5.88) 19 (8.64) 0.88 0.68,3.34 3.38* 1.09,10.55
Pelvic surgery 16 (9.30) 39 (17.49) 2.07* 1.11,3.84 1.44 0.62, 3.35
Sexually Transmitted Disease (STD) 16 (9.41) 28 (12.56) 1.38 0.72,2.65 1.16 0.46,2.92
Lifestyle, n (%)
Overweight 36(21.69) 68 (31.19) 1.64 1.03,2.61 1.42 0.80,2.52
Unprotected sexual intercourse with multiple 18(10.53) 61 (27.23) _ - _ ***3.18 1.80,5.63 3.53** 1.57,7.91
partners
Stress 10 (5.99) 40(18.18) 3.49 1.69,7.21 4.05 1.41,11.60
Class A drug ever 17 (10.06) 26(11.45) 1.16 0.61,2.21 0.56 0.21, 1.51
Alcohol 12 (7.02) 16(7.17) 1.02 0.47,2.23 0.83 0.29,2.37
Smoke 24 (14.46) 24 (10.71) 0.71 0.39,1.30 0.77 0.31,1.92
Caffeine 8(4.71) 18 (7.96) 1.75 0.74,4.13 1.08 0.31,3.74
Marijuana 
Anabolic steroidf
6(3.55) 
1 (0.59)
7(3.13) 
2 (0.88)
0.88 0.29,2.66 0.99 
P = 0.001g
0.19,5.16
Confidence Intervals. 'For not pregnant time to pregnancy = months trying to conceive. fAnabolic Steroid was excluded from univariate and multivariate analysis due to low frequency. ®Overall multivariate model 
significance level. ‘P< 0.10. *P< 0.05. **P<0.01. *"P<0.001
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Secondary Analysis Between Lifestyle Factors and Fertility Indicators
One question raised by the results of the logistic regressions was why some of 
the negative lifestyle factors were unexpectedly associated with increased odds of 
pregnancy (or decreased odds of infertility). One explanation may be that women who 
have been trying for some time but are not yet pregnant modify their lifestyle habits to 
increase their odds of pregnancy. To further explore this possibility women were 
categorised according to both pregnancy and infertility status (see Figure 5.2.1) using 
similar fertility categories as used in the risk research (Olsen, 1991; Stanton & Gray, 
1995; Hassan & Killick, 2004; Ramlau-Hansen et al., 2007). Figure 5.2.1 shows 
sample sizes according to the fertility categories (e.g., fertile, subfertile, presumed 
fertile and infertile). Of those who were currently pregnant, 70.05% (« = 138) 
achieved a pregnancy within 12 months of trying to conceive and were labelled 
‘fertile1, whereas 30.0% (n = 59) of pregnant women took more than 12 months to 
conceive and were labelled as ‘subfertile’. For the women not yet pregnant 16.83% (n 
= 34) had been trying for less than 12 months and were therefore labelled ‘presumed 
fertile’ whereas the remaining 83.17% (n = 168) had been trying to get pregnant for 
more than 12 months and were labelled ‘infertile’. The groups did not differ on 
education (^=12.95, df = 9, P = 0.17).
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Figure 5.2.1. Breakdown of fertility status in women trying to conceive (n =
Trying to Conceive 
N = 399
Subfertile
> 12 months TTP* 
n = 59 (29.95%)
Average months trying 
= 33.53 (SD=30.52)
> 12 months TT* 
n = 168 (83.17%)
Average months trying 
= 54.61 (SD=39.87)
Infertile
Not pregnant 
n = 202 (50.62%)
< 12 months TT+ 
n = 34 (16.83%)
Average months trying 
= 6.35 (SD=3.79)
Presumed Fertile
< 12 months TTP* 
n = 138 (70.05%)
Average months trying 
= 4.19 (SD=3.26)
Fertile
Pregnant 
n = 197 (49.37%)
Note.
*TTP refers to time to pregnancy 
+TT refers to time trying to get pregnant 
aOr 6 months if the woman is > 35 years
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Table 5.2.5 reports the frequency for each of the 19 risk factors according to 
the fertility categories. Individual ANOVA and chi-square tests were conducted on 
each factor revealing significant differences between groups on eight of the 19 risk 
factors. Of particular relevance for the secondary analysis is the pattern of scores on 
the negative lifestyle factors that had produced unexpected results in the logistic 
regressions (i.e., alcohol, smoking, caffeine and marijuana). As shown in Table 5.2.5 
within the pregnant women those who had taken longer to conceive (subfertile) 
reported higher frequencies on all negative lifestyle factors, as predicted, when 
compared to the pregnant women who had taken less time to conceive (fertile). This 
pattern was the same for the not yet pregnant women. That is, the women who had 
been trying the longest (infertile) reported greater frequencies on these negative 
lifestyle factors than those who had been trying for less than 6 months (presumed 
fertile). The two exceptions were smoking and marijuana use where the pattern is 
reversed in the not pregnant women, that is, the presumed fertile reported greater 
consumption than the infertiles.
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Table 5.2.5. Differences o f each risk factor according to fertility category.
Factors Pregnant (n = 197) Not Pregnant (n = 202) F statistic
Fertility category Fertile Subfertile Presumed fertile Infertile
< 12 months (n = 138) > 12 months (n = 59) < 12 months (n = 34) > 12 months (n = 168)
Months trying to conceive (SD) 4.19(3.26)“ 33.53 (30.52)b 6.35 (3.79)° 54.61 (39.87)d 80.93***
Previous birth (%) 44.93“ 44.07“ 44.12“ 14.97b 38.99***
Risk Factors
Demographic
Age (SD) 30.01 (5.07)“ 31.78 (6.05)b 28.39(3.85)“ 31.30 (5.51)b 4.16**
Reproductive % % % % x2 *
Period pains 21.01“ 32.20 23.53 37.13b 10.20
Endometriosis 0.73“ 5.08b 11.7 6b 10.56b 13.82**
Pelvic Inflammatory Disease (PID) 2.22 1.69 6.06 4.19 2.17
Menstrual cycle less than 21 days 9.56 6.78 5.88 2.99 5.74
Menstrual cycle more than 35 days 18.52 15.25 25.0 19.63 1.35
Menstrual cycle irregular 20.44“ 44.07b 41.18b 42.17b 19.26***
Period 4.41 6.78 11.76 9.32 3.60
Pelvic surgery 7.25al 5.08“ 17.65b 21.95b 18.19***
Sexually Transmitted Disease (STD) 7.35 12.07 17.65 12.73 3.88
Lifestyle #*
Overweight 19.40“ 19.30“ 31.25 35.40b 11.68
Unprotected sexual intercourse with multiple 7.23“ 13.79“ 23.53b 31.93b 30.23***
partners
~  -  *#
Stress 6.77“ 14.29 2.94“ 19.5 lb 13.91
Class A drug 1.48 1.69 0 0.60 1.21
Anabolic steroids 0.70 1.70 0 0.60 1.01
Alcohol 8.76 12.07 0 5.45 6.01
Smoke 14.29 18.64 15.15 7.88 5.92
Caffeine 5.88 8.47 0 7.78 3.25
Marijuana 3.6802 10.17“ 3.03 0.61b 12.52**
Note. Number or percent with different superscripts are significantly different. ’Trend reported for fertile compared to presumed fertile (P = 0.06). 2Trend reported for fertile and subfertile (P — 0.07) and fertile and 
infertile (P = 0.06). *P< 0.05. **P<0.01. ***P<0.001.
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Discussion
The main finding of the current study has been demonstrating that it is 
possible to generate a significant multivariate model of correlates of female fertility 
status. The model discriminated between currently pregnant and non-pregnant women 
and between fertile and infertile women. The most important univariate correlates 
were endometriosis, unprotected sexual intercourse with multiple partners and 
irregular menstrual cycles. These univariate correlates were also the most important 
when all the factors were considered as a group with stress and amenorrhea also 
emerging as important correlates. The pattern of results also demonstrated that women 
may modify their lifestyle to increase their chances of conceiving. These findings lend 
further support for the development of a tool to assess personal fertility potential.
The first aim of the present study was to replicate the associations between 
individual risk factors and indicators of female fertility. The results support past 
research in showing that risk factors such as endometriosis, previous pelvic surgery, 
period pains, irregular menstrual cycles, overweight, unprotected intercourse with 
multiple partners and stress were all associated with a lower likelihood of pregnancy 
and a time trying to conceive of more than 12 months. Endometriosis was associated 
with the largest odds ratio in the likelihood of pregnancy (OR 0.20, Cl = 0.09, 0.41) 
and stress was associated with the largest odds ratio in time trying to conceive (OR 
3.49, Cl = 1.69, 7.21). Age was found to have the weakest significant association on 
time trying to conceive (OR 1.06, Cl = 1.02, 1.10) and for pregnancy status (OR 0.95, 
C I= 1 .02, 1.10). PID and STD were not consistently significant but were in the right 
direction for both pregnancy (OR below 1) and fertility (OR above 1). These results 
were unexpected considering that STD and PID had the largest averaged odds ratios 
for fertility difficulties in the empirical literature (see Table 5.1.4, page 170). A
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possible explanation for the inconsistency may be the low frequency of STD and PID 
in the present sample. Indeed only 13 women reported suffering from PID. Cohen and 
Cohen (1983) report that correlations will be underestimated where the proportion of 
cases is highly skewed in dichotomous variables, as was the case in the present study.
The only set of reproductive risk factors to show an inconsistent pattern of 
results was the menstrual set. Shorter menstrual cycles were (unexpectedly) associated 
with better fertility, longer cycles with both reduced pregnancy and increased fertility, 
amenorrhea with both reduced pregnancy and increased fertility (but reduced fertility 
in multivariate analysis), and irregular cycles were (as predicted) associated with 
reduced fertility potential (both reduced pregnancy and increased infertility). Previous 
research has found that self-reported menstrual cycle length can be problematic due to 
individual variation in response to menstrual cycle questions (e.g., when does it start? 
how long is the bleed?) and therefore self-report may not provide the most accurate 
data (Jukic et al., 2007). The lack of consistency among menstrual questions within 
this study and between this study and past research (e.g., Jukic et al., 2007) may 
reflect this lack of clarity. More pilot testing might have provided a better fit between 
the meaning of menstrual cycle questions between researcher and participant.
The pattern of results with lifestyle factors was more complex. When focusing 
on pregnancy status (pregnant versus not pregnant women) the results were the exact 
opposite to the predicted direction for drinking alcohol, smoking (tobacco and 
marijuana) and caffeine consumption, that is, all these factors were associated with an 
increased chance of pregnancy. This was surprising given that these have all shown 
significant associations with lack of pregnancy in numerous other studies (Wilcox et 
al., 1988; Hatch & Bracken, 1993; Olsen et al., 1997; Hakim et al., 1998; Hull et al.,
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2000; Hassan & Killick, 2004; Axmon et al., 2006). There is isolated evidence for the 
benefit of some of these lifestyle factors. For example caffeine consumption has been 
associated with increased sperm motility (Sobreiro, Lucon, Pasqualotto, Hallak, 
Athayde & Arap, 2005). However, the overall pattern of association across different 
lifestyle risk factors would argue for a more systematic account for the findings.
There are two possible explanations for this surprising finding: pregnant 
women may be risk seekers or non-pregnant women may be risk averse. It may well 
be that the pregnant women in the present sample were risk takers in general, that is 
that they were drinking more, smoking more and potentially, that this risk taking 
extended to their sexual life and led to the current pregnancy. Indeed such level of 
high risk taking is seen in some young teenage mothers (Stevens-Simon, Kelly & 
Kulick, 2001), perhaps representing a subgroup of women that are obscuring the 
expected pattern of results. However, if this were true then one would expect to find 
that these risky behaviours were mirrored in a number of the other risk factors such as 
unprotected sexual intercourse, younger age, and higher incidence of STD’s. However 
none of these risk factors were higher in the pregnant women, quite the opposite in 
fact (age was indeed younger in the pregnant women but comparable to national age 
at first birth, Office of National Statistics, 2004). In addition, the incidence of lifestyle 
factors in the pregnant women was not greater than the population values (see Table 
5.2.2, page 194). Thus, it seems unlikely that the pregnant women represent a highly 
‘risky’ group of women.
Alternatively, and perhaps a more plausible explanation, is that the not 
pregnant women were risk averse, and perhaps even actively modified their lifestyle 
habits over time because they were trying to get pregnant leading to lower risk
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activity. If true this would create a spurious positive association between negative 
lifestyle factors and pregnancy. Efforts to influence chances of conception among 
women has been noted in other contexts, for example taking relaxation sessions to 
increase success of treatment (Domar, Zuttermeister, Seibel & Benson, 1992) or 
abstaining in sexual activity to improve sperm quality (De Jonge, LaFromboise, 
Bosnians, Pharm, Ombelet, Cos & Nijs, 2004). Chapter 4 highlighted that people are 
aware of a number of lifestyle factors that are associated with a detrimental effect on 
female fertility; therefore people may attempt to modify these behaviours when they 
do not get pregnant. Research on lifestyle change in men and women diagnosed with 
cancer suggests that adapting lifestyle habits (e.g., diet, exercise) may induce a sense 
of personal control over their situation (Patterson, Neuhouser, Hedderson, Schwartz, 
Standish, & Bowen, 2003). The factors with unexpected results (smoking, alcohol and 
caffeine consumption) were also the easiest factors for people to control and modify. 
They can all be almost immediately reduced with little adverse effect (depending on 
the level of dependency of the drug). Other lifestyle factors showing the expected 
pattern of results can also be modified (e.g., weight) but may take longer to achieve 
and involve more effort and commitment (e.g., change in diet, exercise regime) or 
could not be changed as they had already occurred (e.g., previous misuse of Class A 
drugs).
When the groups were examined in more depth in secondary analyses the 
expected negative association between risk and fertility was observed since the 
women who had been trying the longest to conceive (subfertile and infertile) had the 
highest frequency of negative lifestyle factors when compared to women who had 
been trying for a lesser amount of time (fertile and presumed fertile). The pattern of 
results presented here suggests a complex relationship between these lifestyle factors
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and fertility potential. In order to adequately test this hypothesis one would have to 
conduct a prospective study to follow women from the moment they start trying to 
conceive to see whether lifestyle habits do change over time and, if so, at what point 
this change begins.
The second aim of the current study was to examine whether a multifactorial 
approach to assessment of risk factors would identify areas of overlap among 
reproductive and lifestyle factors in their association with fertility indicators. On the 
whole, the majority of the risk factors were significantly associated with female 
fertility potential in both the univariate and multivariate analyses. This pattern of 
results indicates that each risk factor was an independent risk factor associated to 
fertility due to its own unique aspects rather than because it correlated to some other 
fertility risk. Where there was change in significance, the reduction appeared mainly 
due to a change in power rather than a change in actual importance of the factor, as 
the majority of the OR’s did not change direction but reduced in size. The original 
power calculations recommended recruitment of over 1000 women, indeed this 
sample size was achieved, however, once exclusions were made due to selection 
criterion the sample size was greatly reduced by more than 300 women. Future studies 
should therefore aim to increase initial recruitment in order to maximise frequencies 
of all the risk factors.
Methodological Implications and Limitations
The main methodological issue arising from the present results is the use of 
cross-sectional data. While the methodology is cost effective and very useful in 
highlighting potential factors associated with female fertility difficulties it cannot lead 
to cause and effect. For example, in the present study a large odds ratio was found for
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the effect of stress on chance of pregnancy. Such a result may be due to the fact that 
stress reduces the chance of pregnancy as suggested by prospective research (Stoleru 
et al., 1993; Hjollund et al., 1999). Conversely it could be due to the fact that as 
failure to conceive persists, stress increases. Only prospective research could further 
support the argument that the correlates identified here are also predictors of fertility, 
and this research would be essential to correctly advise women about the impact such 
a factor may have on the chances of achieving a successful pregnancy.
The recruitment method was successful with a large number of women being 
recruited over a short period of time. One noteworthy limitation with the sample size 
was the fact that while a large number of women were recruited not all were planning 
to conceive and this markedly reduced the sample size in the infertility status analysis 
(due to no data on TTP in the unplanned pregnancies), reducing the chance of 
achieving a large sample size for the low frequency factors (e.g., anabolic steroids). 
This criterion was used to index exposure (i.e., time to pregnancy) but in the current 
sample over half (63%) of pregnant women (n = 532) stated that the pregnancy was 
not planned. Previous data suggests that around 40 -  50% of all pregnancies are 
unplanned (Ray, Singh & Burrows, 2004; WHO, 2005; Lakha & Glasier, 2006; 
Mohllajee, Curtis, Morrow & Marchbanks, 2007), and future studies should take into 
account this ratio in recruitment in order to maximise the prevalence of the low 
frequency events such as anabolic use or PID.
Due to the software used to develop the online survey there was no way of 
ascertaining drop out in the internet sample, as participation could only be recorded 
once the participant had submitted their response. In the clinic sample the 
participation rate was 32.41% (33% return rate from the antenatal units, 35% from the
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fertility unit and 28% from the abortion clinic). This is lower than a review of nearly 
200 published studies on medical mail surveys where the average response rate was 
60% (Asch, Jedrziewski & Christakis, 1997). However, this average did include a 
number of studies where written and telephone reminders were used, which was found 
to increase participation rate. In the present study it is difficult to judge whether the 
people with less favourable habits (e.g., drug use, past STD) declined to participate 
because disclosure of such behaviours was necessary. However, as the prevalence of 
all the risk factors was similar to those found in the population it seems likely that the 
sample was representative.
Finally, the present study did not take into account factors that affect male 
fertility potential. This may have introduced unknown bias into the results as female 
fertility depends on male fertility. The development of future research needs to assess 
female, male and couple risk factors in order to exercise more control over this.
Clinical Implications and Future Directions
The present study has demonstrated that a multivariate model of risk correlates 
assessing fertility potential is possible. Current statistics and research shows 
individual risk factors are on the increase in Western societies, and thus people need 
to be made aware of the potential impact these factors may have on a woman’s 
fertility potential. The results from the present study may provide some evidence that 
people are adopting changes in some of their lifestyle habits (e.g., alcohol 
consumption) but it is unclear at what point these changes (if any) may begin to occur. 
Further not all factors that can be changed appeared to be targeted (e.g., overweight) 
suggesting that people may not be behaving in the most optimal way even when it is
211
Chapter 5 Risk factors associated with female fertility potential
possible and even when they have been trying to conceive for many months and even 
years.
Future research needs to employ prospective designs that can provide causal 
data between the risk factors, pregnancy and fertility status over time to adequately 
assess the factors predictive of reduced fertility potential. Such data would be 
especially valuable in providing more accurate effect sizes for each of the risk factors, 
which would contribute to better understanding of the factors to target when people 
cannot conceive. General Practitioners receive clear guidance about which factors to 
treat and in which order when it comes to reproductive risk factors (through the use of 
guidelines published by organisations such as NICE) and it might be beneficial to do 
the same at a personal level. This may be of importance when one considers that 
people may modify lifestyle factors that are not as important as others. For example, it 
may be more beneficial for an overweight woman to attempt to lose weight than for 
her to modify other less important lifestyle factors such as alcohol consumption 
(although they may be related). Further, if people are modifying factors that have no 
or minimal impact on fertility potential then people may be unnecessarily delaying 
when they should be seeking medical advice regarding their situation. Finally, people 
need to be informed of the importance of these factors prior to trying to conceive so 
that they become more aware of, and have the option to prevent, change and/or 
modify their current habits in order to reduce the potential impact they may have on 
their future life goals of becoming a parent.
Notwithstanding the issues surrounding the use of cross-sectional data the 
present study has established the importance of a number of reproductive and lifestyle 
factors that can be addressed in women thinking about having children now or in the
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future in order to reduce the impact that these factors can have on female fertility 
potential.
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Chapter 6
General Discussion
The aim of the studies presented in this thesis was to better understand help 
seeking behaviour in the context of fertility problems, establish risk factors associated 
with fertility potential, and identify targets for public health campaigns to improve 
fertility health related behaviour. The current chapter will present an overview of the 
main findings, discuss the clinical implications of these findings, and identify areas 
for future research.
Help Seeking Behaviour in the Context o f Fertility Problems
Infertility is a prevalent problem in society, affecting 72 million couples 
worldwide (Chapter 2), yet perhaps unexpectedly and most importantly the present set 
of results revealed that uptake of medical treatment is much lower than expected with 
a similar rate between more and less developed nations. The low uptake of fertility 
medical services was an unanticipated finding given the documented importance of 
parenthood as a central life goal desired by the majority of young men and women in 
all societies around the world. Thus one would have expected to see this desire 
mirrored by high uptake rates of medical services under the premise that such action 
would assist couples in achieving their parenting goal when faced with difficulties 
conceiving. In addition, one would have also expected to see higher rates of treatment 
seeking behaviour given that the high success rates of fertility treatment make 
treatment a very viable option to resolve the fertility problem.
This research showed that taking steps to seek treatment was also dependent 
on psychological factors and this confirmed previous empirical research and 
theoretical predictions and provided support for the application of help seeking
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theories in decision making for fertility health issues. Specifically, these centre mainly 
on perceived susceptibility that a problem actually exists, a fear of diagnosis as a 
result of seeking advice, attitudes towards treatment (e.g., is medical treatment 
unnatural?) and the mechanics of actively seeking out medial care (e.g., knowing how 
to and where to access medical help).
Three issues arising from the present studies warrant further investigation. 
First, there is a pressing need for more up-to-date data on the prevalence of infertility 
and demand for fertility medical services. A number of the studies reviewed were 
more than a decade old and there appeared to be a distinct lack of prevalence research 
from the less developed nations, especially with regard to the demand for medical 
services. Data should be collected through population-based prospective and cross- 
cultural designs that take a multidisciplinary approach due to the established 
importance of psychological, social and cultural factors. Further, it would be 
especially valuable to generate better estimates of those seeking advice, of those 
seeking treatment and of those actually receiving treatment since the latter stages 
might be the ones to differentiate according to developmental status. For example, in a 
recent world report on the availability of assisted reproductive technologies, the 
number of cycles per million varied considerably, with a 1000-fold difference 
between countries with the highest (Israel, 3263 cycles) and lowest (Guatemala, 2 
cycles) values (Adamson et al., 2006).
In accordance with the conclusions made by Schmidt and Munster (1995) in 
their review of prevalence a key issue prior to the undertaking of these prospective 
studies is the need for better consistency between researchers on the operational 
definitions for infertility and the most appropriate time frames of exposure to be
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assessed since comparisons between data is made much more difficult when different 
definitions have been employed. In 2006 The International Committee Monitoring 
Assisted Reproductive Technologies (ICMART) published a glossary of Assisted 
Reproductive Technologies (ART) terminology which included a definition of 
infertility (failure to conceive after at least one year of unprotected coitus) (Zegers- 
Hochschild et al., 2006). However, there is little current prevalence data so it is not 
possible to establish yet whether this definition is being actively used. Perhaps the 
reason why consensus in prevalence research has not been achieved is that the debate 
on what the agreed definition should be has yet to be fully resolved (Habbema et al., 
2004; Homburg, 2005; Larsen, 2005).
Second, there is a need for more in-depth information about why people are 
not seeking treatment as the present research only explored a limited number of 
variables. Of particular interest would be to establish whether inaction is a result of 
decisions to actively remain childless, or a result of a lack of knowledge about how to 
seek medical help or lack of access to medical help. In addition, there may be other 
psychological and cultural beliefs and values that impact on decision making that 
warrant further investigation (e.g., religion). A more in-depth understanding of the 
importance of the factors associated with decision making will help establish ways in 
which barriers to seeking medical help (for those who wish to access it) can be 
overcome. The present results also lend support to the need for more cross-cultural 
research because there would seem to be far more ‘behind’ the similarity in the 
numbers of couples seeking medical help that warrants explaining. Further, the 
methods used to recruit women trying to conceive (i.e., internet sampling) were not 
very successful in reaching people of other cultures, or a wider range of educational 
levels. A clearer understanding of any cultural factors that influence decision making
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will impact on the formulation of help provided to couples faced with difficulties 
conceiving. For example, access to fertility treatments has been shown to be more 
limited in less developed nations (Adamson et al., 2006) which could go towards 
explaining the low numbers of treatment uptake found in the review for these 
countries. Conversely in more developed nations the low uptake of treatment could 
reflect a broader change in parenting interests in men and women. Changes in 
Western society (e.g., women remaining in education for longer) may impact on 
decision making when difficulties trying to conceive occur, as couples may decide 
that they have other life goals that could be pursued (e.g., career progression and 
development) instead of seeking medical help.
To better inform on the factors that impact on decision making prospective 
research is now needed in order to identify more conclusively on the causal 
mechanisms identified in the present research (e.g., attitudes, perceived susceptibility, 
and fear) so that one could be more confident of manipulating these factors to 
facilitate help seeking in people who want treatment. This would have to be 
conducted in an ethical way as by doing so it might be misconstrued as undue 
pressure on people to submit to pronatalist norms, which is to do absolutely 
everything possible to conceive a child (Remennick, 2000; K. Park, 2002). However, 
it is also important to recognise that for at least 20% of women who had a strong need 
for parenthood action had not occurred despite trying for nearly two years (Chapter 
3). This inaction appeared to be associated with a fear of finding out whether a 
fertility problem existed and the consequences of such a diagnosis (e.g., fear of being 
labelled infertile).
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Third, the present studies did not address decision making taking into account 
the medical provider. This is an important area needing further investigation as past 
research does provide some evidence that provider delay can impact on whether 
couples who seek initial medical help are referred to the appropriate specialist to get 
that help (Gunnell & Ewings, 1994). Further, an assessment of whether guidelines 
developed for use by general practitioners when people present with fertility 
difficulties (e.g., NICE, 2004) are being effectively implemented needs to be 
undertaken, so that all people who want medical help and treatment are provided with 
accurate information in a consistent manner in order to aid their decision making.
Deciding on a course of action when suspecting fertility difficulties might also 
be helped by decision support technologies (DST) that would guide decision making 
about treatment seeking behaviour. DSTs are designed to aid decision making through 
providing people with detailed information on the different options available to them 
and the likelihood of certain outcomes occurring (e.g., chances of pregnancy) 
depending on particular courses of action (e.g., seeking medical treatment). They have 
been developed and extensively used for a variety of health conditions and treatments 
that involve complex decision making (e.g., deciding whether or not to take an 
amniocentesis test, Durand, Boivin, & Elwyn, 2008). The development of the tools 
rely on both quantitative and qualitative research methodologies to form an inclusive 
representation of the processes involved in decision making when someone is faced 
with a specific problem. One would hope that through the use of such approaches men 
and women faced with a fertility problem can come up with decision making 
strategies that provide individuals with all the relevant information needed to find 
solutions to the problem, future research could benefit from the development of such a 
tool informed by both patients and general medical practitioners.
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A final consideration of the present research is the lack of male data. Men 
were not intentionally excluded from this research, but recruitment of men may have 
been hindered by the use of predominately female orientated websites (e.g., 
gettingpregnant.co.uk). Previous literature does suggest that it is the female partner 
who takes the prominent role in decision making regarding reproductive impairment 
(Greil et al., 1988) with men less likely in general to initiate seeking medical help 
when they are ill (Banks, 2001). Nevertheless fertility impairments involve both 
partners so exploring factors associated with decision making from a male perspective 
warrants future examination.
Risk Factors Associated with Fertility Potential
The second part of this thesis took a comprehensive approach to establishing 
the factors associated with reduced female fertility potential. A thorough literature 
review and consultation with medical and reproductive experts produced a critical list 
of risk factors associated with female fertility. These 14 risk factors were then 
successfully shown to be associated with fertility status (i.e., pregnant/not pregnant) 
replicating previous findings, and further emphasising their importance. Perhaps more 
importantly the present research is the first in the literature to assess so 
comprehensively not only the unique contribution of these factors on female fertility 
but also their shared contribution, providing valuable data to show these risk factors 
retain their individual importance even when assessed in a multifactorial way. Further, 
the present research demonstrated that young people were aware of many of these 14 
risk factors, and that in fact those trying to get pregnant may even try to increase 
fertility potential by modifying some of the risk factors (e.g., alcohol consumption).
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These findings have important implications for future research. The next step 
in this research would be to determine whether these risks can predict individual 
fertility status. In addition conducting a prospective study affords unique opportunities 
to explore more possible risk factors that have received limited research to date (e.g., 
ethnicity). As was the case for the future research on prevalence, prospective studies 
would need to reach consensus on the use of operational definitions (e.g., infertility) 
as the research reviewed showed variations on associations depending on whether the 
research focused on pregnancy status or infertility status. These data could also 
confirm proposals made here, for example, that people change risk behaviour (e.g., 
alcohol consumption) to increase fertility potential.
Another issue that showed variations in associations was in regard to a lack of 
consistency on the critical thresholds associated with risk. If smoking 10 cigarettes a 
day is the critical threshold for a detrimental effect of tobacco smoking on fertility 
then what happens if someone reduces to nine cigarettes a day? Further, is nine 
cigarettes smoked with more depth and longer duration of inhalation healthier than 10 
cigarettes smoked more lightly? This specificity has been established in other research 
focusing on people trying to reduce their exposure to nicotine by restricting cigarette 
intake (Shields, 2002), and in settings where individuals have to smoke a cigarette 
quickly (e.g., short smoking breaks in working environment, Chapman, Haddad, & 
Sindhusake, 1997). Thus, even though a behaviour change in smoking habits may 
occur through increased awareness about the risk of the behaviour on subsequent 
disease, the individual may actually fail to reduce their risk in any way.
As was the case in help seeking research, future prospective data needs to take 
a multifactorial approach. The current research is the first of its kind to assess all 14
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risk factors together. The literature reviewed revealed that only 19% of studies took a 
multifactorial approach to the assessment of risk factors, but even these only assessed 
a few of the risk factors. These studies did find evidence for mediating and 
moderating factors (Stanton & Gray, 1995; Tolstrup et al., 2003), an issue that was 
not explored in the thesis but worthy of future investigation. This would be especially 
important when one considers how people may perceive themselves to be ‘at risk’ 
when an individual has some risk factors, but not others. For example, knowing that 
you are not at risk for one factor may provide one with a false sense of security about 
other factors even though the factors may be related. For example, Strychar et al. 
(1998) assessed the impact of dietary change in men receiving blood cholesterol test 
results and reported that the men who received a low cholesterol test result but ate 
foods high in saturated fat falsely believed it would be ok to continue eating such fatty 
foods because they had low cholesterol. In relation to risk associated with infertility, 
people who have unprotected sex but do not have an STI may be given a false sense 
of security that unprotected sexual intercourse is in fact safe. If the future of this 
research is to educate people about their risk of fertility difficulties it would be 
imperative to establish the exact risk.
Taken together with other research there is converging evidence supporting 
associations with these 14 factors and fertility impairment. Evidence also shows that 
young people were aware of a number of the risks, yet these risks do not appear to be 
reducing in the general population, quite the contrary, with research demonstrating 
that the majority of the negative lifestyle risks (e.g., obesity, smoking) and 
reproductive risks (e.g., STD) associated with fertility are on the rise. Perhaps the 
future of this research lies in personalising information. The NHS is now actively 
encouraging people to take more control over their own health and wellbeing by
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providing them with specific knowledge about the risks associated with a detrimental 
impact on their health (Department of Health, 2006). Therefore these fertility risk 
factors could be targeted. During the past five years there has been some increase in 
raising awareness bout fertility health issues (ASRM, 2006), however, as yet no 
personalised fertility campaign has been conducted to raise personal fertility 
awareness, and perhaps this is the direction that future research needs to explore.
The debate regarding informing people about risks centres on a balance 
between increasing awareness to better educate, reduce fear and motivate change 
where needed compared to provoking unnecessary fear and worry. The arguments for 
increasing awareness appear to outweigh the arguments against, providing that people 
are educated in an appropriate way, that is by giving accurate knowledge that aids 
effective decision making (e.g., to reduce one’s risk of developing lung disease one 
should cut down or stop smoking), and giving support when change is required (e.g., 
free nicotine replacement patches, support counselling). In the context of fertility 
health it remains to be established as to whether providing young people with such 
information would result in active behaviour change when needed (e.g., reduction in 
smoking).
Finally, poor participation rates of men in studies 3 and 4 resulted in the 
decision to only review and test the risk factors associated with female infertility. 
However, successful conception is dependent on both female and male fertility 
potential and the data provided in the present thesis is therefore only presenting half 
of the story. In future research the same process involved in the identification of risks 
using the female FRFS should be applied to identify risks for male fertility. Such 
studies would have to address ways in which men can be recruited. However, there
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are male orientated websites that could be a place to target men. A pilot study 
(conducted in the same laboratory) using a preliminary internet version of a male 
FRFS recruited nearly 200 men in one month; therefore such future studies may well 
be feasible.
Key methodological Issues
Through the completion of the set of studies presented in this thesis two 
common methodological issues have arisen, that warrant further discussion. The first 
is in regards to sampling issues and the second is in regards to the measurement of 
individual constructs.
Sampling issues.
Having a representative sample is a main aim when conducting research, that 
is, that the characteristics and behaviours measured in the participant pool are an 
accurate reflection of those found in the population (Heiman, 1999), thus minimising 
any potential biases that may impact on any assumptions or conclusion drawn (e.g., 
education, socio-economic status, age). The benchmark for obtaining a representative 
sample would be through population-based surveys that access everyone in a specified 
population using, for example, a local electoral role. However, in the present set of 
studies such a design could not be implemented, therefore one has to question whether 
the samples obtained for the studies presented, and thus the conclusions drawn, 
accurately represent, and are applicable to a wider community. Indeed the majority of 
the women employed in the studies conducted were recruited via the internet, which 
as already discussed does have limited accessibility to all. However, unlike previous 
studies that also did not use population based surveys but relied on recruiting couples 
once registered in the medical system (thus are prone to biases concerning only those
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who seek treatment -50% of couples), the internet offers the opportunity to recruit 
women at all stages of trying to conceive. Indeed this was achieved when one looks at 
the ranges of months trying to conceive in Chapters 3 (0 -  132 months) and 5 (0 -  204 
months). Further, the average age of women in these Chapters was similar to the 
national average at first birth in the United Kingdom. In addition, population 
comparisons were made in the sample recruited in study 5.2, which showed a good 
level of agreement between the frequencies of factors reported in the recruited sample 
and those reported in the general population.
Such results lend support that the samples recruited in the studies presented 
showed good representation compared to the population in terms of reproductive 
matters (e.g., age at first birth). However, there was an over-representation of highly 
educated samples and further, no attempts were made to assess the socio-economic 
status of participants. Therefore it is unknown to what extent the participant’s sampled 
are representative in different socio-economic categories. In addition, the majority of 
respondents from Chapter 3 onwards were from more developed nations (mainly UK 
and USA) and therefore one has no way of assessing whether the current issues 
addressed are applicable across developmental status. Future research must therefore 
look to validate the data collected to date in population based samples that will ensure 
a representative sample from all socio-economic backgrounds, with an emphasis on 
collecting data from less developed nations.
Another sampling issue concerns the size of samples recruited, more 
specifically the size of sub-samples used. For example, while a projected sample size 
calculation was conducted for study 5.2, of which it was achieved, when the sample 
was broken down into sub-groups for analysis (e.g., pregnant, not pregnant, intended
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pregnancy) over one third of the sample were excluded from the majority of the 
analysis (unplanned pregnancy). This is problematic when one wants to look at 
individual effects or interactive effects on specific variables when the frequencies of 
such variables are very low. For example, it would be hard to examine the impact of 
illegal drug use and smoking tobacco in pregnant women who tried to conceive 
compared to not yet pregnant women, when there were less than 5 women in each 
group who reported partaking in both activities. While these comparisons would be 
very useful to look in more detail at any relationships between risk factors, with small 
sub-sample sizes they become near impossible to conduct, and thus future research 
may benefit from setting a minimum sample size for any proposed sub-groups prior to 
the start of recruitment.
One also has to be cautious when reviewing samples obtained from different 
studies which may impact on the interpretation of the results reported. For example, in 
Chapter 2 a comprehensive review of the prevalence literature was conducted on 
studies using population based samples. These prevalence ratings were then compared 
and averaged to estimate the prevalence of current and lifetime infertility in couples in 
more and less developed nations. However, one important issue is any differences 
between the samples reviewed, that may impact on the interpretation of the prevalence 
rates reported. For example, when one compares the prevalence rating for the Gunnell 
and Ewring’s (1994) study (26.4% lifetime prevalence) to the Schmidt et al. (1995) 
study (15.7% lifetime prevalence) there appears to be quite a difference between the 
two numbers reported. A possible explanation for the difference in numbers is 
concerning the samples used. For example, in the Gunnell and Ewring (1994) study 
they sampled all women, that is, women who stated they were voluntarily and 
involuntarily childless. Whereas in the Schmidt et al. (1995) study they only sampled
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women who stated they were involuntarily childless. Therefore, the estimate from the 
Gunnell and Ewring (1994) study includes more women, even though the intentions 
of the women categorised as ‘infertile’ may be for different reasons (e.g., no intention 
to try to conceive). However, while this could account for some difference between 
the two prevalence scores previous research suggests that the estimated number of 
voluntarily childless women is relatively small (Chancey, 2006).
Perhaps a more plausible explanation for the divergence in the prevalence 
ratings concerns the age of the samples recruited. In the Gunnell and Ewring (1994) 
study the sample selected for analysis aged 3 6 -5 0  years old compared to 15-44  
years old in the Schmidt et al. (1995) sample. Indeed the Schmidt et al. (1995) study 
does provide a breakdown of the number of infertile women according to age, 
reporting a 22.1% prevalence rate for women aged 35 -  44, which is much more 
similar to that reported by Gunnell and Ewrings (1994). Differences in the 
characteristics of samples reviewed are important issues to consider for future 
research in order to make accurate comparisons between studies that will not impact 
on the interpretation of results.
A final sampling issue is the emphasis of the current research to focus only on 
female infertility. This exclusion was not meant to encourage the idea that infertility 
only concerns females and is not a couple problem, but more of a consequence of a 
lack of male participation. If the ultimate goal of this body of work is to raise better 
awareness about fertility health issues it would be futile to believe that fertility health 
only concerns females and that only one person (the female) is important in achieving 
reproductive success. While it is important to ascertain individual information about 
reproductive and lifestyle habits in order to better educate people about how their
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behaviours now (e.g., unprotected sexual intercourse with multiple partners, illegal 
drug misuse) may impact on future life goals of becoming a parent, it is also 
important to ascertain a couples risk. For example, if a woman is trying to get 
pregnant one cannot just base the chances of conceiving on responses only about her 
reproductive, medical and lifestyle history, as the partner’s reproductive, medical and 
lifestyle history will also impact on the chances of success. Only considering 
individuals and not couples may also impact on the way feedback and advice is 
provided concerning being ‘at risk’ when one is trying to conceive. For example, if a 
couple are trying to conceive and the women does not consume alcohol, smoke 
tobacco or take illegal drugs, she would be deemed at low risk for these negative 
factors impacting on her chances of successful conception. Therefore the information 
she may be provided in an attempt to raise awareness about her fertility health would 
reflect her responses concerning negative lifestyle habits. However, her partner may 
well partake in all these negative habits and thus may be impacting on their chances of 
conceiving. As already discussed, future research needs to make more of an effort in 
attempting to recruit men into psychological studies concerning fertility research in 
order to better understand the male decision making processes associated with 
unsuccessful attempts when trying to conceive, and the factors associated with having 
a detrimental impact on male fertility potential. Further, these issues also need to be 
explored from the couple’s perspective as well.
Measurement of individual constructs.
The second methodological issue surrounds the way in which constructs were 
measured in each study conducted. The majority of the studies presented in the thesis 
have attempted to take multifactoral approaches throughout. For example, in Chapter 
3 this involved the amalgamation of a number of constructs from different decision­
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making theories, models and previous empirical literature. Taking such an approach 
has allowed for the testing of multiple constructs and variables associated with the 
question in hand (e.g., decision making about help-seeking behaviour, the effect of all 
lifestyle factors on fertility potential). However, one issue with such an approach is 
that it may lead to an over simplification of the measurement of individual constructs. 
That is, through such a design do individual effects get lost, and are constructs being 
adequately assessed. For example, in Chapter 4 and 5 to measure stress one sentence 
was used (“I am experiencing levels of stress that I cannot cope with”). While this is a 
valid measure to ascertain extreme levels of stress, it may not fully capture the 
underlying processes of dealing with stressful situations. Indeed in the case of 
infertility it is often referred to as a low-control stressor, that is, a stressful situation in 
which the infertile couple can do little to alter any possible causes or outcomes of 
their situation (Schmidt, Holstein, Christensen & Boivin, 2005). Thus, measuring 
stress in one question may not adequately reflect the complex nature of the stressor 
involved. Further, some effects may be a general response to everyday situations (e.g., 
stable coping mechanisms) while others may have some specificity to a certain 
situation (e.g., infertility) which may make measuring coping styles as a ‘snap shot’ 
and not a process difficult to apply to all situations. For example, couples who enter 
fertility treatment are often encouraged to be optimistic about their chances for a 
successful outcome (Schmidt et al., 2005). This may lead to more ‘wishful’ thinking 
about the situation (“wished for a miracle to happen”). However, such wishful 
thinking can often be categorised as a type of escapism coping (Terry & Hynes,
1998), which may be interpreted as the individual not adequately coping with the 
situation in hand.
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An additional issue with measuring multiple factors is that some factors have 
established modes of action, for example smoking in women has been linked to a 
reduction in the number of viable oocytes, leading to an earlier onset of the 
menopause (Zavos & Zarmakoupis_Zavos, 1998) but also modes of action which may 
reflect correlated attributes, for example marijuana effects may reflect smoking. 
However, measuring and analysing such relationships can be complicated, especially 
when testing so many variables, of which many may be correlated.
Therefore, a potential draw back of a multifactoral approach employed in the 
present studies is that it may not fully capture the individual processes of each 
construct measured (e.g., stress, coping, smoking). However, this may not just be a 
problem associated with taking a multifactorial approach, but perhaps is more 
concerned with the use of retrospective designs. While the present studies have 
provided a wealth of knowledge about the issues addressed, what is really needed now 
to better understand decision making and risk associated with fertility potential (e.g., 
risky behaviours over time) is prospective longitudinal data that will be able to 
disentangle cause and effect, that will offer the advantage to assess the processes of 
certain constructs measured over time.
Finally, another possible set of influences (e.g., genetics) have not been taken 
into account in the present research that may impact on the results obtained, and 
warrant consideration in future research. For example, there is now a large body of 
evidence to suggest that genetic influences may predispose people’s behaviours 
towards alcohol consumption (Devor & Cloninger, 1989). This may have an impact 
on one’s tolerance and biological reaction towards alcohol consumption, which may 
in turn impact on the effect alcohol consumption, could have on fertility potential.
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Further, such genetic influences may interact with other factors, such as ethnicity, 
which may impact on the ways in which raising awareness can be applicable to all or 
just specific groups of people.
The research presented in this thesis does provide a better understanding of 
help seeking behaviour in the context of fertility problems and has established a set of 
risk factors associated with female fertility potential. A key message from the present 
research is the need for better awareness about one’s fertility health and fertility 
potential. Further, as will be presented in the next section, this research has 
highlighted the potential targets for such fertility awareness campaigns. However, 
what is now needed is prospective research that takes into consideration the key 
methodological themes discussed in the current section. Only through the validation 
of the results found in the present set of studies bearing in mind these methodological 
issues (e.g., population based studies to ensure good socio-economic representation) 
can this research move forward to the next step, that is, increasing personal and public 
awareness about fertility health issues, making sure that the information provided is 
relevant and useful in helping all people (female, male and couples) realise their 
parenting goals.
Targets for Public Health Campaigns to Improve Fertility Health Related 
Behaviour
The present research has identified two potential groups that may benefit from 
future public health campaigns to improve fertility health related behaviour. First, 
public health campaigns could take a preventative approach targeting factors 
identified in the current research, on the understanding that through the prevention of 
the risk factors fewer women (and men) would be faced with fertility difficulties in 
the future. Indeed the factors shown to have some of the largest negative impacts on
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fertility status (e.g., PID, STD) are easily preventable, and thus young people 
especially need to be informed about such risks in order for them to realise that their 
actions now can severely impact on their future fertility potential. A second goal of 
preventative strategies would be to empower women to become more aware of their 
fertility (e.g., what is your menstrual cycle, is it what it should be?). The increase in 
personal awareness about one’s fertility may also help young people become more 
attuned to changes that may warrant appropriate action to be taken (e.g., sudden 
increase in menstrual cramping), to prevent worsening of the condition (e.g., 
treatment for endometrial scarring). Ultimately, providing people with information 
about the risks allows that individual to make informed decisions about their own 
future fertility.
While the preventative public health campaigns would hope to reduce risks 
and thus reduce the number of couples affected by infertility some couples would still 
be faced with difficulties conceiving. Thus a second public health campaign should 
target couples trying to conceive. The emphasis for these targets would not just be 
prevention of risks (although this would be important) but would focus more on 
effective decision making when faced with a difficulty conceiving, so that timely 
action could be taken, if warranted.
Such a campaign would take two approaches to effectively tackle the main 
barriers that appear to inhibit effective action. First, people need to be better informed 
about treatment seeking behaviour and the options available to them if a fertility 
problem occurs. Namely, people need to know what to do when conception does not 
occur. There has been some attempt to tackle these issues. The Assisted Conception 
Taskforce (2006) released a pamphlet detailing the pathways towards seeking medical
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advice and getting treatment. The pamphlet provided a step by step guide for couples 
trying to conceive in an attempt to help them understand every step from the initial 
first attempts at trying to conceive, through the initial consultation with a general 
practitioner to the more complex treatment options available, thus providing them 
with accurate information about the treatment seeking process from which they can 
make decisions based on informed choice. While such a pamphlet provides couples 
with invaluable advice about the treatment process, it was unfortunately not widely 
advertised.
A second approach to tackle barriers associated with inaction would involve 
the active reduction of fear associated with seeking medical help. That is, the fear that 
through seeking advice (or treatment) one may face being told the worst fear, which is 
that one, cannot have children. Fear has been shown to be a major cause of delay in 
other health areas (e.g., detection of a lump in the breast or testicle; Facione, 1993; 
Oliveria et al., 1999; Carney et al., 2002; Grunfeld et al., 2002; Bish et al., 2005;
Smith et al., 2005; Facione & Facione, 2006). From this research it is believed that 
through effective public awareness campaigns that promote early detection (e.g., 
improved prognosis: Hillis et al., 1993) and better awareness about the main signs and 
symptoms of illness result in a reduction in delay due to fear. This idea brings one 
back to the need to raise awareness about the risks associated with infertility but also 
highlights the need for people to make timely decisions about their situations. For 
example, if a couple have been trying unsuccessfully for many years without seeking 
any medical help, this inaction may impact on future chances of conceiving for two 
reasons. First, this inaction may have resulted in more disease progression of the 
underlying cause of the infertility (e.g., underlying untreated STD which has resulted 
in the development of tubal factor infertility). Second, this inaction will have resulted
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in the couple increasing risk of age related infertility. Current estimates of age at first 
birth in the United Kingdom (mean 27.1, Office for National Statistics, 2000) suggest 
that a delay of 2 -  3 years would put couples in an age bracket where their fertility 
would start to decline. Thus persistent inaction for couples who wish to become 
parents may be increasing the chances that they will remain involuntary childless.
Only through a systematic approach of increasing awareness about the risks 
associated with infertility and tackling the main barriers associated with inaction when 
couples are faced with fertility difficulties can people make informed choices.
Conclusions
The present research comes at time when the importance of fertility health 
issues is ever-increasing. Indeed infertility has been recognised as a public health 
issue worldwide by the World Health Organisation (WHO) (Vayena et al., 2001), and 
has been prioritised on both public health and social policy agendas by the European 
Union (Evans, 2007). The research presented in this thesis could help to provide the 
foundational groundwork for public health campaigns to increase awareness about 
fertility health issues and further, maintain infertility as an important public health 
issue that warrants continual investigation. Ultimately the research presented in this 
thesis proposes that the future of fertility health care should be centred on providing 
people with information leading to informed choice about all aspects of their own 
fertility health.
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Appendices:
Appendix A: Medline search for prevalence of infertility and demand for
fertility treatment
Prevalence o f infertility
Search History in Medline/PubMed (1990 to 2006). Search conducted 25.05.08
#1 Infertility/epidemiology [Majr:NoExp] OR Infertility [Majr:NoExp] AND 
epidemiological studies (85 references found)
#2 Infertility, Female [Mesh] AND Prevalence [Mesh]
(122 records, 9 reviews)
#3 Infertility[Mesh] AND Infertility [Title/abstract] AND 
Infertility/epidemiology [MeSH] (563 records, 40 reviews)
Need and demandfor fertility treatment
Search History in Medline/PubMed (1990 to 2006). Search conducted 25.05.08
#1 Infertility [MeSH] AND Patient Acceptance of Health Care [MeSH]
(141 records, 15 reviews)
#2 Infertility [Title/Abstract] AND Patient Acceptance of Health Care [MeSH] 
(135 records/ 14 reviews)
#3 Infertility [Title/Abstract] AND treatment-seeking [MeSH]
(9 records/ 1 review)
Appendix A: Medline search 
#4 Infertility [MeSH] AND treatment-seeking [MeSH]
(9 records/ 1 review)
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Appendix B: Treatment Decision Making Questionnaire (TDMQ) Ethical
Approval
03/11/2005
The School of Psychology Ethics Committee has considered and approved 
your proposal: Intentions to seek medical advice when efforts to conceive are 
unsuccessful (EC.05.12.06.615). Please note that if any changes are made to the above 
proposal then the Ethics Committee will need to be made aware of them.
Regards, Dominique Bird
Secretary to the Ethics Committee
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Appendix C: Items in the Treatment Decision Making Questionnaire (TDMQ) matched to constructs in the theoretical framework
Table Al.
Items in the Treatment Decision Making Questionnaire (TDMQ) matched to constructs in the theoretical framework.
TDMQ Question Theory of Planned 
Behaviour
Transtheoretical
Model
Health Belief Model Help-Seeking Model for Infertility
Background Information (11 items)
Gender
Country of residence 
Age
Relationship status 
Years together (months)
Age of partner 
Parity (yes/no)
Education level (Partner education level)
0 = None, 1 = Primary, 2 = Secondary, 3 = 
Trade/technical, 4 = College/university
External variables 
External variables 
External variables
Behavioural intention 
External variables
Demographic & socioeconomic 
Demographic & socioeconomic 
Demographic & socioeconomic
Demographic & socioeconomic 
Demographic & socioeconomic
Predisposing and Enabling conditions 
Life course factors 
Life course factors
Life course factors
Predisposing and Enabling conditions
General health
1 = Poor, 2 = Fair, 3 = Good, 4 = Very good, 5 = 
Excellent
Perceived behavioural 
control
Cues to action Predisposing and Enabling conditions
Your Fertility (3 items)
How fertile do you believe you are?
1 = Not at all, 2 = Slightly, 3 = Moderately, 4 = Very, 
5 = Extremely
Perceived behaviour 
control
Contemplation,
Precontemplation
Perceived susceptibility Predisposing conditions, symptom salience
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Table A l.
Items in the Treatment Decision Making Questionnaire (TDMQ) matched to constructs in the theoretical framework (continued).
TDMQ Question Theory of Planned 
Behaviour
Transtheoretical
Model
Health Belief Model Help-Seeking Model for Infertility
Well Being (34 items)
Need for parenthood (6 items)
1 = Strongly disagree, 2 = Somewhat disagree, 3 = 
Neither, 4 = Somewhat agree, 5 = Strongly agree
Behaviour intention Contemplation Perceived benefits, Barrier 
identification
Symptom salience, Individual and social cues
How optimistic are you (Life Orientation Test, 12 
items)
0 = Strongly disagree, 1 = Disagree, 2 = Neutral, 3 = 
Agree, 4 = Strongly agree
Personality variables Personality variables Personality variables Personality variables
Coping style (THWC, 16 items)
0 = Not used, 1 = Used somewhat, 2 = Used quite a bit, 
3 = Used a great deal
Personality variables Personality variables Personality variables Personality variables
Engagement in Medical Treatment (32 items)
Have you sought medical services? (yes/no) Action
What contributes (a)/contributed (b) to seeking medical 
advice (16 items)
1 = Contributes not at all, 2 = Slightly, 3 = Moderately, 
4 = Very, 5 = Extremely 
Awareness of a problem Behavioural 
intention, Perceived 
behavioural control
Contemplation Perceived susceptibility, 
Cues to action
Symptom salience
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Items in the Treatment Decision Making Questionnaire (TDMQ) matched to constructs in the theoretical framework (continued).
TDMQ Question Theory of Planned Transtheoretical Health Belief Model Help-Seeking Model for Infertility
Behaviour Model
Engagement in Medical Treatment (32 items) (continued).
Told about a fertility problem Behavioural attitude Contemplation Barrier identification Predisposing and Enabling conditions
Being labelled
Scared of what doctor might say 
Embarrassment discussing private topic 
Disrupt relationship
Talk confidentially about fertility concerns
Reassurance nothing wrong
For/against medical interventions
Success of medical treatment
Worry about medical treatments going wrong
High-tech procedure
Medical treatment invasive
Complicated/easy to get help Perceived behavioural Contemplation, Barrier identification Life course factors, Predisposing and Enabling
How to get help control Preparation conditions
Cost of treatment __________ ________________ ___ _____________________________________________ ____________________________________________________
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Items in the Treatment Decision Making Questionnaire (TDMQ) matched to constructs in the theoretical framework (continued).
TDMQ Question Theory of Planned 
Behaviour
Transtheoretical
Model
Health Belief Model Help-Seeking Model for Infertility
Engagement in Medical Treatment (32 items) (continued).
How does each consequence make you feel (9 items) Behavioural attitude 
3 = Extremely good, 2 = Quite good, 1 = Slightly 
good, 0 = Neither, -1 = Slightly bad, -2 = Quite bad, - 
3 = Extremely bad 
Treatment would lead to:
Becoming a mother
Finding out if something is wrong
Disrupting social life and work commitments
Disrupting relationship with partner
Visiting the doctors
Financially worse off
Taking drugs and undergoing procedures
Happier relationship and marriage
Talking to someone about fertility concerns
How strongly do you agree with the following:
People important to me (2 items)
Partner important to me (2 items)
3 = Strongly agree, 2 = Somewhat agree, 1 = Slightly 
agree, 0 = Neither, -1 = Slightly disagree, -2 = 
Somewhat disagree, -3 = Strongly disagree 
How comfortable are you confiding in family and 
friends
1 = Not very comfortable, 2 = Somewhat 
uncomfortable, 3 = Neither, 4 = Somewhat 
comfortable, 5 = Very comfortable_______________
Subjective norms, 
Normative beliefs, 
Motivation to comply
Subjective norms, 
Normative beliefs, 
Motivation to comply
Contemplation Perceived susceptibility, 
Perceived threat
Predisposing and Enabling conditions
Preparation
Preparation
Cues to action Individual and social cues
Cues to action Individual and social cues
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Appendix D: Treatment Decision Making Questionnaire (TDMQ)
Decision-Making about Fertility Issues
This web survey was programmed by /lJJEapts
Introduction
We are interested in understanding decision-making around fertility issues. Hie majority of 
couples wil conceive without using medical treatment. However, a smal percentage of people 
w l need fertility treatment We are interested in people's perceptions and reasons for and 
against seeking medical help because many people who could benefit from treatment do not 
seek help or do not get the medical help hey need.
We are interested in the opinions o f all who are trying to conceive, even those who do not 
need medical treatment.
In order to find out more about this process we are asking people who are currently trying to 
conceive to complete a questionnaire. The questions concern your fertility, your perceptions of 
the medical process and your wcfl being.
The questionnaire takes between 10 • 15 minutes to complete and you cm omit any questions 
you do not wish to complete.
Your participation would be very valuable in helping us better understand decision-making 
around fertility issues, especialy about engaging in the medical process.
This study is being conducted by Laura Bunting with the supervision of Dr Jacky Boivin from 
Cardiff University who can be contacted via the folowing email address: boivin@cardiff. ac.uk.
Participation in this study is anonymous and wfl not involve any known risks. Data gathered in 
the study wS be for research purposes only. We wil not be able to trace responses to 
individual participants. Note, however that there is a possibility that someone could intercept 
your responses on the way to us but this risk is negligible.
You are free to withdraw from the study at any time without penalty or loss of benefits to which 
you are otherwise entitled.
This study has been approved by the Ethics Committee of the School of Psychology, Cardiff 
University, which can be reached via Judy McPherson (mcpherson@cardiff ac.uk).
ff you are IS or over, understand he statement above and freely consent to participate in this 
study then dick on the '1 Agree" button to begin tiie study.
© Cardiff University
l l
1 I Do Not Agree 1
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Background Information
1. Your country o f residence:
2. Your gender
3. Your age: Years old
4. Your partner's age: Years old
5. Your highest educational qualification:
4. Your partner's highest educational 
qyafificafion:
7. How long have you and your partner 
been living together?
5. Do you or your partner have any 
children?
Years: Months:
If YES then Tick afl that apply
9. In general would you say your health is:
□  I have a child/children with my current 
partner.
□  I have a child/children with a previous 
partner.
□  My partner has a child/childreu with a 
previous partner.
Continue
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Your Fertility
1. How fertile do you believe you are?
2. Please rate how confident you are that you (or your 
partner) w i become pregnant.
(Note: 0% = Not Confident at AM, 100% = Completely 
Confident)
3. Please indicate how long you have been trying to 
conceive/get pregnant?
%
Years: Months:
Continue
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Engaging in Medical Treatment
Hie majority of couples w i conceive without using medical treatment. However, a small 
percentage of people wil need fcrtflity treatment. We are interested in people's perceptions 
and reasons for and against seeking medical help. In particular, we want to know about your 
decision making and plans if  your efforts to conceive are unsuccessful.
1 a. Have you consulted a doctor about trying to conceive/get pregnant?
Continue
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Engaging in Medical Treatment 
Continued
1 1. How long would you now wait before consulting a 
doctor?
Yews: Months:
2. Below you wil find various reasons for and against seeking medical advice and/or treatment 
Please read each reason and indicate to what extent it would contribute to your own decision to 
seek medical advice and/or treatment
a. I would go if I felt I had a fertility problem or was at 
risk.
b. I would be worried that medical treatments would go 
wrong.
c. B would give me the chance to talc to someone 
confidential^  about my fertility concerns.
(LI would not want to be labeled infertie.
e. Seeking medical advice would give me reassurance 
that nothing was wrong and I was doing everything 
correctly.
f. I would feel awkwwd and embarrassed discussing 
such a private topic with someone I dkl not know.
1
1
3
3
Continue
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Engaging In Medical Treatment Continued
h. I am against medical interventiofis to conceive.
LI would not want to be told I had a fertility problem. 
j-I do not think medical treatments are successful, 
k. I would not know how to get help.
LI would be worried about how much treatment would
cost.
m. ft would be too complicated to get help.
n. I would be afraid that treatment would involve very 
high-tech procedures.
o. I would be too scared of what the doctor could tel
me.
p. Seeking medical advice would disrupt my relationship. 
Other consequences: please specify below:
Continue
B
B
B
B
B
B
B
B
1
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Engaging in Medical Treatment Continued
3. Seeking medical advice could have various different consequences. Please rate how each 
consequence below would make you feel (if it were to happen to you):
a. I could become a mother/father.
b. I could find out if there is anything wrong.
c. Treatment could disrupt my social life and work commitments.
d. Treatment could cause friction between me and my spouse.
e. Treatment would involve me having to go to the doctors.
f. We could be financially worse off
g. I could have to take drugs and undergo high-tech procedures.
h. I could have a happier relationship and marriage with my partner. 
LI could talk to someone about my fertility concerns.
D
D
B
Other reasons: please specify below:
r1
Continue
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Engaging in Medical Treatment Continued
4. Hie folowiug statements refer to how you think the people closest to you would want you 
to behave if  your attempts to conceive were unsuccessful. Please indicate 011 each scale how 
strongly you agree or disagree with each statement:
a. I think most people who are important to me would want me to seek medical advice:
Strongly Moderately Somewhat Somewhat Moderately Strongly
Neutral
Agree Agree Agree Disagree Disagree Disagree
O O O O O O O
b. Generaty speaking, I want to do what most people who are close to me think I should do:
Strongly Moderately Somewhat Somewhat Moderately Strongly
Neutral
Agree Agree Agree Disagree Disagree Disagree
O O  O O O  O O
c. I think my partner would want us to seek medical advice:
Strongly Moderately Somewhat Somewhat Moderately Strongly
Neutral
Agree Agree Agree Disagree Disagree Disagree
O O O O O O  O
d. Generaly speaking, I want to do what my partner thinks is best
Strongly Moderately Somewhat Somewhat Moderately Strongly
Neutral
Agree Agree Agree Disagree Disagree Disagree
o o o o o o o
5. How comfortable are you about confiding in family and friends regardmg trying for a child:
Very Not Very
Comfortable Comfortable
O O O O O
r
Continue
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Well Being
Now, we would like some feedback concerning how you are feeling about becoming a parent 
and about your attitude towards life hi general
1. Please indicate on the scale below to what extent you agree with the following statements:
a. Having a child is die most important thing in life.
b. Its hard for me to imagine a life without children.
c. Having a child is not necessary for my happiness.
d. Couples without a child are just as happy as those with children.
e. Being a parent is one of die most important things a person can 
do.
f. There is a certain freedom without children that appeals to me.
Continue
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Well Being Continued
2. The following questions are concerned with your attitudes towards life in general There are 
no light or wrong answers. Please be as honest and as accurate as you can, and try not to let 
your answers to one question influence your answers to other questions.
a. Iii uncertain times, I usually expect the best.
Strongly Strongly
Agree Neutral Disagree 
Agree Disagree
o o o o o
b. IPs easy for me to relax.
Strongly Strongly
Agree Neutral Disagree
Agree Disagree
o o o o o
c. If something can go wrong for me, it will.
Strongly Strongly
Agree Neutral Disagree
Agree Disagree
o o o o o
d. I always look on the blight side of things.
Strongly Strongly
Agree Neutral Disagree 
Agree Disagree
o o o o o
Continue
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Well Being Continued
e. I'm always optimistic about my future.
Strongly
Agree
O
Agree Neutral Disagree
O O o
Strongly
Disagree
O
f. I enjoy my friends a lot.
Strongly
Agree
Agree
O O
g. It’s important for me to keep busy.
Strongly
Agree
Agree
O O
Strongly
Neutral Disagree
Disagree
OO o
Strongly
Neutral Disagree
Disagree
o o o
It. I hardly ever expect things to go my way.
Strongly Strongly
Agree Neutral Disagree 
Agree Disagree
O O o o o
i. Things never work out the way I want them to.
Strongly Strongly
Agree Neutral Disagree 
Agree Disagree
O O o o
Continue
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Well Being Continued
j. I don't get upset too easily.
Strongly Strongly
Agree Neutral Disagree
Agree Disagree
o o o o o
k. Tm a believer in the idea that “every cloud has a silver lining”
Strongly Strongly
Agree Neutral Disagree
Agree Disagree
o o o o o
1.1 rarely count on good things happening to me.
Strongly Strongly
Agree Neutral Disagree 
Agree Disagree
o o o o o
Continue
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Well Being Continued
This is the filial question set in the questionnaire and consists of 16 items:
3. Listed below are statements that describe different ways people have of handling a 
problem. Please read each statement and mdicate to what extent you have used each 
statement when dealing with a problem:
a. Got busy with other things to keep iny mind off the problem.
Used
Used Used
Not Used a Great
Somewhat Quite a Bit
Deal
o o o o
b. Daydreamed or imagined a better time or place than the one I was in.
Used
Used Used
Not Used a Great
Somewhat Quite a Bit
Deal
o o o o
c. Thought about what steps to take to deal with the problem.
Used
Used Used
Not Used a GreatSomewhat Quite a Bit
Deal
o o o o
Continue
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Well Being Continued
d. Talked with friends about how I was feeling.
Not Used
O
Used Used
Somewhat Quite a Bit
O O
e. Tried to think of ways of dealing with die problem.
Not Used
O
Used Used
Somewhat Quite a Bit
O O
f. Hoped a miracle would happen.
Used 
a Great 
Deal
O
Used 
a Great 
Deal
O
Used
Used Used
Not Used a Great
Somewhat Quite a Bit
Deal
o o o o
g. Talked with a spouse or other relatives about how I was feding.
Not Used
O
Used Used
Somewhat Quite a Bit
O O
h. Wished I could change the situatioa
Used 
a Great 
Deal
O
Not Used
O
Used Used
Somewhat Quite a Bit
O O
Used 
a Great 
Deal
O
Continue
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Well Being Continued
i. Considered several alternatives for handling the problem.
Used 
a Great 
Deal
O
j. Avoided being with people in general.
Used Used
Not Used
Somewhat Quite a Bit
O O
UsedUsed Used
Not Used a Great
Somewhat Quite a Bit
Deal
o o o o
k. Made light of the situation; refused to get too serious about it.
Used
Used Used
Not Used a Great
Somewhat Quite a Bit
Deal
o o o o
1. Tried to see the positive side of the situation.
Used
Used Used
Not Used a Great
Somewhat Quite a Bit
Deal
o o o o
Continue
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Well Being Continued
m. Let niy feelings out somehow.
Not Used
O
Used Used
Somewhat Quite a Bit
O O
n. Tried to step back from the situation and be more objective.
Not Used
O
Used Used
Somewhat Quite a Bit
O O
o. Set some goals for myself to deal with the problem.
Not Used
O
Used Used
Somewhat Quite a Bit
O O
p. Kept my feelmgs to myself.
Used 
a Great 
Deal
O
Used 
a Great 
Deal
O
Used 
a Great 
Deal
O
Not Used
O
Used Used
Somewhat Quite a Bit
O O
Used 
a Great 
Deal
G
Continue
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Your Comments
Before providing you with additional information about the purpose of the study, we invite you 
to make any comments about decision-making about fertility issues in the box below:
Now to submit afl your data to the researcher and be debriefed click on the submit button.
Submit |
© Cardiff University 308
Appendix D: Treatment Decision Making Questionnaire (TDMQ)
Decision-Making about Fertility Issues
Tins web survey was programmed by j  Expts
Debrief
Thank you for taking the time to complete tins important questionuake.
Many individuals can benefit from seeking medical advice in order to conceive. However, many 
couples are either not seeking advice or are not receiving the medical help or treatment they 
reqtnre. We are interested in people's perceptions and reasons for and against seeking medical 
help. Specificafly we are concerned with people's intentions to seek medical advice and/or 
treatment if conception is unsuccessful. Two theories have proposed ways in winch people 
change or adopt new behaviours, and have been used to predict and understand peoples' 
decision making in other health areas, such as the decision to quit smoking or the decision to 
start (or increase) exercising on a daily basis. These theories predict that an individual's belief 
about medical treatment, their evaluations about what medical treatment can achieve and their 
perceptions and values of the people close to them wifl have an influence on whether or not 
they would seek medical advice. Other theories suggest that decision-making is determined by a 
process of stages. Such theories predict that an individual must progress through each of the 
stages in order to achieve success in adopting a new behaviour. There is no time Ihmt for each 
stage and some individual's may progress through certain stages quicker than others. Such a 
theory may be able to account for why a number of individuals are not seeking medical advice 
when conception is unsuccessful. In this study we were examining which theory is most useful 
hi the context of fertility.
Thank you again for your time, and we would lice to assure you that the data you have just 
provided us wifl be held auouymously.
If you have any further questions about this research then please contact boiviii@cardiff. ac.uk.
Continue
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Appendix E: Factors Affecting Fertility Scale (FAFS) Ethical Approval 
10/07/2006
The School of Psychology Ethics Committee has considered and approved 
your postgraduate project proposal - Risk factors and infertility 
(EC.06.08.15.864/942). Please note that if any changes are made to the above 
proposal then the Ethics Committee will need to be made aware of them.
Regards, Dominique Bird
Secretary to the Ethics Committee
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Appendix F: Factors Affecting Fertility Scale (FAFS)
Factors that affect Fertility
Tins web survey was program m ed by j  Expts
Introduction
We are interested in how you think various factors affect female and nude fertility.
Hie study takes between 10 -15 minutes to complete and you can omit any questions you do not 
wish to complete.
This study is being conducted by Laura Bunting with die supervision of Dr Jacky Boivin from 
Cardiff University who can be contacted via the following email address: boivin@cardiff. ac.uk.
Participation in this study is anonymous and wil not involve any known risks. Data gathered in the 
study wil be for research purposes only. We wil not be able to trace responses to individual 
participants. Note, however that there is a possibility that someone could intercept your responses 
on tiie way to us but this risk is negligible.
You are free to withdraw from the study at any time without penalty or loss of benefits to which 
you are otherwise entitled.
This study has been approved by the Ethics Committee of die School of Psychology, Cardiff 
University, which can be reached via Dominique Bird (birdd3@cardifif.ac.uk).
If you are 18 or ova*, understand die statement above and freely consent to participate in this 
study then click on the 1  Agree" button to begin the study.
UAgreeJ 
1 I Do Not Agree )
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Background Information
1. Your gender: B
2. Your age: Years old
3. Your highest educational qualification:
r* ■ . .. .........- S
Continue
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Instructions
We are interested in the factors that may have an effect on fertility. By fertility we 
mean you or your partner getting pregnant.
We will present you a list of factors. Beside the list of factors is a scale that goes from 
0 women to 100 women. Imagine that 100 women were trying to get pregnant. On 
average we would expect 50 women to achieve this goal within three months.
We would like to know whether you believe any of the factors listed would affect this 
fertility rate.
If you think the factor would DECREASE the chance of getting pregnant then click on 
a number BELOW 50 women, if you think the factor would INCREASE the chance of 
getting pregnant click on a number ABOVE 50 women. How much below or above 50 
you put your dot depends on how much you think the factor affects fertility. If you 
think the factor has no effect on the chance of getting pregnant then keep the dot on 50. 
Consider each factor individually.
Continue
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Instructions
Here is an example:
Eating 10 strawberries a day will...
If you place your dot on 85 women, it means you think an extra 35 women (above the
50) would get pregnant, meaning a 70% increase in the number of women getting
pregnant due to eating strawberries (see example below).
100 - c
95 - C 
90 -C
85 5 __________________________,
80 - (jCauses 35 extra women to get pregnant, meaning a 70%
75 ------ 1
70 - r  
65-C  
60 -C  
55 -C
50 - C Factor has NO effect 
45 - c  
4 0 - r  
35 - C 
30 - C  
25 - r  
20 -C  
15 -C  
10-C  
5 -C  
o - r
Continue
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Instructions
If instead you placed your dot on 15 women, it means you think 3 5 fewer women 
would get pregnant, meaning a 70% decrease in the number of women getting pregnant 
due to eating strawberries.
100 - o  
95 -O 
90 -O 
85 -O 
80-O 
7 5 - r  
70 -O 
65 - C  
60 -C  
55 -O
50 - O Factor has NO effect 
45 -C  
40 - r
35 - o  
3 0 - 0  
2 5 - 0
20-0
r —|
15 h S _______________________________
- TCauses 35 fewer women to get pregnant, meaning a 70%"
5 ^decrease h  the number of women getting pregnant.
0 - 0
Note, hovering over a point on the scale with the mouse wffl show a pop-up text 
caption that provides more information about what the point means. Also note 
that this pop-up text caption may take a few seconds to appear.
Continue
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Please rate the effect that adopting a baby will have on a woman’s fertility 
and then click on die continue button below.
Women
100-0
9 5 - 0
9 0 - 0
8 5 - 0
8 0 - 0
7 5 - 0
7 0 - 0
6 5 - 0
6 0 - 0
5 5 - 0
50 - © Factor has NO effect 
45 -o 
4 0 - 0  
3 5 - 0  
3 0 - 0  
2 5 - 0  
20-0 
1 5 - 0  
10-0 
5 - 0  
0 - 0
Continue
© Cardiff University 316
Appendix F: Factors Affecting Fertility Scale (FAFS)
Factors that affect Fertility
This web survey was programmed by I* i p E x p t s
Debrief
Thank you for taking the time to complete this important questionnaire.
Hie majority of couples w i get pregnant after toying for 12 months. However, for a smal 
number of couples it may take longer. Current government guidelines (NICE) recommend 
couples to seek medical advice if they have been toying for longer than 12 mouths without 
success. A number of studies however, have hjgfrjjghted that many couples are either not 
seeking advice or are not receiving the medical help or treatment they require. Furthermore, 
previous research has revealed that peopleis knowledge of fertihty and the factors that can have 
a negative effect on it is limited. This could he^ p to explain why some couples are not seeking 
help. We therefore want to determine what people bekeve are risk factors for fertihty and 
whether the general populations' bc&efs about fertflty correspond with die current literature and 
research in the area.
We are also interested to see if changing the way in which infonnahon is presented in the 
response scales would have an effect on a participant's rating of each factor. In the current 
study there were three scales that varied in the way information was presented to each 
participant You would have only had one of the three response scales presented to you. One 
scale presented information in frequencies (e g , [risk factor [...causes 35 extra women to get 
pregpant); another in percentages (e g , ...causes 75% increase in the number of women getting 
pregnant) and the other presented information in frequencies and percentages (e g , ...causes 35 
extra women to get pregnant. This means a 75% increase in the number of women getting 
pregnant). We wanted to determine whether varying the way information was presented to a 
participant would have an impact on their ratings of each factor. S  is important to provide 
response scales in such a way as to provide relevant information (Le., what the numbers mean 
in terms of an increase or a decrease in the number of pregnancies) without influencing what a 
participant decides about a risk factor (Le., whether and how much of an effect it has).
Thank you again for your time, and we would Mke to assure you that the data you have just 
provided us w l be held anonymously.
If you have any further questions about this research then please contact boivm@cardiff. ac.uk.
p ~ *
Continue
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Appendix G: ASRM poster campaign
Appendix G: American Society fo r  Reproductive Medicine fertility awareness
campaign
Reproduced without permission from http://www.protectyourfertility.org/ (last 
accessed 22 August 2008).
A N  U N H E A L T H Y  B O D Y  W E I G H T  MAY 
P R E V E N T  YOU  F R O M  H A V I N G  C H I L D R E N
Low body weight and obesity can cause infertility.
Your decisions now can impact your ability to conceive in the future.
www.ProledYourFertllily.org 1.866.228.6906 GET THE FACTS
AMERICAN SOCIETY FOR R EPR O D U C TIV E M EDICINE
P R A C T I C I N G  S A F E  S E X  NOW.  P R O T E C T S  
Y O U R  A 8 I L I T Y T 0  H A V E  C H I L D R E N  L A T E R .
Sexually transm itted infections are the leading cause  of infertility 
and often have no symptoms.
Your decisions now can impact your ability to conceive in the future.
Appendix G: ASRM poster campaign
Reproduced without permission from http://www.protectyourfertility.org/ (last 
accessed 22 August 2008).
I
I F  Y O U  S M O K E  T H I S  M I G H T  B E  Y O U R  
O N L Y  U S E  F O R  A  B A B Y ' S  B O T T L E .
Smoking can affect your ability to have children.
It can cause infertility in w om en and men.
Your decisions now can im pact your ability to conceive in the future.
www.ProlectYouifertility.org 1.866.228.6906 GET THE FACTS
A M ERIC A N  SO CIETY  FOR REPRODUCTIVE M ED IC IN E
n
A D V A N C I N G  A G E  D E C R E A S E S  Y O U R  
A B I L I T Y  T O  H A V E  C H I L D R E N .
While women and their partners must be the ones to decide w hen 
(and if) to have children, wom en in their tw enties a n d  th irties are  
m ost likely to conceive.
Your decisions now can impact your ability to conceive in the  future.
www.ProtectYourFeitility.org 1.866.228.6906 GET THE FACTS
AM ERICAN SO C IE TY  FO R  R E P R O D U C T IV E  M E D IC IN E
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Appendix H: Medline search fo r  risk factors fo r  study 5,1
Search History in Medline/PubMED (1978 to 2008)
Search conducted25,05,08
#1 Female Infertility 
Female Infertility AND:
#2 Risk Factors 
#3 Population Characteristics 
#4 Age Factors 
#5 Ethnic Groups 
#6 Occupation 
#7 Environmental Exposure 
#8 Reproductive History 
#9 Endometriosis 
#10 Menstrual Cycle 
#11 Dysmenorrhea 
#12 Amenorrhea 
#13 Oligomenorrhea
(19,026 records/ 2,335 reviews)
(600 records, 157 reviews) 
(1,500 records/ 189 reviews) 
(648 records/ 92 reviews)
(56 records/ 3 reviews)
(15 records)
(81 records/ 19 reviews)
(232 records/ 11 reviews)
(1587 records/ 331 reviews) 
(1395 records/ 147 reviews) 
(135 records/ 20 reviews)
(877 records/ 85 reviews)
(91 records/8 reviews)
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#14 Pelvic Inflammatory Disease (782 records/ 104 reviews)
#15 Polycystic Ovary Syndrome (830 records/ 185 reviews)
#16 Sexually Transmitted Diseases (536 records/ 87 reviews)
#17 Chlamydia (356 records/ 42 reviews)
#18 Gonorrhea (53 records/ 13 reviews)
# 19 Lifestyle (54 records/ 21 reviews)
#20 Alcohol Drinking (28 records/ 8 reviews)
#21 Alcohol-Related Disorders (15 records/ 2 reviews)
#22 Caffeine (17 records/6 reviews)
#23 Contraceptive Agents (320 records/ 61 reviews)
#24 Exercise (27 records/ 11 reviews)
#25 Coitus (142 records/ 18 reviews)
#26 Substance-Related Disorders (32 records/ 5 reviews)
#27 Cocaine (2 records)
#28 N-Mthyl-3,4-methylenedioxyamphetamine (Esctasy/LCD) (0 records) 
#29 Amphetamine (0 records)
#30 Heroin (diacetylmorphine) (1 record)
#31 Marijuana, Smoking (1 record)
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#32 Tobacco Use Cessation (5 records)
#33 Tobacco (25 records/ 10 reviews)
#34 Stress
#35 Stress, Psychological
(33 records/ 12 reviews)
(115 records/ 20 reviews)
#36 Chemotherapy, Adjuvant (19 records/ 7 reviews)
#37 Radiotherapy (107 records/ 40 reviews)
#38 Coeliac (13 records/ 2 reviews)
#39 Diabetes Insipidus (8 records)
#40 Diabetes Mellitus (96 records/ 28 reviews)
#41 Epilepsy (20 records/ 8 reviews)
#42 Heart Diseases 
#43 Kidney Diseases
(57 records/ 12 reviews)
(58 records/ 10 reviews)
#44 Lupus Erythematosus, Systemic (18 records/ 9 reviews)
#45 Appendicitis/Appendectomy (15 records/ 1 review)
#46 Perforation of the appendix (4 records)
#47 Anti-depressive Agents (6 records/ 2 reviews)
#48 Antidepressants (17 records/ 2 reviews)
#49 Anti-Inflammatory Agents (48 records/ 10 reviews)
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#50 Asthma (5 record)
#51 Asthma Medicine (1 record)
#52 Hormone Replacement Therapy (47 records/ 21 reviews)
#53 Anemia, Sickle Cell (3 records)
#54 Thrombophilia (13 records/ 3 reviews)
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Appendix I: Medical and Reproductive Reviewers 
11/12/2006
Ms Sandra K Dill ESHRE PLF, ICSI, ACCESS Australia
Ms Beverly Hanck Infertility Awareness Association of Canada
Dr Andrea Borini Tecnobios Procreazione, Italy
Dr Jacky Boivin Psychologist, School of Psychology, Cardiff University, UK
Ms Chantal Seror-Ramogida Follow Up, France
Dr Thomas Hahn Institut fur IVF and Reproduktionsmedizin, Germany
Mr Conrad Engler Advocacy AG/Verein Kinderwunsch, Switzerland
Dr Richard Porter IVF Australia
Dr Micheal Schenk Kinderwunsch Institut, Austria
Ms Geertrui De Cock Fertility Association of Belgium
Prof. Petra De Sutter Ghent University Hospital, Belgium
Dr Albert Yuzpe Genesis Fertility Centre, Canada
Dr David Rumpik Clinic of Reproductive Medicine and Gynecology, Czech 
Republic
Dr Petra Thom Patient Representative, Wunschkind, Counsellor, Germany
Mr Declan Keane Human Assisted Reproduction Ireland (HARI)
Ms Helen Hayes-Browne National Infertility Support & Information Group (NISIG), 
Ireland
Ms Donatella Caione Associazione Mammeonline. Italy
Prof. Karl-Gosta Nygren Sophiahemmet Hospital, Sweden
Mr Robert Forman Centre for Reproductive Medicine, UK
Mrs Susan Seenan Infertility Network UK
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Appendix J: Summary of design characteristics of each study
Table A2. Summary o f design characteristics o f each study._______________________________________________________
Authors Risk factor Bias Control Outcome Definitions Sample
Retrospective
Akande et al.(2004) Endometriosis Selection, drop out Yes Reduced 
conception rate
Infertility > 12 
months unprotected 
sexual intercourse
117 unexplained infertile women & 
75 women with laparoscopic 
diagnosed endometriosis (< 40), 
questionnaire & 3 year follow-up 
United Kingdom 1985 - 1995
Axmon et al. (2006) Menstrual, 
Age, Alcohol, 
smoking, 
stress
Selection Yes Increased TTP Excluded women > 
12 months 
unprotected sexual 
intercourse
1,578 women (23 - 39), randomly 
selected from general population, 
questionnaire, recall menstrual 
cycle length every 3 months of 
trying to conceive, Sweden, 2000
Bolumar etal. Caffeine Selection Yes Increased TTP > Excluded women > 3,187 women (25 - 44) randomly
(1997) 9.5 months 12 months 
unprotected sexual 
intercourse
selected from general population, 
interview, Europe 1991 - 1993
Bolumar et al. (2000) Weight No information 
available
Yes Increased TTP Excluded women > 
12 months 
unprotected sexual 
intercourse, clinical 
pregnancy
2,587 pregnant women at least 20 
weeks gestation (25-44), prenatal 
care unit, questionnaire or 
interview, Europe 1992
Eggert et al. (2004) Alcohol No information No, did not ascertain Risk of infertility Medical 7,393 (18 - 28) randomly selected
available information on lifestyle 
factors other than alcohol
diagnosis/hospital
admission
women from general population, 
questionnaire, Sweden, 1969
Gesink Law et al. Weight No information Yes Increased TTP Censored at 13 7,327 pregnant women median
(2007) available months unprotected gestation 16 weeks, interview,
sexual intercourse, 
clinical pregnancy
United States 1959 - 1965
Green et al. (1988) Weight Misclassification, Yes Risk of ovulatory Diagnosis of 380 infertile cases & 1,520
recall infertility ovulatory infertility demographic & socioeconomic- 
matched controls given birth same 
year (20 - 39), interview, US 79 -81
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Table A2. Summary o f design characteristics o f each study (continued).
Authors____________ Risk factor Bias______________ Control________________ Outcome________ Definitions__________ Sample
Retrospective (continued)
Greenlee et al. (2003) Alcohol,
smoking,
weight
No information
available
Yes Risk of infertility Infertility > 12 
months unprotected 
sexual intercourse
322 primary infertile cases & 322 
age-matched pregnant (during 1st
trimester) controls (18 - 35), 
interview, Canada 1997 - 2001
Gordley et al. (2000) Stress Selection, 
measurement error
No information available Menstrual
irregularities
Menstrual
irregularities defined
170 women employed by the US 
Air Force (18-41), questionnaire 
about menstrual patterns in 
preceding 3 months , United States
Grodstein et al. 
(1994)
Alcohol,
caffeine,
weight
Interviewer bias Yes Risk of tubal 
infertility & Risk 
of ovulatory 
infertility
Infertility > 12 
months unprotected 
sexual intercourse, 
live birth
1,050 infertile women & 3,833 
women admitted for delivery of 
pregnancy, interview, United States 
& Canada 1981 - 1983
Hassan & Killick 
(2003)
Age No information 
available
Yes Increased TTP > 
12 & 24 months
Infertility > 12 
months unprotected 
sexual intercourse
1,976 pregnant women (25 - 44), 
antenatal units, questionnaire, 
United Kingdom 2000 - 2001
Hassan & Killick 
(2004)
Alcohol, 
caffeine, drug 
use, smoking, 
weight
Sample size within 
groups
Yes Increased TTP Infertility > 12 
months unprotected 
sexual intercourse
1,976 pregnant women (25 - 44) 
antenatal units, questionnaire, 
United Kingdom 2000 - 2001
Hatch & Bracken 
(1993)
Caffeine, Misclassification Yes Increased TTP Infertility > 12 
months unprotected 
sexual intercourse
1,909 pregnant women antenatal 
unit, interview, United States 1980 
-1982
Hillis et al. (1997) STD Under­
representation of 
all chlamydia cases
Yes, but for a number of 
lifestyle factors no 
information ascertained
Risk ofPID Diagnosis ofPID 11,000 women known to have had 
chlamydia trachomatis (10 - 44), 
medical records of registered 
hospitalisation for PID, United 
States 1985 - 1992
Hull et al. (2000) Smoking Recall, selection Yes Increased TTP 6 
& 12 months
Infertility > 12 
months unprotected 
sexual intercourse, 
clinical pregnancy
8,515 pregnant women at least 18 
weeks gestation, questionnaire, 
United Kingdom 1991 - 1992
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Table A2. Summary o f design characteristics o f each study (continued).
Authors Risk factor Bias Control Outcome Definitions Sample
Retrospective (continued)
Juhl et al. (2003) Alcohol Sample size within Yes & Power calculations Increased TTP > Infertility >12 29,844 pregnant women at least 12
groups 12 months & 
shorter TTP
months unprotected 
sexual intercourse, 
clinical pregnancy
weeks gestation (14 - 44), national 
birth cohort, interview, Denmark 
1997-2000
Joesoef et al. (1993) Drug use Limited
information
Yes Shorter TTP Infertility >12 
months unprotected 
sexual intercourse, 
live birth
1,818 infertile cases & 2,817 
controls given birth same year, 
interview, United States & Canada 
1981 - 1983
Kaplan et al. (2005) Age, weight No information No information available Increased TTP > Infertility > 12 798 pregnant women (20 - 40),
available 3 & > 6 months months unprotected 
sexual intercourse
antenatal unit, questionnaire, Israel 
2003
Khadem & Endometriosis, Selection No information available Risk of infertility Infertility >12 100 infertile women & 120 fertile
Mazlouman (2004) menstrual months unprotected 
sexual intercourse
age-matched controls (19-39), 
laparoscopy performed & medical 
records, Iran
Lalos (1988) Endometriosis, Small sample size No information available Risk of tubal Tubal infertility 120 infertile cases & 126 pregnant
pelvic surgery, infertility & confirmed controls with no history of
STD, PID infertility infertility (18 - 43), questionnaire 
& medical records, Sweden 1978 - 
1982
La Rochebrochard & Age Selection & recall Yes Risk of infertility Infertility > 12 6,188 women (25 - 44), randomly
Thonneau (2003) months unprotected selected from census registers,
sexual intercourse interview, Europe 1991 - 1993
Maheshwari et al. Age Change in Yes & Power calculations Risk of tubal & Infertility > 12 7,172 infertile women (20 - 50),
(2008) diagnostic methods unexplained months unprotected medical records based on first
over time infertility sexual intercourse clinic visit, United Kingdom 1993- 
2006
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Table A2. Summary o f design characteristics o f each study (continued).
Authors Risk factor Bias Control Outcome Definitions Sample
Retrospective (continued)
Malik et al. (2006) STD No information 
available
No information available Risk of infertility Infertility > 12 
months unprotected 
sexual intercourse
110 primary & secondary infertile 
cases & 30 healthy term pregnant 
controls (18 - 40), 
hysterosalpingography performed 
on all patients, India 2003 - 2004
Mueller et al. (1990) Drug use Response & Recall Yes Risk of primary 
tubal infertility 
& Risk of 
ovulatory 
infertility
Infertility > 12 
months unprotected 
sexual intercourse, 
live birth
84 infertile cases & demographic & 
socioeconomic-matched controls 
given birth same year (20 - 39), 
interview, United States 1979 - 
1981
Olsen (1991) Caffeine Recall Yes Increased TTP > 
12 months
Infertility >12 
months unprotected 
sexual intercourse, 
clinical pregnancy
10,886 pregnant women at 36th 
week of gestation, questionnaire, 
Denmark 1984 - 1987
Olsen et al. (1997) Alcohol Selection & Recall Yes Increased TTP > 
9.5 months
Clinical pregnancy 2,587 pregnant women at least 20 
weeks gestation & those just given 
birth (25 - 44), interview, Europe, 
1992
Ramlau-Hansen et al. 
(2007)
Weight No information 
available
Yes I ncreased TTP > 
12 months
Infertility > 12 
months unprotected 
sexual intercourse, 
clinical pregnancy
47,835 pregnant women at least 16 
weeks gestation (15-44), two 
telephone interviews during & after 
pregnancy, Denmark 1996 - 2002
Rich-Edwards et al. 
(1994)
Weight Selection, recall Yes Risk of infertility Infertility > 12 
months unprotected 
sexual intercourse, 
clinical pregnancy
2,527 infertile women & 46,718 
women whose first pregnancy 
lasted > 6 months with no history of 
infertility (25 - 42), questionnaires, 
United States 1989 - 1995
Rowland et al., 
(2002)
Menstrual Selection Yes Risk of infertility Infertility > 12 
months unprotected 
sexual intercourse
3,941 women (21 - 40), 
questionnaire, United States 1994 - 
1996
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Table A2. Summary o f design characteristics o f each study (continued).
Authors Risk factor Bias Control Outcome Definitions Sample
Retrospective (continued)
Stanton & Gray 
(1995)
Caffeine Selection Yes Increased TTP > 
12 months
Infertility > 12 
months unprotected 
sexual intercourse
2,501 pregnant women employed at 
semioconductor plants, interview, 
United States, 1989 - 1990
Swasdio et al.(1996) STD No information 
available
Yes Risk of tubal 
infertility
Tubal infertility 
confirmed
55 primary infertile confirmed tubal 
damage cases & 59 postpartum 
controls, past infections assessed 
measuring serum IgG antibodies, 
Thailand 1990 - 1992
Thonneau et 
al.(1992)
Pelvic surgery, 
STD, PID
Recruitment Yes Risk of primary 
infertility & 
secondary
Infertility > 12 
months unprotected 
sexual intercourse, 
live birth
301 infertile cases & 380 controls 
who had just given birth, interview, 
France 1988 - 1989
Urbach et al. (2001) Endometriosis, 
PID, Age, 
smoking
Selection, recall, 
cases not aged 
matched
Yes & Power 
calculations
Risk of tubal 
infertility
Clinical pregnancy 121 primary infertile cases & 490 
clinically pregnant controls (20 - 
44), questionnaires, Canada 1998
Wiesenfeld et al. 
(2002)
STD No information 
available
Yes Risk of
subclinical PID
Diagnosis of 
subclinical PID
556 women (15- 30) with lower 
genital tract infections or 
determined at risk of such 
infections, sexual & reproductive 
health clinics, endometrial 
sampling for histologic analysis, 
United States 1998 - 2000
Augood et al. (1998) Smoking Publication, self- Yes, in all studies 8 studies - longer Infertility >12 Meta analysis of 12 cohort and
(11 studies were 
retrospective, 1 
prospective)
report, recall,
misclassification,
selection
reviewed TTP, 4 studies 
risk of infertility
months unprotected 
sexual intercourse (6 
studies), excluded 
women > 12 months 
unprotected sexual 
intercourse (1 study), 
no definition (2 
studies), pregnant (1 
study), clinical (2 )
case-control studies in the general 
population 1985 - 1997
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Authors Risk factor Bias Control Outcome Definitions Sample
Prospective
Dunson et al. (2004) Age No information 
available
No information available Risk of infertility Infertility > 12 cycles 
unprotected sexual 
intercourse
782 women (18 - 40), randomly 
selected, daily fertility & menstrual 
characteristics recorded, Europe 
1992 - 1996
Fenster et al. (1999) Stress Selection Yes Short menstrual 
cycle < 24 days 
& Risk of 
anovulation >36 
days 
Reduced 
conception rate
Menstrual
irregularities defined
403 women (18 - 39) daily 
menstrual characteristics, urine 
samples & interviews, United 
States 1990 - 1991
Hakim et al. (1998) Alcohol Recall & sample 
size
Yes Conception 124 women (23 - 41), daily urine 
samples & reports of lifestyle 
habits, United States 1989 - 1991
Hjollund et al. (1999) Stress Planning Yes Reduced 
conception rate
Infertility > 12 
months unprotected 
sexual intercourse, 
clinical pregnancy
390 women (20 - 35) monthly 
questionnaires for 6 menstrual 
cycles or until clinical pregnancy, 
Denmark 1992 - 1995
Jensen et al. (1998) Alcohol,
caffeine
Recruitment & 
Selection
Yes Reduced 
conception rate
Clinical pregnancy 423 women (20 - 35), monthly 
questionnaires for 6 menstrual 
cycles or until clinical pregnancy, 
Denmark 1992 - 1995
Kolstad et al.(1999) Menstrual Selection Yes Reduced 
conception rate
Conception 295 trade union women (20 - 35), 
daily urine samples for 5 menstrual 
cycles or until conception, 
Denmark 1992 - 1995
Liu et al. (2004) Alcohol,
smoking
Selection Yes Short follicicular 
phase & 
menstrual 
irregularities
Menstrual
irregularities defined
338 women (20 - 44), daily urine 
samples & reports of lifestyle 
habits, United States 1989 - 1991
Small et al. (2006) Menstrual Sample size Yes Reduced 
conception rate
Infertility > 12 
months unprotected 
sexual intercourse, 
clinical pregnancy
470 women employed by 
government (< 40), interview, urine 
collection 2 days per cycle for year 
or until a clinical preg, US 90 - 94
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Authors Risk factor Bias______________ Control Outcome Definitions Sample
Prospective (continued)
Stoleru et al. (1993) Stress Selection Yes Risk of infertility Infertility > 12 
months unprotected 
sexual intercourse
63 women (20 - 35) trying to 
conceive, questionnaire at 1 & 12.8 
months, France
Tolstrup et al. (2003) Alcohol Recruitment No control for variables 
developing over time 
(e.g., endometriosis)
Risk of infertility Medical diagnosis 
through hospital or 
registration on the 
Danish Infertility 
Cohort Register
7,760 women (20 - 29), randomly 
selected from general population, 
interview, Denmark 1991 - 1993
Westrom (1993) PID No information 
available
Yes Risk of infertility Diagnosed with tubal 
factor infertility
1,966 women all diagnosed with 
acute salpingitis (15 - 34), 
laparoscopy & follow-up 
interviews, Sweden 1960 - 1989
Wilcox etal. (1988) Caffeine No information 
available
Yes, but did not measure 
all lifestyle factors
Risk of infertility Infertility >12 
months unprotected 
sexual intercourse, 
clinical pregnancy
104 women, daily menstrual 
characteristics recorded & 
interviews at 0, 3, 6,12 & 24 
months or until clinical pregnancy, 
United States
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Appendix K : Categories of excludedfactors from study 5.1
The following factors have all been associated with fertility potential. After 
review and consultation with the medical and reproductive experts it was decided that 
they should be removed from the development of the Fertility Risk Factors Scale 
(FRFS) for the following reasons:
Factors do not have an independent impact on fertility potential (5 factors)
■ Exercise (lifestyle)
■ Underweight (BMI <19)
■ Ethnicity (Demographic)
■ PCOS (Reproductive)
■ Epilepsy (medical)
Evidence for factors impact on fertility is contradictory (4 factors)
■ Contraception use (lifestyle)
■ Occupation and environmental exposures (demographic)
■ Asthma medication (medical)
■ Prescribed drug use (medical)
Factors associated with an impact on fertility after conception (3 factors)
■ Heart disease (medical)
■ Coeliac (medical)
■ Thrombophilia/ Deep Venous Thrombosis (medical)
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Exclusion of all non-reproductive medical factors (5 factors) 
Low prevalence (2 factors)
■ Sickle cell anaemia
■ Lupus Erythematosus SLE
Previous knowledge (3 factors)
■ Cancer, Chemotherapy and Radiotherapy
■ Diabetes
■ Kidney disease and transplantation
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Appendix L: Calculation of odds ratios for study 5.1
Dunson, D.B., Baird, D.D., Columbo, B. (2004). Increased infertility with age in men and 
women. Obstetrics & Gynecology, 103, 51-56.
(0) Age (1)
Pregnant 19-26 27-34 Total
Yes 92 86.5 178.5
No 8 13.5 21.5
Total 100 100 400
[92 x 13.5]/ [8x86.5] = 1.79
(1242) (692)
(0) Age (1)
Pregnant 19-26 27-34 Total
Yes 92 82 174
No 8 18 26
Total 100 100 400
[92 x 18]/ [8x82] = 2.52 
(1656) (656)
Kaplan, B., Nahum, R, Yairi, Y., Hirsch, M., Pardo, J., Yogev, Y., Orvieto, R. (2005). Use of 
various contraceptive methods and time of conception in a community-based population. 
European Journal o f Obstetrics & Gynecology and Reproductive Biology, 123, 72-76.
3 months trying
(0) BMI (1)
Pregnant <25 >25 Total
Yes 44 37 81
No 56 63 119
Total 100 100 400
[44x63]/[56x37] = 1.34 
(2772) (2072)
6 months trying
(0) BMI (1)
Pregnant <25 >25 Total
Yes - 74 54 128
No 25 46 72
Total 100 100 400
[74 x46] / [26 x 54] = 2.42 
(3404) (1404)
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Khadem, N., & Mazlouman, S. J. (2004). Study of endometriosis related infertility, a 
comparative study. Acta Medica Iranica, 42, 383 -  388.
% Infertile
Dyspareunia Yes No
Yes 12 3
No 88 97
[12x 9 7 ]/[8 8 x 3 ] = 4.41 
(1164) (264)
% Infertile
Endometriosis Yes No
Yes 38 11.6
No 62 88.4
[38x88.4]/[62x11.6] = 4.67
(3359.2) (719.2)
% Infertile
Pelvic Pain Yes No
Yes 28 3
No 72 97
[2 8 x97]/[72x3] = 12.57 
(2716) (216)
% Infertile
Dysmenorrhea Yes No
Yes 55 31.7
No 45 96.3
[55x96.3]/[45x31.7] = 3.71
(5296.5) (1426.5)
Kolstad, H.A., Bonde, J.P., Hjollund, N.H., Jensen, T.K., Henrikden, T.B., Ernst, E., 
Giwercman, A., Skakkebaek, N.E., Olsen, J. (199). Menstrual cycle pattern and fertility: a 
prospective follow-up study of pregnancy and early embryonal loss in 295 couples who were 
planning their first pregnancy. Fertility and Sterility, 71, 490-496.
Cycle length
Pregnant <40 >40
Yes 16 11
No 84 89
Total 100 100
[16 x 89]/[84 x 11] = 1.54 
(1424) (924)
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Lalos, O. (1988). Risk factors for tubal infertility among infertile and fertile women. 
European Journal o f  Obstetrics & Gynecology and Reproductive Biology, 29, 129- 
136.
% Infertile
Gonorrhoea Yes No
Yes 13 2
No 87 98
[13x 9 8 ]/[2 7 x 2 ] = 7.32 
(1274) (174)
% Infertile
Previous Surgery Yes No
Yes 59 25
No 41 75
[59x75]/[41x25] = 4.32
(4425) (1025)
% Infertile
Endometriosis Yes No
Yes 10 3
No 90 97
[10x97] / [90x3]  = 3.59 
(970) (270)
% Infertile
PID Yes No
Yes 41 14
No 59 86
[41 x 86]/[59 x 14] = 4.27 
(3526) (826)
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Appendix M: Fertility Risk Factors Survey (FRFS) Ethical Approval
University Ethical Approval 
24/04/2007
Extract from the unconfirmed University Research and Ethics Committee 
(UREC) meeting minutes of 24 April 2007 follows:
"128 PROJECT REFERRAL Received paper 06/1026B, 'School of 
Psychology, Cardiff University Ethics Proforma
NOTED
.1 That UREC's approval has been sought for a PSYCH student research 
project in view of the nature of the study.
RESOLVED
.2 That the research project is in an important and valid academic area and 
scientifically robust; .3 That the research subjects will be totally anonymised and 
safeguarded and that participation in the study is entirely voluntary; .4 That the 
project be approved by this Committee."
Dr Kathryn Pittard Davies confirmed that using the University notice board 
would not be a problem.
Dr Kathryn J Pittard Davies
Head of Research Policy and Management, Research and Commercial 
Division, Cardiff University.
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NHS South East Wales Research Ethics Committee Ethical Approval 
24/04/2007
&
NHS
WALES
G IG
CYMRU
Eict*  e y V Y o u rflncyftQurref
W e f e h  H e a l t h  T e l e p h o n e  N e t w o r k  1 8 7 2  
D i r e c t  H n e A J in e il  p n lo o g y r d h o l
C a r d i f f  a n r f V a i *  N H S  Y m d d M « l o t o * t i t  G IG
C a e r d y d d  a ' r T i p
University Hospital of Wales 
Ysbyty Athrofaol Cymru
Heath Palfc, ,
C s n d l f f  C F 1 4  4 X W  
P h o n e  0 2 9  2 0 7 4  7 7 4 7  
M in ic o r n  0 2 9  2 0 7 4  2 6 3 2
Pare Yiflynydd Byetnn. 
Caerdydd CF14 4Xw 
029 2074 7747 
Minicom 029 2074:
From; Professor MF Scanlon 
Trust R&D Director 
Radnor House 
University Hospital of Wales 
Cardiff 
CF144XW
E-mail: Research. Development@cartfiffiandvale. wales, nhs.u k 
02 July 2007
Tel: 029 20743742
Fax: C©9 20745311
Or Jacky Boivin 
Schoof Of Psychology 
Cardiff University, Tower Building 
Park Place Cardiff CF10 SAT
Pear Dr Boivin
Prefect ID; 07/RPM/3999: Survey Of Fertility Health Issu es
Thank you for your recent communication regarding the above project, which was 
reviewed on 29 June 2007 by tie  Joint Trust/Unrversrty Risk Review Committee.
I am p ieasedto  inform you that the project has been approved and that Cardiff 
University will act as research Sponsor under t ie  Research Governance Framework 
for Health and Social Cara. Cardiff & Vale NHS Trust Is therefore happy for the 
project to begin, subject to:
1) Approval from the appropriate NHS Research Ethics Committee
2) Honorary Contracts, where required, being in place before the research begins.
Please ensure that the appropriate Research Ethics Committee have a  copy of this 
letter. Once you have gained ethical approval, please forward a copy of the approval 
letter to the Research and Development Office at the above address.
May I take this opportunity to wish you success with the project and remind you that 
as Principal Investigator you are required to:
« Inform the Trust R&D Office if any external or additional funding is awarded for 
this project In the future.
• Inform the Trust R&D Office of any am endm ents relating to toe protocol, 
including personnel changes and amendments to toe actual or anticipated 
start I end dates.
P a g e t  o f2
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• Complete any documentation sent to you by the Trust R & D  Office or 
University Research & Commercial Division regarding this project.
• Ensure that adverse event reporting is in accordance with Cardiff and Vale 
NHS Trust Policy and Procedure for Reporting Research-Related Adverse 
Events (Refs 164 & 174) and the Trust incident Reporting and Investigation 
Procedure (Ref 108).
• Undertake the projeti In accordance with ICH-GCP.
• Adhere to the protocol as approved by the Research Ethics Committee.
• Ensure tee research complies with the Data Protection Act 1998.
Yours sincerely,
Professor MF Scanlon
Chair of the Joint Trust/University Peer & Risk Review Committee
CC Chris Shaw, Research and Commercial Division, Cardiff University
CC R&D Lead Professor A Fiander
Lieiudy fafcte»\399»RD LadersW-RPM’OSKHi Rtek Rbim*  Approval LeOer O2-07-2OC7.doc
Page 2 of 2
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$  Business Servians, Centre
South E ast Waies Research E thics Committee Panel B
Telephone: 02920 376823 
Facsimls: 02920 376835 
Email: Cart.pMillpstJIbsawates.nhs.uk
Dr Jacky Boivin
School of Psychology
Cardiff Unlveirsity
Psychology Building, Pack Place
Canfiff
CF103AT
1 October2007
DearDrBdvin
Full title of study: Survey of fertility health issues
REC reference number 07/WSE02flT
Thar* you for your letter of 26 September 2007, responding to the Committee's request for 
further information on the above research, and for submiffing revised documentation.
The further information has been canstderad on behalf of the Committee by the Chair.
Confirmation of aihicai opinion
On behalf of tie  Commitee, 1 am pleased to confirm a favourable ethical opinion for tie  
above research on the basis described in tie  application form, protocol and supporting 
documentation [as revised].
Ethical review of research sites
The Committee has designated this study as exempt from site-specific assessment (SSA).
There is no requirement for (other] Local Research Ethics Committees to be informed or for 
site-specific assessment to be canted out at each site.
Conditions of approval
The Favourable opinion is given provided that you comply with the conditions set out In the 
attached document
You are advised to study the conditions carefully.
C a n o i f e n  G w a a e r a e t h e u  B u s r x s s
Ty Churchill
17 Ffadd Churchill
Caerdydd. CF1DZTW
FKn: 029 20 378820 WHTN 1803
Ffec*; 029 20 376626
Business Services Centre 
Chunchil House 
1 7  C h u n * *  W a y  
Cardiff. CF10 2TW
Telephone; 029 20 376820 WHTNi 1*09 
F a r 02920376826
rt«R  a Addysgu Swrdtf lechyd Lleoi Powys i part erf Pow ys le ach in g  Local Health EkJ*KJ
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SE02/T7. 2
Approved documents
The final list of documents reviewed and approved by the Committee is as follows:
; ::' vJ . '  * ‘ '■ " , y , :.w Date ' iv •!'
Application 5 A 0? August 2007
Investigator CV J Boivin 07 August 2007
Investigator CV L Bun&>g 25 September 
2007
Protocol 1 06 August 2007
Letter from Sponsor Cardiff University 26 June 2007
Peer Review Joint TrustAJniversity Peer 
& Risk Review Committee
02 July 2007
Compensation Arrangements UMAL 01 August 2007
Quesiiormaim: Survey of fertility health issues 1 07 August 2007
Letter of invitation to participant 2 - Evans 25 September 
2007
Letter of invitation to participant 2-Penketh 25 September 
2007
Participant Information Sheet 1 -James 07 August 2007
Participant Informafion Sheet 1 - Jose 07 August 2007
Participant informafion Sheet 1 - Evans 07 August 2007
Response to Request for Further Information 25 September 
2007
R&Papproval
AS researchers and research collaborators who will be participating in the research at NHS 
sites should apply for R&D approval from the relevant cate organisation, If they have not yet 
done so. R&D approval is required, whefoer or not the study is exempt from SSA. You 
should advise researchers and local coSaborators accordingly.
Guidance on applying for R&D approval is available from 
htfo://www. rdfonOT.nhs.uk/rdfofm.htrn.
Statement of compliance
The Committee is constftuted In accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.
Feedback on the application process
Now that you have competed the application process you are invited to give your view of 
the service you received from the National Research Ethics Service. If you wish to make 
your views known please use the feedback form available on foe IMRBS website a t
httpsi/AwBW-nrasform.org, uk/App Form/Modules/Feodbedk/EthicalRevi&w. aspx
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n tn  Page 3
We value your views and comments and will use them to inform the operational 
process and further Improve our service.
07/WSE02/77 Please quote this number on all correspondence |
Witt the Committee's best wishes for the success of tits project
:rely
Carl Phflfips
South East Wales Research Ethics Committees
Enclosures: Standard approval conditions SL-AC2
Copy to: R&D office tor Cardfff UniversHy
R&D office for Cardiff & Vale NHS Trust
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CteKtfen GwasameftauBusnes 
Business Services Centre
South East Wales Rwraich Ethics Committee Panel B
Tat 02920 376822)l6823 
Fax: 02920 376835
25 January 2008
Dr Jacky Boivin 
Reader
School of Psychology, Cardiff University 
Psychology Building, Park Race 
Cardiff
CF10 3AT UK
Dear DrBoivir
Study title: Survey of fertility health issues
REC reference: 07/WSE02/77
Amendment number; Amendment No. 1
Amendment date; 16 January 2007
Thank you lor submitting the above amendment, which was received on 25 January 20QS. I 
can confirm that this is a valid notice of a substantial amendment and will be reviewed by 
the Sub-Committee of the South East Wales REC -  Panel B at Its next meeting.
Documents received
The documents to be reviewed are as foltaivs:
Vwsioti V 1 1 m il
Questionnaire: Survey of reproductive health ieeuee 2 16 January 2007
Protocol 2 16 January 2006
Participant Information Sheet 2 16 January 2007
Notice of Substantial Amendment (norv-CTiMPs) Amendment No. 1 16 January 2007
Letter of invitation to participant 3 16 January 2007
Notification of the Cocnmittee’s  decision
The Committee wll issue an ethical opinion on tie  amendment within a maximum of 35 
days from the date of receipt.
* . AL1_GIGCVMiU
CanoCan Gwasanaatheu Busne*
TyCtvrchffl
1?RorddChun*i«
Caerdydd, CF10 ZTW
F«n; 0213 20 376820 WHT ft 1809
Ffrc*; 029 20 376826
Busanee* S e rv e s  Centre 
ChurcMII House 
17 Chupchi Way 
CartSff, CF102TW
Telephone: 02920376820 WHTN: 1809 
Fax: 029 20 378826
rihan oAddysgu&wddiechydLleotPowy*/part of Powys ToacWng Local HteaSOi Board
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R&D approval
All investigators and research collaborators in the NHS should notify the R&D office for the 
relevant NHS care organisation of this amendment and check whether it affects R&D 
approval for the research.
| 07/WBSEQ3/77: Phase quote this numbsr on »H cornMtpondonca |
Yours sincerely
IHSJdhu 
ee Co-ordinator
E-mail: JagiLsidhii@bsc.wries. nhs.uk
Cqpyfo.' R&D office for C&tvSff Untversity
R&D office for CanEffand VahNHS Trust
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South East Wales Research Ethics Committee Panel B
Tel: 02920 376823 
Fax: 02920 376836 
E-mail; Cari.phill^s^t»c,W9tes.nh8.uric
Dr J&ckyBoMn
School of Psychology
Cardiff Uriiverety
Psychology BuAdhw, Parte Place
Caitiff
CF103AT
14 February2008
Dear Or Botvin
Study title:
REC reference:
Survey of fertility health issues 
07/WSE82/T7
Amendment number: M-------- »> 4A im ngrm nr n o . i
Amendment date: 1C January 2007
The abqye amendmerrfwas reviewed at the mealing of the Executive Sub-Cammittsfe of 
Panel B of the South East Wales Research Ethics Committees held on 13 February 
2008.
Hhkari opinion
The members of ttie Committee present gave a  favourable ethical opinion of the 
amendment on the basis described In the notice of amendment farm and supporting 
documentation.
Btafly^ rahtP <” IgfMffiniTnff
The members of the Committee who were present at the meeting are listed on the 
attached sheet
R&PapprovN
Ail investigators and research colaborators in the NHS should notify the R&D office for 
the relevant NHS care organisation of this amendment and check whether it affects R&D 
approval of the research. v
Cenolfan Gwasanaeihau Busoss 
Ty Church*
17 Ffodd Church*
Caerdydti, CF102TW
Fffio; 029 20 076820 WHTN: 1800
Rises; 028 20 376826
Business Services Centre
Churchill House
17 Church* Way 
Cardiff, CF10 2TW
Telephone: 020 20 376820 WHTN: 1809 
Fax: 029 20376826
l
rhen o Addysgu Bwrdki Ischyd Lleol Powys/part of Powys T e e in g  LocaJ Heal&i Board
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Approved documents
Tho documents reviewed and approved at the meeting were:
F l B f r p
Questionnaire: Suvey of reproductive 
health issues
2 1$ January 2007
Protocol 2 1S January 2008
Participant information Sheet 2 16 January 2007
Notice of Sutxrtantial Amertdmenf (non- “ 
CTIMPs)
Amendment No. 
1
16 January 2007
Letter erf invitation to parttef pent 3.........  1 16 January2007' * r^t7
Stetynwitqfpoffii i^pai
$The Committee to constituted in accordance with tie  Governance Arrangements for 
Research Ethics Committees {July 200!) end complies fully with the Standard Operating 
Procedures for Roooorch Ethics Commfttees in the UK.
l07/W3BP2/77: Pleeae quote this number on all correspondence
Carl Philips 
Executive Officer
South East Wales Research Ethics Committeee
Enclosures List of names and professkms erf members who were present at foe
meeting and those who submitted written comments
Copy to; R&D office for CanSff University
R&D office for CarcHf and Vale NHS Trust
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^  South East Wales Research Ethics Committee Pane) 8
. Attendance at Sub-Committee of Sia REC mealing on 13 February 2008
a w n n i i F ^ L . i j f f i
Mrs A Dowden Chair and Lay Member
'M M M m i  ’** i' • «5*!EScSMHS!3B:'x -•
Lay
Dr 1J Karfay Consonant Oncologist Expert
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"^ M«nduu*jNU*ih*t—
Ffo
University Hospital of Wales 
Ysbyty Athrofaol Cymru
H rth  terk. Pane Y Mynydd Bychan,
Cardiff CF14 4XW Caerdydd CF14 4XW
Phene 989 20747747 Ffdn 029 2074 7747
Mlnteom 029 2074 *32 Nflnkom 029 2074 3632
Professor MF Scanlon 
Trust R&D Director 
Radnor House 
University Hospital of Wales 
Cardiff 
CF14 4XW
Dr Jacky BoMn 
School Of Psychology 
Cardiff University, Tower Building 
Park Place Cardiff CF10 3AT
Dear Dr BoMn
Project ID: 07/RPM/3999 : Survey Of Fertility Health Issues
REC Reference: 07/WSE02/77 
Amendment Number: 1 
Amendment Date: 16/01/08
The above amendment has been received by the Joint Trust/University Peer and 
Risk Review Committee.
The documents reviewed were:-
Document Version Date
Protocol 2 16/01/08
Patient Invitation Letter 2 16/01/08
Survey of Reproductive Health Issues 2 16/01/08
Patient Information Sheet 2 16/01/08
South East Wales REC approval Letter 14/02/08
I can confirm that the above support documentation has been approved and that you 
may continue with this study accordingly.
Please ensure that the appropriate Research Ethics Committee have a copy of this 
letter.
May I take this opportunity to wish you success with the project and remind you feat 
as Principal Investigator you are required to:
Page 1 of 2
Tel: 029 20743742 From:
Fax: 029 20745311
Research,DevelopnieEit@c8rdlirfandvale,waieSsnh&.iik
07 April 2008
/ j K  NHS
WALES
W  G IG
CYMRU
Eldh tyfWxjr ref 
Eta cy&Our raf
Welsh Health telephone Network 1872 
Direct IfMflUineil unkmgyrchoi
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• Inform the Trust R&D Office if any external or additional funding is awarded for 
this project in the future.
• Inform the Trust R&D Office of any further amendments relating to the 
protocol, including personnel changes and amendments to the actual or 
anticipated start I end dates.
• Complete any documentation sent to you by the Trust R & D  Office or 
University Research & Commercial D Ms ion regarding this project
• Adhere to the protocol as approved by the Research Ethics Committee.
• Ensure the research complies with the Data Protection Act 1998.
Yours sincerely, 
to Professor MF Scanlon
{1 Chair of die Joint Trust/University Peer & Risk Review Committee
CC R&D Lead Prof Alison Fiander
Chris Shaw, Research and Commercial Division, Cardiff University 
Miss Laura Elizabeth Bunting
C :V in y  d o c o m e n t s ^ J t o S d a r a b a s e s M j d y  M d e < » t399C H R D  L e t t e r s \07- R P l ^ 3S 98 A m * n d m e n U  A k e r  A p p r o v a l  07'  
04-200S . d o c
P a g e  2 o f 2
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Research and Commercial Division
Director Geraint W Jones 
Adran Ymchwif a  Masnach 
CyfarwydtfwrGerakttW Jones
CARDIFF
i 'MVTRSiTY 
PKIPYSGOL
26 Jons 2007 CarcSfl Ufcwctsly 
?Ul Floor
30  »38 MeniHMt ftoosi 
caw # CfZAOOe 
w ai«t uk
Dr Jtocky Bofvin 
PSYCH
Card iff University UK FKn +«{0J28 2087 5834 
Pa* flfcxs +44(0)28 2067 4189
Dear DrBoivin
Sarny of Fertility Health bncs
P*ffi#IG aaidpktUtm7
3 0 -3 6  Hool CfcsnaMyttt Cam**; era oreQmj yDtyrtU$Qrt»K)l
I understand that you are acting as Academic Supervisor for the above PhD project to be conducted by Laura 
Banting.
1 confirm dwt Cardiff University agrees is principle to act as Sponsor for the above project, is required by 
die Research Govcnrace FMraeworic fir Health and Social Care,
Final acceptance of Sponsorship retporaMities is dependent on fee project receiving approval from;
• tire joint Cardiff and YaicUHS Trust / University Pew and Risk Review Committee (JTUPeRR)1;
• the appropriate Research Ethks Committee<s);
Once RACD has received evidence of the above approvals, the University k considered to have accepted 
Sponsorship..
Prior to suhmtttkig yow COREC application form for review by an NHS Research Ethics Committee, you 
will be required to contact RACD to arrange signature of tie ’Declaration by the Sponsor Representative* 
(Part B, section 7 of the COREC application form).
May 1 take this opportunity to remrad you thet, as Principal Investigator, you are required to:
• ensure you toe familiar with your responsibilities under the Research Governance Framework for 
Health and Social Care;
• undertake die Thai in accordance with Cardiff University’s Research Governance Framework and 
the principles of Good Clinks! Practice;
• ensure the Research compJki with the Data Protection Act 1998;
• inform the Research and Commercial Division (RACD) of any amendments to the protocol or Ttial 
design, utchidmg changes to start / end dates;
• co-operate with any audit inspection of the project files or any request* from RACD for further
Yon should quote the following unique reference number in any correspondence relating to sponsorship for 
the above project:
information.
SPON404-07
This reference number should be quoted on all documental km associated with this project.
Yourt sincerely
Dr K J Pittard Darin
Head of Research Policy A M aaigmtat
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Appendix N : Online Fertility R isk Factors Survey (FRFS)
Online FRFS (Pregnant women)
Survey of fertility health issues
Ptddjeheetife surveys help doctors to i^ am abeut many health issues, for example heart disease and
surveys help find out hew tm tfm o r  m e * symptom is and whether a 
®-poieiip trupfat or rciiphl not develop a disease, Such information also helps to
MSOy ^ hpaiHMiy sumys b m  btin  csnM  out for arthritis, asthma, hsat crease and other common 
sfimstfofc* ffowiwar, aNi da not fotSMF as nmch about foctildy heaffh issues. The purpose of this survey ie to 
cadesfc rtdhp.thforfaslion on fodore ihal may or rnay net affect fortifty.
Youwi be asked to state how many statements apply to you. The questions witt ask for general information 
abeut yourself (e.g., age), your lifestyle habits (e.g.. smoking, alcohol consumption) and reproductive history 
(e.g., menstrual cycle). Please be as honest as possible, aM answers wiH remain anonymous.
We wtt not be able to trace arty responses to individuai participants. Note, however, that there is a possibility 
thd oPttfeotte cotddinfercepf ybur respanees on the way to us but this ride is negligible.
You are ffsstooitMl any questions you do not wish to answer or withdraw from the study at any time by 
dosing th* weetoow
The project has received ethical approval torn UREC. Cardiff University. If you have any questions about this 
project then pleats contact toe principal investigator Or Jacky Boivin at boMn@cardiff.ac.uk.
If you are 18 or over, understand the statement above and freely consent to participate in this study please tick YES' 
and continue by clicking 'Next' below. If you do not want to complete the surrey please close this window now (this
survey is for women onty).
Yes
O
I Next ]
3 0% complete
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Survey of fertility health issues
Please note this survey is for women only
How old are you?
What is your country of residence?
On which website did you find this 
survey?
Highest education recieved (Please tick)
O Primary School 
O Secondary School 
O Post-secondary/College 
O University
Are you pregnant?
Yes
O
No
o
Back Next
120% complete
© Cardiff University 352
Appendix N: Online Fertility Risk Factors Survey (FRFS Pregnant version)
Survey of fertility health issues
A bout you:
How many weeks pregnant are you?
How long did it take you to get pregnant? Years
L  ■
Months
Please tick which of the followinq statem ents applies to you. By contraception we mean all form s that ACT to prevent 
pregnancy (e.g. oral contraception, condoms, and rhythm methods).
Prior to my pregnancy 1 was...
O  1. Sexually active and always used contraception
O  2. Sexually active, not using contraception and trying to get pregnant.
O  3. Sexually active, not using contraception but not particularly intending or trying to get pregnant.
O  4. Not sexually active.
I f  you ticked answer 2 o r 3 above: Years Months
How long had you been having unprotected sex?
--------------------1 ---------------J,
© Cardiff University 353
Appendix N: Online Fertility Risk Factors Survey (FRFS Pregnant version)
Your reproductive h istory: Please answer the questions as they applied to you before your current pregnancy.
1 had previously given birth Yes No
o o
1 suffered from severe period pains Yes No
O O
1 suffered from endometriosis Yes No
O O
1 had previously had pelvic inflammatory disease (PID) Yes No
O
On average my menstrual cycle was unpredictable when not using contraceptives (My period often came more than 5 
days earlier or later than expected.)
O Yes 
C 'N o
G1 did not have a period
1 When not using contraception my menstrual cycle w as on average:
O  Less than 21 days 
O Between 21 and 35 days
0 More than 35 days
0 1 did not have a period
My male partner had mumps 
after puberty
Yes No
O O
Dont know No partner
o o
My partner had (or previously 
had) undescended testicles
Yes No
o o
Dont know No partner
o o
I had had pelvic surgery Yes No
. . .
i f  YES. describe the type o f surgery
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Survey of fertility health issues
Your lifestyle: Please answer the questions as they applied to you before your current pregnancy.
I had unprotected sex with multiple partners Yes
o
No
o
I was more than 13 kilos (28 pounds/2 stone) overweight Yes
How much did you weigh? 
(Answer in either stones & pounds 
or kilos.)
Stones Pounds
My height was: (Answer in either 
feet & inches or centimeters.)
Feet Inches Centimeters
I was experiencing levels of stress that I could not cope with Yes
O
No
o
I had previously had a sexually transmitted infection Yes
_Q_
No
If YES. what infection d id  you have?
Had you ever taken class-A drugs? (e.g., heroin, cocaine, e cs ta sy
If YES, which drug(s)?
If YES, was this within the 11 months prior to your pregnancy?
Myself and/or my partner had taken anabolic steroids in the previous 12 months Yes
o
No
o
If YES. which steroids)?
I drank more than 14 units of alcohol per w eek  (1 unit = small glass of wine, 1/2 
pint of beer, 1 single measure of a spirit)
Yes
O
No
O
was a smoker who regularly smoked ten or more cigarettes per day Yes
o
No
o
I drank more than 7 units of caffeine pet day (1 unit = cup of coffee. 1/2 unit = cup Yes 
of tea or can of soft drink such as cola) q
No
O
smoked marijuana frequently (more than four times a week) Yes
o
No
o
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Survey of fertility health Is-i sues
Finally, this section is for everyone to fill out. Please would you write how much on a v erag e  you consumed of the 
following before your curren t p regnancy . If you did not consume any please put a zero in the box:
How many units of alcohol did you drink p e r w eek ? (1 unit = small glass o f wine, 
1/2 pint o f beer, 1 single measure of a spirit)
How many cigarettes did you smoke p e r day?
How many cups of coffee did you drink p er day?
How many cuds of tea did you drink per day?
How many cups/cans of soft drink such a s  cola did you drink per day?
How many times had you used class-A drugs in the past 12 months?
How much marijuana did you smoke p er w eek ?
£ = 3  I
Additional comments:
Thank you for participating in this survey!
Back j | Next |
140% complete
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Survey of fertility health issues
T hank  you for your tim e in com pleting  this survey
Below is some more information about our research
One of the most important issues in determining health behaviour is how we perceive our own health 
and illness (Berry 2004). Successful public health campaigns have used a strategy of increasing public 
awareness of certain illnesses by researching the relevant health indicators for each illness, ensuring 
most people are aware of the signs and symptoms of such diseases (e.g., cancer, heart disease). Such 
research has highlighted the effectiveness of health indicators; health indicators can be used to monitor 
needs for health care, and evaluate the effectiveness and impact of health care programs (Temmerman 
et al., 2006).
The majority of couples will get pregnant after trying for 12 months. However, for a small number of 
couples it may take longer. There has been little research highlighting the main indicators for those that 
might have difficulties getting pregnant. Further to this relatively few people know the signs of 
reproductive disease or the risk factors for fertility difficulties (Dyer et al., 2002). With reference to the 
success of other health campaigns/surveys we wanted to examine the frequency of a number of factors 
that might or might not be important predictors of fertility. We hope to use the information provided to 
develop campaigns to keep people healthy. At the end of the project we will post a brief report on this 
website.
It was important to ask a range of personal questions about your lifestyle and reproductive history and we 
would like to assure you that all the data you have provided us is anonymously, that is, it is impossible to 
trace back to you.
If you have concerns about your health please contact your family doctor or local GP.
If you have any further questions about this research then please contact the principal investigator:
Dr Jacky Boivin 
School of Psychology 
Cardiff University 
Tower Building, Park Place 
Cardiff, Wales 
CF10 3AT 
boivin@cardiff.ac.uk
Dr Jacky Boivin is interested in the psychosocial aspects of reproductive health. She has conducted 
many studies in this area on issues such as the link between stress and fertility, differences between 
men and women in emotional reactions to fertility problems, whether counselling helps people cope with 
fertility problems, how children conceived with fertility treatment develop, and much more.
This research has been carried out with the help of women from many countries worldwide. You can see 
some of the published reports of this work on Dr Boivin's website at the School of Psychology, Cardiff 
University; http://www.cardiff.ac .uk/psvch/home/boivin/indexmain .html
| B a c k  j [ Subm it 
180%  com plete
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Online FRFS (Not pregnant women)
Survey of fertility health issues
Please note this survey is for women only
How old are you?
W hat is your country of residence?
On which website did you find this 
survey?
Highest education recieved (P lease  tick)
O  Primary School 
O  Secondary  School 
O  Post-secondary/C ollege 
O  University
Are you pregnant?
Yes
0
No
O
Back Next
] 2 0 %  complete
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Please note this survey is for women only
H o w  old are you?
W h a t  is your country of residence?
O n  w hich  w ebsite  ,  '  ' 'h is
s u r r e y ?
H ig h e s t  education recieved (P lease  tick)
O P rim ary  School 
C S e c o n d a ry  School 
O P ost-secondary /C ollege 
C University
A re  you pregnant?
Yes No
B ack  ] [ Next
0
]  20% complete
© Cardiff U niversity 359
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Survey of fertility health issues
A bout you:
Are you currently tryinq to qet preqnant? Yes
o
No
O
, m “ ............. ...  .
Years Months
Please tick which of the following statem ents applies to you. By contraception we 
pregnancy (e.g. oral contraception, condoms, and rhythm methods).
mean .ill form s that ACT to prevent
I am currently...
O 1. Sexually active and always use contraception.
O 2. Sexually active, not using contraception and trying to get pregnant.
O 3. Sexually active, not using contraception but not particularly intending or trying to get pregnant.
O 4 Not sexually active.
If you ticked answer 2 o r 3 above:
How long had you been having unprotected sex?
Years Months
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Survey of fertility health issues
Your reproductive history:
1 have previously given birth Yes No
O O
1 suffer from severe period pains Yes No
O O
1 suffer from endometriosis Yes No
O o
1 have had pelvic inflammatory disease (PID) Yes No
o O
On average my menstrual cycle is unpredictable when not using contraceptives (My period often comes more than 5 days
earlier or later than expected.)
O Yes
O N o
O 1 do not have a period
When not using contraception my menstrual cycle is on average:
O Less than 21 days
G Between 21 and 35 days
O More than 35 days
O 1 do not have a period
My male partner had mumps Yes No Dont know No partner
after puberty O o O o
My partner has (or has had) Yes No Don't know No partner
undescended testicles o o o o
1 have had pelvic surgery Yes No
O o
If YES, describe the type of surgery
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Survey of fertility health issues
Your lifestyle:
have had unprotected sex with multiple partners Yes
O
No
o
I am more than 13 kilos (28 pounds/2 stone) overweight Yes
o
No
o
How much do you weigh? 
(Answer in either stones & pounds 
or kilos.)
Stones Pounds Kilos
What is your height? (Answer in 
either feet & inches or centimeters.)
Inches Centimeters
am experiencing levels of stress that I cannot cope with Yes
o
No
o
I have had a sexually transmitted infection
If YES, what infection did yon  have?
Have you ever taken class-A drugs? (e.g., heroin, cocaine, ecstasy) Yes
O
No
O
If YES, which drug(s)?
If YES, was this within the last 12 months? Yes
o
No
O
Myself and/or my partner has taken anabolic steroids in the previous 12 months
If YES, which steroid(s)?
I drink more than 14 units of alcohol per w eek  (1 unit = small glass of wine, 1/2 
pint of beer, 1 single measure of a spirit)
Yes
o
No
o
am a smoker who regularly smokes ten or more cigarettes per day Yes
o
No
o
I drink more than 7 units of caffeine per day (1 unit = cup of coffee. 1/2 unit = cup of Yes 
tea or can of soft drink such as cola) q
No
o
I smoke marijuana frequently (more than four times a week) Yes
o
No
o
© Cardiff University 362
Appendix N: Online Fertility Risk Factors Survey (FRFS Not pregnant version)
Survey of fertility health issues
Finally, this section is for everyone to fill out. Please would you write how much you consume on average of the 
following. If you did not consum e any please put a zero in the box:
How many units of alcohol do you drink per w eek? (1 unit = small glass of wine, 1/2 
pint of beer, 1 single measure o f a spirit)
How many cigarettes do you sm oke per day?
How many cups of coffee do you drink per day?
How many cups of tea do you drink per day?
How many cups-cans of soft drink such as cola do you drink per day?
How many class-A drugs have you taken in the past 12 m onths?
How much marijuana do you smoke per week?
Additional comments:
Thank you for participating in this survey!
Back ) f Next ]
]6 0 %  complete
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Thank you for your time in completing this survey
Below is som e more information about our research
One of the most important issues in determining health behaviour is how we perceive our own health 
and illness (Berry 2004). Successful public health campaigns have used a strategy of increasing public 
awareness of certain illnesses by researching the relevant health indicators for each illness, ensuring 
most people are aware of the signs and symptoms of such diseases (e.g., cancer, heart disease). Such 
research has highlighted the effectiveness of health indicators; health indicators can be used to monitor 
needs for health care, and evaluate the effectiveness and impact of health care programs (Temmerman 
et al., 2006).
The majority of couples will get pregnant after trying for 12 months. However, for a small number of 
couples it may take longer. There has been little research highlighting the main indicators for those that 
might have difficulties getting pregnant. Further to this relatively few people know the signs of 
reproductive disease or the risk factors for fertility difficulties (Dyer et al., 2002). With reference to the 
success of other health campaigns/surveys we wanted to examine the frequency of a number of factors 
that might or might not be important predictors of fertility. We hope to use the information provided to 
develop campaigns to keep people healthy. At the end of the project we will post a brief report on this 
website.
It was important to ask a range of personal questions about your lifestyle and reproductive history and we 
would like to assure you that all the data you have provided us is anonymously, that is, it is impossible to 
trace back to you.
If you have concerns about your health please contact your family doctor or local GP.
If you have any further questions about this research then please contact the principal investigator:
Dr Jacky Boivin 
School of Psychology 
Cardiff University 
Tower Building, Park Place 
Cardiff, Wales 
CF10 3AT 
boivin@cardiff.ac.uk
Dr Jacky Boivin is interested in the psychosocial aspects of reproductive health. She has conducted 
many studies in this area on issues such as the link between stress and fertility, differences between 
men and women in emotional reactions to fertility problems, whether counselling helps people cope with 
fertility problems, how children conceived with fertility treatment develop, and much more.
This research has been carried out with the help of women from many countries worldwide. You can see 
some of the published reports of this work on Dr Boivin's website at the School of Psychology, Cardiff 
University; http://www.cardiff.ac .ukfosvch/home/boivin/indexmain html
Back l [ Submit |
180% complete
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Appendix O: Clinic Fertility Risk Factors Survey (FRFS) 
Clinic FRFS (Antenatal unit)
NHS
WA L E S
GIG
C Y M R U
Cardiff and Vale NHS Trust
Bch cyf/Your ref 
Ein cyf/Our ref
Welsh Health Telephone Network 1872 
Direct Rne/Uinell uniongyrchol
Ymddiriedolaeth GIG 
Caerdydd a'r Fro
University Hospital of Wales 
Ysbyty Athrofaol Cymru
Heath Park,
Cardiff CF14 4XW 
Phone 029 2074 7747 
Minicom 029 2074 3632
Parc Y Mynydd Bychan, 
Caerdydd CF14 4XW 
Ffon 029 2074 7747 
Minicom 029 2074 3632
Dear Patient,
We are currently trying to find out more information about factors that may or may not affect fertility. To 
meet this goal we would like patients to answer a short survey about their reproductive history and lifestyle.
We are inviting all women attending the clinic to take part in a research study. Participation in the 
study is voluntary and if you do not wish to complete the survey please place it in the box labelled “Survey 
Responses" or alternatively return to the reception desk. A decision to withdraw at any time or a decision not 
to take part, wiH not affect the standard of care you will receive.
If you would like to take part please fill out the short survey in this pack. The questions will ask you general 
information about yourself, your lifestyle habits and reproductive history. We need to ask these questions to 
represent all the people in the community and all factors that may impact on fertility. Please be assured that 
we have no way of tracing the responses back to you. The survey asks you to tick a s  many of the statements 
as apply to you. Completing the attached survey should take about 5 minutes of your time and would be 
very helpful in developing a greater knowledge on the indicators of fertility health. Participation is completely 
anonymous so please do not put your nam e on any of the form s.
Once you have completed the survey, simply fold it and put it in the box labelled “Survey Responses" 
which you will find in the waiting room. Alternatively, if you would like to fill the survey out elsewhere then 
please use the prepaid freepost envelope provided in your pack to send it back to us once completed.
Thank you very much for helping us with this project
Sincerely.
Richard Penketh 
Director.
Cardiff and Vale Antenatal Clinic 
NHS Trust
Mary James
Clinical lead midwife 
Cardiff and Vale Antenatal Clinic 
NHS Trust 
Llandough hospital
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S urvey  of fertility hea lth  is s u e s
We are interested in the frequency of reproductive and fertility health issues in the general population.
Please do not write your name anywhere on the survey as it is anonymous
About you:____________________________________________________________________________
How old are you?
How many weeks pregnant are you?
How long did it take you to get pregnant?
P lease tick which of the following statem ents applies to you. By contraception we mean all forms that ACT to prevent 
pregnancy (e.g. oral contraception, condoms, and rhythm methods).
Prior to my pregnancy I was:__________________________________________________________________________
1. Always using contraception
2. Not using contraception and trying to get pregnant
3. Not using contraception but not particularly intending or trying to get pregnant
If you ticked yes to 2 or 3 above:
How long had you been having unprotected sex? L - ............ I
Your reproductive history: please circle yes or no for all statem ents that applied to you before your current pregnancy.
I had given birth
I suffered from severe period pains
I suffered from endometriosis
I had pelvic inflammatory d isease (PID)
My menstrual cycle lasted less than 21 days (When I w as not using 
contraceptives)
My menstrual cycle lasted more than 35 days (When I was not using 
contraceptives) YES NO
My menstrual cycle was unpredictable. My period often cam e more than 5 
days earlier or later than I expected (When I w as not using contraceptives)
I had periods (When I was not using contraceptives) NO
My male partner had mumps after puberty
My partner has (or has had) undescended testicles Don't know No Partner
I had pelvic surgery
If YES. describe the type of surgery
Your lifestyle: please circle yes or no for all sta tem ents that applied to you before your current pregnancy.
I had unprotected sex with multiple partners
1 was more than 13 kilos (28 pounds/2 stone) overweight
How much did you weigh before getting pregnant?
What is your height ?, Feet and Centimetres
I had sex less than twice a week
I had a sexually transmitted infection
If YES. what infection did you have?
I was experiencing levels of stress that I could not cope with
Have you ever taken Class A drugs (e.g.. heroin, cocaine, ecstasy)
If YES, was this within the 12 months prior to your pregnancy?
If YES, which drug(s)
Myself and/or my partner had taken anabolic steroids in the previous 12 m onths
If YES, which steroid(s)?
I had been drinking more than 14 units of alcohol per week (1 unit = small glass o f wine, Vi pint 
of beer, 1 single measure of a spirit)
I was a smoker who regularly smoked ten or more cigarettes per day
I drank more than 7 units of caffeine per day (1 unit = cup of coffee. 'A unit = cup of tea or can 
of soft drink such as cola)
I smoked marijuana frequently (more than four times a week)
PLEASE TURN OVER
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The final se t of questions are for everyone to answer. Please would you write how much you co n su m ed  of the 
following before your current pregnancy (If you did not consume any please put a zero in the box):______________
How many units of alcohol did you drink per week? (1 unit = small glass of wine. 1/2 pint of beer or  
1 single measure of a spirit)
How many cigarettes did you smoke per day?
How many cups of coffee did you drink per day?
How many cups of tea  did you drink per day?
How many cups/cans of soft drink such a s  cola did you drink per day?
How much marijuana did you smoke per week?
Highest education received (please tick)
Primary School
Secondary School
Post-secondary/College
University
Thank you for the time you spent completing this survey.
Please place it in the box labelled fertility survey in the waiting room, alternatively you can send it back via post using the
prepaid envelope provided in your pack.
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NHS
WA L E S
G I G
C Y M R U
Cardiff and Vale NHS Trust
Eich cyf/Your ref 
Bn cyf/Our ref
Welsh Health Telephone Network 1872 
Direct line/Uinell urtiongyrchol
Ymddiriedolaeth GIG 
Caerdydd a'r Fro
University Hospital of Wales 
Ysbyty Athrofaol Cymru
Heath Park,
Cardiff CF14 4XW 
Phone 029 2074 7747 
Minicom 029 2074 3632
Parc Y Mynydd Bychan, 
Caerdydd CF14 4XW 
Ff6n 029 2074 7747 
Minicom 029 2074 3632
INFORMATION SHEET FOR PATIENTS
R esearch project
Survey of fertility health issues
You are being invited to take part in a research study. Before you decide, it is important that you understand 
why the research is being done and what it will involve. Please take time to read the following information 
carefully and discuss it with friends and relatives if you wish. Ask us if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take part.
Consumers for Ethics in Research (CERES), publish a leaflet entitled Medical Research and You’. This leaflet 
gives more information about medical research and looks at some questions you may want to ask. A copy is 
available on request for additional background reading.
Thank you for reading this.
W hat is the  purpose of this study?
Public health surveys help doctors to leam about many health issues, for example heart disease and diabetes 
in the community. Such surveys help find out how common or rare a symptom is and whether a  symptom 
can identify whether a person might or might not develop a disease. Such information also helps to develop 
campaigns to keep people healthy. Many community surveys have been carried out for arthritis, asthma, heart 
disease and other common ailments. However, we do not know as much about fertility health issues. The 
purpose of this survey is to collect more information on factors that may or may not affect fertility.
Why have I been chosen?
You have been chosen because we are inviting all women attending the Cardiff and Vale Trust Antenatal 
Clinics.
Do I have to take part?
No. it is up to you to decide whether or not to take part. If you decide to take part you will be given this 
information sheet to keep. If you decide to take part you are still free to withdraw at any time and without giving 
a reason. A decision to withdraw at any time or a decision not to take part, will not affect the standard of care 
you receive.
What will happen to me if I take part?
If you decide to take part we will ask you to complete one survey. The survey asks you to tick the number of 
statements that apply to you. There are three sections consisting of demographic (e.g., age), reproductive 
history (e.g., menstrual cycle), and current lifestyle questions (e.g., alcohol consumption, smoking). The survey 
will take 5 minutes and you can fill it in white waiting for your medical appointment. Alternatively, if you wish 
to complete the survey elsewhere please use the envelope provided in the pack. Postage has been paid in 
advance for the envelope. No participation fee will be offered. At the end of the study we will put a summary of 
the results on the notice board in the patient waiting room.
W hat do I have to do?
If you would like to participate please fill in the survey and return it in the box marked fertility survey study, 
which is in the patient waiting room. Alternatively, if you wish to complete the survey elsewhere please use 
the prepaid envelope provided in the pack Please do not write your name anywhere on the survey as it is 
anonymous. If you do not finish the survey before your appointment, you can finish it after the appointment or 
return it at a later date using the prepaid envelope provided. This study does not require any changes to your 
treatment or lifestyle.
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What will happen if I don’t want to participate?
If you do not wish to participate, put the survey, without filling it, in the collection box marked fertility survey 
study, which is in the patient waiting room. Your decision not to participate will not affect your treatment in any 
way.
What are the side effects of taking part?
There are no side effects anticipated in this project as there are no drugs or invasive procedures being tested. 
However, if you feel any discomfort as a result of participation in the study then please contact Dr Jacky Boivin 
(see details below) who is a psychologist specialising in reproductive and fertility issues. If you feel worried 
about your health then contact your local GP.
What are the benefits of taking part in the study?
We cannot promise the study will help you but the information we get will be used to advance our understanding 
of reproductive health and fertility issues.
Will my taking part in the study be kept strictly confidential?
Our procedures for handling, processing, storage and destruction of your data are compliant with the Data 
Protection Act 1998. All information you will provide us is anonymous and cannot be traced back to you
individually. The anonymous data will be retained for indefinitely in accordance with the Data Protection Act,
and stored on a computer that is password-protected and belongs to Dr Jacky Boivin.
What if there is a problem?
If you have a concern about any aspect of this study, you should ask to speak with the researchers who will do 
their best to answer your questions (see contact details below). If you remain unhappy and wish to complain 
formally, you can do this through the NHS complaints procedure. Details can be obtained from the hospital.
What will happen to the results of this research study?
The results of this study will be published in peer reviewed fertility journals. You cannot be identified in any 
report or publications.
Who is organising and funding the research?
Dr Jacky Boivin, School of Psychology Cardiff University.
Who has reviewed the research?
The South East Wales Local Research Ethics Committee has reviewed and approved this study.
You will be given a copy of the Information sheet to keep for your records.
Contact Details
You can contact the research team for any question on:
Mary James Dr Jacky Boivin
Clinical lead midwife School of Psychology
Cardiff and Vale Antenatal Unit Cardiff University
Llandough hospital Tower Building, Park Place
Tel: 02920 716 097 Tel: 02920 875 289
Thank you very much for taking time to read this leaflet.
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Clinic FRFS (Fertility unit)
NHS
WA L E S
GIG
C Y M R U
Cardiff and Vale NHS Trust
Etch cyf/Your ref 
Bn cyf/Our ref
Welsh Health Telephone Network 1872 
Direct line/UtneM uniongyrchol
Ymddiriedolaeth GIC 
Caerdydd a'r Fro
University Hospital of Wales 
Ysbyty Athrofaol Cymru
Heath Park,
Cardiff CF14 4XW 
Phone 029 2074 7747 
Minicom 029 2074 3632
Parc Y Mynydd Bychan, 
Caerdydd CF14 4XW 
Ffon 029 2074 7747 
Minicom 029 2074 3632
Dear Patient,
We are currently trying to find out more information about factors that may or may not affect fertility. To 
meet this goal we would like patients to answer a short survey about their reproductive history and lifestyle.
We are inviting alt women attending the clinic to take part in a research study. Participation in the 
study is voluntary and if you do not wish to complete the survey please place it in the box labelled “Survey 
Responses’ or alternatively return to the reception desk. A decision to withdraw at any time or a decision not 
to take part, will not affect the standard of care you will receive.
If you would like to take part please fill out the short survey in this pack. The questions will ask you general 
information about yourself, your lifestyle habits and reproductive history. We need to ask these questions to 
represent all the people in the community and all factors that may impact on fertility. Please be assured that 
we have no way of tracing the responses back to you. The survey asks you to tick as many of the statements 
as apply to you. Completing the attached survey should take about 5 minutes of your time and would be 
very helpful in developing a greater knowledge on the indicators of fertility health. Participation is completely 
anonymous so please do not put your name on any of the forms.
Once you have completed the survey, simply fold it and put it in the box labelled “Survey Responses” 
which you will find in the waiting room. Alternatively, if you would like to fill the survey out elsewhere then 
please use the prepaid freepost envelope provided in your pack to send it back to us once completed.
Thank you very much for helping us with this project.
Sincerely,
Mrs Janet Evans 
Director,
Cardiff Assisted Reproduction Unit 
University Hospital Wales
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S urvey  of fertility health  is su e s
We are interested in the frequency of reproductive and fertility health issues in the general population. 
Please do not write your name anywhere on the survey as it is anonymous 
About you:
How old are you?
How long have you been trying to get pregnant?
Your reproductive history:
1 have given birth
1 suffer from severe period pains
1 suffer from endometriosis
1 have had petvic inflammatory disease (PID)
My menstrual cycle lasts less than 21 days (When I am not using 
contraceptives)
My menstrual cycle lasts more than 35 days (When I am not using 
contraceptives) YES NO
My menstrual cycle is unpredictable. My period often com es more than 5 
days earlier or later than 1 expected (When 1 am not using contraceptives)
When 1 am not using contraceptives 1 have periods
My male partner has had mumps after puberty
My partner has (or has had) undescended testicles Don t know
1 have had pelvic surgery
If YES, describe the type of surgery
Your lifestyle:
1 have had unprotected sex with multiple partners
1 am more than 13 kilos (28 pounds/2 stone) overweight
How much do you weigh?
What is your height?
I have sex less than twice a week
I have had a sexually transmitted infection
If YES, what infection did you have?
I am experiencing levels of stress that I cannot cope with
Have you ever taken Class A drugs (eg., heroin, cocaine, ecstasy)
If YES, was this within the last 12 months?
If YES. which drug(s)?
Myself and/or my partner have taken anabolic steroids in the previous 12 months I y e s
If YES, which steroid(s)?
I drink more than 14 units of alcohol per week (1 unit -  small glass of wine, 'A pint of beer, 1 
single measure of a spirit) YES NO
I am a smoker who regularly smokes ten or more cigarettes per day
I drink more than 7 units of caffeine per day (1 unit = cup of coffee. 'A unit = cup of tea or can 
of soft drink such as cola) YES NO
I smoke marijuana frequently (more than four times a week)
The final se t of questions are for everyone to answer (If you did not consume any please put a  zero in the box):
How many units of alcohol do you drink per w eek? (1 unit = small glass of wine. 1/2 pint of beer or 
1 single measure of a spirit)
How many cigarettes do you smoke per day?
How many cups of coffee do you drink per day?
How many cups of tea do you drink per day?
How many cups/cans of soft drink such a s  cola do you drink per day?
How much marijuana do you smoke per w eek?
© Cardiff University PLEASE TURN OVER
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Highest education received (please tick)
Primary School
Secondary School
Post-secondary/College
University
Thank you for the time you spent completing this survey.
P lease  place it in the box labelled fertility survey in the waiting room, alternatively you can send it back via post using the
prepaid envelope provided in your pack.
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NHS
W A L E S
GIG
C Y M R U
Cardiff and Vale NHS Trust
Eicfi cyf/Your ref 
Ein cyf/Our ref
Welsh Health Telephone Network 1872 
Direct line/Une# uniongyrchol
Ymddiriedolaeth GIG 
Caerdydd a'r Fro
University Hospital of Wales 
Ysbyty Athrofaol Cymru
Heath Park,
Cardiff CF14 4XW 
Phone 029 2074 7747 
Minicom 029 2074 3632
Parc Y Mynydd Bychan, 
Caerdydd CF14 4XW 
Ffon 029 2074 7747 
Minicom 029 2074 3632
INFORMATION SHEET FOR PATIENTS
R esearch  project
Survey of fertility health issues
You are being invited to take part in a research study. Before you decide, it is important that you understand 
why the research is being done and what it will involve. Please take time to read the following information 
carefully and discuss it with friends and relatives if you wish. Ask us if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take part.
Consumers for Ethics in Research (CERES), publish a leaflet entitled Medical Research and You’. This leaflet 
gives more information about medical research and looks at some questions you may want to ask. A copy is 
available on request for additional background reading.
Thank you for reading this.
W hat is th e  p u rp o se  of this study?
Public health surveys help doctors to team about many health issues, for example heart disease and diabetes 
in the community. Such surveys help find out how common or rare a symptom is and whether a symptom 
can identify whether a  person might or might not develop a disease. Such information also helps to develop 
campaigns to keep people healthy. Many community surveys have been carried out for arthritis, asthma, heart 
disease and other common ailments. However, we do not know as much about fertility health issues. The 
purpose of this survey is to collect more information on factors that may or may not affect fertility.
Why have I been  ch o sen ?
You have been chosen because we are inviting ail women attending the Cardiff Assisted Reproduction Unit. 
Do I have to  take part?
No. it is up to you to decide whether or not to take part. If you decide to take part you will be given this 
information sheet to keep. If you decide to take part you are still free to withdraw at any time and without giving 
a  reason. A decision to withdraw at any time or a decision not to take part, will not affect the standard of care 
you receive.
W hat will happen  to  me if I take part?
If you decide to take part we will ask you to complete one survey. The survey asks you to tick the number of 
statem ents that apply to you. There are three sections consisting of demographic (e.g., age), reproductive 
history (e.g., menstrual cycle), and current lifestyle questions (e.g., alcohol consumption, smoking). The survey 
will take 5 minutes and you can fill it in while waiting for your medical appointment. Alternatively, if you wish 
to complete the survey elsewhere please use the envelope provided in the pack. Postage has been paid in 
advance for the envelope. No participation fee will be offered. At the end of the study we will put a summary of 
the results on the notice board in the patient waiting room.
W hat do  I have to d o ?
If you would like to participate please fill in the survey and return it in the box marked fertility survey study, 
which is in the patient waiting room. Alternatively, if you wish to complete the survey elsewhere please use 
the prepaid envelope provided in the pack. Please do not write your name anywhere on the survey as it is 
anonymous. If you do not finish the survey before your appointment, you can finish it after the appointment or 
return it at a later date using the prepaid envelope provided. This study does not require any changes to your 
treatment or lifestyle.
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What will happen if I don’t want to participate?
If you do not wish to participate, put the survey, without filling it, in the collection box marked fertility survey 
study, which is in the patient waiting room. Your decision not to participate will not affect your treatment in any 
way.
What are the side effects of taking part?
There are no side effects anticipated in this project as there are no drugs or invasive procedures being tested. 
However, if you feel any discomfort as a result of participation in the study then please contact Dr Jacky Boivin 
(see details below) who is a psychologist specialising in reproductive and fertility issues. If you feel worried 
about your health then contact your local GP.
What are the benefits of taking part in the study?
We cannot promise the study will help you but the information we get will be u se d  to advance our understanding 
of reproductive health and fertility issues.
Will my taking part in the study be kept strictly confidential?
Our procedures for handling, processing, storage and destruction of your data are compliant with the Data 
Protection Act 1998. All information you will provide us is anonymous and cannot be traced back to you 
individually. The anonymous data will be retained for indefinitely in accordance with the Data Protection Act, 
and stored on a computer that is password-protected and belongs to Dr Jacky Boivin.
What if there is a problem?
If you have a concern about any aspect of this study, you should ask to speak with the researchers who will do 
their best to answer your questions (see contact details below). If you remain unhappy and wish to complain 
formally, you can do this through the NHS complaints procedure. Details can be obtained from the hospital.
What will happen to the results of this research study?
The results of this study will be published in peer reviewed fertility journals. You cannot be identified in any 
report or publications.
Who is organising and funding the research?
Dr Jacky Boivin, School of Psychology Cardiff University.
Who has reviewed the research?
The South East Wales Local Research Ethics Committee has reviewed and approved this study.
You will be given a copy of the Information sheet to keep for your records.
Contact Details
You can contact the research team for any question on:
Mrs Janet Evans Dr Jacky Boivin
Director School of Psychology
Cardiff Assisted Reproduction Unit Cardiff University
University Hospital Wales Tower Building, Park Place
Tel: 02920 874 446 Tel: 02920 875 289
Thank you very much for taking time to read this leaflet.
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Clinic FRFS (Abortion unit)
GIG
C Y M R U
NHS
WA L E S
Cardiff and Vale NHS Trust Ymddiriedolaeth GIG 
Caerdydd a'r Fro
University Hospital of Wales 
Ysbyty Athrofaol Cymru
H e a t h  P a r k ,
Cardiff CF14 4XW 
Phone 029 2074 7747 
Minicom 029 2074 3632
Parc Y Mynydd Bychan, 
Caerdydd CF14 4XW 
Ffon 029 2074 7747 
Minicom 029 2074 3632
Bch cyf/Your ref 
Ein cyf/Our ref
Welsh Health Telephone Network 1872
Direct hne/Lind uniongyrchol
Dear Patient,
We are currently trying to find out more information about factors that may or may not affect reproductive 
health. To meet this goal we would like patients to answer a short survey about their reproductive history and 
lifestyle.
We are inviting all women admitted for a medical abortion procedure aged 18 and above to take 
part in a research study. Participation in the study is voluntary and if you do not wish to complete the 
survey please return it sealed in the envelope provided in the pack. A decision to withdraw at any time or 
a  decision not to take part, will not affect the standard of care you will receive.
If you would like to take part please fill out the short survey in this pack. The questions will ask you general 
information about yourself, your lifestyle habits and reproductive history. We need to ask these questions to 
represent all people in the community and all factors that may influence reproductive health. Please be 
assured  that we have no way of tracing the responses back to you. The survey asks you to tick a s  many of 
the statem ents a s  apply to you. Completing the attached survey should take about 5 minutes of your time and 
would be very helpful in developing a greater knowledge on the indicators of reproductive health. Participation 
is completely anonymous so please do not put your name on any of the forms.
Once you have completed the survey, simply return it sealed in the envelope provided in the
pack.
Thank you very much for helping us with this project.
Sincerely,
Dr Caroline Scherf 
Consultant,
Sexual and Reproductive Health 
Department of Gynaecology 
Llandough Hospital
Carolyn Alport 
Ward Manager,
Sexual and Reproductive Health 
Department of Gynaecology 
Llandough Hospital
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Survey of reproductive health issues
We are interested in the frequency of reproductive health issues in the general population. 
Please do not write your name anywhere on the survey as it is anonymous 
About you:
How old are you?
How advanced is th is pregnancy?
Please tick which of the following sta tem ents applies to you. By contraception we m ean all forms that ACT to prevent 
pregnancy (e.g. oral contraception, condom s, and rhythm methods).
Prior to the pregnancy I was:________________
1. Always using contraception
2. Sometimes using contraception
3. Not using contraception and not trying to  get pregnant
4. Not using contraception and not particularly intending to get pregnant
5. Not using contraception and trying to get pregnant
If you ticked yes to 2, 3, 4 or 5 above:
How long had you been having unprotected sex?
Your reproductive history: p lease  circle yes or no for all sta tem ents that applied to you before you became pregnant.
I had given birth
I suffered from severe period pains
I suffered from endometriosis
I had pelvic inflammatory d ise ase  (PID)
My menstrual cycle lasted less than 21 days (When I w as not using 
contraceptives)
My menstrual cycle lasted more than 35 days (W hen I w as not using 
contraceptives) YES NO
My menstrual cycle w as unpredictable. My period often cam e more than 5 
days earlier or later than I expected (W hen I w as not using contraceptives)
I had periods (When I w as not using contraceptives)
My male partner had m umps after puberty
My partner has (or has had) undescended  testicles Don't know
I had pelvic surgery
If YES, describe the type of surgery
Your lifestyle: please circle yes or no for all sta tem ents that applied to you before you became pregnant.
I had unprotected sex with multiple partners
I was more than 13 kilos (28 pounds/2 stone) overweight
How much did you weigh before aettina pregnant?
What is your height? Feet and Inches or Centimetres
I had sex less than twice a week
I had a sexually transmitted infection
If YES, what infection did you have?
I was experiencing levels of s tre ss  that I could not cope with
Have you ever taken C lass A drugs (e.g., heroin, cocaine, ecstasy) NO
If YES, which drug(s)
If YES, was this within the 12 months prior to the pregnancy? YES NO
Myself and/or my partner had taken anabolic steroids in the previous 12 months
If YES, which steroid(s)?
I had been drinking more than 14 units of alcohol per week (1 unit = small glass of wine, 'A pint 
of beer, 1 single measure of a spirit)
I was a smoker who regularly sm oked ten  or more cigarettes per day
I drank more than 7 units of caffeine per day (1 unit = cup of coffee. 'A unit = cup of tea or can 
of soft drink such as cola)
PLEASE TURN OVER
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I sm oked marijuana frequently (more than four times a week)
The final s e t of questions are for everyone to answer. P lease  would you write how much you consum ed of the 
following before you became pregnant (If you did not consume any please put a zero in the box):______________
How m any units of alcohol did you drink per week? (1 unit = small glass of wine, 1/2 pint of beer or 
1 single measure of a spirit)
How m any cigarettes did you sm oke per day?
How m any cups of coffee did you drink per day?
How m any cups of tea  did you drink p e r  day?
How m any cups/cans of soft drink such a s  cola did you drink p er day?
How m uch m arijuana did you sm oke p er week?
Highest education received (p lease  tick)
Primary School
Secondary School
Post-secondary/C ollege
University
Thank you for the time you sp e n t completing this survey.
Please  sea l it in the  envelope provided and leave it on your bedside locker.
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INFORMATION SHEET FOR PATIENTS
Research project
Survey of fertility health issues
You are being invited to take part in a research study. Before you decide, it is important that you understand 
why the research is being done and what it will involve. Please take time to read the following information 
carefully and discuss it with friends and relatives if you wish. Ask us if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take part.
Consumers for Ethics in Research (CERES), publish a leaflet entitled Medical Research and You’. This leaflet 
gives more information about medical research and looks at some questions you may want to ask. A copy is 
available on request for additional background reading.
Thank you for reading this.
What is the purpose of th is s tudy?
Public health surveys help doctors to learn about many health issues, for example heart disease and diabetes 
in the community. Such surveys help find out how common or rare a symptom is and whether a symptom 
can identify whether a person might or might not develop a disease. Such information also helps to develop 
campaigns to keep people healthy. Many community surveys have been carried out for arthritis, asthma, heart 
disease and other common ailments. However, we do not know as  much about reproductive health issues. 
The purpose of this survey is to collect more information on factors that may or may not affect reproductive 
health
Why have I been chosen?
You have been chosen because we are inviting all women at the Sexual and Reproductive Health Clinic 
admitted for a medical abortion procedure aged 18 and above.
Do I have to take part?
No. it is up to you to decide whether or not to take part. If you decide to take part you will be given this 
information sheet to keep. If you decide to take part you are still free to withdraw at any time and without giving 
a reason. A decision to withdraw at any time or a decision not to take part, wiN not affect the standard of care 
you receive.
What will happen to me if I take part?
If you decide to take part we will ask you to complete one survey. The survey asks you to tick the number of 
statements that apply to you. There are three sections consisting of demographic (e.g., age), reproductive 
history (e.g., menstrual cyde), and current lifestyle questions (e.g., alcohol consumption, smoking). The survey 
will take 5 minutes and you can fill it in while waiting on the ward. No participation fee will be offered. At the 
end of the study we will put a summary of the results on the notice board in the waiting room of the Community 
Sexual Health (Family Planning Clinic).
What do I have to do?
If you would like to participate please fill in die survey and place it in the envelope provided and leave it on 
your bedside locker. Please do not write your name anywhere on the survey as it is anonymous. This study 
does not require any changes to your treatment or lifestyle.
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What will happen if I don’t want to participate?
If you do not wish to  participate, put the survey, w ithout filling it, sealed, in the envelope provided in 
the pack and leave it on your bedside locker. Your decision not to participate will not affect your treatment 
in any way.
What are the side effects of taking part?
There are no side effects anticipated in this project as there are no drugs or invasive procedures being tested. 
However, if you feel any discomfort as a result of participation in the study then please contact Dr Jacky Boivin 
(see details below) who is a psychologist specialising in reproductive issues. If you feel worried about your 
health then contact your local GP.
What are the benefits of taking part in the study?
We cannot promise the study will help you but the information we get will be used to advance our understanding 
of reproductive health.
Will my taking part in the study be kept strictly confidential?
Our procedures for handling, processing, storage and destruction of your data are compliant with the Data 
Protection Act 1998. All information you will provide us is anonymous and cannot be traced back to you 
individually. The anonymous data will be retained for indefinitely in accordance with the Data Protection Act, 
and stored on a computer that is password-protected and belongs to Dr Jacky Boivin.
What if there is a problem?
If you have a concern about any aspect of this study, you should ask to speak with the researchers who will do 
their best to answer your questions (see contact details below). If you remain unhappy and wish to complain 
formally, you can do this through the NHS complaints procedure. Details can be obtained from the hospital.
What will happen to the results of this research study?
The results of this study will be published in peer reviewed fertility journals. You cannot be identified in any 
report or publications.
Who is organising and funding the research?
Dr Jacky Boivin, School of Psychology Cardiff University.
Who has reviewed the research?
The South East Wales Local Research Ethics Committee has reviewed and approved this study.
You will be given a copy of the Information sheet to keep for your records.
Contact Details
You can contact the research team for any question on:
Caroline Scherf Dr Jacky Boivin
Consultant School of Psychology
Sexual and Reproductive Health Cardiff University
Department of Gynaecology Tower Building, Park Place
Llandough Hospital Tel: 02920 875 289
Tel: 02920 716 121
Thank you very much for taking time to read this leaflet.
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